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Advancing clinical practice in the management of Deep Vein 
Thrombosis (DVT). Development, application and evaluation of the 
AUTAR DVT risk assessment scale. 
Abstract 
Deep Vein Thrombosis (DVT) is a disease of hospitalised patients and is a 
precursor of Pulmonary Embolism (PE), a potentially fatal complication. DVT 
and PE are preventable and venous thromboprophylaxis consensus groups 
recommend that patients be risk assessed and accordingly receive 
appropriate prophylaxis. 
The Scope of Professional Practice (UKCC, 1992) enables nurses with 
appropriate knowledge and clinical competence to explore· new territories, 
previously the exclusive province of doctors. In the spirit of the position 
statement of professional practice framework, the Autar DVT scale (1994) 
was developed to identify patients at risk, so that appropriate venous 
thromboprophylaxis can be initiated. The scale is composed of seven 
categories of risk factors derived from Virchow's triad in the genesis of DVT. 
In this study, the DVT scale was re-validated on 150 patients across three 
distinct clinical specialities in order to allow for generalisation of the findings. 
DVT is a continuing problem and for this significant reason, the patients 
were followed up for a minimum of three months after discharge from 
hospital. Interestingly, 39 per cent of the patients with DVT (11/28) 
developed this insidious condition at home. Five reproducibility studies on 
the orthopaediC, medical and surgical directorates achieved kappa values 
ranging between 0.88 to 0.95, confirming the consistency of the instrument. 
A Receiver Operating Characteristic (ROC) curve was constructed to 
determine the optimal predictive accuracy of the DVT scale and a cutoff 
score of 11 yielded approximately 70 per cent sensitivity. Data from two 
patients, who could not be followed up, on account of discharge to no fixed 
abodes, were excluded for the sensitivity analysis of the DVT scale. Overall, 
115 patients out of the 148 (78%) were correctly classified. 
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However, the administration of venous thromboprophylaxis masked the 
predictive efficiency of the DVT scale in relation to its sensitivity and 
specificity. A high predictive value of 84 per cent of negative outcome was 
achieved at the cost of a predictive value of 37 per cent of positive outcome. 
The DVT scale exhibited good clinical and practical application. Data 
extrapolation also suggests that although the clinical areas use some 
venous thromboprophylaxis strategies, in practice they are not consistently 
applied. 
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Chapter One 
INTRODUCTION 
Scope of Professional Practice 
The healthcare needs of the nation are forever changing. As a result, the 
nature, organisation and delivery of healthcare have evolved in response to 
the challenge. In order to meet the changing needs of patients, the Scope of 
Professional Practice (UKCC, 1992) enables nurses with the appropriate 
knowledge, skills and competence to boldly explore new territories that were 
previously the exclusive province of doctors. However, registered nurses 
"must ensure that any enlargement or adjustment of the scope of personal 
professional practice must be achieved without compromising or 
fragmenting existing aspects of professional practice and care" 
UKCC, 1992. 
Clinical skills such as intravenous drug administration, cannulation, 
venepuncture and endoscopic examination have become commonplace and 
subsumed into the core of nursing practice and education. 
An innovative and groundbreaking Post Registration Education and Practice 
(PREP) framework was launched in 1994 and UKCC agreed that: 
"Specialist practitioners will demonstrate higher levels of clinical decision 
making and will be able to monitor and improve standards of care through 
supervision of practice, clinical nursing audit, developing and leading 
practice, contributing to research, teaching and supporting professional 
colleagues" 
UKCC, 1994: PREP 9:47, 28:10. 
Nurses are no longer the "mechanical hands of doctors" (CastJedine, 1996) 
but are now recognised as an equal partner in the delivery of holistic care. 
The rapidly evolving environment of heath care provision has witnessed the 
emergence of nurses working at a Higher level of Practice (HlP). 
Developments in the structure, funding and organisation of health care will 
continue to offer new challenges and opportunities to nurse practitioners. In 
some NHS trusts, advanced neonatsl practitioners are replacing junior 
doctors in special care baby units, surgical nurse practitioners run pre-
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admission clinics and organise theatre lists (Tuthill, 1995; Oowling et ai, 
1996). In 1997, the government had signalled its wish to: 
"extend the recent developments in the roles of nurses working in acute and 
community services. The government is committed to encouraging and 
supporting the development of nursing practice in these ways" 
(The New NHS. Modem. Oependable,1997). 
Similar initiatives have led to the setting up of nurse-led anticoagulant clinics 
(Brown. 1998) and a nurse-led outpatient anticoagulant clinic (Pout, 1999). 
Traditionally. such departments have been managed exclusively by 
consultant haematologist services, with little or no involvement of specialist 
nurses. Historically. nurse led anticoagulant clinics have emanated from 
studies in USA managed by an Anticoagulant Nurse Specialist (ANS). 
Taylor et al (1997) evaluated the cost and effectiveness of ANS services 
and concluded that they are a viable alternative model of anticoagulant 
service provision. Such services have a number of advantages over 
consultant haematologist services. As there is an increase in the number of 
patients being referred for life long treatment, ANS are able to provide 
domiciliary services for the housebound. Patient's satisfaction is increased 
and the services provided by ANS are very acceptable to GPs. They also 
ensure a reduction in the quantity of drugs that might interact with the 
homeostatic mechanisms (Van de Pette & Mackie. 1996). 
Indeed, it is within the scope of the professional practice development 
framework that OVT as an area of recognised and growing concern across 
diverse patient groups was explored as illustrated in table 1.1, highlighting 
the scale of the problem. A OVT risk assessment tool was developed (Autar, 
1994) to facilitate its proactive and comprehensive management by nurses, 
doctors and other members of the multidisciplinary team, in particular the 
physiotherapists and occupational therapists. 
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Table 1.1: Risk level by patient group 
Speciality Incidence of DVT (weighted mean) % 
General surgery 25 
Orthopaedic surgery 45-51 
Urology 9-32 
Gynaecological surgery 14-22 
Neurosurgery including strokes 22-56 
Multiple Trauma 50 
General Medical 17 
Source: International Consensus Statement, 1997. 
Deep Vein Thrombosis: scale of the problem . 
. 
Deep vein thrombosis (DVT), as the term implies, is the formation of a clot in 
the deep vein. The deep veins are so-called because they are embedded 
intramuscularly in the deep fascia, in contrast to the superficial veins that 
are extramuscularly, outside the deep fascia (Autar 1996 c). While deep 
veins are present throughout the body, venous thrombosis commonly 
occurs in the deep veins of the legs. Deep veins tend to thrombose, while 
superficial veins are prone to varicose. 
DVT is widely viewed as a complication of hospitalisation (Anderson et ai, 
1992). It is a multicausal condition due to the additive effects of some risk 
factors such as acute injury, surgery and some medical illnesses 
(Rosendaal, 1999). Data extrapolation from four epidemiological studies , 
suggests that the annual frequency of DVT in the general population is 
approximately 160 per 100,000 (Lindblad, 1988; Lindblad, et a11991; 
Anderson et ai, 1992 and Nordstrom et ai, 1992). DVT is a serious threat to 
recovery and is the third most common vascular disease, after ischaemic 
heart disease and stroke (Turpie, 1997; Anands et ai, 1998). In the 
immediate course, DVT is a precursor of over 90% of Pulmonary Embolism 
(PE), a potentially lethal and acute complication (Borrow & Goldson, 1981). 
The rate of fatal PE is estimated to be around 60 per 100,000 of the general 
population (European Consensus Statement, 1991). Wiseman first 
described PE in 1676 and Homans (1957) confirmed the relationship 
between DVT and PE. The National Institute of Health (NIH, 1986) lends 
further support to the close link between the development of DVT and PE. 
5 
Randomised clinical trials involving more than 1200 persons indicated that a 
68 per cent reduction in DVT was associated with a 49 per cent reduction of 
PE. 
Most deaths due to PE occur suddenly in otherwise healthy patients without 
any antecedent clinical signs of DVT (Coon, 1976). The Thromboembolic 
Risk Factors consensus group (THRiFT. 1992) reported that nine per cent of 
patients admitted to a general hospital die and 10 per cent of these deaths 
are due to PE.This is approximately 77.000 UK deaths in 1992 as reported 
by the Office of Health Economics (1996). The Scottish Audit of Surgical 
Mortality and the National Confidential Enquiry into Peri-Operative Deaths in 
England (NCEPOD. 1993) have both highlighted the significance and major 
contribution of PE. It is the most commonly reported cause of maternal 
death during pregnancy and the puerperium in the UK. (DoH, 1994). Fatal 
PE is often under-diagnosed as the signs and symptoms prior to death are 
non-specific and may be similar or attributed to myocardial infarction, 
pneumonia or other chest pathology (SIGN, 1995). PE is a significant cause 
of mortality in surgical and non-surgical patients alike. It causes death in 
over 100,000 patients each year in the United States and contributes to 
further 100,000 deaths (Dalen et ai, 1986). This finding is further supported 
by the Worcester (Massachusetts) DVT study (Anderson et al. 1992). In this 
community wide study of 16 acute short stay hospitals in Massachusetts, an 
annual incidence of 48 per 100,000 DVT and 23 per 100,000 PE were 
reported. Data extrapolation suggests that approximately 170,000 new 
cases of venous thromboembolism are treated in short stay hospitals per 
year in the USA. Sandler & Martin (1989) found evidence to suggest that PE 
causes 10% of the general hospital deaths. The 5 year retrospective 
analYSis of autopsy reports undertaken by Sandler & Martin provides 
compelling evidence of the serious underestimation of the true incidence 
and scope of the problem. 
To determine further the frequency of venous thromboembolism, Linblad et 
al (1991) also studied necropsy reports over 30 years and concluded that 
the incidence of venous thromboembolism has been remarkably stable and 
unchanged over the 30 years. During this period the proportion of the 
population aged over sixty five years has doubled, and this may have 
masked the benefits of prophylaxis and early mobilisation. 
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The total number of UK annual deaths from venous thromboembolism has 
been recently estimated at over 188,900 in the UK (Office for National 
Statistics, 1995). 
Although PE is a leading cause 'of death in USA and Europe, national 
morbidity statist!CS do not always reflect that fact for two reasons. Firstly, the 
diagnosis is frequently missed and most people, who die as a result of 
embolism, often have other major medical problems to which death is often 
attributed (Hirsh &Hull, 1982, Dismuth & Wagner, 1986). 
In the longer-term sequelae, patients face an uncertain Mure as DVT can 
complicate into Post Phlebitis Syndrome (PPS), a chronic disabling 
condition (Dalen et ai, 1986). PPS occurs in more than 50 per cent of 
patients (Strandness et ai, 1983) and although it is clinically less dramatic in 
outward clinical presentation, it causes considerable suffering (Kakkar & 
Lawrence, 1985). There is no readily available data on the prevalence of 
PPS in UK, but in Sweden and Switzerland 1-2% of the population have 
Post Phlebitis Syndrome. Approximately 800,000 people in USA have this 
condition (Dalen et ai, 1986). Reportedly, sixty percent of patients with 
proximal DVT develop post thrombotic syndrome manifested by phlebitis, 
leg ulceration and pigmentation (Brandjies et ai, 1997). Long term 
complication of PPS commonly results in venous insufficiency and chronic 
venous leg ulceration. Venous ulcers develop in at least 300 per 100,000 
population and the proportion due to DVT is about 25% (Nelzen et ai, 
1991a; Nelzen 1991b). Nelzen et ai, (1991a) claim that there is an 
underestimation of the leg ulcer problem among the elderly. With an 
expected increase of elderly population, this problem has to be fully 
resolved as treatment of venous ulcers costs the NHS about £600 million a 
year (Drug & Therapeutics Bulletin, 1992). 
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The long term clinical course of acute OVT is illustrated in table 1.2. 
Table 1.2: Long tenn course of acute DVT 
Clinical course 2 years 5 years a years 
Recurrent OVf 17.5% 24.6% 30.3% 
Post thrombotic ~ndrome 28% 28% 29.1% 
Adapted from: Prandoni et ai, 1996. 
Screening studies with objective diagnostic tests, indicate that surgical 
patients with previous OVf, have a three times higher incidence of DVT 
following abdominal surgery compared with the same population without a 
history of OVT (Kakkar et ai, 1970). 
Nicolaides & Irving (1975) who reported an incidence of 68% also 
acknowledge the high recurrence rate of DVT in patients with a previous 
OVT. 
DVT: The silent killer 
DVT is a hidden condition and a silent killer (Autar, 1996 c; Oavis, 1998) and 
primary prophylaxis is the challenge (Moser, 1989). This can be achieved by 
early identification of those at risk and the prompt application of the most 
appropriate intervention, as clinical diagnosis is notoriously unreliable even 
to the most watchful observer (Sharnoff, 1980). Traditionally, the routine 
physical examination in patients with suspected OVf included a careful 
inspection ofthe leg, measurement of leg circumference and elicitation of 
Homans'sign. 
The typical classic manifestation associated with the diagnosis of DVT is 
outlined below: 
Clinical diagnosis of DVT 
• Asymmetrical ankle oedema. 
• Increased diameter of one calf, ankle or thigh in relation to each other. 
• Loss of concavity of the malleolar space in one leg. 
• Heavy and dull aching pain. 
• Tenderness over the affected vein in 75% of cases. 
• Low grade fever 
• Homans'sign positive in less than one third of patients. 
• Dilation of superficial veins. 
8 
• Mottled and cyanotic skin. 
• Phlegmasia cerulea dolens (painful blue inflammation). 
• Phlehmasia alba dolens (painful white inflammation). 
• Affected extremity· is warmer to touch than the other unaffected 
extremity. 
Data: Weinmann & Salzman, 1994; Paiement & Mendelsoln, 1995; 
Wallis & Autar, 2001. 
Bames (1982) found approximately 50% inaccuracy when using the 
Homans'sign to diagnose OVT clinically. Homans is the presence of pain in 
the calf on forceful dorsiflexion, which is considered as a specific sign of 
distal calf OVT. 
When Homans'sign is used diagnostically in symptomatic patients, it is 
falsely negative in two thirds of cases of OVT and is falsely positive in more 
than one half of patients suspected of having OVT whose venograms were 
later found to be negative (Hirsh &Hull, 1982). Typical clinical findings such 
as leg pain or swelling and shortness of breath or chest pain are absent in 
more than half the affected individuals, including a majority of patients who 
die of PE (Goldhaber et al; 1983; Berqgvist & Undblad, 1985). 
Many patients exhibit no signs to indicate the presence of OVT (Ogston, 
1987). Objective tests have shown that clinical physical signs are inaccurate 
with a frequent false positive diagnosis despite careful daily clinical 
examination (Joffe, 1975; Weinmann & Salzman, 1994). Both DVT and PE 
manifest few specific symptoms and are clinically insensitive (Clagett et ai, 
1992).On the other hand, a perivascular tissue inflammation may cause 
local pain, tenderness and swelling without thrombosis. Furthermore, non-
thrombotic obstruction of large proximal veins may cause pretibial and ankle 
oedema. Such symptoms are therefore very misleading in the diagnosis of 
DVT (Lambie et ai, 1970). Clinical assessment is therefore full of pitfalls and 
clinical diagnosis of DVT is little better than a flip of a coin (Redman,1988). 
Most thrombi are silent when first detected by objective methods, probably 
because they do not totally obstruct the vein and because of collateral 
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circulation. DVT is not often suspected until it has propagated or caused PE 
(Sandler & Martin, 1989). 
Even when OVT is symptomatic, the signs and symptoms are non-specific 
and can mimic those of other conditions affecting the lower limbs (Hull et ai, 
1981; Prandoni & Mannuci, 1994). Among 87 consecutive patients with 
clinically suspected DVT, 37 had a musculo-skeletal cause, 12 had impaired 
lymphatic flow and 4 Popliteal Inflammatory Cyst (Baker's cyst). A diagnosis 
of DVT suspected on clinical ground is therefore flawed and must be 
confirmed by a sensitive objective test. Even in high risk patients it has a 
sensitivity and specificity of less than 50% (Paiement & Mendelsohn, 1996). 
The justification for an objective DVT risk assessment arises out of the silent 
nature of DVT and the unreliability of its clinical diagnosis. As it is difficult to 
diagnose DVT clinically, its frequency has therefore been underestimated. 
Additionally, clinical diagnosis is cost ineffective as the majority of patients 
have their in-patient stay prolonged by 7-10 days (Hull, Hirsh, 
Sackett,1981). ·Minimalleg symptoms may be associated with extensive 
venous thrombosiS, whereas classic symptoms and signs of pain, 
tenderness and swelling of the leg can be caused by non-thrombotic 
disorders· (Verstraete, 1997). 
A list of the differential diagnosis of DVT is illustrated below (Table 1.3). 
Table 1.3: Differential diagnosis of DVT 
• Superficial phlebitis 
• Muscle strain of calf or thigh muscles 
• Cellulitis 
• Baker's cyst 
• Chronic venous inSufficiency 
• Nerve compression syndrome 
• Lymphodema 
• Arterial occlusive disorders. 
Data: Verstraete, 1997: p 123. 
-------------------------------------------------
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Monetary cost of DVT and PE 
OVT and PE are very costly to the NHS. In 1993, the Office of Health 
Economic (OHE, 1996) estimated 0.21 million GP consultations for OVT in 
England and Wales (OHE, 1996). With an average cost of £11.90 per 
consultation, the cost of OVT in general practice alone is calculated at 
around £ 2.5 million. Post surgical DVT and PE are estimated to cost the 
NHS between £204.7 and £222.8 million in 1993 (OHE, 1996). This 
estimate ignores the costs incurred by the patients and their families. It is 
estimated that if all the high risk patients (over 45 years and have 
undergone major surgery) had received adequate prophylaxis, NHS would 
have made a cost saving of between £33.4 and 81.8 million. The number of 
deaths due to post-surgical PE would also have been reduced by more than 
400. In the United States, the cost of treating a patient for OVT is estimated 
at $ 2926 and $ 4179 for PE per patient (Oster et ai, 1987). 
DVT and fatal PE are an easily preventable cause of hospital death (Morrell 
& Dunnill, 1968; Kendall, 1992). 
Essentially, there are two types of venous thromboprophylaxis: primary and 
secondary. Primary prophylaxis using either pharmacological or mechanical 
methods or both is directed at preventing the occurrence of DVT. This 
proactive approach to DVT management requires the identification of those 
at risk, followed by the administration of the most appropriate 
thromboprophylaxis. Hull et al (1986) argue that an ideal primary 
prophylactic approach is one which is free of clinically important side effects 
and well tolerated and accepted by patients, nurses and medical staff. It 
should also be easily administered, inexpensive and require minimal 
monitoring. 
On the other hand, secondary prophylaxis is reactive to DVT and is 
achieved by early detection and treatment of subclinical DVT to prevent PE. 
Secondary prevention by screening should never replace primary 
prophylaxis and is reserved for those patients in whom effective primary 
prophylaxis is either unavailable or contra indicated (Hull, Raskob & Hirsh, 
1986). 
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In monetary terms, primary prophylaxis is considerably less expensive than 
secondary prevention because the latter requires full anticoagulation of 
large numbers of patients with subclinical DVT (Kakkar & Stringer, 1990). 
The average cost of some first level preventative management is less than 
£10 for patient at risk, on whom at least £ 2,000 is likely anyway, to be spent 
on the hospital service. The average cost of DVT crisis management is 
£2,300 (Mackmurdo, 1991). So the first safety decision is whether to spend 
£2000 on a patient and risk a relatively high number of deaths and a 
relatively high number of additional £2,300 costs per patient In attempting to 
treat the crisis. Alternatively, it is prudent to spend £2,010 on a patient and 
risk a relatively low number of deaths and a relatively low number of 
additional expenses of £2,300. The expenditure required for preventative 
measures represents both good patient care and good clinical management 
(Janssen et ai, 1987). Routine DVT prophylaxis could save between 4000-
8000 lives annually (Hull et ai, 1986). 
In the absence of prophylaxis, the frequency of fatal PE ranges from 0.1-0.8 
per cent in patients undergoing general elective surgery (Weinmann & 
Salzman, 1994) and 0.3-0.7 per cent in patients with hip arthroplasty 
(Kakkar et ai, 1997). 
Patients in the low risk category, have less than 10 per cent risk of 
developing calf DVT. Without thromboprophylaxis, DVT incidence ranges 
from10-40 per cent in the moderate risk group. The reported frequency of 
DVT varies between 40-80 per cent in the high risk category as summarised 
in table 1.4 
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Table 1.4: DVT risk categories 
Risk categories DVT risk 
Low risk: 0-1 risk factor may be present. 
Minor surgery with anaesthesia < 30 minutes 
or 
Major surgery in < 40 yrs old. <5% 
No other risk factor is present or 
Minor trauma or medical illness. 
Moderate risk: 2-4 risk factors may be 
present. 
Major surgery in >40 yrs old or 
Major surgery or lower limb surgery in 
patients on contraceptive pill. 5-40% Major medical illness (heart failure or acute 
myocardial Infarction) with prolonged 
immobilisation. 
Leg fracture in a patient < than 40 years old. 
High risk: > 4 risk factors may be present. 
Major orthopaedic surgery to lower limbs, 
including hip or knee arthroplasty or 
Fractured pelvis, hip, leg. 
Major surgery in patients with malignancy or 
Major surgery in patients with previous 
>40% thromboembolism or > 60 yrs old. 
Lower limb paralysis or hemiplegia or CV A or 
Paraplegia 
Thrombophilia with additional disease 
Recent history of DVT or PE. 
Adapted from: National Institutes of Health (NIH, 1986). 
Caprini et ai, 1991. 
Kendall, 1992. 
SIGN, 1995 
International Consensus Statement,1997 
THRIFT 11, 1998. 
PE risk 
0.01% 
0.1-1.0% 
1-10 % 
Although the consensus groups in Europe, United Kingdom and North 
America each published their own recommendations and therefore differ in 
some details, their general recommendations are similar. 
When no prophylaxis is used, the unnecessary loss of life and the costs of 
diagnosing and treating established DVT and PE are substantial and the risk 
unacceptable. Among patients undergoing total joint arthroplasty without 
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prophylaxis, venous thromboembolic diseases have been reported in 50% 
to 75% of cases (NIH, 1986). A retrospective venous thromboprophylaxis 
cost analysis of controlled clinical studies for hip fracture surgery, suggests 
that prophylaxis does not only decrease post surgical morbidity and 
mortality but also reduces healthcare expenses for complications of DVT 
(Mol & Egberts, 1994). Cost analysis factors that are difficult to quantify such 
as the monetary value of human life, cost of treating PPS and the adverse 
effects of the prophylaxis itself, were not included in the retrospective 
analysis. Additionally, in most hospitals, the cost of tests and treatment is 
not known exactly. Hospitals use reimbursement tariffs that may be different 
from the real costs. Tariffs also vary among insurance companies. 
Therefore, the result of any pharmaco-economic study may not be very 
accurate. Nevertheless, this approach gives a general impression of the 
total cost of prophylactic measures (Mol & Egberts, 1994). Finally, the 
clinical management of thromboembolic complications may vary between 
hospitals and patients. 
On the whole, DVT and PE prophylaxis reduces the incidence by 50% or 
more and Vanek et al (1991) and THRIFT (1992) recommend that 
prophylaxis should be mandatory in moderate and high-risk patients. OHE 
(1996) estimates that if all patients at high risk of developing a post-surgical 
DVT had received adequate prophylaxis, NHS would have made a cost 
saving of between £33.3 and £81.8 million and the number of deaths due to 
a post-surgical PE reduced by more than 400. With clinical effectiveness 
and evidenced-based practice on top of the NHS agenda, much would be 
achieved by application of those research findings to DVT 
thromboprophylaxis. 
In reality, physicians and hospitals have been very slow to develop 
consistent pOlicies for preventable conditions. Deaths from PE are so 
infrequent within the experience of individual medical practitioner that it is 
tempting not to worry about venous thromboprophylaxis strategies because 
bleeding from anticoagulated patients is relatively common and worrisome 
(Becker, 1986). 
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Clinical negligence and national guidelines . 
There is a growing concern within the NHS about the rise in the number of 
claims made against the health authorities for medical negligence and 
increase in settlement amounts (NAHAT, 1991). 
Within a climate of increasing health care litigation, the DoH (1996) seeks to 
foster strategies and management techniques that will reduce the incidence 
and the adverse impact of clinical negligence lawsuit. NHS trusts are 
vigorously advised to reduce incidence and impact by adopting prudent risk 
management strategies. This means that there should be clear procedure 
for involving front-line staff, in particular doctors and nurses in undertaking a 
comprehensive risk assessment. 
The Scottish Intercollegiate Guidelines Network in 1995 (SIGN) strongly 
recommends a national guideline to enable individual clinicians, hospital 
departments and hospitals to produce local protocols. 
A number of controversial issues surround clinical guidelines. It is argued 
that they are a fetter on clinical discretion, clinical freedom and lead to 
"cookbook medicine" (Wilson, 1995). Others maintain that they are essential 
element of safeguarding appropriate health care delivery (NHS Executive, 
1996). 
Risk assessment should be at the primacy of protocol development and 
clinical guidelines should take into account include age, past medical history 
of DVT and the nature of surgery. Explicit guidelines improve clinical 
practice when introduced in the context of rigorous evaluations (Grimshaw & 
Russell, 1993). 
The aims of the national guideline (SIGN, 1995) are to: 
• Identify patients at moderate to high risk of venous thromboembolism. 
• Administer and monitor appropriate and effective prophylaxis in such 
patients routinely. 
In the presence of overwhelming evidence supporting the efficacy of venous 
thromboprophylaxis, it is considered clinical negligence not to provide DVT 
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prophylaxis to the moderate and high risk patients (Parker-Williams & 
Vickers, 1991). 
Following the development of local protocols, providers can implement and 
audit their use through the following actions: 
• Local protocols should be circulated to all relevant staff and displayed on 
all units where prophylaxis should be given. 
• Patient- specific reminders for staff at time of consultation or admission. 
• Continuing education. 
• Audit. 
• Quality Assurance. 
• Funding. 
• Research. 
Source of data: SIGN, 1995. 
Risk assessment: The way forward 
Risk management is seen as part of the concept of clinical governance. 
Under section 18 of the Health Act 1999, there is a statutory obligation for 
the NHS to promote quality, which requires employer to undertake risk 
assessment and management (Health Service Circular, 1999). 
With a remarkably high incidence of DVf being described as silent, 
asymptomatic and unsuspected. morbidity and mortality can be reduced by 
risk assessment followed by the implementation of the most appropriate 
intervention (Letsky, 1989; THRiFT, 1992). 
The challenge for the prevention of DVT is therefore to assess and 
individualise patient for risk factors, pathophysiology, planned surgical 
procedures and specific medical condition. An objective and comprehensive 
risk assessment derived from the known clinical criteria and variables places 
patients into one of the three main categories: low, moderate and high. 
In 1992, a group of UK clinicians (THRiFT, 1992) met in Sheffield and 
considered the risk to hospital patients and made the follOwing general 
recommendations: 
-------------------------------------------------
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• All hospital patients should be assessed for clinical risk factors and an 
overall risk of thromboembolism. Effective prophylaxis mandates a clear 
understanding of the risk factors in DVT, so that the relevant variables 
can be controlled. 
• Patients should receive prophylaxis according to their risk categories. 
• Clinicians, units and hospitals should develop written policies for 
prophylaxis 
• Prophylaxis should be included in the clinical audit and in the patient 
care plan, 
The appropriateness, efficacy and implementation of the different 
thromboprophylaxis modalities depends on the degree of risk in different 
patient groups and the nature of the surgical procedures being undertaken. 
Table 1.5 illustrates the recommended DVT prophylaxis by risk category. 
Table 1.5: Venous thromboprophylaxis strategies 
Risk category Recommended DVT prophylaxis 
Early mobilisation + 
Low risk Active and passive exercises + Graduated compression stockings 
Early mobilisation + 
Graduated compression stockings + 
Moderate risk Low dose heparin or Low molecular weight heparin or 
Intermittent pneumatic compression 
Graduated compression stockings + 
Adjusted dose of heparin or 
High risk Low molecular weight heparin + Intermittent pneumatic compression, except 
for open limb injury. 
Data: NIH, 1986 
European Consensus Statement, 1991 
THRiFT, 199211998 
International Consensus Statement, 1997 
A number of variable based laboratory tests and forbiddingly complex DVT 
prognostic equations have been developed to predict patients for risk of 
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OVT (Gallus, 1989). But the lack of standardisation in the laboratory 
procedures creates inconsistency in the estimated outcomes. This 
inconsistency and dependence on laboratory data to enable a 
comprehensive assessment and diagnOSis is probably the reason why the 
prognostiC indices have not been widely and successfully applied to date. 
Laboratory tests tend to lead to a delay and can only be initiated by medical 
staff and this excludes a significant element of the health care team from 
contributing to risk reduction. 
In the development of a predictive index that is user friendly, reproducible, 
robust and cheap. Ruckley (1985) suggests that simple criteria such as age, 
type of surgery, previous OVT, malignancy, obesity and varicose veins could 
be used to identify those at risk of OVT. Such criteria would fit automatically 
into the ward routine and are much more likely to be consistently and 
successfully applied by nurses and doctors as they involve readily available 
information. 
Nursing management of DVT 
Nurses are very well placed to make an appropriate OVT risk assessment, 
followed by appropriate referral to house officers for thromboprophylaxis. 
The very nature of their duties enables nurses to: 
• Provide continuity of care and monitor OVT events. 
• Undertake regular ward rounds and assess patient for risk. 
• Participate in routine exercise that aid venous return. 
• Know patients who are immobile and the nature of the immobility. 
• Maintain and administer prophylaxis: primary and secondary. 
• Participate in collaborative management of OVT with medical staff. 
Safety, effectiveness, simplicity and cost effectiveness are the chief 
characteristics associated with venous thromboprophylaxis (Caprini et ai, 
1994). Importantly, nurses take a leading role in the safe administration of 
effective non-invasive methods of OVT prophylaxis (Reid, 1997). They are 
able to advocate and apply graduated compression stockings, which 
increase venous return. Intermittent pneumatic compreSSion devices 
promote venous return, increase fibrinolytic activity and may be indicated, 
especially during prolonged surgery. Other non-invasive preventive 
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measures undertaken by nurses include leg elevation, early ambulation, and 
exercise for patients who are chair or bedbound, ensuring adequate 
hydration and avoiding pressure on the popliteal spaces when legs are 
crossed. Patients who are at risk would receive the appropriate venous 
thromboprophylaxis by nurses and be observed continuously for signs of 
DVT such as erythema, unilateral swelling and pain or pressure on the calf 
muscles (Mills, 1997). Although such clinical observations are often 
unreliable, they could be used to estimate clinical probability in patients 
suspected of DVT (Wells, 1995 a). While the design and Implementation of 
protocols currently remain part of prescribed medical care, the incorporation 
of the nursing process documentation and active involvement of nurses 
serve to enhance compliance (Byrne et ai, 1996). The patient centred 
approach to nursing emphasises that nurses manage DVT holistically and 
proactively by minimising risk in contrast to the medical approach that is 
problem orientated and manages DVT reactively through the crisis 
intervention model (Autar, 1996 b). A comparative analysis ofthe patient 
centred model and the medical model is outlined in table 1.6 
• 
Table 1.6: A comparative analysis of the medical and nursing models 
Medical model Nursing model 
Doctor- centred Patient- client centred 
Problem oriented Not problem oriented 
Parts of the patient Whole patient- client 
Reductionist approach Holistic approach 
Focuses on what is wrong Focuses on what is right 
Negative approach Positive approach 
Focuses on quantity Focuses on qualitv 
Treats symptoms Works with causes 
Emphasises secondary prevention Emphasises primary prevention. 
Source: Armentrout, 1993. 
Historically, patients with DVT have been treated initially with intravenous 
unfractionated heparin, neceSSitating inpatient care for dosing and close 
monitoring of anticoagulation (Pout et ai, 1999). 
With the introduction of Low Molecular Weight Heparin (LMWH) and its safe 
administration and cost effectiveness outperforming Standard Heparin, 
hospitals are now treating people with OVT in outpatient clinics and at home 
(Levine et al,1996; Oeagle, 1998). Patients are requested to visit the clinic 
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run by an anticoagulant nurse practitioner. The Southampton University 
Hospitals Trust (SUHT) who introduced the initiatives has developed a 
protocol, in conjunction with the Southampton Community Health services 
NHS Trust, to treat patients with OVT at home, using the community nursing 
team. Tinzeparin is the LMWH of choice used by SUHT. 
This is very cost effective. A medical bed at SUHT costs £350 per night. 
SUHT had 236 confirmed OVT admissions in 1996197, with an average stay 
of 7-8 days and another 400 suspected OVT's who stayed overnight. The 
cost of the OVT community programme includes 1.5 trained nurse per 
annum, £74 per patient for drugs and a modest annual payment to the 
community trust (Oeagle, 1998). 
To enable them to take over the many functions of the clinic effectively. the 
consultant haematologists, laboratory staff and pharmacists devise specific 
training packages. The following are the areas focused on: 
• Normal processes of coagulation and the mode of action of Warfarin 
• Pharmacology and drugs interaction 
• Interpretation of the computer dosing system for anticoagulation 
• Laboratory testing and overriding the computer should problems occur 
• GPs liaison 
• Initiation of anticoagulant treatment 
• Maintaining therapeutic control and dosing based on the International 
Normalised Ratio (INR) 
• Managing minor surgical and dental intervention 
• Reversal of coagulation 
Source: Brown et ai, 1998 
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The benefits of a nurse-led anticoagulant service are listed below: 
Benefits of a nurse-led anticoagulant service 
• Elimination of the inconvenience of a week-long hospital stay. 
• Avoidance of exposure to hospital infection and risk associated with 
immobility . 
• Autonomy of the anticoagulant nurse for implementation of the 
patient's entire anticoagulation programme. 
• Reduction of bed days and laboratory costs in the local hospital. 
• Enhancement of skill base of the nurse-led anticoagulant team. 
Source: Bevan et ai, 2000. 
The role of the nurse in the management of DVT prophylaxis has been 
further endorsed by a prospective audit undertaken by Byme et ai, 1996. 
Strategies directed by consultants in placing the burden of responsibility 
primarily on house officers, to ensure that patients at risk receive the 
appropriate thromboprophylaxis, achieve only fifty seven per cent uptake. 
When nursing staff are actively involved in formal risk assessment, venous 
thromboprophylaxis uptake increases to ninety four per cent. Medical staff 
do not routinely carry out risk assessment and monitor DVT events; In 
contrast nurses are well placed to spot such oversights. 
Nursing assessment as a domain of practice is undergoing considerable 
change and refinement. A variety of nursing instruments are now available, 
enabling nurses to carry out systematic, comprehensive and objective 
nursing diagnoses. Norton et al (1962) introduced the pressure sore risk 
scale and Gosnell (1973) and Waterlow (1985) later developed this risk 
calculator. The Barthellndex (Mahoney & Bartel, 1965) for assessment of 
the activities of daily living and a number of Pain-o-meters enable nurses to 
carry out objective nursing assessment to guide practice. The Glasgow 
Coma Scale (Teasdale, 1975) was developed to enable nurses and doctors 
equally to monitor patients with an altered level of consciousness so that 
timely intervention could be initiated. 
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An investigation into the assessment of clients for risk of DVT confirms 
inconsistency in the assessment of practice and is based on subjective 
judgement or standard pre-printed care plan (Autar, 1994). A blanket 
nursing diagnosis of potential problem of DVT provides only a crude index of 
measurement of the problem. It fails to address the nature of risk in an 
individual in the context of multifactoral aetiology. 
Unless risk is identified by category and the assessment is tailored to the 
individual, preventative measures are likely to be inappropriate and 
therefore ineffective. 
Identifying those at risk is equally important as those who are not. It allows 
for the targeting of the limited resources and ensures that nursing action is 
individualised and founded on a sound rationale and not ritualistic. A risk 
assessment system based on clearly defined clinical criteria can yield an 
index of no, low, moderate and high risk of DVT (Autar, 1998). One risk 
factor is present in the low risk group. Two to four factors are present in the 
moderate risk and more than four factors are present in the high risk group 
(Arcelus et a11991; Caprini et ai, 1991). 
The array of assessment strategies available to identify patients at risk of 
DVT are based on laboratory prediction. The haematological tests are 
invasive, expensive, time consuming and often unreliable. Estimation of 
Euglobulin Lysis Time (EL n is one such specific laboratory test for 
hypercoagulability. It measures the amount of fibrinolytic activity present: too 
little leads to intravascular coagulation and too much induces haernorrhagic 
tendency. To measure ELT, the plasma is diluted and acidified. A precipitate 
is formed containing plasminogen, plasminogen activator and fibrinogen. 
The precipitate is then redissolved and fibrinogen clotted with thrombin and 
the time for lysis on incubation at 37 degrees Celsius is observed. The 
normal range is between 90 to 249 minutes. As described above, the test is 
very intricate and fiddly, may be difficult to interpret and requires strict 
standardisation and precision in the laboratory (Letsky, 1985). On the other 
hand, fibrinogen measurement is a cheap and widely available laboratory 
test for hypercoagulability but there is an urgent need to standardise 
methodology and establish an international standard (Palareti et ai, 1991). 
22 
-------------------------------------------------
Test standardisation should reduce the confusion for the reader who 
encounters widely different mean Fibrinogen levels in different published 
studies. Haematological tests such as Fibrinogen Degradation Products 
(FOP) showed promise in the prediction of preoperative DVT (Clayton et ai, 
1976; Crandon et ai, 1980) but the illness for which surgery is performed 
also influences the preoperative levels of FOP (Lowe et ai, 1982). 
Rheological variables such as plasma viscosity, white cell count and 
haematocrit values have been applied as predictors for venous thrombosis 
(Ernst, 1987). Although these blood tests are undertaken routinely. their 
predictive value in relation to DVf is uncertain (Lowe et ai, 1992). D~Dimer 
measurement is the most recent entrant in this galaxy of haematological 
tests. D~Dimer is a specific degradation product of crosslinked fibrin that is 
released when the endogenous fibrinolytic system attacks the fibrin matrix of 
fresh formed venous thrombi (Moser, 1994). While this new arrival is 
promising in supporting the diagnosis of suspected DVT (Wells et ai, 1995). 
it is of no value in its primary prevention. 
The heavy dependence on laboratory findings also involves delay in 
processing the investigation. As a result, venous thromboprophylaxis is 
being withheld until test results become available. For prophylaxis to be 
effective, it has to be promptly initiated (Caprini et al. 1991). The 
Department of Health (DoH 1993) has suggested that assessment 
processes that are overly time consuming and complex should be discarded 
in favour of prompt intervention and patient~specific approaches. The fatality 
associated with OVT created the urgency to develop a simple and easy to 
use instrument that will identify those individuals at risk before a DVT crisis 
occurs. The Autar DVT risk assessment scale (1994) was developed to fill a 
void in this area of risk assessment and management and in the spirit of the 
DoH recommendation. The DVT risk assessment tool is illustrated in figure 
1. It is simple, timesaving and can be promptly applied at the time of 
admission, providing sufficient information for the surgeon or physician who 
ultimately decides which prophylaxis regimen if any is to be used. Founded 
on eviden~based risk factors in the genesis of DVT. the DVT scale is 
designed to have a practical application in diverse clinical areas where DVT 
is a problem. 
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Aims of this study 
The main aims of the study are to: 
1. Evaluate the sensitivity and specificity of the DVT risk assessment scale 
as a predictive index. 
2. Determine the consistency of the DVT risk calculator as an assessment 
tool. 
3. Evaluate the practical application of the DVT scale by registered nurses. 
4. Explore the current venous thromboprophylaxis strategies in the context 
ofthe consensus groups' recommendations (NIH, 1986; International 
Consensus Statement, 1997; THRiFT, 1998), 
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Summary 
DVT is an invisible and insidious condition that crosses all traditional 
departments, specialities and sub specialities of clinical practice. It is a 
threat to recovery and can seriously damage the health of the hospitalised 
patients. Pulmonary embolism, a potentially lethal and ultimate complication 
of Dvr accounts for 10 per cent of hospital deaths. DVT and PE are 
preventable and the cost of treating patients with such problems is 
considerably higher than for primary prevention. Although the treatment of 
DVT is the province of physicians, nurses have a clear role in its prevention. 
The justification of risk assessment arises from the silent nature of DVT and 
its clinical diagnosis being notoriously flawed. The Autar DVT risk 
assessment scale was developed as a simple and easy to use risk 
calculator to identify those at risk of DVT as well as those who are not. 
Placing the patients into one of the risk categories facilitates the application 
of the most appropriate venous thromboprophylaxis as recommended by the 
national and international consensus groups. 
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Chapter Two 
This chapter explains the nature of the literature search strategy applied to 
the study and then focuses fundamentally on the theoretical framework 
underpinning the development of venous thromboembolic complications. 
The risk factors in the genesis of ovr and PE are examined in the context 
of the best external evidence derived from research reports and 
biosciences. 
Literature search strategy 
As an essential part of the study, the following two areas of the literature 
were considered: 
• The literature relevant to venous thromboembolic complications, risk 
assessment scales in general and ovr risk calculators. 
• The literature on research methodology and data collection tools for the 
development, application and evaluation of a ovr risk assessment 
scale. 
The literature on this topic comprised research reports of different materials, 
including books, articles and national and international consensus group 
statements on venous thromboprophylaxis. Official and legal publications 
derived from government statistics in North America, Northern and Central 
Europe provided vital information on the epidemiology of Dvr and the scale 
of the problem. 
In order to provide a focus for the search the following key words were 
looked at: Oeep Vein Thrombosis (OVT) 
Pulmonary Embolism (PE) 
Venous Thromboembolism 
ovr prophylaxis 
Risk assessment scales 
ovr risk assessment 
Clinical risk management 
Venous disorders 
ovr integrated pathways 
---------------------------------------------------
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The quick reference section of nursing and clinical medical sciences libraries 
were accessed for specific reference books on venous disorders with 
particular reference to the universally recognised work of Virchow in the 
development and causation of OVT. Additional to providing the key words 
for the search, the quick reference guide offered a better understanding of 
the natural history and course of DVT, deemed to be important to the 
content and construct validity of the DVT scale. 
The OPAC (Online Publishing Access Catalogue) allowed for the key words 
defined earlier to be searched by authors, subjects and the Dewey 
Decimalisation System. The indexes and abstracts were used to search for 
online databases such as: CINAHL (Cumulative Index for Nursing & Allied 
Medical Library). 
BNI (British Nursing Indexes) 
Medline (Medical Literature) 
Gateways to the topic were explored on the intemet. The following websites 
were particularly very specific to the chosen subject: 
• www. Nelh.nhs.ukl cochrane.asp 
• www.Emedicine.com 
• www. NcbLnlm.nih.gov/entrez/ PubMed 
• www.nelh.Shet.ac.uk! nelk! kitlc 
The most specific literature on the topic was accessed via the following 
consensus groups on venous thromboprophylaxis: 
• NIH, 1986) National Institute of Health, USA 
• European Consensus Statement, 1991 
• THRiFT, 1992 &1998 (Thromboembolic Risk Factors Consensus Group 
• SIGN, 1995 (Scottish Intercollegiate Guideline Network) 
• ACCP, 1996 (Associated College of Chest Physicians) 
• International Consensus Statement, 1997 & 2001) 
The selection of the material for the study derived from multi sources was 
primarily determined by the levels and types of evidence attributed to Gray 
(1997) available on venous thromboembolism (Table 2.1). 
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Table 2.1: Levels and types of evidence 
Level Type of evidence 
1a Evidence obtained from meta-analysis of randomised 
controlled trials 
1b Evidence obtained from at least one randomised controlled 
trial 
2a Evidence obtained from at least one well designed controlled 
study 
2b Evidence obtained from at least one other type of well 
designed quasi-experimental study 
3 Evidence obtained from well designed non experimental 
descriptive studies, such as comparative studies, correlation 
studies and case control studies 
4 Evidence obtained from expert committee reports or opinions 
and I or clinical experiences of respected authorities 
Adapted from Gray, 1997. 
Some seemingly dated reports (Sevitt & Gallagher, 1961, Gibbs, 1957, 
Kakkar et ai, 1970) have also been considered in this study, on account of 
achieving the level of evidence defined by Gray (1997) and the pioneering 
and groundbreaking work of the respected researchers. On the other hand, 
the publications from the venous thromboprophylaxis consensus groups 
provided the most up to date literature and compelling evidence based 
research reports. 
Theoretical framework 
The application of effective venous thromboprophylaxis mandates a clear 
understanding of the risk factors in ovr, so that the responsible variables 
can be controlled (Comerata et ai, 1989; Clagett et ai, 1992). A reduction in 
morbidity and mortality from OVT can be achieved by timely recognition of 
the predisposing factors and selective use of prophylaxis (Letsky, 1992). 
There is now increasing consensus that clinical variables can be used to 
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predict the high, moderate and low risk groups of patients on admission to 
hospital (NIH, 1986; THRiFT, 1992; Belcaro, Nicolaides, Veller, 1995). 
Our ability to prevent DVT has come with an understanding of its 
epidemiology, natural history and properly evaluated prophylaxis strategies 
(Becker, 1986). A fitting tribute is due to RudolfVirchow (1821-1902) for his 
pioneering work in providing a comprehensive and sound understanding of 
the pathophysiology of DVT. 
Virchow's classic triad of risk factors in the genesis of DVT is the foundation 
of our understanding of the cause of DVT and remains valid today 
(Mammen 1992). The postulated requirements for thrombogenesis, 
including a triad of factors as first explained by Vi rchow (1846), are 
illustrated in figure 2.1. 
Figure 2.1: Virchow's triad 
HypercoagulabiJity 
Stasis 
The triad of factors for the origin of venous thrombosis are: 
1. Veaael Trauma 
Vessel Trauma 
Changes in the vessel wall due to intimal damage of the endothelium lining 
the blood vessel. The endothelium is now recognised as not simply being 
the innermost lining to blood vessels but is also a highly specialised 
metabolically active interface between blood and the underlying tissue. It 
maintains vascular tone and predominantly serves to inhibit platelet 
adherence and initiation of clot formation (Hunt and Jurd, 1998). 
Conversely, injury to the endothelium exposes highly thrombogenic 
components to the platelets. Trauma, fracture, thermal injury, surgical 
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procedures, instrumentation and inflammation may cause injury to the 
endothelium by endotoxin. Even in the absence of direct trauma to the 
veins, the widespread vasodilatory effect of many general anaesthetics can 
result in microtears and disruption of endothelial integrity (Merli and Martinez 
1987; Comerata et ai, 1989). 
2. Stasis 
Changes in blood flow due to venous stasis. Immobility is one of the major 
contributors to venous stasis. Venous stasis causes abnormal blood flow in 
valve pockets, which are the potential sites for clot formation. Venous stasis 
prevents clearance of activated coagulating factors and retards inflow of 
clotting factor inhibitors (Rolling, 1995). Stasis also induces anoxia of the 
endothelial cells, which release serotonin and histamine, and this provokes 
local thrombi formation. The endothelial cells contract, exposing the 
basement membrane and activating the coagulation cascades (Oas, 1994). 
3. Hypercoagulablllty 
Changes in the compOSition of blood due to hypercoagulability. Increased 
platelet activity and or a decrease in physiological anticoagulant and 
fibrinolytic activity cause increased coagulation. Fibrinolysis is a system, 
which is concerned with the dissolution of clots as well as the prevention of 
thrombi formation (Marsh 1981; Poller, 1993). Plasma proteins contain an 
euglobulin called plasminogen. When a clot is formed, plasminogen is 
trapped in it. The trapped plasminogen remains inactive until the injured 
tissue releases tissue plasminogen activator (t-pa) which converts 
plasminogen into plasmin. Plasmin is a powerful enzyme, which digests 
fibrin threads and destroys some of the clotting factors. 
Increased blood viscosity occurs in response to surgery or injury and this 
physiological change is known as the -acute phase reaction" (Lowe, 1979), 
causing "fibrinolytic shutdown" (Stewart-Rose, 1998). Acute phase reaction 
is a life preserving measure as it is designed to prevent excessive 
potentially life threatening blood loss. This phase persists for up to about 
four days (Chakrabarti et aI1969). Oral contraceptives, pregnancy and 
puerperium are other risk factors contributing to hypercoagulability. Impaired 
. fibrinolysis is noted in obesity and advancing age. 
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Some common congenital and acquired conditions associated with 
hypercoagulability are listed below: 
• Deficiencies of Antithrombin III 
• Protein C deficiency 
• Protein S deficiency 
• Circulating lupus anticoagulant 
• Myoproliferative diseases 
• Dysfibrinogenemia 
• Disseminated intravascular coagulation 
• Malignancy. 
• Oestrogen use. 
• Inflammatory bowel disease. 
Experimentally and clinically, it is now recognised that at least two of these 
postulated factors in combination are significant in the development of DVT 
(Mammen, 1992). Virchow's seminal work has made it possible and 
practical to examine the multifactoral context of identifying those at risk and 
so allows for the implementation of the most appropriate venous 
thromboprophylaxis. It is within this conceptual framework that the Autar 
DVT risk assessment scale was developed and tested. 
Risk factors In DVT 
A number of clinical circumstances increase the risk of DVT. There is 
convincing evidence that a number of clinical factors increase the 
preponderance to DVT (Kakkar et ai, 1970; Ruckley, 1985; Caprini et ai, 
1991). The clinical factors for thromboembolism can be conveniently broken 
down into factors associated with patients or those associated with the 
disease or surgical procedure. Patients' factors include increasing age, 
obesity, varicose veins, immobility, paraplegia, pregnancy and puerperium, 
previous DVT or PE and congenital or acquired thrombophilia. Factors 
associated with the disease or surgical procedures include abdomino- pelvic 
surgery, malignant disease, inflammatory bowel disease, haemolytic 
anaemia, sickle cell anaemia, polycythaemia and heart diseases. The 
application of these factors to the patient population forms the basis of 
identifying the degree of risk (RCOG, 1995). The risk factors for DVT are 
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associated with vascular injury, activation of blood coagulation and venous 
stasis, which are the Virchow's triad of factors in the pathogenesis of DVT 
(Rosendaal, 1997). The thrombosis risk factors that are frequently 
considered by surgeons when deciding to use prophylaxis are tabled below: 
Table 2.2: Risk factors influencing surgeons on when to give 
prophylaxis 
Thrombosis risk factors Response rate by 
surgeons (Ok) 
Previous DVT 85 
Immobilisation 44 
Duration of surgery 43 
Hypercoagulability 37 
Obesity 32 
Malignancy 29 
Age 25 
Pelvic surgical procedure 22 
Varicose veins 10 
Data: Caprini et ai, 1994: Anderson & Wheeler, 1995. 
In this survey, 85% of surgeons consider a previous DVT to be the most 
important risk factor when prescribing prophylaxis, compared to a response 
rate of only 10% for varicose veins. 
The following well-recognised DVT risk factors will now be critically 
examined in terms of their potential for causing DVT: 
• Surgery 
• Trauma 
• Increasing age 
• Obesity 
• Prolonged immobility 
• Specific DVT risk factors 
• High risk diseases 
• The hypercoaguable states. 
• Other risk factors which include sex distribution, diabetes, smoking and 
long distance travel. 
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Review of the compelling evidence on each of these risk factors will form the 
basis for selecting the most convincing clinical risk factors for ensuring the 
construct and content validity of the Autar DVT risk assessment tool. 
Surgery 
It is well recognised that venous thromboembolism is a common 
postoperative complication (Undblad et ai, 1991) and is the major DVT risk 
factor (Moser, 1989). 
Nature of surgery: 
The nature of surgery carries different weighting risk. Major surgery is 
defined as a procedure on a patient requiring more than 30 minutes of 
general anaesthesia and carries higher risk (Goucke, 1989; Maser, 1989). 
Dilatation of the veins occurs during anaesthesia. Comerata et al (1989) 
measured venous dilation in patients undergoing hip replacement surgery 
and found 20 % of patients with the most venous dilation went on to develop 
DVT. Coleridge-Smith et al (1990) have also demonstrated venous dilation 
in patients undergoing general surgery. They found that by the end of 
surgery, the gastrocnemius veins were dilated by 22-28%, providing direct 
evidence that there are significant increases in the diameter of the deep 
veins. Incidence of DVT is greater for patients receiving general 
anaesthesia, being thirty one percentage points higher than for patients 
receiving regional anaesthesia (Sorenson & Pace, 1992). 
In patients undergoing major surgery, the period of risk extends from the 
time of operation through the first 7-10 postoperative days (Kakkar and 
Stringer, 1990). The temporal relationship continues to be controversial, but 
studies reveal that the risk of developing DVT may be present for a period of 
3 weeks postoperatively. The onset of DVT occurs commonly after the 
second postoperative day (Scurr, 1990). Thrombi of clinically significant 
proportions are present as early as 24-48 hours postoperatively, peak at 5-
10 days and may continue for as long as several weeks (Brown and 
Newman, 1995). 
Virchow's triad of risk factors is all present perioperatively, making surgery 
the front runner in the risk factors in DVT. 
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Venous ,tasis: 
Stasis is caused by pre and postoperative immobilisation and general 
anaesthesia with concurrent loss of venous pump function. Thiopentone 
induction anaesthesia also produces stasis by venodilation. Furthermore, 
fibrinolytic activity markedly drops with anaesthesia and returns to normal 
after only two days (Mansfield, 1972). Stasis and surgery combine to set up 
conditions conducive to clot formation. 
Hypercoagulabillty: 
During surgery, thromboplastin is released, increasing coagulability of blood. 
In addition to decreased clearance of activated clotting factors, a redudion 
in fibrinolytic activity after surgery may contribute to thromboembolic 
complications. 
Vessel trauma: 
Trauma to the vessel wall and increased level of platelet count favour the 
formation of thrombi. Intraoperative venodilation is associated with focal 
endothelial damage. As a result, subendothelial collagens are exposed, 
serving as initiation sites of clot formation (Comerata et ai, 1989). 
Duration of surgery: 
There is a linear relationship between the incidence of DVT and the duration 
of surgery. Incidence of DVT in surgery less than 2 hours is 20% and 46% 
for 2-3 hours, escalating to 62.5% in surgical procedure over 3 hours 
(Borrow & Goldson, 1981). Table 2.3 illustrates the association between 
incidence of DVT and duration of surgery. 
Table 2.3: Association between duration of surgery and Incidence of 
DVT 
Duration of surgery DVT incidence (%) 
< 2 hours 20 
2-3 hours 46.6 
> 3 hours 62.5 
Data: Borrow and Goldson, 1981 
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Types of surgery: 
Some surgical procedures are associated with comparatively higher 
incidence of DVT than others. Table 2.4 outlines the incidence of DVT after 
different surgical procedures. 
Table 2.4: Association between DVT and types of surgery 
Type of surgery DVT Incidence (%) 
Knee surg_ery 75 
Hip repair surgery 60 
Elective hip su('gelY 50-55 
Urological surgery 9-36 
General abdominal surgery 30-35 
Gynaecological surgery 25-30 
Neurosurgery 20-30 
Inguinal hernia repair 10 
Data: Das 1994, International Consensus Statement, 1997. 
The risk following below waist orthopaedic surgery is greater than for other 
procedures, partly because of trauma to the tissue surrounding the deep 
vein and partly due to the difficulty in moving the injured limb to maintain 
venous return. Manipulation of the leg causes distortion and occlusion of the 
femoral vein and is claimed to be causative of DVT (Stamatakis et ai, 1977). 
Trauma 
It is generally recognised that DVT and PE are major contributors to late 
mortality in trauma patients. An even greater contributor to long term 
morbidity Is post-phlebitis syndrome, a long term complication of DVT 
(Wheeler, 1988; Caroll, 1993). As a result of improved trauma care, large 
populations of severely injured patients survive for prolonged periods of time 
in the intensive care setting. Immobilised by multiple fractures or on life 
support systems, this population is at high risk of DVT and subsequent 
potentially fatal PE (Kudsk et ai, 1989). 
The main predisposing factors to DVT and PE are venous stasis, 
hypercoagulability and intimal vessel damage, which are all present in the 
trauma patients. 
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Venous stasis: 
Inactivity or bed rest is associated with a decrease in venous blood flow. 
Besides, in lower limb trauma, due to either the application of plaster of 
Paris or external fixator, complex wound or traction, the commonly applied 
DVT prophylaxis such as intermittent pneumatic compression and 
graduated compression stockings may be contraindicated. With complex leg 
wounds caused by compound or open fracture, anticoagulation is not 
always advised as it may interfere with the healing process or increase the 
risk of haemorrhage. Stasis is particularly important in spinal paralysis 
patients because it has been shown that venous stasis is markedly 
increased in the paralysed limb (Swan & Black, 1984). The incidence of 
OVT is higher in patients with spinal fracture who have complete lesion of 
the cord being 18% compared to only 8% in those who have incomplete 
lesion (Watson, 1968). 
Venous endothelial damage: 
Injury to the venous endothelial lining caused by the trauma, releases 
thromboplastic substances locally and exposes the basement membrane. 
This activates the clotting cascade (Shackford & Moser, 1988). 
Hypercoagulable state: 
Trauma imposes a transient hypercoaguable state because of the reactive 
effect of circulating tissue thromboplastin and other procoagulants. 
Additionally, there is a decrease in fibrinolytic activity (Chakrabarti et al. 
1969). Further, in states of hypoperfusion, which frequently accompany 
severe trauma, the liver may not be able to clear the activated clotting 
factors from the circulation (Hirsh. 1977). Trauma patients also have a 
moderate increase in catecholamines. which are known to increase platelet 
aggregation (Hirsh, 1981; Bennett & Towler. 1985). 
The reported incidence of OVT in patients with trauma varies between 20 to 
90 percent (Shackford. Moser. 1989). There is an increase in the DVT 
incidence of patients with fractured neck of femur, ranging from 27-83 % 
(Monterey et ai, 1993). However. the inclusion of patients after isolated hip 
fractures may give an unfair representation of the true incidence of DVT in 
multiple trauma patients (Kudsk et ai, 1989). Patients with hip fractures often 
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belong to an elderly population with coexisting medical conditions 
associated with thrombogenesis. In hip trauma, OVT risk starts at the time of 
injury due to the nature and site of injury (Grace, 1993). Accidental damage 
to the endothelium occurs during manipulation and repair of the hip 
(Stamatakis et ai, 1977). 
Review of literature on trauma patients yielded 8 studies firmly exhibiting 
variability in the incidence of OVT. The incidence of OVT analysed in the 8 
studies is outlined in table 2.5. 
Table2.S: Incidence of DVT in trauma patients 
Study Year No of patients DVT (%) 
with DVT 
Sevitt & Gallagher 1961 125 81 
Freeark et al 1967 124 44 
NyJander & Semb 1972 15 7 
Silver et al 1975 100 18 
Brach et al 1977 10 9 
Rossi etal 1980 18 13 
Willen et al 1982 38 8 
Myllynen et al 1985 37 18 
Data from: Autar, 1996 c 
Some groups of young patients are also at high risk due to the nature and 
types of injuries sustained. OVT occurs at a high frequency in patients with 
spinal cord injury with a reported incidence of up to 72% or more in the 
absence of prophylaxis (Hull, 1992). 
Spine patients have a number of risk factors for developing DVT after 
surgery: prolonged bedrest, lengthy operative procedure, and manipulation 
of the great vessels during anterior spine approaches. In addition, nursing 
the patients in prone position on certain frames may compress the femoral 
vein (Bret et ai, 1993). 
Acute spinal cord injury patients reportedly have increased coagulability and 
decreased venous return (Merli et ai, 1988), 
The incidence of OVT in spinal injury patients is tabled below: -
38 
-------------------------------------------------
Table 2.6: Incidence of DVT in spinal injury patients 
Study No of patients DVT (%) 
Perkish et al,1978 50 16 
Rossi et ai, 1980 18 72 
Frisbie & Sasahara,1981 17 6 
Myllynen et al,1985 23 100 
Merli et al,1988 17 47 
Petaja et al,1989 9 67 
Yelnik et ai, 1991 127 23 
Data: Hull, 1992 
Despite the consensus that DVT and PE are considered common 
complications after major trauma, the frequency associated with different 
types of injuries have not been comprehensively quantified. To this end, 
Geerts et al (1994) undertook a prospective study in a Regional Trauma 
Unit on 349 patients and reported the wide variability in the incidence of 
OVT associated with different types of trauma (Table 2.7) 
Table 2.7: Association between DVT and types of Injury 
Injury DVT (%) 
Face,chestorabdornen 50 
Major head Injury 54 
Pelvic Injury 61 
Spinal Injury 62 
Tibial Injury 77 
Femoral Injury 80 
Data: Geerts et ai, 1994. 
Advancing age 
There is a strong correlation between increasing age and OVT development 
(Anderson et ai, 1991; Nordstrom et ai, 1992). Post mortem and clinical 
studies have demonstrated that the frequency of OVT increases 
exponentially with age (Gibbs, 1957; Rosendaal, 1997). The increased 
frequency may be due to increased likelihood of coexisting medical 
condition or surgery. Age represents a definitive risk factor in DVT and is 
thought to be due to reduced mobility and scarce utilisation of the calf 
muscle pump with venous stagnation in the veins of the lower limb (Gibbs, 
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1957}. Multiple regression analysis of possible risk factors has also revealed 
that age is a definite risk factor for DVT (Havig, 1977). As age advances, the 
calf muscle mass also decreases and the soleal veins increase in number, 
size and tortuosity (Coon, 1976). Such physiological changes reduce the 
efficiency of the venous pump and contribute to a decrease in the rate of 
venous return from the lower limbs. 
In ageing, the level of Antithrombin Ill, which is the direct inhibitor of Factor 
X, is reduced, leaving the patients more susceptible to blood dotting (Lowe, 
1979). 
DVT is uncommon in children (Rosendaal, 1999) and rises sharply with age. 
It is considerably rare in children with a clinical prevalence of 1.2 per 10,000 
admissions, to a children hospital (Coon, 1976). Even when it occurs it is 
associated with conditions such as multiple trauma, leg or foot surgery or 
femoral vein cannulation (Jones & Maclntyre, 1975). No venous thrombosis 
or embolism was reported under the age of fourteen (OPCS, 1990). The 
linear relationship between increasing age and DVT is listed under the 
International Classification of Diseases (ICD) number 453 and illustrated in 
table 2.8. 
Table 2.8: Increasing age and associated venous embolism and 
thrombosis: ICD 453 
Age groups Recorded cases per 1000 
45-49 11 
50-54 12 
55-59 19 
60-64 54 
65-69 100 
70-74 123 
75-79 205 
Data: opes, 1990: Cause of Mortality Statistics. 
The different age groups are another important consideration in the 
development of DVT. Although it increases sharply with year, risk becomes 
appreciable after the age of 40 (THRIFT, 1998). In an autopsy survey on a 
population who died from burns and injuries, isolated venous thrombosis 
occurred in 47 per cent of patients under 45 years of age, 62 per cent 
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among patients aged 46- 75 and 74 per cent in those aged over 75 (Sevitt & 
Gallagher, 1961). . 
A higher frequency of thrombi has been reported in postoperative patients 
over the age of 60 (Kakkar et ai, 1970) as illustrated in the table below: 
Table 2.9: Frequency of DVT In over forties 
Age groups DVT Incidence ( %) 
40-59 24 
>60 45 
Data: Kakkar et ai, 1970 
Samama et al (1993) reported 50 per cent thrombosis in patients between 
60-80 years old. The exponential increase was further confirmed by Borrow 
& Goldson (1981) and Caprini & Natonson (1989) who reported a DVT rate 
of 20 per cent in 40-60 years old patients having hip surgery. This doubles 
between the age of 60 years and 70 years and in patients over 70 this figure 
trebles. 
A number of predictive indices have been developed to identify patients 
preoperatively for risk of OVT and the researchers have all included 
advancing age as a dominant risk predictor (Clayton et ai, 1976; Lowe et ai, 
1982; Sue-Ling et ai, 1986). 
Obesity 
Obesity, a condition of excess accumulation of body fat, is generally defined 
using Body Mass Index (BMI). BMI allows for the effects of height on weight 
and can be calculated using the following equation: 
BMI= 
Weight (kg) 
Height (m2) 
The BMI is the simplest and most common method of body build 
categorisation used in clinical practice. 
In Ut<. a BMI of over 30 is commonly used to define obesity in adults. A BMI 
of between 25 and 30 generally indicates that an individual is overweight 
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The term umorbid obesity" may be used when the BMI is greater than 40 
(Green, 1997). 
The 1991 Health Survey for England reported that 13 per cent of men and 
16 per cent of women aged 16-64 had a BMI of more than 30 (White et ai, 
1993). If these trends continue. in 10 years more than a quarter of adults in 
UK will be obese, with devastating consequences for health (Jebb. 
2000).The obese patients appear to have twice the normal risk of 
developing post operative DVT than their lean counterparts (Kakkar et al. 
1970). 
It has been suggested that the risk of DVT in obese patients may be 
increased because of impaired fibrinolytic activity and prolonged immobility 
after surgery (Coon, 1984; Poller, 1993). Obesity predisposes to DVT 
caused by venous stasis: a pendulous abdomen. in particular. mechanically 
increases intra abdominal pressure and interferes with venous return. 
Obesity also causes venous dilation, resulting in venous stasis (Herzog, 
1992). Arguably, obesity commonly leads to relative Immobility and 
increases the likelihood of venous stasis. Obesity as a risk factor was further 
substantiated by Schaub et al (1975). Of the 95 subjects studied. OVT was 
detected in 52 obese patients as diagnosed by routine ,125 Fibrinogen 
scanning. 
Whether it is associated with immobility or impaired fibrinolysis, obesity is a 
risk factor (Becker, 1986). Increased adiposity in women has been 
confirmed as an important long term factor for significant pulmonary 
embolism at autopsy (GoIdhaber et ai, 1983). This Framingham study raises 
the possibility that weight reduction in obese women may decrease the 
chances of PE. 
Among women matched for age and parity. it was found that women who 
developed DVT were on average10 Ibs (4.5kg) heavier than those who did 
not rJessey & Doll. 1969). In women weighing over 76 kg. confidential 
enquiries into maternal death, reported that one in five women had fatal 
pulmonary embolism (DoH, 1994). In a post-mortem survey, Coon (1976) 
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found that 21.9 per cent of those more than 20 per cent overweight had 
pulmonary emboli compared to 14.4 per cent in the non-obese subjects. 
A significant association between obesity and OVT has been reported in 
some studies (Kakkar et ai, 1970, Lowe et al. 1982) but not in others. 
Nicolaides and Irving (1975) found that the association between obesity and 
OVT were not associated independently. after controlling for other major risk 
factors such as age, previous history of ovr and major surgery. In a 
prospective epidemiological study of 2877 patients undergoing elective 
surgery. obesity was not found to be a significant risk factor for post 
operative OVT (Sigel et ai, 1974). 
In the analysis of variables for a post operative predictive index, obesity as 
an independent risk factor was ruled out (Sue-Ling et ai, 1986). The 
evidence to justify the inclusion of obesity as a direct risk factor in the 
causation of ovr is questionable and inconclusive (Ogston, 1987). 
Immobility 
Immobility as a OVT risk factor is defined in terms of the number of days 
required before the patient is able to ambulate unaided (Scurr et ai, 1987). 
Venous return to the heart requires the combined efforts of cardiac 
contraction, respiratory inspiration and expiration, calf muscle pump and the 
unidirectional leg vein valves. The calf muscle pump is the powerhouse 
forcing venous blood towards the heart. Ouring quiet standing when the full 
effect of gravity is exerted, venous pressure at the ankle Is approximately 
85-90mmHg. Rhythmic contraction of the calf muscle lowers the pressure to 
less than 30 mmHg (Kaisary, 1980). Lack of movement of the calf muscle 
causes a drop in venous return and subsequent stasis. 
Plasminogen activator is normally synthesised and released from venous 
endothelium in response to exercise (Vanek et ai, 1991) and patients who 
are immobile have less fibrinolytic activity than active adults (Browse et ai, 
1977). Immobility causes stasis and is a major contributor of ovr. When 
normal venous pump function is impaired as a result of confinement in bed 
rest, venous stasis manifests itself in two ways. First of all, there is an actual 
decrease in the linear velocity of blood, compromising venous return from 
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the lower extremities. Secondly, this is followed by dilation of the veins 
delaying further venous return (Caprini et ai, 1988). 
There is a striking relationship between the length of confinement to bed 
and the occurrence of DVT (Gibbs, 1957). In an autopsy series of 253 
patients Gibbs (1957) found a strong association between bed rest duration 
and venous thrombosis; the incidence being only15 percent for confinement 
to bed for less than a week but more than 80 per cent for more than a week. 
This association is further confirmed by other studies (Sevitt & Gallagher, 
1961; Sigel, 1974). The incidence of DVT associated with bed rest is 
tabulated below: 
Table 2.10: Incidence of DVT associated with bed rest 
Study No' of DVT cases DVT incidence (%) 
Gibbs,1957 149 59 
Roberts,1963 58 54 
Havig,1977 161 62 
Early ambulation is generally accepted as increasing venous flow and 
reducing stasis (Rose 1979). Sharnoff and Rosenburg (1969) compared 
immobilised patients who have undergone open reduction and internal 
fixation for fractures with mobile patients with prostatectomies. The 
conclusion drawn from this experimental study is that immobility is a potent 
and discriminatory factor in the development of DVT.lmmobility as a high 
risk factor was further supported by Miller et al (1976) who reported a 
marked reduction in the incidence of DVT in patients with myocardial 
infarction, who were mobilised within 2-3 days of the onset of their acute 
attack. Coronary care units now favour the regime of early mobilisation of 
patients following acute myocardial infarction. 
In a comparative study of medical patients with those who have undergone 
surgery, compelling evidence indicates that immobility due to bed rest has a 
direct causal relationship whereas surgery per se is indirectly responsible 
(Murray et ai, 1970). 
In a study of 109 non surgical bedridden patients, Kierkegaard et al (1987) 
reported a total of 13 per cent incidence of DVT. The study was restricted to 
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the first 8 days following admission and the investigators claimed that not all 
events were recorded. A much higher incidence would be reported if the 
patients were studied for the full duration of their stay in hospital. 
The Lassan and Borris (1991) case control study to evaluate the impact of 
immobility on patients after hip surgery, confirms the importance of early 
mobilisation in DVT prophylaxis. Incidence of DVT in patients with hip 
surgery is usually between 48-74 per cent (Madden & Hume 1976). The 
patients in the experimental group who were mobilised on the fourth day 
had an incidence of 23 per cent compared to 75 per cent in the control 
group whose mobilisation was delayed to the ninth day. 
The significance of immobility in the pathogenesis of DVT is further 
substantiated by the following clinical illustrations: 
• Spinal cord injury patients with paralysis are at high risk and 10-64 per 
cent of such subjects develop DVT (Merli et ai, 1988). 
• A comparison of two small groups of spinal cord injury patients, one with 
paralysis and the other without, yielded a 100 per cent DVT incidence in 
the paralysed group but not in the non paralysed patients (Myllynen et ai, 
1985). 
• In acute stroke patients, the paralysed limbs had a 63 per cent rate of 
DVT as compared to only 7 per cent in the non paralysed limb (Warlow 
et ai, 1976). 
• Autopsy studies revealed a relationship between bed rest and DVT 
(Glbbs, 1957; Sevitt & Gallagher, 1961). 
• Pre operative immobility was associated with higher postoperative 
incidence of DVT (Sigel, 1974). 
• Postoperative patients remain at higher risk during the entire period of 
immobility, especially if they remain immobile after discontinuation of 
prophylaxis (Gallus et ai, 1976). 
• Patients with fractures of the lower limbs are at high risk when the limbs 
are immobilised in a plaster cast (Hamilton et ai, 1970). 
• Assuming a compromised posture or restricted mobility due to rigid 
confinement in an air raid shelter or on long confining rides in car or 
plane and prolonged sitting can cause DVT (Homans, 1954). 
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.In brief, the evidence is compelling and conclusive that immobile patients 
are a high risk group and that the stasis factor in Virchow's triad is the 
dominant cause of Dvr. 
DVT special risk category 
Some patients have an additive risk of developing DVT due to specific 
factors, which predispose to hypercoagulability. For example: patients on 
oestrogen therapy as a form of contraception and those in pregnancy and 
the puerperium state belong to a special risk group. Hormone Replacement 
therapy has also been implicated. 
Oral contraceptives 
Contraceptive methods are judged by their effectiveness, acceptability and 
freedom of side effects. Oral contraceptives remain the most popular 
method of fertility control but are not without side effects. Sartwell et al 
(1969) and Vessey and Doll's (1970) controlled investigations 
overwhelmingly support the evidence that oestrogens increase the risk of 
OVT. One in every 2000 women using oral contraceptives developed DVT 
compared to one in every 20,000 not using them 01essey and Doll, 1970). 
They also reported a DVT occurrence of 2.5 times greater in women aged 
35-44 than those aged 20-34. There is an increased risk of OVT associated 
with the third generation oral contraceptives: progestogens, desogestrel and 
gestodene (Maling, 1998). Five epidemiological studies have reported the 
risk of DVT to be twice as high with the third generation oral contraceptives 
containing desogstrel and gestodene (WHO, 1995). 70-80 per cent of oral 
contraceptives used in these studies are the -third generation" compared 
with less than 5 per cent in Australia, 15 per cent in the USA and 50 per 
cent in UK (Maling, 1998). 
From the biological basis of DVT perspective, oral contraceptive therapy 
causes hypercoagulability due to increased clotting factors, venous stasis as 
a result of venodilation and reduced blood flow velocity and consequential 
vessel trauma from increased vascular endothelial permeability (Coon, 
1977; BNF, 1994). The general findings from many published trials on the 
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effects of oral contraceptives, indicate increased in procoagulants, reduction 
in antithrombin III levels and a depression in fibrinolytic activity (Poller, 
1978). Overall, there is an imbalance of the homeostatic mechanism 
towards hypercoagulability. 
Currently, a progressive reduction in the dose of oestrogen to less than 50 
micrograms, complemented by better supervision has reduced the risk of 
DVT (Stadel, 1981). Risk of DVT in women taking oral contraceptives during 
the month prior to surgery or trauma appears to increase four to six fold 
(Sartwell & Stolley, 1982). To minimise this risk, it is recommended that 
women scheduled for elective surgery should stop taking oral contraceptives 
3-4 weeks prior to hospitalisation (Guillaband 1985; BNF, 1994). If 
discontinuation of oral contraceptives is not possible, as in an emergency, 
and the patients is still on an oestrogen containing pill, heparin prophylaxis 
and graduated compression stOCking should be considered (BNF, 2000). 
However, opinion remains divided on the management of patients taking 
oral contraceptive and undergoing surgery. Sue-Ling and Hughes (1988) 
argue that the routine use of prophylaxis for OVT in women on the pill is 
probably unnecessary, particularly in those who have no other risk factors. 
Most women taking oral contraceptives are generally young, slim and fit and 
they mobilise early after surgery. 
Hormone Replacement Therapy (HRT) 
There is little doubt that HRT has numerous long term benefits in 
menopausal women. These include the prevention of osteoporosis and 
reduction in cardiovascular diseases such as myocardial infarction and 
stroke. Recently, it has been suggested that HRT has a protective role 
against Alzheimer's disease (Morris, 1998). The female brain thrives on 
oestrogen, which controls psychological health. In a way, menopausal 
women are suffering from natural tranquilliser withdrawal because some of 
the effects of oestrogen are as therapeutic as the tranquillisers (Stoppard, 
2001). HRT also relieves menopause symptoms, especially hot flushes, 
night sweats, tiredness and irritability (BNF 2000). 
However, HRT has been linked with the occurrence of thromboembolism 
(THRIFT, 1998). At the time ofthe literature review and at the launch of this 
study, there was no available data to indicate, whether or not HRT increases 
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the risk of venous thromboembolism. No causal relationship between 
postmenopausal oestrogen replacement therapy and DVT has been 
identified (Gow & MacGilluray, 1971; Boston Collaborative Drug 
Surveillance, 1974; Moore, 1976). It must be noted that most women who 
are receiving HRT may have other risk factors, particularly age or 
undergoing gynaecological surgery. Notelovitz & Ware (1982) and Carter 
(1992) have also found no association between HRT and DVT. 
At the time of the development, application and evaluation of the Autar DVT 
risk assessment scale (1994), available data were insufficient and 
inconclusive (RCOG, 1995) and HRT was not considered as a risk factor in 
the DVT calculator. 
On the other hand, two recent studies (Daly et ai, 1996 and Jick et al (1996) 
have both demonstrated that current use of HRT is associated with an 
increased relative risk of 3.5 and 3.6 respectively of developing DVT. 
Grodstein et al (1996) reported that the risk of PE was about twice that in 
non users but this finding was based on only five cases of current users of 
oral contraceptives together with HRT. To evaluate further the assooiation 
between HRT and risk of venous thromboembolism, Perez Gutthann et al 
(1997) conducted a case control cohort study of 347,253 women aged 50 to 
79 without major risk factors for DVT. It confirmed previous findings and 
concluded that current users of HRT have an overall twofold increased 
relative risk of venous thromboembolic diseases. 
Although HRT confers some health benefits, in several observational and 
one randomised controlled trial study, Lowe et al (2000) reported a threefold 
relative risk increase of venous thromboembolism. 
In the light of these recent findings supporting the association between HRT 
and DVT; hormone replacement therapy as a risk factor will be considered 
in the revalidation of the Autar DVT scale. 
Pregnancy and puerperium 
Normal pregnancy brings about homeostatic changes. An increase in 
coagulation factors such as raised fibrinogen, platelets and suppressed 
fibrinolysis serve to combat the danger of haemorrhage at delivery. Plasma 
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fibrinolytic activity is decreased during pregnancy, remains low during labour 
and delivery and returns to normal within one hour of placental delivery 
, 
(Bonner et ai, 1969). As a result, pregnancy is associated with a high risk of 
venous thromboembolism, accounting for the highest cause of direct 
maternal death (DoH, 1996). The direct causes of maternal deaths in UK 
between 1991 and 1993 are broken down in Table 2.11. 
Table 2.11: Direct causes of maternal deaths in UK (1991-1993) 
Direct causes Frequency (%) 
Venous thromboembolism 27.1 
Hypertensive disorders 15.5 
Early pregnancy 14.2 
Haemorrhage 11.6 
Amniotic fluid embolism 7.8 
Other direct deaths 7.5 
Sepsis 7.0 
Anaesthesia 6.2 
Genital tract trauma 3.1 
Data: DoH, 1996. 
Like general obeSity, a pendulous abdomen in pregnancy increases intra-
abdominal pressure which delays venous return. In addition, during 
pregnancy as the gravid uterus grows heavier, increased pressure on the 
pelvic veins reduces blood flow, especially venous return from the legs. 
Bedrest, immobility and obesity may exacerbate this state of venous 
stagnation (Allotey & Louca, 1997). 
Thrombotic risks in pregnancy can be divided into those of the antepartum 
and the puerperium period. Antepartum occurs before the onset of birth. 
Puerperium covers the period immediately following delivery until the 
reproductive organs return to their non pregnant state. It usually lasts for 6-8 
weeks. Antepartum risks reflect the physiological changes of pregnancy 
such as changes in venous stasis in the lower limbs. Puerperal risks reflect 
tissue breakdown plus an additional traumatic or surgical component such 
as prolonged labour or caesarean section. It is generally recognised that 
caesarean section delivery has a higher maternal mortality and morbidity 
due to venous thromboembolic diseases. The report on the Confidential 
Enquiry into Matemal Deaths stated that 13 of the 17 maternal deaths were 
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from thromboembolism in the puerperium (DoH, 1996) during the three 
years .. 
The incidence of DVT is consistently higher in the puerperal period than the 
antepartum period. In a study of the incidence of DVT among a group of 
14,869 pregnant women. Kierkegaard (1983) found a 0.13 per 1000 
incidence of DVT in antepartum and 0.16 per 1000 in the puerperium 
attributable to increased blood viscosity. Two physiological changes 
increase viscosity in the puerperium. In the early post partum days, there is 
a major diuresis as the kidneys excrete the unwanted body fluid. The blood 
becomes more coagulable due to liberation of clotting factors to prevent 
post partum haemorrhage and decreased in the fluidity of plasma from the 
diuresis (Beischer & Mackey, 1986). 
The relative risk of OVT and PE in women who are pregnant or post partum 
is 5.5 times greater than in non pregnant and non puerperal women not 
taking oral contraceptives (Coon, 1976). The prevalence has been 
estimated to be 2.5 per 1000 deliveries (Bonner, 1981). In the triennium 
1976-1978,47 UK deaths were coded to PE following DVT, with one third 
occurring in the antenatal period (DOH, 1982). In the triennium 1988-1990. 
33 maternal deaths from pulmonary embolism were coded for venous 
thrombosis (DoH. 1994). Predisposing factors such as gross overweight, 
increasing age and operative form of delivery augment the risk of OVT 
(Letsky, 1985). A decline in mortality from pulmonary embolism after a DVT 
could be due to trend towards young mothers and smaller families, the 
. 
reduction in traumatic operative delivery and early mobilisation. 
High risk diseases 
Data documenting DVT in medical patients are less extensive than those of 
the surgical patients. A number of medical conditions are associated with an 
increased risk of DVT and PE (Arcelus et ai, 1991). Such clinical conditions 
are: 
• Ulcerative colitis 
• Hypercoagul~ble states such as sickle cell anaemia, haemolytic anaemia 
and polycythaemia. 
• Cardiac conditions such as heart failure and myocardial infarction 
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• Malignancy 
• Varicose veins 
• Cerebrovascular accident 
• Previous DVT. 
Ulcerative colitis 
Inflammatory Bowel Disease (IBO) patients have a threefold increased risk 
of developing DVT and PE (Bemstein et ai, 2001). Ulcerative colitis is a 
chronic inflammatory bowel disease, in which part or whole of the large 
bowel becomes diffusely inflamed with haemorrhagic tendencies. Edwards 
and Truelove (1964) first documented the association between DVT and 
chronic ulcerative colitis. Overall, a low incidence of 1.3 to 6.4 per cent has 
been reported in inflammatory bowel disease. DUring a 10-year period from 
1970 to 1980, thromboembolic complications developed in 92 out of the 
7,199 patients (1.3%) with chronic ulcerative colitis (Talbot et ai, 1986). The 
occurrence of DVT in patients with ulcerative colitis appears predictable 
since it is associated with many of the factors known to encourage thrombi 
formation: anaemia, dehydration, prolonged bed rest and surgical 
procedures (Graf et ai, 1966). Ulcerative colitis is not necessarily an 
independent risk factor for thromboembolic complications. Most DVT is 
reported during the acute phase of the illness (Lam et ai, 1975) when other 
risk factors are also present. 
Ulcerative colitis may be a secondary hypercoaguable state. Drug 
interaction may also result in ineffective anticoagulation and recurrent 
thrombosis (Deykin, 1970). Prednisolone, which is often prescribed to 
counteract the inflammatory bowel condition, is also reported to decrease 
fibrinolysis by inhibiting plasminogen activator production (Lang, 1983). 
Physiological changes such as an increase in clotting factor VIII and 
fibrinogen concentration occur in response to the haernorrhagic tendency. 
Ulcerative colitis is associated with hypercoagulability and raised platelet 
count, favouring thrombi formation (Wyshock et ai, 1988). 
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Haematologieal conditions 
OVT is often a complication of sickle cell anaemia and haemolytic anaemia. 
They are characterised by increase in blood viscosity, significantly raised 
platelet count and venous stasis, creating an internal environment, which 
favours the formation of thrombi (Se~eant, 1992). However, the overall 
incidence of OVT is low (Bell et ai, 19n). 
In patients with polycythaemia vera, an elevated haematocrit value and 
increased blood viscosity clearly play a role in the pathogenesis of 
thrombotic complications. Pearson and Wetherley-Mein (1978) have 
·demonstrated a positive correlation between the incidence of vascular 
occlusive episodes and the haematocrit level in patients undergoing 
treatment for polycythaemia.The Polycythaemia Vera Study (PVS) group 
has also reported a markedly increased risk of OVT in patients over 70 year 
old, particularly those with a prior thrombotic event (Wassermann et ai, 
1981). 
Blood groups 
Blood group A has been implicated as a risk factor. Patients with 0 blood 
group have been reported to have half the incidence of OVT compared to 
those in group A. Jick et al (1969) found that 0 group is under represented 
with venous thrombosis compared to other groups. They also found higher 
level of antihaemophilic globulin in the plasma of A compared with 0 
patients. 
Mourant et al (1971) collected and analysed data from 17 studies in 
connection with blood groups and OVT. They claim that group A has a 
tendency to thrombose while the 0 group bleed. However, due to the 
pattern of the ABO blood group distribution in the population, the sample in 
those studies was too small to draw any firm statistical conclusions. The 
relative proportions of blood groups vary from country to country. In UK, 47 
% of people are group 0, 42% group A, 8% group Band 3% group AB 
(Campbell, 1993). Nordstrom et al (1992) also found no Significant 
difference in the incidence of DVT for blood group A, B, AB and O. 
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Cardiac conditions 
Clinical and pathological studies report a relationship between certain 
cardiac conditions and venous thromboembolism. Heart diseases are 
associated with cardiac arrythmias, elevated venous pressure and 
immobility, which result in venous stasis. The frequency of DVT and PE is 
three and a half times greater in patients with heart diseases than those 
without (Coon, 1976). Patients with atrial fibrillation and congestive heart 
failure are particularly at risk and an incidence of 10-20 per cent has been 
reported. In patients with acute myocardial infarction DVT incidence ranges 
between 20 to 40 per cent (Carter et ai, 1987). Claggett et al (1992) 
reported an overall incidence of 24 per cent among myocardial infarction 
patients not receiving antithrombotic therapy (Table 2.12). 
Table 2.12: Incidence of DVT In patients with myocardial Infarction with 
and without prophylaxis 
Regimen No of trials No of patients No ofDVT Incidence (%) 
Control subjects 4 214 51 
Low dose heparin 4 165 11 
High dose heparin 2 70 3 
Source of data: Clagetts et ai, 1992. 
Simmons et al (1973) studied 98 patients admitted to a coronary care unit 
following acute myocardial infarction and reported a DVT incidence of 27 
per cent. The study also confirms that DVT is more likely to develop in 
patients over the age of 60 and with a past medical history of angina 
pectoris, left ventricular failure and congestive cardiac failure. 
24 
7 
4 
Maurer, Wray and Shillingford (1971) reported a 37 per cent incidence of 
calf vein thrombosis among the 90 patients admitted to a coronary care unit 
who were not anticoagulated. In a preliminary study, for patients with 
confirmed myocardial infarction not treated with anticoagulants. the 
incidence of DVT was 38 per cent and those treated was 5.5 per cent. This 
preliminary study supports the relatively high incidence of DVT also reported 
by Maurer et ai, (1971). 
In a series of descriptive studies using leg scan positivity to diagnose CYr in 
patients who had myocardial infarction, an incidence of 20-40 per cent has 
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been recorded (Carter et ai, 1987). However, myocardial infarction was not 
proven to be an independent risk factor since the treatment of the patients in 
these studies involved prolonged bed rest. Many other factors are also 
associated with myocardial infarction. Advanced age, a history of 
thromboembolism and the presence of varicose veins may augment the risk 
of DVT. In fact, most studies related to patients with myocardial infarction 
are old dating from a time when a different mobilisation routine was 
dominant (Bergqvist, 1988). 
Malignancy 
The relationship between neoplastic diseases and DVT has long been 
recognised, since Armand Trousseau (1865) first reported a high incidence 
of DVT in a series of patients with gastric carcinoma. In the majority of 
cases, ovr occurs after the clinical detection of cancer (Goldberg et ai, 
1987). 
The overall incidence of DVT in patients with cancer has been reported to 
be between 1 per cent and 11 per cent but in post mortem studies this is 
considerably higher (Rickles & Edwards, 1983). Post mortem studies by 
Sproul (1938) confirmed the high frequency of DVT in patients who had died 
of cancer. In fact, cancer is often seen in patients with DVT. It is five times 
more commonly diagnosed within six months after DVT than a controlled 
group matched for age and sex (Nordstrom et ai, 1994). Ahrned and 
Mohyuddin (1996) also found 3 cases of cancer in 113 patients with primary 
DVT (2.65%). 
In postoperative patients, the presence of cancer increases the risk of DVT 
threefold when compared to patients without cancer, regardless of other risk 
factors (Kakkar et ai, 1970). Browse et al (1977) reported an incidence of 56 
per cent DVT in patients with malignancy and this figure is similar to those of 
other previous studies (Kakkar et ai, 1970). 
Surgical procedures also increase the risk of DVT in patients with cancer to 
a greater extent than in patients with non malignant conditions. Pineo et al 
(1974) reported 10 ofthe 30 patients with cancer developed DVT following 
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abdominothoracic surgery as opposed to only 14 of 134 control subjects 
undergoing similar procedure for non malignant conditions. 
An increase of DVT associated with cancer can possibly be explained on 
the basis of prolonged surgery and extended post operative bed rest 
{Gallus, 1976; Hirsh et ai, 1981). In addition, malignant tumours are often 
associated with advanced age, which may enhance the risk of DVT. 
Malignancy is associated with hypercoagulability. Abnormalities in routine 
blood coagulation tests have been reported to occur in as many as 92 per 
cent of patients with cancer. The most common clotting abnormalities are 
elevated levels of fibrin and fibrin degradation product (Rickles & Edwards, 
1983). Patients with malignant disease and those with thrombosis have a 
fibrinolytic shut down favouring thrombi formation (Browse et ai, 1977). 
Because malignancy commonly is associated with a number of other risk 
factors, the direct effect of malignancy is uncertain. 
Varicose veins 
Anatomically, veins have semilunar valves, occurring at regular intervals. 
The valves are arranged so that blood flow is towards the heart (venous 
return). Stretching the veins increases their cross-sectional areas, but the 
valves do not increase in size. As a result, the valves do not close 
completely. When this develops, the pressure in the veins of the leg 
increases still more owing to failure of the venous pump. Consequently, 
venous stasis is' inevitable. Varicosities of the veins cause phlebitis, leading 
to increased risk of DVT. Varicose veins are associated with venous stasis 
in the pathogenesis of DVT. 
Varicose veins as a risk factor for DVT have received considerable publicity 
by both the national and international consensus groups (NIH, 1986; 
International Consensus Statement, 1997; THRiFT, 1998). Schaub et al 
(1975), who reported a 48 per cent incidence of DVT, found that more than 
half of the patients in the study had a history of varicose veins. 
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The following studies have all included varicose veins as a risk factor in their 
predictive equation for DVT: 
• Kakkar et ai, 1970 
• Nicolaides et ai, 1975 
• Clayton et ai, 1976 
• Lowe et a, 1982 
• Sue-Ling et ai, 1986 
However, opinion remains divided as to whether varicose vein is an 
independent risk factor. Although Kakkar et al (1970), Nicolaides et al 
(1971) and Coon (1977) claim that varicose vein is a powerful discriminatory 
DVT risk factor, its significance as an independent factor remains 
controversial. May (1979) reported only one case of DVT in a study of 
30,000 patients undergoing surgery for removal of varicose veins. On the 
other hand, varicose veins may coexist incidentally with other well-
documented risk factors to cause DVT. For example, occurrence of DVT is 
positively associated with history of varicose vein in patients taking HRT 
(Perez Gutthann et, 1997). Gallus (1976) also concedes that varicose vein 
may contribute to the risk of DVT but concludes that definitive work in this 
area has still to be conducted. While general surgeons recognise varicose 
veins as an associative risk factor, necessitating some form of venous 
thromboprophylaxis, vascular surgeons are sceptical about this association. 
In a survey of DVT prophylaxis for varicose vein surgery only 29 percent 
prescribe venous thromboprophylaxis (Campbell and Ridler, 1995). 
Cerbro-Vascular Accident (CV A) 
Venous thromboembolism is a major and often unrecognised cause of 
morbidity and mortality in patients after acute CVA (Strokes) (McCarthy et 
al,1977). 
DVT of the lower extremities is reported to occur frequently in patients who 
have had a stroke (Warlowet ai, 1972; Warlow et ai, 1976). Within a few 
days after a stroke, 40- 53 per cent of patients develop DVT as diagnosed 
with 1125 fibrinogen technique (Warlow, 1978). However, the fact that ,125 
fibrinogen technique does not detect thrombi in the upper thigh suggests 
that the incidence of DVT was underestimated. 
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The DVT occurs exclusively in the paralysed leg and this finding is 
consistent with 42 chronic hemiplegic patients where the frequency is also 
42 per cent (Kamal, 1987). The incidence of DVT in stroke patients has 
been reported as high as 75 per cent (Brunner & Suddarth, 1992). 
Physiologically, changes in haemostatic parameters occur after stroke. 
There is a rise in plasma fibrinogen and an increase in fibrinogen and fibrin 
formation. An increase in platelet count contributes to blood 
hypercoagulability. Prolonged immobility whether due to lack of power or 
sensory loss may apply pressure on the .calf and initiate venous thrombosis 
(Warlow, 1978). 
Without prophylaxis, DVT occurs in 60-70 per cent of patients with dense 
hemiplegia and between 1-2 per cent suffer fatal PE (Turpie et ai, 1987). 
Sioson et al (1988) also found that 33 per cent of stroke patients admitted to 
a rehabilitation hospital developed OVT. 
Previous DVT 
A clinical history of previous DVT has been shown to be strongly associated 
with an increased frequency of venous thrombosis (Carter et ai, 1987). In 
one of the studies, stepwise logistic regression of the clinical variables has 
indicated that a previous history of DVT is an independent risk factor 
(Nicolaides & Irving. 1975). All the three elements of Virchow's triad are 
embraced, explaining why recurrence of the condition is so remarkably high. 
Physiologically, venous thrombosis causes scarring of the intimal lining of 
the vein and a nidus for future clot formation (Hirsh et ai, 1981). Secondly. 
valvular destruction following the DVT impairs the venous pump, thus 
causing venous stagnation in the lower limbs (Christopoulos et ai, 1989). 
Thirdly, there is a depression in the fibrinolytic activity in patients with post 
thrombotic syndrome compared to patients within the normal population 
(Polter, 1993). 
Screening studies with objective diagnostic tests Indicate that surgical 
patients with a past history of OVT have a threefold incidence of OVT 
following abdominal surgery compared with a population without a history of 
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DVT (Kakkar et ai, 1970). They reported an incidence of DVT as high as 68 
percent. 
Coon & Willis (1973) studied the recurrence of venous thromboembolism 
and found that the risk was very high immediately after hospital discharge 
and then gradually declined to reach a plateau after a period of three years. 
In a retrospective analysis, Badaracco & Vessey (1974) estimated that there 
was about a 12 per cent risk of DVT or PE in pregnancy if a woman had a 
history of thromboembolism. The risk was not affeded by the circumstances 
of the previous event, whether associated with pregnancy or oral 
contraception. 
Nicolaides & Irving (1975) reported a frequency of 61 per cent in patients 
with previous DVT, compared to 26 per cent in patients without a prior 
history. Dalen et al (1986) claim that patients with previous DVT when 
exposed to stressful situations such as surgery, are four times more at risk 
of developing new DVT. Based on available findings, Rocha et al (1988) and 
Caprini et al (1991) utilised previous DVT as a powerful predictive variable in 
their prognostic indices. A previous DVTIPE (appendix 1) is assigned a risk 
factor value of 3 (Arcelus et ai, 1991; Caprini et al. 1991). In Nordstrom et 
ai's study (1992) a past history of DVT was found in 26 per cent of cases 
and is considered to be a major risk factor for the development of recurrent 
thromboembolism. 
The long term course of acute DVT is illustrated in table 1.2. Patients with 
DVT have a high risk of recurrence of the condition that persists for many 
years (Prandoni et ai, 1996). The cumulative incidence of recurrent DVT is 
17.5% after 2 years, rising to 24.6% after 5 years and 30.3% after 8 years. 
In the SIRIUS study, Samama et al (1993) reported that a past history of 
DVT or PE has an odds ratio of 7.9 for the development of a recurrence 
during hospitalisation. Thus, a patient with previous DVT is nearly eight 
times more likely to develop a new episode during a subsequent period of 
increased risk, as compared to an otherwise similar patient without a 
previous history of DVT or PE. 
-------------------------------------------------
58 
The Hypercoaguable states 
Patients with hypercoaguable states have laboratory abnormalities or 
clinical conditions that are associated with an increased risk of thrombosis. 
This category also includes patients with recurrent DVT with no recognizable 
predisposing factors (Shafer, 1985). The number of hypercoaguable states 
is still growing but the nine that have been confirmed and classified as 
Thrombophilia or Hereditary Thrombotic Diseases (HTD) are listed below: 
• Protein C deficiency 
• Protein S deficiency 
• Antithrombin III deficiency 
• Plasminogen deficiency 
• Dysfibrinogenia 
• Tissue Plasminogen Activator deficiency (t-PA). 
• Plasminogen Activator Inhibitor excess (PAl). 
• Heparin cofactor 11 
• F actor V Leiden 
Of these hypercoaguable states listed above, Protein C (10%), Protein S 
(12%) and Antithrombin'" deficiencies (3%) are most common (Cooper, 
1994). Factor V Leiden is an inherited mutation in the gene coding for Factor 
V and accounts for about 5% of the white population. It causes activated 
protein C resistance (APCR) resulting in an increased susceptibility to 
develop DVT (Vandenbroucke et ai, 1996). 
About 70 per cent of cases of hereditary thrombotic disease have no known 
genetic cause N"/ood & Bunn, 1994). 
Protein C and Protein S deficiency are inherited as an autosomal dominant 
trait and are both vitamin K-dependent proteins similar to factors VII, IX, and 
X and prothrombin (Marlar & Mastovich, 1990). 
Patients with decreased levels of Protein C and S are at high risk of venous 
thromboembolism and life long management with warfarin is recommended 
for this patient population (Griffin et ai, 1981; Broekmans et ai, 1983). 
Antithrombin III is a single chain plasma glycoprotein. Through its inhibition 
of thrombin, and other activated coagulation factors, Antithrombin III plays a 
central role in the regulation of haemostasis. Deficiency of Antithrombin III is 
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responsible for two per cent of thromboembolic diseases (Rosenberg, 
1975). 90-95 per cent of patients with thrombophilia develop OVT (Marlar & 
Mastovich, 1990). However, this DVT occurs in specific vessels (mesenteric, 
spleenic, hepatic) and based on its hereditary nature is usually recognised 
by surgeon and neurologist. The thrombotic state may occur spontaneously 
or related to some other underlying hypercoaguable risk factor such as 
trauma or pregnancy. 
Hypercoaguable states are resistant to conventional antithrombotic therapy 
(Shafer, 1985). Most patients are treated indefinitely with warfarin beeause 
of their predisposition to recurrent thrombotic events (Merli & Martinez, 
1987). 
The clinical indicators of primary hypercoaguable state as described by 
Shafer (1985) are summarised below: 
• Family history of thrombosis 
• Recurrent thrombosis without any apparent risk factor 
• Thrombosis in unusual sites 
• Thrombosis at an early age 
• Resistance to conventional venous thromboprophylaxis. Confirming a 
diagnosis frequently means life-long treatment with anticoagulants. 
Other miscellaneous risk factors 
A number of miscellaneous risk factors have been frequently cited in the 
development of OVT. Smoking, diabetes and gender have been implicated 
and recently long haul travel thrombosis has received much publicity. Each 
of the risk factors will now be considered in terms of their association and 
potential for OVT causation. 
Smoking 
The association between smoking' and cardiovascular disorders such as 
coronary heart disease and myocardial infarction is well-documented 
(Meade, 1983; Connaughton, 2001). The citation of smoking as a possible 
risk factor for DVT causation comes as no surprise. It is assumed that 
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smoking increases platelet adhesiveness by the release of catecholamines 
such as epinephrine caused by nicotine absorption. An alternative 
explanation is that smoking increases platelet adhesiveness by release of 
fatty acids, which may increase the build up of fibrinogen (Howel, 1970). 
Vessey & Doll (1969) first reported the association between cigarette 
smoking and OVf. In the study of the relationship between oral 
contraceptive and OVf, Vessey and Doll (1969) noted that their affected 
patients were heavier smokers than the controls. However, the difference 
between the case and control group was not statistically significant. In the 
study of mortality in relation to smoking among British doctors, no 
association was found between mortality from OVT and smoking (Doll & 
Peto, 1976). 
Analysis of Cigarette smoking as a clinical variable for OVf demonstrates a 
negative association (Clayton et ai, 1976). This report is further supported 
by Lowe et al (1982) who concluded that cigarette smoking is a subjective 
clinical variable and not a predictive index for OVT. Samama et al (1993) did 
not find any association between OVf and smoking in medical patients. 
On the other hand, increasing levels of cigarette smoking were found to be 
associated with a reduced incidence of OVT. Handley and Tether(1974) 
found that OVT incidence in the patients who gave a history of regular 
cigarette smoking within the month before admission was significantly lower 
than that of non smokers. This finding is confirmed by Marks and Emerson 
(1977) who reported leg thrombosis in 50 per cent in the control group who 
did not smoke but only 2 per cent in those who were Cigarette smokers. The 
protective effect of cigarette smoking is observed in all ages in both medical 
and surgical patients (Prescott et ai, 1978). Table 2.13 illustrates the 
incidence of OVT in relation to smoking habits. 
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Table2.13: DVT incidence and smoking habits 
Smoking habit Number of patients Number with DVT (%) screened DVT 
Non smoker 219 43 20 
Pipe smoker 21 4 17 
Cigar smoker 3 0 0 
1-9 cigarettes daily 50 7 14 
10-19 cigarettes daily 92 9 10 
20-39 cigarettes daily 89 9 10 
40+ cigarettes daily 12 0 0 
Data: Prescott et ai, 1978. 
Overall, there is sufficient evidence to conclude that smoking is not a risk 
factor. In some circumstances, smoking may even have a protective effect 
against DVT as seen in some patients after myocardial infarction: the 
smokers in the group had a lower incidence of DVT than the non-smokers 
(Meade, 1983). 
Diabetes as a risk factor 
Diabetes mellitus is the most common endocrine disorder known to diffusely 
involve the vascular system, predominantly the arterial side (Millbank, 1970). 
Although diabetes has frequently been cited as a risk factor for DVT, it is not 
certain whether patients with diabetes mellitus are at greater risk than non 
diabetic subjects. Relatively little literature exists on the question of venous 
thrombosis from diabetes per se. 
A frequency of 20 per cent of PE was reported in 349 diabetics aged 30 or 
over (Coon, 1976). However, of the 71 patients with PE, 52 had associated 
heart disease and 12 had other risk factors for DVT. In an autopsy study 
with multiple regression analYSis of risk factors, Havig (19n) found no 
association between diabetes and PE. Diabetics are susceptible to disease 
of the large arteries, especially those supplying the myocardium and the 
microvessels of the retina (Banga & Sixma, 1986). Arterial diseases are due 
to atherosclerosis or arteriosclerosis while venous diseases are the result of 
endothelial or valve damage (Rosendaal, 1997). 
62 
------------------------------------------------
Disturbance of fibrinolytic activity has been Implicated in diabetic patients. 
Decreased fibrinolytic activity has been detected in diabetes, particularly in 
Non Insulin Dependent Diabetes Mellitus (NIDDM). However, the 
relationship of these changes to vascular complications needs to be clarified 
by further studies (Banga & Sixma, 1986). 
Sex distribution 
Although gender difference has also been mentioned as a risk factor the 
percentage of males and females with detectable PE at autopsy is almost 
identical (Coon et ai, 1973). In the Worcester DVT study, Anderson etal 
(1991) reported a higher incidence of DVT for female subjects. However, 
after taking into account the fact that women live longer than men and risk 
factors such as pregnancy, the puerperium and the use of oral 
contraceptives, it appears unlikely that sex difference exists in the incidence 
of DVT. In hospital, men and women are reported to be equally affected 
(Coon, 1976}.The incidence of acute DVT in the population of Malmo, 
Sweden, during 1987 revealed no significant difference between men and 
women (Nordstrom et ai, 1992). 
Seasonal variations as a risk factor 
In many temperate countries, coronary events and strokes are more 
common in winter than summer (Wjlshurst, 1994). Fatal PE has also been 
reported more often in winter (Gallerani et ai, 1992). 
Physiologically, this trend is explained in terms of changes in coagulation 
factors and peripheral vasoconstriction, leading to reduced blood flow in the 
legs. On the other hand, venous stasis due to venodilation is greatest in 
summer (Boumerneaux et ai, 1996). To test these uncertainties, 
Bournerneaux et al (1996) reviewed data on patients with Dvr over five 
years. They concluded that in Geneva, a city with a continental climate with 
temperature differences between summer and winter, there is no seasonal 
variation in the incidence of DVT. 
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Bouley et al (2001) analysed discharge data for Dvr and PE in France over 
four years and claim that a clear seasonal variation exist in hospital 
admission for DYT and PE, suggesting thrombogenic factors could involve a 
seasonal trend. A sedentary lifestyle in winter encourages reduced mobility 
and predisposes to venous stasis. However, the study was retrospective 
and the accuracy of diagnosis of OYT and PE might be questioned. 
Traveller's thrombosis: myth or reality 
Traveller's thrombosis refers to a thromboembolic disease occurring 
generally after a prolonged airflight. OYT may be apparent a week or two 
after the flight and may not be preceded by a painful calf (Cruickshank et ai, 
1988). The term "Economy Flight Syndrome" was coined by Cruickshank et 
al (1988) who reported three cases of venous thrombosis after flying. 
Economy Class Syndrome raises the notion that the degree of being 
cramped may be an important aetiological factor. However it should be 
noted that one of the three cases travelled by business class and the other 
two cases were doctors. On this evidence, it could equally be called 
travelling doctor's syndrome. There is plausible physiological explanation as 
to why sitting for long periods might predispose to OVT (Milne, 1992). It 
seems likely that cramped seating for prolonged periods puts pressure on 
the popliteal and femoral veins and may have led to clot formation (Homans, 
1954). The development of DVT or PE is not limited to air travel. Homans 
(1954) described a 19-year-old woman with DVT after a drive from 
Nebraska to Boston. A very important factor in DVT and PE is likely to be 
the effect of immobility (Moyses, 1988). 
During flight dehydration occurs, and this can be further exacerbated by 
alcohol consumption, causing venous stasis and predisposing to DVT 
(Carruthers et ai, 1976). 
Reduced oxygen tension or reduced atmospheric pressure has been 
suggested as aetiological factors for DVT or PE (Carruthers et ai, 1976). It is 
unlikely that they do, otherwise an increased incidence of DVT in people 
living at altitudes or in patients with hypoxia would be reported. 
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On the other hand majority of patients with traveller's thrombosis appear to 
have other risk factors. At least one risk factor is present in 75-80 per cent of 
cases (Kesteven, 2002). The most common risk factors are previous DVT, 
malignancy, hormone treatment or recent surgery. This is consistent with 
Rosendaal's multi-hit theory in the aetiology of Dvr (Rosendaal, 1999). 
The association between air travel and DVT was documented by Ferrari et 
a11988) in a retrospective case control study. The researchers concluded 
that a history of recent air travel is found almost four times more frequently 
in the DVT group and the odds ratio in patients who travel is 3.98. 
Literature and publication like Ferrari et al (1988) lend support to the 
hypothesis that venous thrombosis is associated with air travel but carefully 
controlled studies are needed to test this association properly. Most of the 
studies give no details of the number of thromboembolic episodes from 
which those associated with travel were drawn. The cases described by 
Symington and Stack (19n) represented only 8 out of 182 cases of PE over 
three years, suggesting that travel is not a major cause. 
In a retrospective study of 254 patients, Eklof et al (1996) identified 44 
patients (24 males and 20 females) with a mean age of 63 years, who 
presented with venous thromboembolic complications. Flight times were 5-
17 hours. Seven cabin-related and five patient-related risk factors were 
identified. 
The seven cabin-related risk factors are listed below: 
• Low humidity 
• Dehydration 
• Diuretic effect of alcohol 
• Smoking 
• Hypoxia 
• Immobilisation 
• Coach position 
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The five patient-related risk factors present in varying percentages are 
tabulated below: 
Table 2.14: Patient-related risk factors in traveller's thrombosis 
Patient-related factors Percentage 
Previous DVT 34 
Malignancy or chronic diseases 25 
Hormone Replacement Therapy 16 
Recent lower limb injury 11 
Recent surgery 9 
Data: Ecklof et ai, 1996 
Although the patient-related risk factors may be potentiated by the cabin-
related risk factors, Ecklof et al (1996) concede that further work is required 
to support this assumption and concluded that modern air transportation is 
safe. 
There is no prospective epidemiological data to support the association 
between air travel and venous thrombosis, current evidence is weak and 
traveller's thrombosis is much less common than the impression created by 
recent publicity (Geroulakos, 2001). 
Summary of theoretical framework 
The review of the theoretical framework in the epidemiology of DVT has 
provided an understanding of the nature and magnitude of the problem. A 
discussion of the risk factors has also highlighted a theoretical model 
underpinning the clinical assessment of patients at risk of DVT. Such clinical 
data should be seriously considered in hospitalised patients. The risk factors 
are of practical value in predicting which patients are most likely to develop 
DVT. The data can also be used to stratify patients into DVT risk categories. 
Surgery, trauma, high risk diseases, advancing age, immobility, pregnancy 
and puerperium, oral contraceptives and other miscellaneous factors have 
been discussed in terms of their potential causation of DVT. Those risk 
factors have been examined to point out the commonality of the Virchow'S 
postulates and to justify their inclusion in the development of the Autar DVT 
risk assessment scale in chapter three. 
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Chapter Three 
Development of the Autar DVT risk assessment scale 
Risk generally refers to the probability of some untoward event. It is 
restricted to describe the likelihood that people who are without a disease, 
but are exposed to certain factors, will acquire the disease. Risk factors are 
those characteristics or events that have been shown to increase the 
probability of becoming diseased. While risk factors are indicators of an 
increased probability of a specific outcome, they mayor may not be directly 
related to the cause of the health problem (Harkness,1995). 
Risk assessment scales are developed to measure an individual's degree of 
risk. The recognised risk factors are translated into some quantifiable data, 
which identify the nature and degree of risk. Risk assessment facilitates the 
application of early and timely intervention that minimises potential 
complication or at the very best, prevents its occurrence completely. 
An ideal risk assessment tool has high sensitivity and specificity. Risk 
assessment tools have practical application and enable a systematic 
approach to risk assessment. However, risk assessment tools are no 
substitute for clinical decision making, based on continued observations and 
what the patient says, for this is often the best evidence (Castledine, 1997). 
Clinical and professional judgement supplements the application of a risk 
assessment tool. Although the Autar DVT risk assessment scale can stand 
alone, its consistency and predictive accuracy can be further enhanced by 
the complementary, effect of clinical decision making (Capper, 1999). For 
example, it does not necessary follow that an immobile patient on complete 
bed rest is unable to perform some ankle flexion and dorsiflexion exercise to 
promote venous return. In such a case, the nurse assessor must use the 
DVT scale as designed but also make written observation of the ability of 
the patient to execute simple instructions and carry out some form of ankle 
exercise. 
Prediction or probabilities can guide clinical decision-making (Altman 1994). 
Even when the prediction does not come true in an individual patient, it will 
usually be borne out in many cases (Fletcher, Fletcher and Wagner, 1996). 
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Patients' DVT risk assessment status does not usually remain static and 
fluctuates within a continuum of no risk to high risk (Table 3.1). 
Table 3.1: DVT risk continuum 
Risk categories Risk percentage 
No risk 0 
Low risk <10 
Moderate 11-40 
High risk 41> 
Data: Salzman & Hirsh, 1982; Hull et ai, 1986; Caprini et ai, 1988; 
Anderson & Wheeler, 1995. 
DVT prognostic indices 
The Autar DVT scale was developed and named after the investigator to 
differentiate it from the other DVT prognostic indices chronologically listed 
below: 
• Nicolaides and Irving, 1975 
• Clayton et ai, 1976 
• Lowe et ai, 1982 
• Sue-Ling et ai, 1986 
• Janssen et ai, 1986 
• Rocha et ai, 1988 
• Arcelus et ai, 1991 
• Caprini et ai, 1991 
• Bahal & Silverman, 1993 
Extensive search and review of medical literature have highlighted the 
plethora of prognostic indices listed above for the identification of patients at 
risk. Nicolaides and Irving (1975) devised a method that could determine the 
risk of DVT in patients before surgery without the need for special 
haematological tests. Using a multivariate analysis and logistic regression, 
they identified age, varicose veins, history of DVT and PE, premedication 
with Omnopon, obesity and severity of operation as discriminating clinical 
risk factors. 
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Clayton et al (1976) devised a simple prognostic index for predicting which 
patients would develop postoperative DVT. It comprised five variables 
deemed to be of the best predictive power which were: 
• Euglobulin (ELT) 
• Age (Yrs) 
• Presence of Varicose Veins (Var) 
• Fibrin Related Antigens (FRA) 
• Percentage Overweight (OWl) 
The equation of the prognostic index is: 
I: Index = -11.3 + 0.009 (ELT) +0.085 (Age) +2.19 (Var), 1 when present 
and 0 when absent) + 0.22 (FRA) + 0.043 (Own. 
Validated on 124 patients undergoing major gynaecological surgery, the 
prognostic index identified 95% of those who developed DVT and 
misallocated 28% of those who did not develop DVT. 
Further to confirm the validity of the Clayton predictive index, Rakoczi et al 
(1978) tested it on patients undergoing abdominal hysterectomy for 
malignant diseases. A cutoff score of +4 for the equation identified 8 of 9 
patients with DVT. The promising reported results generated considerable 
interest into further validation of the tool. Crandon et al (1980) investigated 
62 consecutive patients aged 40 years or older undergoing major 
gynaecological procedures by either vaginal or abdominal routes. The 
predictive index identified 9 out of 10 patients correctly and incorrectly 
identified 7 out of 52 patients. 
Lowe et al (1982) modified and applied'the Clayton et al index to 144 
patients aged 40 and over undergoing gastrointestinal surgery. The five 
variables were age, weight, presence of varicose veins, sex and cigarette 
smoking, plus a battery of non routine laboratory variables such as Plasma 
viscosity, Blood viscosity, Plasminogen, Fibrinogen, Red Cells Deformability. 
Using stepwise logistic discriminant analysis, Sue-Ling et al (1986) identified 
7 out of 18 clinical and laboratory variables to construct an index for 
preoperative prediction of patients at high risk of DVT after major elective 
abdominal surgery. The seven diSCriminating variables were age, ELT, 
previous abdominal surgery, varicose veins, antithrombin III concentration, 
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cigarette smoking and platelet count. Preoperatively, the predictive index 
correctly identified 91 % of patients in whom DVf developed and wrongly 
allocated to the high risk group 19% of those in whom it did not The 
application of successful DVf prophylaxis depends on the ability to identify 
high-risk patients. To this end, Janssen et al (1987) devised an interactive 
computer programme to aid physicians' predictive power and not to 
preclude their clinical judgement. The programme comprised of 21 risk 
factors drawn from the literature. Each of the factors was assigned a relative 
risk based on available data. 
Rocha et al (1988) also used a stepwise logistic discriminant analysis to 
identify preoperative DVf predicting factors. The three laboratory variables 
identified were Fibrinogen Degradation Product (FOP), Plasminogen 
Activator Inhibitor (PAl) and tissue Plasminogen Activator (t-PA). The 
laboratory variables were measured in one hundred and eleven patients and 
achieved 100% sensitivity and 95% specificity. 
Laboratory variables are far from being user-friendly and in the interest of 
reproducibility, robustness and ease, Ruckley (1985) suggests that simple 
clinical criteria could be used to identify those at risk of DVf. Such clinical 
features would fit automatically into ward routine and are much more likely 
to be consistently and successfully applied. In the footsteps of Ruckley 
(1985), Caprini et al (1991) and Arcelus et al (1991) developed a risk 
assessment score sheet based on 20 clinical risk factors for assessment of 
surgical and medical patients respectively (appendix 1). The index was 
derived from primary and secondary hypercoaguable states that are 
frequently associated with DVf. No validated data were reported as to the 
efficacy of the two predictive indices. 
Bahal and Silverman (1993) developed a DVf risk assessment sheet based 
on 13 recognised risk factors. A scoring protocol identified the high risk 
category. No predictive data were available, although its evaluation audited 
a high uptake of prophylaxis when a formal risk assessment chart was in 
place. 
Numerous problems have been identified with these prognostic indices. The 
frequently tested Clayton et al (1976) index was biased towards a 
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favourable result for their own types of patient from whose data it had been 
originally derived. 
The instruments developed by the various investigators are dissimilar both 
in terms of contents and the weighting of the risk factors. The equations 
derived to calculate the cutoff scores are forbiddingly complex and the 
haematological variables have tended to be specific to their home laboratory 
(Gallus, 1989). Lack of standardisation in the laboratory procedure for 
estimating ELT inevitably accounts for inconSistency in the results. For 
example, the higher cutoff point used by Rokoczi (1978) resulted from 
longer ELT. Although Fibrinogen estimation in the detection of DVT is cheap 
and widely available, there is an urgency to standardise methodology or 
establish an international standard. Palareti et al (1991) found that 
calibrated procedure proposed by the manufacturer of a standard analysed 
kit was not always precise. Poller and Taberner (1982) also reported an 
international variation in the mean Warfarin dose due to the different types 
of thromboplastin tissue used in blood clotting tests. 
Lowe (1993) concedes that some of the haematological variables are more 
predictive of arterial thrombotic events than venous thromboembolism. 
Arterial thrombosis is associated with atherosclerosis whereas venous 
endothelial damage is implicated in DVT (Rosendaal, 1997). 
Some of the clinical variables identified as discriminating risk factors are 
inexplicable and may have occurred by chance. Lowe's index (1982) 
identification of smoking as a risk factor shows no positive association with 
DVT (Prescott et ai, 1978, Meade, 1983). Nicolaides and Irving (1975) 
identify omnopon premedication as an independent risk discriminant, 
without any explanatory biological foundation. 
The Janssen et al (1987) interactive computer programme based on 21 
relative risk factors was derived from out of date data. Some risk factors . 
were identified but not assigned any relative risk value. For example, it is 
generally acknowledged that varicose veins are a risk factor, albeit direct or 
indirect in nature. However, the computer interactive programme did not 
assign any relative risk percentage to varicose veins. 
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Because many of the prognostic indices were developed for a specific 
clinical area, they varied in contents, cutoff scores and practical application 
and therefore lacked transferability. The Clayton et al index used in 
gynaecological surgery is not readily applicable to other general surgery. 
Similarly, although the Rocha et al index (1988) achieved high sensitivity, 
arguably, the predictive index for an already high risk group such as total hip 
replacement, does not permit generalisation of findings. Additionally, as 
illustrated in table 3.2, five investigators have used different cutoff levels for 
the same predictive index, with varying outcomes. 
Table 3.2: Cutoff levels for Clayton et al predictive Index 
Investigator Cutoff level Sensitivity % Specificity % 
Where I = Index 
Clayton et al,1976 1= -2.5 95 72 
Crandon et al,1980 1= -2.0 90 87 
Rokoczi et ai, 1978 1= -2.5 100 20 
Lowe et ai, 1980 1= 1.75 90 52 
Melbring & Dalgren, 1983 1= 1.75 76 27 
Sue-Ling et ai, 1986 1= -1.5 91 69 
Adapted from: Gallus, 1989 
Lowe et al (1982) developed a simple index based on age and body weight 
and claim that it was a useful basis for selecting DVT prophylaxis in 
gastrointestinal surgery. When Melbring and Oahlgren (1983) looked for 
OVT in similar patients, they found that the Lowe index had low sensitivity 
and specificity and concluded that it did not work (table 3.2). An instrument 
that is transferable to a number of settings is likely to yield more information 
not only about its reliability and validity, but also about the practicalities, 
appropriateness, acceptability and suitability of the instrument (Gibbon, 
1998). 
Although a few predictive indices have shifted their focus from laboratory 
variables to essentially clinical risk factors to eliminate delay in decision 
making, they are not readily understood in terms of why some individuals 
with risk factors develop OVT relative to those who do not. 
The majority of the assessment strategies available to predict patients at risk 
of OVT continue to be laboratory-dependent, expensive, invasive in nature 
____________________________________________ 72 
and remain the prerogative of medical staff. Nurses are well placed to 
manage proactively the OVT risk assessment and its primary prevention. 
Two audit studies have demonstrated that when nurses are actively involved 
in risk assessment of patients, the uptake of venous prophylaxis is 
increased by 50 percent (Bahal and Silverman, 1993, Byrne et al 1996). A 
risk assessment tool that is easy to understand and apply, user friendly and 
inexpensive is more likely to be accepted by everyone. It can make a major 
contribution to further harmonisation between the clinical roles of nurses and 
doctors to enhance the notion of collaborative care. One such assessment 
tool was developed to assess the level of consciousness by Teasdale and 
Jennett (1974). The popular and well-established Glasgow Coma Scale 
devised to monitor altered level of consciousness, is effectively applied by 
nurses and doctors alike. Its psychometric properties are easily understood 
and the coma scale is now universally accepted. 
The need for a generally applicable scale for assessing patients at risk of 
OVT is clinically justified on the following arguments: 
• Clinical diagnosis of OVT is notoriously unreliable even to the most 
watchful observer and there is general agreement on the need to assess 
patients to guide decision making (Prandoni and Mannucci, 1994; 
THRiFT, 1998). Barnes (1982) found approximately 50% inaccuracy 
when using the Homans' sign to make a diagnosis of OVT. In 
Homans'sign, pain is elicited on dorsiflexion. Two thirds of venous 
thrombi are silent (Salzman, 1986) and only 3.5 % of patients develop 
clinical symptoms (Caprini and Natonson, 1989). 
• Assessment of patients into DVT risk categories enables the 
implementation of the most appropriate venous thromboprophylaxis 
strategies, as recommended by consensus groups. 
• A formalised risk assessment protocol increases the uptake of venous 
thromboprophylaxis (Bahal and Silverman, 1993, Byrne et aI, 1996). 
• There are marked inconsistencies in the existing system for assessing 
patients at risk of OVT. A diagnosis of potential problem of OVT provides 
a very crude index of risk assessment. A systematic and objective 
assessment of risk factors should be performed on each patient to 
facilitate a management plan (Paiement and Mendelsohn, 1996). Unless 
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the degree of risk is precisely identified, venous thromboprophylaxis is 
likely to be ineffective. 
• There is a lack of an organised strategy for DVT risk assessment, 
resulting in ambiguities and misunderstandings during communication 
and decision-making (Vanek, 1991). 
Objectives of the Autar DVT scale 
The Autar DVT scale (1994,1997) as illustrated in figures 1 and 3 was 
developed to: 
• provide objective evidence of risk status 
• provide a DVT risk calculator that is simple to be used equally 
reproducibly by nurses, medical staff and other health care professionals 
• provide a comprehensive assessment of patients at risk of DVT 
• calculate the degree of risk in an individual, in the context of multifactoral 
aetiology, across diverse clinical areas. 
• provide consistency in the clinical assessment of practice 
• provide evidence to support decision making and practice 
• enable the application of preventative measures, commensurate with the 
category of risk 
• allow the targeting of limited resources 
• provide quantifiable data for auditing purposes and quality assurance 
• develop a body of clinical nursing knowledge, embedded in practice. 
• provide a teaching tool for the understanding of the pathophysiology of 
DVT. 
• empower nurses within the scope of professional practice (UKCC 1992, 
Autar, 1996 b) and the Higher Level of Practice (HLP) framework 
proposed by the UKCC (2001). With the inception of Advanced NurSing 
Practitioners, nurses are now exploring new territories and developing 
new roles in the interest of enhancing patient care. HLP has already 
contributed to the appointment of Nurse Consultant and is already being 
used to structure job description, inform life long learning and support 
risk management. 
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IMAGING SERVICES NORTH 
Boston Spa, Wetherby 
West Yorkshire, LS23 7BQ 
www.bl.uk 
TEXT BOUND CLOSE TO 
THE SPINE IN THE 
ORIGINAL THESIS 
Name: 
Unit No: 
Ward: 
Age Group 
10-30 
31-40 
41-50 
51-60 
61+ 
Build 
Underweight 
Average 
Overweight 
Obese-
Very Obese 
Risks 
Ambulant 
Umited (uses aids self) 
Very limited (needs help) 
Chair bound 
Complete bed rest, 
Figuretbree Autar DVT -RiskAssessment Scale (Revised 1997) 
BMI 
16-19 
20-25 
26-30 
31-40 
41+ 
Score 
0 
I 
2 
3 
4 
Score 
0 
I 
2 
3 
4 
BMI = wt(kg)lht(m)l 
Score 
o 
1 
2 
3 
'" 
.'!, .. ~ .. ",:·~,~,1$":"""'H' j" 
Oral contraceptive: Score 
I 20-35 yrs 
35+ yrs 2 
I Pregnancy/Puerperium 3 
Score ~6 
Score 7-10 
Score 11-14 
Score 15~ 
No risk 
low Risk «10%) 
Moderate Risk (11-40%) 
High Risk (>41%) 
Please tick the appropriate presCTibed OVT prophylaxis 
Leg Elevation 
Graduated Elastic Compression Stockings (GECS) . 
Pneumatic Compression (PC) 
Intennittent or . 
Continuous 
Heparin 
Heparin Sodium (standardlunfrilctionated) 
Calciparine {heparin calcium) 
Minihep (heparin sodium) 
Minihep Calcium (heparin calcium) 
Monoparin (heparin sodium) 
Monoparin Calcium (heparin calcium) 
Multiparin (heparin sodium) 
Pump-Hep {heparin sodium) 
Unihep {heparin sodium) 
Uniparin (heparin sodium) 
Uniparin Calcium {heparin calcium) 
Low Molecular Weight Heparin 
Fragmin (dalteparin sodium) 
Oenne (enoxaparin Heparin) 
lMohep (tinzaparin) 
logiparin (tinzapann) 
Warfarin 
Others, please specify: 
No Prophylaxis 
, ! 
o 
o 
o 
o 
o 
o 
o 
o 
Cl 
o 
Score item(s) ONLY pre-operatively 
Head 
Chest 
Spinal 
Pelvic 
IlowerUmb 
Score only ONE appropriate item 
Minor Surgery «30 mins) 
Major Surgery 
Emergency Major Surgery 
Thoracic 
Abdominal 
Urological 
Neurosurgical 
Orthopaedic 
Ulcerative Colitis 
Anaemia: Sickle Cell 
Polycythaemia 
Haemolytic 
Chronic Heart Disease 
Myocardial Infarction 
Malignancy 
Varicose Veins 
Previous DVT or 01 A 
Score 
I 
I 
2 
3 
4 
Score 
1 
2 
3 
3 
3 
3 
3 
4 
Score . 
I 
2 
2 
2 
3 
4 
5 
6 
7 
Identift ~ items, odd and ~ score bdow 
Assessor Date ScOre 
.PHPP 1) P,.f Auu/ "r,JifJltl 1-"7 
The Autar DVT scale is based on Virchow's triad in the genesis of DVT. In 
the selection of the risk factors to prospectively identify patients prone to 
DVT, the dependent and explanatory variables are considered. The 
dependent variable is DVT and the explanatory variables are the risk factors 
whose presence or absence is associated with occurrence of DVT (Sigel et 
al,1974). 
In the consideration of the risk factors for DVT the following criteria are 
taken into account: 
• The natural history of DVT 
• Initial selection of risk factors 
• Relative risk. 
For the purpose of this study, the natural history of DVT has been divided 
into three stages, namely: 
1. Susceptibility: This relates to the presence of relatively permanent 
factors, which increase the likelihood of DVT in an individual. Factors as 
age, sex and persisting or permanent disease such as chronic heart 
failure, CVA and varicose veins are example of these. 
2. Predisposing factors: These are factors which are often reversible but 
which may initiate and enhance the development of DVT. When these 
effects are diminished, there is a reduction in the likelihood of DVT. 
Trauma, immobility, obesity, surgical interventions and high-risk diseases 
such as ulcerative colitis, acute myocardial infarction and malignancy are 
some contributory factors. 
3. The clinical condition: This refers to patients with a previous history of 
DVT who may be at high risk for the development of further DVT 
episodes. Samarna et al (1993) claim that patients with DVT are eight 
times likely to have recurrence of the condition. 
Initial selection of risk factors: This relates to the most independent and 
discriminating predictors of DVT. In the selection of the best predicting risk 
factors, the investigator was guided by the review in the literature and by 
generally accepted clinical tenets. Additional information was also available 
from the pilot study previously undertaken (Autar, 1994). 
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Relative risk: The effect of a risk factor can be measured by means of an 
odds ratio or relative risk (Fleiss, 1973). The relative risk of a factor depends 
on the incidence of DVT in patients with and without that variable. Relative 
risk is independent of the actual frequency of DVT in different population. 
For example, a patient who is immobile is seven times more likely to 
develop DVT than one who is fully ambulant (Samama et ai, 1993). 
The Autar DVT scale is conceptualised on the triad of aetiological factors 
postulated by Virchow, which are fully addressed in chapter two. 
The DVT scale is composed of seven distinct subscales of risk factors 
drawn from the extensive literature review from nationally and internationally 
recognised authority (NIH, 1986; SIGN, 1985; International Consensus 
Statement. 1997; THRiFT 11, 1998). 
The seven parameters of the subscales are illustrated in table 3.3. 
Table 3.3: DVT 8ubscales. 
DVT subscales Item rating 
Age Specific Group 0-4 
Build I Body Mass Index ( BMI) 0-4 
Mobility 0-4 
Special Risk Category 1-4 
Trauma Risk Category_ 1-4 
Surgical Intervention Category 1-4 
High Risk Diseases 1-7 
Data: Autar, 1996 a; Autar, 1997 
The descriptors or options in each subscale are assigned a risk score in the 
light of their relative risk and potential for initiating DVT. A value of 0 is 
assigned to no risk and a score of 1 to the lowest risk factor. Other risk 
factors are calculated relative to this value based on previous studies and 
the incidence of DVT. Independent and high risk factors in the genesis of 
DVT are weighted at a score of 4 or more. 
It is the purpose of this section to draw on the most relevant reviewed 
theoretical framework and biological basis of DVT to highlight the rationale 
. underpinning the selection of the well-recognised risk factors and their 
clinical justification as covariates of the Autar DVT scale. 
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Age specific group 
Kakkar et al (1970) and Nicolaides & Irving (1975) reported a strong 
correlation between advancing age and the risk of DVT. In their prognostic 
indices developed to identify patients prone to OVT, Clayton et al (1976); 
Lowe et al (1980) and Sue-Ling et al (1986) have convincingly 
demonstrated that increasing age is not just a significant risk factor but also 
has a powerful predictive power. 
The age specific group subscale comprised of five distinct age groups 
(Table 3.4). 
Table 3.4: Age specific group 
Age group Item rating 
10-30 0 
31-40 1 
41-50 2 
51-60 3 
61+ 4 
Young age appears to have a protective effect against OVT (Rohrer et al. 
1996). The descriptor 10-30 age group of the subscale is assigned a score 
of 0 to indicate that patients in this group are not at risk. Incidence of DVT is 
very rare in children (Jones & Mclntyre, 1975) and an incidence of 7 per 
100,000 children per year has been estimated (Hirsh & Hoake 1996; 
Rosendaa', 1997). Young patients who develop OVT invariably have strong 
risk factors (Coon 1976; Berstein et al,1986; David & Rivard,1991). 
Incidence of DVT rises after the age of 30 (Coon, 1976) and Janssen et al 
(1987) computed a relative risk of 1 for patients over 35 years old. Equally, a 
weighted score of 1 is allocated to the 31-40 age group of the subscale. 
The risk of OVT rises sharply after the age of 40 (Caprini et ai, 1991; 
THRiFT, 1992). Kakkar et al (1970) reported a DVT incidence of 24 % in 
patients between the age 41-50 and 47% for those in the 60-80 years old. 
Samama et al (1993) claim 50% of DVT occurs in patients in their 60-80's. 
As DVT increases exponentially with advancing age (OpeS 1990; 
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Rosendaal, 1997) descriptors 51-60 age group and 61+ are assigned the 
relative weighted score of 3 and 4 respectively. 
Build I Body Mass Index (BMI) 
In this subscale, patients are broadly classified into one of the five groups of 
builds, according to their body mass index (Table 3.5). 
Table 3.5: Build I Body Mass Index (BMI) 
Build Item rating 
Underweight 0 
Average ( normal I acceptable) 1 
Overweight 2 
Obese 3 
Very Obese 4 
Build is a subjective term and is often ill-defined In clinical studies (Anderson 
et ai, 1995). BMI offers a simple and objective assessment of patients' 
builds derived from the formula: 
BMI=Welght (kg) I Height (m2) 
Another major advantage of the BMI is that the standards are applicable to 
both male and female patients. A BMI build conversation chart is 
landscaped on the reverse of the DVT scale data collection tool, to facilitate 
quick and ready reckoning of the build (figure four: p 108). 
The incidence of DVT in overweight patients is 47.9% compared to 21.7% in 
non-obese patients as illustrated in table 3.6. 
Table 3.6: Incidence of DVT by build 
Build DVT Incidence % 
Underweight 21.7 
Average 27.2 
Overweight 47.9 
Data: Kakkar et ai, 1970. 
_______________________________________________ 79 
There is an association between obesity and the risk of DVT but its 
significance disappears when other risk factors present in patients are 
considered (Nicolaides & Irving, 1975). Coon (1976) also reports that 
obesity increases the risk of DVT and PE between 1 to 5 times that of the 
general patient population. Noting the finding of Coon (1976) Janssen et al 
(1987) assigned a 1.5 times greater risk of DVT for obese than non obese 
patients, in their interactive computer risk assessment programme. 
Although the effect of obesity on the risk of DVT is inconclusive and 
questionable, Anderson et al (1995) concede that it is only an additive 
marker, not necessitating prophylaxis in itself. 
From the physiological perspective, obesity is associated with diminished 
venous return (Christopoulos et ai, 1980; Mammen 1992). Some impairment 
in their fibrinolytic system has also been reported (Vanek, 1991; Poller, 
1993). 
In the light of available data, in this subscale, the underweight patients have 
a rating of 0 and a score of 1 assigned to the average build. The obese and 
grossly obese patients who are three times at risk of DVT (Samama et ai, 
1993) are allocated a score of 3 and 4 respectively. The assignment of a 
score range of 0 for the underweight build and 4 for the very obese is also 
harmonious with the grading system of build and Body Mass index (Table 
3.7) 
Table 3.7: Grading system for Build and Body Maaalndex 
Grading system for build and BMI 
Grade Build Body Mass Index (BMI) 
0 Underweight 16-19 
1 Averagel desirable 20-25 
2 Overweight 26-30 
3 Obese 31-40 
4 Very obese 41+ 
Data: Garrow & Webster, 1985 
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Mobility 
There is a striking relationship between immobility and the incidence of DVT 
(Gibbs, 1957; Warlow, 1978; Kierkegaard et ai, 1987). In the mobility 
subscale, patients were identified into one of the five functional levels of 
classification (Table 3.8). 
Table 3.8: The five levels of functional mobility. 
Mobility Item rating 
Ambulant 0 
Limited (uses aids, self) 1 
Very limited (needs helpl 2 
Chair bound 3 
Complete bed rest 4 
Immobility causes impairment of the venous pump and stasis which is one 
of the three elements in Virchow's triad predisposing to DVT. It is generally 
recognised that early mobilisation minimises the risk of DVT (Rose,1979; 
Kierkegaard et ai, 1987). The old and trusted prophylactic approach to DVT 
is early ambulation. During weight bearing, a venous plexus in the sole is 
rapidly emptied into the deep vein of the leg. This flow produced by 
mobilisation, flushes out the valve pockets in which thrombi are thought to 
originate (Gardner & Fox, 1983). 
The ambulant patients are judged not to be at risk and are assigned a zero 
score. Patients who have limited mobility and use aids (self) are given a 
score of 1 and for those who have very limited mobility and require the 
assistance of another person, a relative risk score of 2 is deemed 
appropriate. 
Poor sitting position causes venous stasis (Singer, 1983; Schaubs et ai, 
1984). The chair bound patients were assigned a score of 3 as "prolonged 
Sitting position occasions a degree of dependency stasis·, resulting in the 
formation of DVT (Homans, 1954). Sitting in a chair or on the bed with the 
legs dangling dependently serves to worsen stasis and increases the risk of 
DVT (Rose, 1979). 
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Kierkegaard et al (1987) reported a DVT incidence of 13 percent in non-
surgical bedridden patients. In immobilised multiple trauma patients, a DVT 
incidence of 69 percent has been recorded (Kudsk et ai, 1989). The 
frequency of DVT following complete bed rest is mainly due to the scarce 
utilisation of the calf muscle pump with venous stagnation in the lower limbs 
(Gibbs, 1957). Confinement to bed is synonymous with muscle inactivity 
(Kaisary, 1980) and the completely bed ridden patients are judged to at high 
risk of DVT and fittingly assigned a score of 4. 
Special risk category 
Hypercoagulability is the most pronounced element of Virchow's triad 
present in this special risk category. This subscale comprises aetiological 
risk factors such as oral contraceptives and pregnancy and puerperium 
(Table 3.9). 
Table 3.9: Special risk category 
Special risk factor Item rating 
Oral Contraceptives: 20-35 years old 1 
Oral Contraceptives: 35+ years old 2 
Pregnancy and Puerperium 3 
In patients taking oral contraceptives, Coon (1977) documented an 
increased probability of clotting problems due to: 
• Increased vascular endothelium permeability. 
• Reduced venous tone. 
• Reduced blood flow velocity 
• Increase in clotting factor levels. 
The relative risk of oral contraceptives depends on the dose of oestrogen 
(Stadel, 1981). The risk of DVT is twice as high with "third generation" oral 
contraceptives containing desogestrel and gestodene (WHO, 1995). 
Sartwell et al (1969) attributed a risk factor of 4.4 times as the average value 
for oral contraceptives. However, a 50 microgram dose of oestrogen is 
arbitrarily assigned a risk of 1, 100 microgram dose as causing 3.2 times 
increased risk and 150 microgram as resulting in 5.9 times increased risk 
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01essey & Inman, 1973). On the other hand, lowering the dose of oestrogen 
(Anderson et ai, 1995) has markedly reduced the risk of DVT associated 
with oral contraceptives. 
Among women taking oral contraceptives, Vessey and Doll (1970) reported 
2.5 times increased incidence of DVT in those aged 35-44 group over 
women in the 20-34 group. Noting this finding, the women in 20-34 age 
group are assigned a score of 1 and a relative score of 2 used for the over 
35 years old. 
The increased risk of DVT during pregnancy and puerperium period is 
approximately 5.5 times that of nonpregnant women who are taking no oral 
contraceptive (Coon, 1977). Natural haematological changes occur during 
pregnancy. Fibrinogen levels in the blood in late pregnancy are at least 
double the levels found in the nonpregnant state (Letsky, 1989). As 
illustrated in table 3.10, pregnancy is a more risky option than taking the 
combined oral contraceptives (Allotey and Louca, 1997) and this risk factor 
is assigned a relative risk score of 3. 
Table 3.10: Annual DVT Incidence per 100,000 women 
Risk factor DVTcases 
Non pregnant and no oral 5 
contraceptive 
Combined oral contraceptive 15 
High risk combined oral 30 
contraceptive 
(Third generation contrace(!tives} 
Pregnancy and Puerperium 60 
Data: Family Planning and Reproductive Health Care,1995 
Trauma risk category 
Varied reports on multiple traumas and the diverse nature of the injuries 
have made it very hard to interpret the data. Shackford et al (1990) claim 
that the incidence of DVT in trauma patients has been artificially over 
estimated. This is largely due to the inclusion of an elderly population of 
patients with hip fractures who are already a high risk group. However, in a 
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prospective study of venous thromboembolism after major trauma, Geerts et 
al (1994) found DVT in 47% of the patients. 
The Trauma Risk Category subscale is represented by five musculo-skeletal 
injuries (Table 3.11). 
Table 3.11: Trauma risk category subscale 
Trauma risk factor Item rating 
Head injury 1 
Chest injury 1 
Spinal injury 2 
Pelvic injury 3 
Lower limb inlury 4 
Coon (1976) claims that all patients with accidental trauma, irrespective of 
sites, are at risk of DVT. Although head and chest injuries are associated 
with DVT development, their actual percentage is not significantly higher 
. than that expected in the general patient population. Head and chest injuries 
carry 2.5% risk each and it increases to 14% for spinal injury. An average 
incidence of DVT of 38% is associated with spinal injury (Geert et ai, 1994), 
although varied reports in literature have documented DVT, ranging from10 
t0100% depending on the method of evaluation (Merli et ai, 1988). The 
estimated risk for pelvic injury is 22% (Coon, 1976) and DVT was found in 
56% of trauma patients (Geerts et ai, 1994). Lower limb trauma patients are 
a high risk group and DVT incidence ranges between 77-80% for tibial and 
femoral fractures (Geerts et ai, 1994, Turpie, 1997). Risk of DVT is 
calculated at 1.4 times for spinal fractures, 2.7 times for pelvic fractures and 
approximately 5 times for tibial and femoral fractures (Janssen et ai, 1987). 
Based on the available data on trauma, the muscular skeletal trauma items 
are scaled according to their ascending percentage of risk and potential for 
causing DVT. 
Head and chest injury is each apportioned a score of 1. Spinal and pelvic 
injuries are rated a risk score of 2 and 3 respectively. All three elements of 
Virchow's triad are present in lower limb injury and this item is affiliated with 
a score of 4. In multiple trauma patients, more than one risk factor may be 
present, in which case, the risk scores are summated. 
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The trauma risk category subscale is applicable to patients in both the 
surgical and orthopaedic specialities. Head and chest injury patients are 
more likely to be admitted to the surgical directorate and spinal, pelvic and 
lower limb injuries to the orthopaedic and trauma unit. 
It is recommended that this subscale is recorded only preoperatively and is 
ignored as and when the patient has the appropriate surgical procedure in 
the surgical intervention category of the OVT scale. The surgery indicated 
for the trauma by its very therapeutic and corrective nature cancels the 
trauma risk category. For example, a patient with a hip fracture would 
initially be assigned a score of 4 from the Trauma subscale but this would 
then be substituted by a new score of 4 for the orthopaedic surgery in the 
surgical intervention subscale. Concurrent scoring of both the trauma risk 
category and surgical intervention subscales inflates the aggregate score, 
over estimates the risk, misclassifies the patient and consequently predicts a 
false positive (Autar, 1994). 
Surgical Intervention category 
It is well recognised that OVT is a common postoperative complication 
(Lindblad, 1991) and surgery is the leading risk factor (Moser, 1989). All the 
three elements of Virchow's triad are interactive: venous stasis, 
hypercoagulability and vessel trauma. 
The surgical intervention category subscale comprises eight surgical 
options, ranging from minor surgery, posing low risk of OVT to orthopaedic 
surgery, notorious for its very high incidence of OVT (Table 3.12), 
Table 3.12: Surgical Intervention category subscale 
Type of surgery Item rating 
< 30 mins 1 
2 
3 
3 
3 
3 
3 
3 
4 
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Only one appropriate surgical option is applicable to patients. The options 
cover a wide range of surgical specialities, signifying the universal 
applicability of the DVT scale. 
There is a positive correlation between the duration of surgery and the 
incidence of DVT (Borrow and Goldson, 1981; Moser, 1989). The 
performance of a surgical procedure on a patient requiring more than 30 
minutes of general anaesthesia is a critical risk factor. Gouke (1989) defines 
major surgery as a procedure requiring general anaesthesia for more than 
30 minutes. This definition has serious implication for even a relatively 
simple procedure requiring 30 minutes of anaesthesia and places the 
patient at risk. Flanc et al (1969) first reported an incidence of 44 percent of 
DVT for major surgery, in comparison to a low 15 percent for minor surgery. 
Elderly patients in their 60-80's undergoing minor surgery have a DVT 
incidence of 31.6 percent compared to 51 percent for major surgery 
matched for the same age group (Kakkar et ai, 1970). 
Appropriately, minor surgery is weighted at a low risk score of 1 and 2 
assigned to major surgery. Incidence of DVT ranges from 0.2-2.2 percent for 
elective major surgery compared to 2.7 percent for emergency major 
surgery and the latter is given a risk score of 3. 
The overall frequency of thromboembolic complications after thoracic, 
gynaecological, abdominal, urological and neurosurgery is relatively of the 
• same magnitude (International Consensus Statement, 2001). It is for this 
reason that they are all assigned a risk score of 3(Table 3.12). 
Some surgical procedures are associated with comparatively higher 
incidence of DVT than others. The risk following below waist orthopaedic 
surgery is greater due to manipulation of the leg causing distortion and 
occlusion of the femoral vein (Stamatakis et ai, 1977). One in two patients 
undergoing total hip replacement develops DVT (Parker-Williams and 
Vickers, 1989). Table 3.13 illustrates the incidence of DVT with different 
types of surgery. 
____________________________________________ 86 
Table 3.13: Association between types of surgery and Incidence of 
DVT 
Types of surgery DVT incidence (%) 
Orthopaedics: 
Knee arthroplasty 75-84 
Hip fracture repair 60-70 
Hip arthroplasty 30-65 
AbdominoThoracic 26-33 
General abdominal 3-51 
Gynaecological 7-45 
Urological: 
Transvesical 21-51 
prostatectomy 
Neurosurgery 29-43 
Data: Becker, 1986; Das, 1994 and Zahn et ai, 1999 
Proportional to the average incidence of DVT associated with the types of 
surgery, thoracic, abdominal, gynaecological, urological and neurosurgery 
are all assigned a rating risk score of 3. All below waist orthopaediC 
procedures carry a risk score of 4. 
High risk diseases category 
In this subscale, ten high risk diseases are represented (Table 3.14). 
Table 3.14: High risk diseases 
High risk diseases Item rating 
Ulcerative colitis 1 
Anaemia: Sickle cells 2 
Polycythaemia 2 
Haemolytic 2 
Chronic heart disease 3 
Myocardial infarction 4 
Malignancy 5 
Varicose veins 6 
CVA 7 
Previous DVT 7 
One or more risk factors may be present in a patient. This subscale is not 
primarily confined to the medical directorates as such pre-existing illnesses 
are commonly encountered in many other clinical areas. The evidence that 
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significantly more than half of the postoperative OVT is present prior to 
surgery emphasises the importance of the pre-existing diseases as a cause 
of DVT (Wright et ai, 1951, Sevitt and Gallagher, 1969). One of the three 
elements of Virchow's triad is implicated in the high high risk diseases. 
Ulcerative colitis, the anaemias and malignancy are characterised by 
increased in procoagulants. The cardiovascular disorders such as chronic 
heart failure and myocardial infarction cause venous stasis and intimal 
vessel wall changes and damage to the valves are evident in varicose veins 
and previous OVT. The association between the incidence of OVT and the 
high risk diseases is illustrated in the following studies: (Table 3.15). 
Table 3.15: The association between high risk diseases and Incidence 
ofDVT 
Study Diseases DVT% 
Edward and Truelove,1964 Ulcerative colitis 1.3-6.4 
Truelove,1984 
Wyshock et al,1988 
Shafer,1985 Sickle cell anaemia Insufficient and 
Polycythaemia vera unclassified data 
HaemolytiC anaemia 
Coon,1977 Heart failure 10-20 
Coon.1977, Carter et ai, Myocardial infarction 20-40 
1987 
Kakkar et al,1970 
Browse et al,1977 Malignancy 40-56 
Warlow et al,1978 CVA 46-53 
Nicolaides & Irving,1975 
Schaub et ai, 1975 
Clayton et al,1976 Varicose veins 48-56 
Sue-Ling et ai, 1986 
Nicolaides & Irving, 1975 
Samama et al,1993 Previous OVT 68 
Inflammatory Bowel Disease (IBO) such as ulcerative colitis predisposes to 
thrombosis. Physiological changes such as an increase in clotting factor VIII 
and fibrinogen occur in response to haemorrhagic tendency. Edwards and 
Truelove (1964) first reported the association between OVT and ulcerative 
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colitis. A risk score of 1 represents the low reported incidence of 1.3-6.4 for 
ulcerative colitis. 
DVT is often the complication of some haematological conditions such as 
sickle cell anaemia, haemolytic anaemia and polycythaemia vera. Patients 
with such disorders exhibit haemostatic complications ranging from bleeding 
to thrombus development (Shafer, 1985). Such patients are therefore 
cautiously assigned a risk score of 2 due to blood hypercoagulabiJity but 
there is insufficient data available on their relative risk and potential for 
causing DVT. 
Nicolaides and Irving (1975) reported a 3.8 times greater risk for patients 
with heart diseases such as atrial fibrillation and congestive cardiac failure. 
Coon (1977) and Carter et al (1987) have documented a DVT incidence of 
10-20 % for chronic heart diseases and 20-40 % for acute myocardial 
infarction. Chronic heart failure and myocardial Infarction are assigned a risk 
score of 3 and 4 respectively. 
The frequency of DVT goes up two to threefold in patients undergoing 
surgery for malignancy. The association between DVT and malignancy has 
some biological basis. Procoagulants have been isolated and fibrinolytic 
activity reduced, thus predisposing to DVT. Kakkar et al (1970) and Browse 
et al (1977) reported a DVT incidence ranging from 40-56 percent for 
malignancy, which is scaled up to a risk score of 5. 
Kakkar et al (1970); Nicolaides and Irving (1975) and Coon (1977) have all 
reported that varicose veins are associated with a twofold increased risk of 
DVT. Varicose veins are associated with impaired venous return, 
predisposing to stasis and thrombi formation. Schaub et al (1975) reported a 
DVT incidence of 56% and that half of the patients who had previous history 
of varicose veins developed postoperative DVT. In their predictive indices, 
both Clayton et al (1976) and Sue-Ung et al (1986) found varicose veins to 
be a good discriminating risk factor. Based on available evidence varicose 
veins are regarded as a high ranking risk factor by THRiFT (1992) and the 
European Consensus Statement (1991). A high risk score of 6 is aSSigned 
to varicose veins. 
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DVT of the lower extremities is reported to occur frequently in patients who 
have had a stroke ~arlow et ai, 1978). Within days after a stroke, 46-53 
patients develop DVT. 
Sioson et al (1981) found that 33% of stroke patients admitted to a 
rehabilitation hospital develop DVT. DVT occurs in 60-70% of patients with 
dense hemiplegia (Turpie et ai, 1987). A high risk score of 7 is recorded for 
the Stroke patients, proportional to the high DVT incidence reported. 
Incidence of DVT is as high as 68% for patients with a previous DVT 
(Kakkar et ai, 1970). Such patients are eight times more likely to have 
recurrence of their condition (Samama et ai, 1993). Previous DVT is the 
single most powerful independent risk factor (Caprini et ai, 1991) and a risk 
score of 7 marks its very high risk of recurrence. 
Other risk factors 
Sex, smoking, diabetes and A blood group type have been cited in the 
genesiS of DVT. Women have a higher incidence of DVT than men (Coon, 
1976). But when other factors such as oral contraceptives and pregnancy 
are taken into account, sex difference disappears (OHE, 1996). In the DVT 
Worcester study (Anderson et ai, 1991) reported a higher DVT occurrence in 
the female patients. But because incidence of DVT increases exponentially 
with age and women as a group live longer than men, there are more. 
episodes of DVT among women. Epidemiological data analysed indicate 
that the incidence of DVT is equal for both sexes (Nordstrom et ai, 1992). 
Smoking has been blamed for many ills and its implication in the causation 
of DVT is no exception. Analysis of cigarette smoking as a clinical variable 
for DVT demonstrates a negative association (Clayton et ai, 1976, Lowe et 
ai, 1982). Astonishingly, smoking has a protective effect against DVT 
(Handley and Tether, 1974; Emerson and Marks, 1977; Prescott et ai, 1978; 
Meade 1983; Nordstrom et ai, 1992). 
Diabetes has been cited as a risk factor but there is little evidence to 
substantiate such an assumption. Diabetes affects predominantly the 
arterial vessels, especially those supplying the myocardium and the 
microvessels of the retina (Banga and Sixma, 1986). 
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Patients with 0 blood group type have been reported to have half the 
incidence of DVT compared to those in group A type (Jick et ai, 1969 and 
Mourante et ai, 1971). However, due to the pattern of ABO blood group 
distribution, the sample in those studies was too small to draw a firm 
statistical conclusion. Nordstrom et al (1992) found no significant differences 
in the distribution for blood groups A, B, AB and 0 types. 
Recently, there has been wide publicity surrounding traveller'S thrombosis. 
Economy class syndrome refers to a thromboembolic disease occurring 
generally after a prolonged air flight. There are plausible physiological 
reasons why sitting still for a long period might predispose to DVT (Milne, 
1992). Ferrari et al (1991) found a history of travel came up almost four 
times more frequently in their venous thromboembolic disease group. 
However, most of the reports are anecdotal and the evidence only 
circumstantial (Geroulakos, 2000). Kesteven (2000) claims that when airline 
passengers develop DVT or PE, there are other risk factors present. Tardy 
et al (1993) reported 21 cases of DVT. All but two had risk factors such as 
obesity (1 case) varicose veins (11cases), cancer (1 case) heart disease (10 
cases). Current data are extremely limited and no prospective controlled 
studies have been undertaken. 
The evidence associated with sex, smoking, diabetes and A Blood group 
type and Traveller'S thrombosis is inconclusive. The reports are anecdotal 
and most of the data have not compared the frequency of a risk factor in 
patients with DVT with its frequency in the total population from which the 
cases were derived. These items are therefore not considered in the 
development of the Autar DVT scale. 
The guiding principle of the Autar DVT scale is that risk factors are additive 
and effects, cumulative. The risk factors may combine synergistically to 
increase the risk of DVT. This principle is consistent with the tlmulti- hit" 
theory proposed by Rosendaal (1997) that the several factors combine to 
provoke an acute episode of DVT. For example, patients who are over the 
age of 40 years, undergoing a surgical procedure lasting for more than half 
an hour with coexisting congestive heart failure are high risk group (Gallus 
et ai, 1994). An association is not necessarily a causation of DVT. Major or 
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independent risk factors have a strong causal consequence, while minor or 
associated additive risk factors acting singly are of little or no significance. 
By the same token, the presence of even a strong factor does not mean that 
the individual is very likely to get the disease (Fletcher, Fletcher and 
Wagner, 1996). Some investigators have used logistic regression modelling 
to assign weights to individual risk factors, suggesting that some risk factors 
are more important (Sue-ling et ai, 1986; Clarke-Pearson et ai, 1987). For 
example, a previous DVT is the most important risk factor for DVT. It has an 
odds ratio of 7.9 for its recurrence and therefore prophylaxis is strongly 
recommended. On the other hand, women taking oral contraceptive have an 
additive risk factor in oestrogen. But the use of oestrogen alone is unlikely to 
present sufficient risk to justify the provision of prophylaxis. 
On the other hand, Kakkar et al (1970) and Salzman and Hirsh (1987) have 
suggested that the incidence of DVT increase in proportion of the number of 
risk factors present. 
The operation of risk factors can usually be understood in terms of one or 
more elements of Virchow's triad, and when there is no risk factor present, it 
is very rare although not unknown for patients to develop DVT. In a review 
of 1231 patients treated for DVT, 96% of the patients had one or more risk 
factors (Anderson and Wheeler, 1995). The proportion of patients with 
clinically suspected OVT in whom the diagnosis was confirmed by objective 
testing increases with the number of risk factors (Table 3.16). 
Table 3.16: Association between risk factors and DVT 
No of risk factors DVT% 
0 11 
1 24 
2 36 
·3 50 
>4 100 
Data: Anderson and Wheeler,1995 
Summation of the cumulative effect of all the risk factors provides a 
discriminatory and prognostic index to ovr. One high risk factor may be 
present in low risk category, escalating to 2-4 factors for the moderate risk 
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group. In the high risk group, more than four factors are present (Caprini et 
a11991; Arcelus et ai, 1991).73% of patients who develop OVT have at 
least two risk factors (Borrow and Goldson, 1981). 
To quantify the individual patient's degree of risk, all the risk factors are 
added up and the patient is classified into one of the four categories 
according to the total score( table 3.17). 
Table3.17: DVT risk assessment protocol 
Risk score Risk category 
~6 No risk 
7-10 Low risk 
11-14 Moderate risk 
~15 High risk 
Most values or tests are not sharply categorised in exact values but exist on 
a range or continuous spectrum (Topf, 1986). The score range should 
therefore not replace the professional judgement but it should be another 
tool to enable nurses to achieve consistency and objectivity in the 
assessment in practice. However, as professional judgement lacks a gold 
standard (Brennan & Hayes, 1992) it must be based on factual information, 
best external evidence and not conjecture or guesswork (Castledine,1997). 
The best external evidence is usually derived from clinically relevant 
research based on biosciences, whereas clinical judgement is the individual 
experience acquired through clinical experience and clinical practice 
(Sackett et ai, 1996). Integrating individual clinical expertise with the 
compelling evidence of the DVT scale can serve to enhance the predictive 
accuracy of the risk assessment calculator. 
The incidence of OVT and PE associated with each of the risk categories is 
illustrated in table 3.18 
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Table 3.18: DVT and PE incidence associated with each risk category 
Risk category DVT incidence % PE incidence % 
Low risk <10 0.01 
Moderate risk 10-40 0.1-0.7 
High risk 41> 1-5 
Modified from Salzman and Hirsh, 1982 
Low risk patients are those under the age 40 without additional risk factor, 
who have an uncomplicated elective surgical procedure or over the age of 
40 without additional risk factor who have minor elective abdominal surgery 
for less than 30 minutes. In the absence of prophylaxiS, these patients have 
less than10% risk of developing proximal DVT and 0.01% risk of fatal 
pulmonary embolism. 
Moderate risk patients are those over the age of 40 who have elective 
general abdominal surgery performed under general anaesthesia lasting for 
at least 30 minutes. Advancing age, presence of malignancy, prolonged bed 
rest. varicose veins and obesity, increases risk in this category. In the 
absence of prophylaxis, patients in this risk category have a 10-40% risk of 
DVT and 0.1 to 0.7% risk of PE. 
High risk patients are those who have a recent DVT, who require surgery 
and those who undergo pelvic or abdominal surgery for advanced malignant 
disease or major orthopaedic surgery of the lower limbs. In the absence of 
prophylaxis, these patients have a 40-80% risk of DVT and 1 to 5% risk of 
fatal PE (Salzman and Hirsh, 1982). 
The validity of an instrument is determined by its ability to measure what it 
claims to measure. Content validity is primarily concerned with whether the 
items of a healthcare assessment tool are relevant and adequate to the 
content area under investigation. Essentially, it involves seeking assurance 
that the items of the tool are very representative and comprehensive 
(Bowling, 1995). On the other hand, construct validity is the degree to which 
an instrument measures the theory or hypothesis under investigation. It is 
also the ability of the assessment tool to confirm the expected hypothesis 
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and discriminate between groups (Anthony, 1999). For example the OVT 
risk assessment tool should be able to discriminate between patients who 
develop OVT and those who do not. Each item was examined to see 
whether it was relevant and any unrelated items were discarded. The 
related items were drawn from extensive literature review and compelling 
evidence from research studies discussed in chapter two. The 
representation of all the clinically justified variables and evidence based 
items derived from theory underpinning the causation of OVT, are indicative 
to both the content and construct validity of the Autar DVT scale. Founded 
on the universally recognised Virchow's triad, the DVT scale has addressed 
all the relevant aspects of the phenomenon of interest. The biological basis 
of DVT in relation to the thrombogenic mechanism of the high risk factors 
constituting the scale is given in table 3.19. 
Table 3.19: Thrombogenic mechanism of high risk factors In DVT 
Vessel Increased 
High risk factor damage blood Stasis 
Coagulability 
Increasing age + 
Obesity + 
Immobilisation + 
Oral contraceptive + + 
Pregnancy and + + Puerperium 
Leg trauma + + .+ 
Surgery + + + 
Ulcerative colitis + + 
Sickle cell + 
anaemia 
HaemolytiC + 
anaemia 
polycythaemia + + 
Heart failure + 
Myocardial + + infarction 
Malignancy + + + 
Varicose veins + + 
CVA + 
Previous DVT + + 
+ denotes the manifestation of a thrombogenic mechanism 
Data: Autar,1996 c. 
Decreased 
Fibrinolysis 
+ 
+ 
+ 
+ 
+ 
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Summary 
The Autar DVT scale was developed as an assessment tool for predicting 
clients at risk of deep vein thrombosis. Based on Virchow's triad in the 
pathogenesis of DVT and culled from an extensive literature review and 
well-founded research findings, the DVT scale can claim high content and 
construct validity. The DVT scale comprises seven well-recognised 
categories of risk factors, namely: age specific group, mobility, buildl body 
mass index, special risk category, trauma, surgical intervention category and 
high-risk diseases. Each risk factor is assigned a risk score based on 
relative risk and the guiding principle of the DVT scale is that risk factors are 
additive. 
One risk factor may be present in the low risk group, rising to 2-4 factors in 
the moderate risk group. More than 4 factors are present in the high risk 
group. 
The scoring system identifies the patients into one of the four risk 
categories: no risk, low risk, moderate and high risk. A high-risk score 
indicates that the patients belong to a high-risk category and they have a 
40-80 per cent risk of DVT and 1.5 per cent risk of fatal PE. 
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Chapter Four 
Research methods 
Research questions 
The purpose of this quantitative and longitudinal study was to evaluate the 
Autar DVT risk assessment scale on orthopaedic, medical and surgical 
directorates. These diverse clinical areas were essentially targeted on 
account ofthe varying levels of risk by patient group (table 1.1), as the Autar 
DVT scale was designed to have universal application. Specifically, the 
research questions sought to assess the DVT scale in relation to its: 
• consistency in the clinical assessment of patients. 
• sensitivity, specificity and predictive validity. 
• practical utility and application. 
Available data were collated to determine current venous 
thromboprophylaxis strategies on the directorate, in the context of the 
recommendations of the consensus groups (NIH, 1986; ACCP, 1996; 
International Consensus Statement, 1997; THRiFT, 1998). 
The study was undertaken prospectively and patients recruited were 
followed up for a minimum of three months, following discharge from the 
ward. In this predictive design data from three groups of patients were 
pooled to evaluate the DVT risk assessment scale, as a tool in the decision 
making process, for the venous thromboprophylaxis programme. 
Ethical clearance and access negotiation 
As required by the local Research Ethics Committee, a formal application 
was submitted for approval of the study and ethical clearance (appendix 2). 
The UKCC code of professional conduct (1992) stipulates that "Each 
registered nurse, midwife and health visitor shall act, at all times in such a 
manner to: 
"Safeguard and promote the interests of individual patients or clients". 
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No harm or inconvenience was foreseen to the patients by testing the 
reliability, validity and practical utility of the DVT scale. The risk calculator 
was a refinement of an assessment strategy and any new tool must be 
rigorously tested for its effectiveness, before it is allowed to enter the 
professional market for general use (Cormack & Reynolds, 1992). For this 
reason, the study was essentially kept to a prospective data generating 
project. The staff involved were advised not to alter the management of the 
patients in the light of the risk assessment, but to give the standard care 
normally given to patients. Any unusual attention to DVT risk might 
deliberately result in more preventative strategies with some consequential 
effect on evaluating the predictive validity of the DVT scale. The oral 
consent of the patients was taken by the data collectors. Patients recruited 
to the study were informed that data collected were being utilised to validate 
the OVT risk assessment tool. They were reassured that data collection 
would not in anyway alter their treatment and that information gathered 
would be very confidential. 
Following approval and ethical clearance by the Research Ethics Committee 
overseeing the targeted NHS trusts (appendix 3). applications were 
submitted to the Research and Development units of each of the selected 
hospitals for indemnity of the study by the trusts (appendix 4). Access to the 
clinical areas was then negotiated. Written consents were obtained from the 
clinical medical directors of the three targeted directorates (appendices 5.1, 
5.2 & 5.3). 
At the same time, the three nurse managers of the clinical directorates were 
approached to negotiate the support of clinical nursing colleagues for 
participation in the data collection. In fact, the nursing staff in the targeted 
clinical areas were very keen to get involved and saw their partiCipation in 
the study as consistent with their Post Registration Education and Practice 
(PREP) requirement for continuing professional development (UKCC, 1994). 
The purpose of the PREP project was to develop standards for a framework 
of post registration education and practice which would contribute to the 
maintenance and development of professional knowledge and competence. 
The responses from the nursing staff were favourable as they stood to gain 
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professionally, in terms of development of their research awareness and 
profile and the implementation of evidence based practice. 
Sample size and subjects 
There are two main reasons to be concerned with sample size. First of all, 
the findings should be generalisable to the population that has been 
sampled. Secondly, the study should have a reasonable chance of detecting 
significant effects where they exist, that is, the study has adequate power. A 
study that has a large sample to be generalisable but which has a low 
probability of detecting effects, is of little value (Ingram, 1998). 
Many factors interplayed in deciding the appropriate sample size for this 
study and the goal was to obtain a large enough sample to show statistical 
significance, yet be expedient and economical at the same time. Sample 
size is often a compromise between statistical precision and resource to 
hand. Increasing the sample size to the detriment of the quality of the rest of 
the research design may not be worthwhile (Jordan, Ong & Croft, 1998). 
Effect sizes as in this study are likely to be small in new areas of research 
enquiry (Cohen, 1977). 
In a previous small scale study (Autar, 1994) the DVT risk assessment scale 
was developed through an action research process. Action research is a 
form of on-going self reflective enquiry that is being commonly applied in 
nursing practice to bring about positive changes (Webb, 1989). 
The DVT scale (1994) was tried and tested on a trauma! orthopaediC ward 
for its practicality, consistency and predictive validity. Seven days risk 
assessment data collected independently by paired registered nurses on 
each of the 21 patients recruited were analysed and the instrument 
achieved a consistency of 70 and 97 percentage agreement in the two small 
reliabi~ity studies respectively. There is a consensus among behavioural 
scientists that an average of 70 per cent is necessary for consistency, 80 
per cent is adequate and 90 per cent good. (Hartmann, 1977, House et ai, 
1981). At a threshold score of 16, the DVT risk calculator also achieved 
100% sensitivity and 81 % specificity. Overall, a predicted accuracy of 83 % 
was recorded in relation to the correct classification of those at risk and 
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those who were not (Autar, 1994). Despite the promising results recorded, 
the nature of the small study does not allow for generalisation of findings 
and population representation. The establishment of validity is an ongoing 
process and any additional validity testing requires the publication of a 
second report (Norbeck, 1985). Further validation of the DVT scale was 
therefore warranted in larger patient populations, across diverse clinical 
specialities. Wasson et al (1985) in suggesting rules for clinical prediction, 
recommend that instruments be tested in more than one setting to eliminate 
unusual, practice-specific relationship between the predictor (DVT scale) 
and the outcome (end point DVT). 
A convenience sample of 150 patients were therefore recruited from the 
orthopaedicl trauma, medical and surgical directorates of two local NHS 
trusts. Fifty patients were studied from each of the three clinical specialities. 
DVT is a problem common to all the three clinical areas and literature review 
confirms that the target populations have been well characterised. Varying 
incidences of DVT had been reported in the three specialities (Table 4.1) 
and they would therefore provide a good testing ground for validating the 
DVT risk assessment tool. 
Table 4.1: DVT Incidence In trauma I orthopaedics. general medical and 
general surgery specialities 
Specialities DVT Incidence 96% Confidence 
Weighted mean interval 
Traumal Orthopaedics 45 41-48 
Hip fractures 
General Medicine 17 10-24 
General Surgery 25 24-26 
Data: Grace, 1993 
Hirsh & Hoak, 1996 
International Consensus Statement, 1997 
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Calculation of sample size 
In order to calculate the power and sample size, a priori analysis was 
undertaken, using the computer software G*Power programme and 
selecting Cramer's V statistic to determine the power of Chi Square for 
scores of patients with and without DVT. G*Power is a general power 
analysis programme, performing high precision statistical power analyses for 
most common statistical tests in behavioural research. It computes power 
value for given sample sizes, effect sizes and alpha levels as 8 priori power 
analyses as well as post hoc power analyses (Appendix 6). 
Choosing the conventional alpha input of 0.05 and the minimum considered 
acceptable power (1-beta) of 0.80 as default, G*Power calculated a small to 
medium effect size of 0.23 (Table 4.2). A power of 0.80 implicitly means that 
a type 11 error (failing to detect an effect) is about one fourth as serious as 
type I error (falsely stating an effect, when no effect exists (Anthony, 1999). 
For the alpha input of 0.05 and given power of 0.80, the Cohen definition of 
large, medium and small (table 4.3) was used to calculate the sample size. 
A small to medium effect of 0.23 at a critical value of chi-square at 3.84 
calculated a sample of 149 subjects (Erdfelder, Faul & Bucher, 1996). 
Table 4.2:A priori calculation of sample size 
Effect Size 0.23 Lambda 7.8621 
Alpha 0.05 Critical value ChfO! (\}=3.8415 
Power 0.80 Total sample size 149 
Deg.fr. 1 Actual power 0.8017 
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Source: G*Power computer software. 
Table 4.3: Cohen effect sizes (1988) 
Effects: d Sizes 
0.10 Small 
0.30 Medium 
0.50 Large 
The G*Power analysis was consistent with Cohen's effect size convention. 
Cohen (1988) claims that for new areas of research falling into this category, 
as in the validation of the DVT scale, group differences are likely to be 
small. 
The available resources in terms of time, location and the willingness of the 
participants to co-operate primarily influenced the choice of population. 
Even though the only true representative sample would be one including the 
entire population (Knapp, 1996), there was a practical, ethical and economic 
limit in choosing the 150 patients, in addition to the recruitment of registered 
nurse participants for the data collection. In order to ensure that the 
information gathered on each patient was kept strictly confidential, it was felt 
that it would be more natural and practical for the own ward nurses to 
undertake the information gathering process. This would" protect all 
confidential information concerning patients and clients obtained in the 
course of professional practice" (UKCC,1992). 
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This strategy would then also allow for the computation of a kappa statistic 
to evaluate the risk calculator: two registered nurses were required to collect 
data on each patient independently. This type of data analysis also had a 
bearing on the sample size. Within the constraint of the number of 
registered nurses available as data collectors, kappa statistic estimation 
could only be undertaken when the paired nurses were on the same duty 
roster, noting that nursing staff work thirty seven and a half hours weekly 
shift. 
A reliability study was undertaken in each of the five wards. The opportunity 
or convenience sample happened to be patients who the paired nurse 
assessors could get hold of, just like the sample available in a natural 
experiment. Convenience sampling is by no mean an ideal sampling 
method, since it is not a random process. However, in nursing research the 
predominant approach to sampling is non random sampling due to the type 
of population and the ethical considerations associated with them (Talbot, 
1995). It would be wholly unethical and unacceptable to randomise an 
experimental and control group of subjects, in order to validate the DVT 
scale. There is compelling evidence on the efficacy of venous 
thromboprophylaxis and to withhold preventative strategies, for the sake of 
estimating the sensitivity and specificity of the OVf risk calculator, is an 
omission of duty of care and considered as clinical negligence (Parker-
Williams & Vickers, 1989). 
The clinical nature of nursing research therefore makes it difficult to use 
probability sampling and the majority of nursing studies continue to rely on 
(' 
sample of convenience (Polit & Sherman, 1990). While it is possible to 
randomise a sample from a list of a few patients coming in as planned 
admissions, it is not possible to do so for the bulk of admissions which are 
non elective and of emergency type. Besides, admission to the wards within 
a directorate takes place on a rotational daily to weekly basis (take days), 
Arguably, there were some elements of sample randomisation and 
generalisation as any patients admitted to that particular ward, on the so-
called"on-take" days when the particular paired assessors were on duty, 
stood to be recruited to the study. This was believed to be important to the 
. . 
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integrity of the research design as all patients admitted on the specific days 
would be studied and therefore self-selection bias was reduced. 
While acknowledging the limitations of a convenience sample, every effort 
was made to ensure that the sample was representative of the clinical 
population. The phenomena under investigation were fairly homogenous 
within the population at large, further minimising bias. One of the strengths 
of the study was that patients exhibited a wide variability of scores, ranging 
from the very highest score of 27 to the lower of 1 for the no risk category. 
Score variability was evidenced in the sample representation of the various 
risk categories (Table 4.4). The estimated mean risk assessment score of 
the sample was 10, a mean risk assessment score of 12 for patients with 
ovr and overall standard deviation of 5. A risk score range of 1-27 for the 
population sample was recorded. 
Table 4.4: Sample representation of the risk categories. 
Risk categories Number of patients Ofo 
High 19 13 
Moderate 37 25 
Low 50 34 
No risk 42 28 
Total 148 100 
The homogeneity of the sample also added weight to the claim of 
generalisability. If the individual subjects are very much alike in all variables, 
other than the one being measured, a smaller sample suffices (Crookes & 
Oavies, 1998). There was little variability in the characteristics of the 
population. The fifty subjects on the trauma /orthopaedic wards were 
prototypical of subjects with hip fractures, as cardiovascular disorders were 
to those on the medical wards (Claggett et ai, 1992). Most of the patients on 
the surgical directorate had undergone major abdominal surgical 
intervention. 
A small standard error of mean (SEM), referring to an estimate of the 
population parameter, also added further credence to the homogeneity of 
the population. With a SO of:c: 5, the estimated SEM was :c: 0.04 (appendix 
7) The smaller the SEM, the more accurate are the sample means as 
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estimates of the population value (Campbell & Machin, 1993; Polit 1996). 
The SEM was much smaller than the SO because the sample mean was not 
. as spread out as the original risk assessment scores. 
The proportion of the population was estimated from the data pooled from 
the three clinical directorates. The following equation was applied to 
calculate the population percentage at 95 % Confidence Interval: 
Equation PQ 1.96 x In 
Where: 1.96 is a constant for 95% confidence limit. 
P: proportion of the sample with OVT= 28/148=0.19. 
Q: proportion of the sample without OVT= 120/148= 0.81 
1.96x..[ 0.19xO.81/148 
1.96 x..[ 0.1539/148 
1.96 x ..[ 0.0103 
1.96 x 0.3224= 0.06. 
0.06 added to the proportion of sample with OVT=0.06+0.19 = 0.25 
(Upper Cl). 
For estimation of the lower limit of Cl, 0.19 was subtracted from the upper 
limit of 0.25, to yield a Cl = 6 to 25%. 
The trade-off for the margin of error is influenced by sample size and the 
choice of confidence interval. 
The larger the sample, the smaller is the margin of error or the width of 
interval and the converse holds. On the other hand, a higher confidence 
interval increases the width of the margin, resulting in less precision. 
Incidence of OVT increases exponentially and sharply with age from 1 per 
100,000 people per year in childhood to nearly one per cent in old age 
(Rosenthal, 1999). It was for this reason that adult clinical areas were 
targeted, ensuring that children were excluded, and that adult patients only 
recruited, irrespective of age groups and sexes. Sex as a predictor of OVT is 
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not a significant and independent factor (Coon et al 1973;Coon, 1978). 
Epidemiological data analysed by Nordstrum et al (1992) reveal no 
difference between men and women in relation to the incidence of OVT. Any 
gender-related risk would be on account of additional risk factors such as 
oral contraceptive or Hormone Replacement Therapy or Pregnancy and 
Puerperium.After taking into account the risk factors; it appears unlikely that 
sex difference exists in the incidence of DVT (OHE 1996). 
Another inclusion criterion was that all patients recruited to the study had to 
be risk assessed within 24 hours of admission. The choice of 24 hours 
admission was considered timely for optimum predictive accuracy when 
patients were very dependent because of their self care deficit and were at 
greater risk of ovr due to the acute nature of their clinical condition or 
surgical intervention with accompanying fibrinolytic shutdown (Merli & 
Martinez, 1987; Kakkar & Stringer, 1990; Stewart Rose, 1998). Thrombi of 
clinically significant proportion are present as early as the first 24 hours of 
admission (Brown & Newman, 1995). In trauma and orthopaedic patients 
DVT occurs as early as preoperatively. Roberts et al (1990) reported a 9 % 
prevalence of preoperative DVT and Hefley et al (1996) recorded a OVT 
incidence of 62 per cent in those patients with hip fractures whose 
operations were delayed more than 48 hours. For this reason, DVT risk 
assessment should be undertaken as early as possible and for those 
patients who would be having surgery within the 24 hours deadline, they 
would be risk assessed immediately on their return from theatre. In the 
immediate postoperative period, both hypercoaguable state and stasis are 
at their maximum (Nicolaides, 1990). Consequently, patients are most 
vulnerable due to the disruption of the endothelial integrity arising from 
widespread vasodilatory effects of many general anaesthetic agents 
(Comerata et ai, 1989).Once the endothelium ofthe veins is disrupted, 
thrombogenic subendothelial substances are exposed and stimulate clot 
formation (Merli & Martinez, 1987). The majority of thrombi formation occurs 
at the time of surgery or in the immediate postoperative period when 
hypercoagulability and venous stasis are at their maximum (Nicelaides, 
1990). This is another reason for the choice of the 24 hours cutoff period for 
undertaking the DVT risk assessment procedure. Inevitably, some surgical 
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patients who were scheduled for surgery within 24 hours of admission, but 
had their procedure postponed, would not be considered for the study. 
In order to ascertain that the 150 patients recruited would provide sufficient 
data for evaluating the predictive validity of the DVT scale and allow for the 
statistical analysis to be significant, aI/ patients admitted primarily for 
treatment of acute DVT were excluded from the sample. 
Finally I many patients discharged from hospital continue to be at risk, as risk 
factors persist in some of them. Besides, most methods of prophylaxis are 
applied to patients in hospital often for the peri-operative period and seldom 
beyond 7 days. The mobility of some patients recovering from the surgical 
procedure may also be decreased when they get home. 
25% of patients who do not have DVT on the ward did so within six weeks 
of discharge in the community (Scurr et ai, 1988; Scurr, 1990). This problem 
is further compounded by the limited healthcare resources, requiring earlier 
patient discharge. As a result, there is an inverse relationship between the 
duration of hospitalisation and the probability of developing DVT following 
discharge home (Hass, 1997). Consequently, all patients were followed up 
for a minimum of three months and monitored for occurrence of Dvr. Of the 
150 patients recruited to the study, it was not possible to follow up two 
patients post discharge and their data were excluded for the estimation of 
the sensitivity, specificity and predictive validity of the DVT scale. 
Data collection tools 
In order to evaluate the predictive validity, consistency, sensitivity and 
specificity of the DVT risk assessment scale, two data collection tools were 
constructed, piloted and developed. The Autar DVT risk assessment chart 
was at the primacy of the information-gathering process for evaluating the 
consistency and validity of the assessment tool. Adjunctively, a Likert type 
questionnaire measured the practical utility of the DVT scale. 
The double- sided DVT risk assessment chart (figure 4) was prominently 
landscaped to exhibit the DVT scale on one side and a BMI ready reckoner 
on the reverse. Body build as a risk category can be very subjectively 
assessed. 
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Figure four AUTAR DVT RISK ASSESSMENT SCALE 
Name: 
Unit No: 
Ward: 
Age Group 
10-30 
31-40 
41-50 
51-60 
61+ 
Build 
Underweight 
Average 
Overweight 
Obese 
Very Obese 
Risks 
Ambulant 
BMI 
16-19 
20-25 
26-30 
31-40 
41+ 
Limited (uses aids self) 
Very Limited (needs help) 
Chair bound 
Complete Bed rest 
Score 
o 
1 
2 
3 
4 
Score 
o 
1 
2 
3 
4 
BMI = wt(kg)/ht(m)' 
Score 
o 
1 
2 
3 
4 
Oral contraceptive: 
20-35 yrs 
35+ yrs 
PregnancylPuerperium 
No risk 
Score 
1 
2 
3 
Score ~6 
Score 7-10 
Score 11-14 
Score IS;?: 
Low Risk «10%) 
Moderate Risk (11-40%) 
High Risk (>41 %) 
Please tick the appropriate prescribed DVT prophylaxis 
Leg Elevation ~ Graduated Elastic Compression Stockings (GECS) 
Pneumatic Compression (PC) 
Intermittent or 
Continuous 
Heparin 
Heparin Sodium (standardlunfractionated) 
Calciparine (heparin calcium) 
Minihep (heparin sodium) 
Minihep Calcium (heparin calcium) 
Monoparin (heparin sodium) 
Monoparin Calcium (heparin calcium) 
Multiparin (heparin sodium) 
Pump-Hep (heparin sodium) 
Unihep (heparin sodium) 
Uniparin (heparin sodium) 
Uniparin Calcium (heparin calcium) 
Low Molecular Weight Heparin 
Fragmin (dalteparin sodium) 
Clexane (enoxaparin heparin) 
lnnohep (tinzaparin) 
Logiparin (tinzaparin) 
Warfarin 
Others, please specify: 
No Prophylaxis 
o 
8 
o 
Printed with support from Huntleigh Healthcare on behalf of De Montfort University, Leicester 
Score item(s) Qi'fl,X preoperatively 
Head 
Chest 
Spinal 
Pelvic 
Lower Limb 
SCORE ONLY ONE APPROPRJATE ITEM 
Minor Surgery «30 mins) 
Major Surgery 
Emergency Major Surgery 
Thoracic 
Abdominal 
Urological 
Neurosurgical 
Orthopaedic 
Ulcerative Colitis 
Anaemia: Sickle Cell 
Po lycythaemia 
Haemolytic 
Chronic Heart Disease 
Myocardial Infarction 
Malignancy 
Varicose Veins 
Previous DVT or CVA 
Score 
I 
2 
3 
3 
3 
3 
3 
4 
Score 
I 
2 
2 
2 
3 
4 
5 
6 
7 
ldelllifY appropriate items. add and record score below 
Assessor Date Score 
© R. Autar Revised 1997 
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Very Obese 
Obese 
Overweight 
Healthy 
Underweight 
BODY MASS INDEX CHART 
HEIGHT (Metres) 
39 38 37 36 35 35 34 33 32 32 31 
38 37 37 36 35 34 34 33 32 32 31 
38 37 36 36 35 34 33 33 32 31 
38 37 36 35 35 34 33 32 32 31 
39 38 37 37 35 35 34 34 33 32 31 
39 38 37 36 35 35 34 33 33 32 31 
39 38 38 37 36 35 34 34 33 32 32 31 30 
39 38 37 36 36 35 34 33 33 32 31 30 29 
40 39 38 37 36 35 35 34 33 32 32 31 30 29 
39 38 37 37 36 35 34 34 33 32 31 30 29 
39 38 37 36 35 35 34 33 33 32 31 30 29 29 
39 38 37 36 35 34 34 33 32 32 30 29 28 
39 38 37 36 36 35 34 33 33 32 31 30 29 29 28 
4039383736353534333232 302929 28 
3938383736353434333231 30292928 28 
39383736363534333232 30 292928 V 
39383736353434333232 3030292828 V 
38373736353433333231 3029292828 V 
383736353534333232 3030292828V V 
383736353433333231 3029292828V ~ 
3736353534333232 30292828VV ~ 
37 36 353434333231 3029292828VV ~ 
37 3636 3534333332 30292928VV~ ~ 
3736 35 3434333231 3029292828VV~ ~ 
37363534333232 30292928VV~~ ~ 
39 383736353534333232 3030292828VV~ ~~ 
3939 3837 36 3534333332 30292928VV~~~ ~ 
3838 37 3636 3534333232 3030292828VV~~ ~~ 
~3838373635 3434333231 30292928VV~~~ ~~ 
393837373635 3433 32 32 3030292828VV~~ ~~~ 
40 3937 37 3635 3434333231 30292928VV~~~ ~~~ 
403937 37 3635 34 333332 3030292828VV~~ ~~~~ 
393836363535 34 3332 31 30292928VV~~~ ~~~~ 
39393836363534333332 30292828VV~~ ~~~~~ 
393837353635 3433~ 30292928VV~~~ ~~~~~ 
403938373535 343333~ 30292828VV~~ ~~~~~~ 
~3838373535 3433~~ 30292928VV~~~ ~MM~~~ 
~39383736 34 34343332 30292828VV~~ ~ M ~~~~~ 
4039373736343433 30292928VV~~~ ~MM~~~~ 
3938373635 3434 33 30292828VV~~ ~MM~~~~~ 
4039383636353333~ 30292928VV~~~ ~M M n~~~~ 
3938373635353333~ 30292828VV~~ ~~M~n~~~~ 
4039 353534~~~ 30292928VV~~~ ~M~~~~~~~ 
4038 35353432 30292828V~~~ ~~~~~~~~~ro 
3938 3433~ 292928VV~~~ M M ~~~~~~~ro 
3938 3433~ 292828V~~~ ~MM~~~~~~roro 
38 37 ~ 31 30 29 28 27 27 ~ ~ 25 24 24 ~ 23 ~ ~ 21 21 21 ro ro 
38 37 30 29 28 28 27 ~ ~ 25 ~ 24 24 ~ ~ ~ ~ 21 21 ro ro 19 
37 36 30 29 29 28 27 27 ~ ~ 25 24 24 ~ ~ ~ ~ 21 21 ro ro ro 19 
39 37 36 ao 30 29 28 28 27 ~ ~ ~ ~ 24 ~ ~ ~ ~ ~ 21 21 ro ro 19 19 
38 37 36 35 30 29 29 28 27 27 ~ ~ ~ 24 24 ~ ~ ~ ~ 21 21 20 20 20 19 19 
38 37 38 35 29 29 28 28 27 ~ ~ ~ 24 24 ~ ~ ~ ~ 21 21 20 20 20 19 19 18 
38 37 36 35 34 30 29 29 28 27 ~ ~ ~ 25 24 24 ~ ~ ~ ~ 21 21 20 20 19 19 19 18 
38 37 36 35 34 30 28 28 27 27 26 26 24 24 ~ ~ ~ ~ 21 21 20 20 20 19 19 18 18 
37 36 35 34 33 30 29 28 28 V ~ ~ 25 ~ 24 ~ ~ ~ ~ 21 21 21 20 20 19 19 18 18 18 
37 36 35 34 33 30 29 28 V V 26 ~ 25 24 24 ~ ~ ~ ~ 21 21 20 20 19 19 19 18 18 17 
36 35 34 33 32 29 28 V V 26 26 ~ 24 24 ~ ~ ~ ~ 21 21 20 20 ro 19 19 18 18 18 17 
38 35 29 28 V 27 ~ 2 25 24 24 ~ ~ ~ 21 21 21 20 20 19 19 18 18 18 17 17 
35 34 30 29 28 28 26 ~ ~ 25 24 24 ~ 23 ~ ~ 21 21 20 20 19 19 19 18 18 17 17 17 
35 34 30 29 28 28 V ~ 26 ~ ~ 24 n ~ ~ ~ 21 21 20 20 19 19 19 18 18 18 17 17 16 
302928VV26 ~ M ~ ~ ~ ~ ~ ~ ~ 2020191918181817 17 17 16 
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While a visual assessment can be a guide to whether or not a person is an 
appropriate weight or build, it is never an adequate or accurate 
measurement of a particular build. This is because different individuals and 
different cultures have different perception of what constitutes a particular 
build, an ideal weight, overweight or obese. What is an obese build can be 
construed as average by an obese rater as clinical judgement lacks a gold 
standard (Brennan & Hays, 1992). The BMI ready reckoner therefore 
facilitated assessors in objectively differentiating between the types of body 
builds and scoring this category of the DVT scale. Using commonly obtained 
data from a nursing health history, specifically the height and weight, one is 
able to calculate the Quetelet BMI. This is obtained by taking the weight in 
kilograms divided by the square of a person's height in meters. The BMI was 
supplementary to the clinical judgement of the raters. The lay-out of the DVT 
scale was designed by the researcher to facilitate the collection of the 
appropriate variables. However, the printed charts for undertaking the 
research study were financially supported and supplied by Huntleigh 
Healthcare (Luton) for acknowledgement of services provided in relation to 
DVT prophylaxis, with respect to the evaluation of the Flowtron Intermittent 
Pneumatic Compression (IPC) device. 
The seven recognised categories of risk factors in the genesis of DVT were 
illustrated in distinctly bold boxed areas to assist the assessment process 
systematically and comprehensively. The addressograph on the top left-
hand corner of the chart identified the patient by a predetermined code 
chosen by the assessors. The unit number of the patients, held on the 
Hospital Inpatient Data System, enabled access to the patients' case note 
library for tracing their final discharge destination and facilitated their follow 
up at the outpatient clinic, anticoagulant clinic or the GP surgery, whatever 
was appropriate. 
All the pharmacological and mechanical venous thromboprophylaxis 
modalities were exhibited in the DVT chart. The pharmacological modality 
was illustrated by a comprehensive list of anticoagulants for primary 
prophylaxis extracted from the British National Formulary (BNF, 1994) and 
registered nurse assessors were required to tick what was actually 
prescribed. Such data would then be collated to audit the current Dvr 
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prophylaxis protocol. For the trauma risk category, the registered nurse 
assessors were issued with specific instruction to score this subscale only 
pre operatively and this risk factor ceased to apply, once the therapeutic 
surgical intervention had been initiated to rectify the trauma or injury. 
Further to supplement the instruction on the DVT risk assessment chart, a 
quick reference instruction card was constructed, outlining the systematic 
step by step completion of a DVT risk assessment. In brief, to complete the 
OVT risk assessment nurses were required to identify the appropriate risk 
factors, add and record the scores. The aggregate could then be referenced 
to the DVT assessment protocol to diagnose the individual risk category of 
the patient. The independently rated aggregate would also be computed by 
the researcher to estimate the kappa coefficient values. 
Reynolds & Cormack (1992) propose certain criteria in the guise of the 
following five broad questions in the evaluation of a model for nursing: 
1. To what extent does the instrument facilitate the identification of actual 
and potential health problems? 
2. How does the tool enable a nursing diagnosis to be made? 
3. Does the tool explain why patients respond to health problems in the 
way they do? 
4. Does the tool enable clinicians to choose the appropriate nursing 
treatment required? 
5. Does the tool provide an understanding of the desired outcome of 
nursing intervention? 
Although the above questions were directed at the evaluation of a nursing 
model for clinical practice, the evaluation criteria are equally transferable 
and readily applicable to any nursing assessment tool. 
It was within the broad framework advocated by Cormack & Reynolds 
(1992) that a postar questionnaire was constructed to evaluate the 
favourability and practical utility of the DVT scale. An attached cover letter 
explained the general purpose of the tool and freepost reply envelope 
enclosed to maximise response rate. 
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Dear colleague, 
Postal questionnaire: Figure 5 
Evaluation of the Autar DVT scale 
Thank you for your support in the data collection process of the research 
project. Your views of the DVT scale are much valued and will be used to 
identify the strengths and areas in need of improvement. 
Further to evaluate the practical application of the DVT scale, I am now 
asking for your help in answering the attached questionnaire. 
For the sake of convenience, the questionnaire is divided into 2 sections. 
Section 1 deals with the biographical data, which are assured of 
confidentiality . 
Section 2 addresses the general issues surrounding the practicality of the 
scale and the specific DVT risk categories. 
On completion of the research project a copy of the report will be made 
available to your ward. 
Thank you again for your help and please return the completed 
questionnaire in the stamp addressed envelope attached. 
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EVALUATION OF THE AUTAR DVT RISK ASSESSMENT SCALE 
All information will be treated as confidential and no name disclosure is 
required. 
SECTION ONE: BIOGRAPHICAL DATA. 
1. How long have you been qualified? 
2. What are your professional qualifications? 
3. What is your job title \ clinical grade? 
4. How long have you been working in this area of practice? 
5. Have you worked in other clinical area(s) where the Autar DVT Scale is 
being used? 
Please comment: 
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SECTION TWO: THE DVT SCALE 
Please tick your response and make any relevant comments. 
6. How many patients have you assessed with the DVT risk assessment 
scale? 
I less fuan 51 5-10 
7. The DVT scale enables me to: 
11-15 more than 
15 
7.1. Make a thorough DVT risk assessment based on the patient clinical 
profile. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
7.2. Individualise the nursing assessment of patients. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
7.3. Translate the risk factors as applicable to patients into DVT risk 
categories. 
Strongly Agree Neutral Disagree Strongly 
J\gree Disagree 
Any comments: 
113 
------------------------------------------------
7.4. State why patients are at risk. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
8. The DVT scale can be applied to facilitate care planning. 
Strongly Agree Neutral Disagree Strongly 
_Agree Disagree 
Any comments: 
9. The DVT scale does not enable me to take preventative nursing action to 
minimise risk 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
10. The DVT scale has no value as a teaching tool. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
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11. The DVT scale has potential application as an audit tool for quality 
assurance. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
12. The DVT scale has practical application to my area of practice. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
13. The layout of the DVT scale facilitates the data collection process for risk 
assessment. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
14. The DVT scale enables me to complete a risk assessment within 
Less than 3 3-6 mins 7-10 mins more than 
mins 10 mins 
Any comments: 
15 Please comment on the strengths of the DVT scale. 
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16. Please comment on the weaknesses \ limitations of the DVT scale. 
17 Any comments on how the practical application of the DVT scale can be 
improved. 
18. Age specific group: 
This category is SUfficiently clear to score. 
Strongly Agree Neutral Disagree Strongly 
Agree DisaQree 
Any comments: 
19. Mobility: 
Scoring item from this category is reasonably clear. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
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20. Build: 
I am able to differentiate between underweight and average build. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Comments: 
20.1. I am able to differentiate the overweight patients from the obese and 
very obese. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Comments: 
21.Special risk category: 
Please answer this question if it is applicable to your patients. 
This category is reasonably clear for me to score. 
Strongly Agree Neutral Strongly 
Agree Disagree. 
Any comments: 
22. Trauma risk category: 
Please answer this question if this category is applicable to your area of 
practice. 
I am reasonably clear as to what constitutes scoring for lower limb injuries. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
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Please answer this question if this category is applicable to your area of 
practice. 
23. Surgical intervention category: 
I am able to differentiate between minor and major surgery 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
23.1. I am able to differentiate between major surgery and the other types of 
surgery. 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
24. High risk diseases: 
I have no difficulty scoring any item from this category: 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
Any comments: 
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The postal questionnaire (figure 5) was primarily preferred for its low cost 
data collection and processing and avoidance of interviewer bias. The 
researcher has a very good professional working relationship with the 
clinicians and this rapport could inadvertently influence the respondents 
towards a bias and socially desirable response. The postal questionnaire 
also made possible reaching the respondents who were dispersed across 
the various clinical settings of the University Hospital of Leicester NHS 
Trust. Another deciding factor for the choice of postal questionnaire over 
interviews was that at the time of access negotiation and staff preparation, 
concerns were raised by clinicians. While nursing staff would voluntarily and 
willingly assist with the study, their involvement should be kept to the very 
minimum. At a time when already chronic staff shortage generates 
increased nursing workload excessive staff time demands would cause 
additional stress and compromise the duty of care. There was consensus by 
the clinicians and the researcher that a scheduled interview would be 
inappropriate, more disruptive and inconvenient to the nurse participants, 
than a postal questionnaire which could be responded timely and at their 
convenience. 
The postal questionnaire was designed to generate a mixture of: 
• Quantitative data for simple descriptive statistical analysis 
• Qualitative data to provide insights into the practical application of the 
DVTscale. 
It was designed to maximise coverage of the pertinent issues, response 
rate, ease of administration, cost and time effectiveness (da Vaus, 1993). 
Although a large number of questions increase the reliability of an 
evaluation tool, the use of more than 30 items would test the respondents' 
patience (Cooligan, 1996). 
The questionnaire was composed of 29 items conveniently split into two 
sections. In the organisation of the items, the funnel approach was chosen. 
Section one addressed the biographical data of the participating nursing 
staff. in relation to their professional experience and competence. This 
biographical data would be used as a basis for explaining similarities and 
differences in responses to the items in section two. In section two, the 
questions were narrowed down to the scope of more specific evaluation of 
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· the practical application and clarity of the DVT risk calculator. Where 
appropriate, to reduce the complexity of the statement, some items as 
illustrated by statements 7 and 21, were broken down into logical and 
specific components, to deal with one task or concept at a time, and 
enabled respondents to interpret them in the same way. It also ensures that 
the investigator actually gets the answers to the questions which 
respondents are willing and able to give and be critical about them in a 
constructive way. Both closed and open questions were used judiciously, so 
that the strength of one offsets the weakness of the other (Parahoo, 1997). 
The questions themselves were short and arranged in a logical sequence, 
easing the respondent into the more important and complex issues further 
on. 
A Likert-type scaling procedure was applied to section two of the tool. 
Respondents were required to place themselves on one of the five pOints 
degree of agreement on an attitude continuum for each statement, running 
from Strongly Agree to Strongly Disagree. The five points were given simple 
weights of 5,4,3,2,1 for scoring purposes but items 9 and 10 of the 
questions were reversed in negative mode and scored 1 for Strongly Agree 
and up to five for Strongly Disagree. This deliberate reversed item 
construction was designed to stop respondents filling in the scale automatic 
and carelessly by going in one column. Generally, there is a tendency to 
agree rather than disagree, resulting in response acquiescence set whereby 
respondents agree with the item, irrespective of the contents rather than 
disagree (Oppenheim, 1992). Items 15 to 17 were also deliberately 
constructed as open-ended questions to break the automatic response 
mode. The respondents would feel less frustrated with this lack of 
constraint, making the whole approach realistic. Respondents "rarely have 
to just agree and disagree without comments· Cooligan, 1996:p 87). 
Odd items as illustrated in statements 8 and 9 were arranged in an 
unpredictable mixture of positive and negative statements. Such a format 
has the culminative effect of keeping the respondents actively thinking when 
making their response (Burns, 2000). 
Items 18 to 24 were very specific to the seven risk categories of the DVT 
scale, and respondents were asked to comment on the ease with which they 
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chose the most appropriate risk factor for each of the subscales. Such 
responses would be analysed to establish the clarity and consistency of 
OVT risk assessment. 
Additionally, for each item in section two of the tool, respondents were 
offered the opportunity to make general comments to obtain unanticipated 
answers, thus allowing for the collection of qualitative data collection. The 
respondents might also describe more closely their real views and increase 
the validity of the measurement (Fowler 1993). 
At the launch of the staff preparation for the study nursing staff were briefed 
that a postal questionnaire would be used to evaluate the practical 
application of the OVT scale, It was not posted to them until data collection, 
using the DVT scale, was completed and the targeted number of patients 
recruited to the study. This delaying tactic ensured that the questionnaire 
was not misplaced and enabled the respondents to be fully familiar with the 
risk assessment tool, thus facilitating them making constructive feedback in 
terms of its strengths, weaknesses and practicality. Such feedback would 
then be used to modify and develop the DVT scale further. 
The questionnaire was applied in its entirety across the three clinical 
directorates and respondents instructed to overlook items that were not 
relevant to their particular speciality. The trauma risk subscale was 
essentially applicable to the trauma/orthopaedic unit and the Surgical 
Intervention Category not applicable to the patients on the medical 
directorate. 
All participants were assured that information gathered would be protected 
in strictest confidence. Name disclosure was not essential as a discreet 
numerical code identified the respondents.The reason was twofold. First of 
all, the coding enabled the researcher to monitor the response rate and that 
any non or slow response could be followed up by a polite reminder and 
sending out a second or third questionnaire as required. A 30% response 
rate is not unusual for mailed questionnaire (Waltz et ai, 1991) and 60% is 
considered adequate (Tal bot, 1995). A high response rate of 79 per cent 
was achieved (22128) as illustrated in the response table below: 
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Table 4.5: Response rate of mailed questionnaire. 
Speciality No. of mailed No. of responses questionnaires 
Orthopaedics I Trauma 13 12 
General Medicine 13 8 
General surgery 2 2 
Total 28 22 (79%) 
N=28 
Secondly, while maintaining confidentiality, in the sense that only the 
researcher would know the identity of the respondents, the biographical data 
in section one of the questionnaire, in terms of their clinical and professional 
experiences, could be analysed to explain their qualitative responses. 
Staff preparation 
Following successful access negotiation and recruitment of registered 
nursing staff as data collectors, a full programme of staff preparation was 
undertaken. On each of the selected wards, several half-day workshops . 
were held. They were all scheduled at the convenience of the staff, so that 
all that participated in the project had uniform briefing and training on data 
collection with the DVT scale. This was judged to be fundamental to the 
accuracy of data collection and the evaluation of the inter rater reliability of 
the instruments in relation to its measure of equivalence and conSistency. 
Inter rater or inter observer reliability refers to "two or more trained 
observers or raters making the same observation simultaneously and 
independently recording the relevant variable, according to a predetermined 
plan- (Polit & Hungler, 1985:124). 
Further to the evaluation of an instrument, Washington and Moss (1988) 
summarised six pragmatic aspects of the process of establishing interrater 
reliability, namely: 
• Understanding of the theoretical perspective. 
• Familiarisation with the research instrument. 
• Number of subjects. 
• Specific time frame. 
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• Concerns for interfering variables. 
• Scoring and discussion. 
All the six aspects p"roposed by Washington and Moss (1988) were applied 
in the preparation of the staff for the study. 
Understanding of the theoretical perspective 
A comprehension of the theoretical framework underpinnings the DVT risk 
calculator was given to the staff who engaged in the study as an essential 
beginning point. A collection of all published articles in relation to the DVT 
scale was made available to them. The rationale for each of the risk 
categories of the OVT scale was explained and the constructs underlying 
the items were fully explained. If there was a question about the 
interpretation of a particular item, the theoretical construct served as an 
important point of reference to clarify the item. Such discussions provided a 
foundation for post observation sessions when raters compared their 
independent ratings. 
Familiarisation with the research instrument 
Familiarisation with a research instrument promotes consistency in its 
application. The study focused on the refinement of a risk assessment tool 
and because it was new, training was imperative. The staff were orientated 
to the risk assessment factors and the scoring of the DVT scale. A trial run 
was rehearsed: those who engaged in the study tried out the DVT risk 
assessment scale on a few patients and any matter arising discussed and 
clarified. It was important that the instrument had clear instruction and that 
each item was stated unambiguously so that the item was interpreted only 
one way. Ambiguity of item increases error and variance and clarification 
enhances correctness of interpretation (Kerlinger, 1986). 
Number of subjects 
In the reliability studies, fifty patients were targeted from each of the three 
clinical directorates. The criteria for inclusion of subjects were explained and 
staff instructed to obtain oral consent from those recruited. Specific criteria 
included such as special risk categories. trauma risk factors, surgical 
intervention and high-risk diseases were also fully explained. 
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Specific time frame 
To ensure that the same set of variables were rated a beginning time and 
ending time was determined. Risk assessment was to be undertaken within 
24 hours of admission to the ward. In the case of patients scheduled for 
surgery within the 24 hours defined time frame, assessors were instructed to 
risk assess the surgical patients on return from theatre recovery, when they 
were deemed to be at optimum risk. By limiting the time frame, the raters' 
recall of events is enhanced and accuracy of scoring increased. This 
strategy allows for an encapsulated set of data of the subjects within the 
specified time to be observed and rated, using only the relevant items of the 
instrument. 
Interfering variables 
Interfering variables may influence the raters' performance and accuracy. 
The Trauma Risk Category, which applies only preoperatively, was 
concurrently scored postoperatively. The trauma risk category ceases to 
apply after surgical intervention and this discrepancy encountered in the dry 
run was clarified and problem resolved. 
Scoring and discussion 
Further to ensure that the scoring procedure was carried out independently, 
the investigator was available for supervision of practice and conSUltation. 
Data collected were kept in separate two box files, with each rater provided 
with one. This strategy ensured discreteness, confidentiality and 
independent rating of variables. The scoring was collated by the investigator 
and items of agreement and disagreement were evaluated and fed back to 
the raters. 
Procedure 
In order to maintain the integrity of the kappa statistic, all the staff were 
given preCisely the same briefing at the OVT workshop to enable them to 
share a common frame of reference. Additionally, the registered nurse 
assessors were paired for data recording by virtue of equality of clinical 
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experience so that parity and consistency of data recording could be 
achieved. 
The following step by step process was pursued in the risk assessment and 
data collection process: 
It was left to the discretion and convenience of the paired assessors to 
decide when they should simultaneously and independently risk assess the 
patient within the 24 hours deadline. Patients undergoing surgery within the 
24 defined time frame, would be risk assessed on return from theatre. Each 
patient would have two completed risk assessment charts by the end of the 
procedure. 
As the data was leaving the clinical areas for analysiS by the researcher, to 
conceal the identity of the patients a coding system was applied. Only the 
data collectors and the researcher would be able to identify the subjects. 
Before the assessment process, the paired assessors would choose a 
predetermined numerical code for the patient from the coding sheet 
supplied. For instance, the first patient would bear the numeral code of 
W100/01 followed by W100/02 for the second subjects and so on. Each 
code was to be used once and recorded in the addressograph section of the 
chart. The assessors would also record the patient name against the chosen 
code on the coding sheet, to enable the researcher to follow up patients on 
discharge. 
To risk assess the patient, the paired assessors Simply ring out the scores in 
the following subscales: 
Age speCific group: This applied to all patients and the assessors would 
score the appropriate age group. 
Body Mass Index (BMI): This applied to all patients and again the 
assessors would ring out the appropriate item. The BMI ready reckoner on 
the reverse of the DVT chart provided a quick referencing guide to the 
raters. 
Mobility: This subscale also applied to all patients and the appropriate level 
of mobility recorded. 
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Special risk category: This box was scored only if applicable to patients. 
Trauma risk category: This category applied selectively to trauma patients. 
One or more items might be applicable but only preoperatively. This 
category ceased to apply when the patient had undergone surgery to repair 
the trauma. 
Surgical intervention category: The raters had to score only one most 
appropriate item form this category. 
High risk diseases: This category would be scored as applicable to the 
patients. In some subjects more than one item would be scored as 
applicable. 
Venous thromboprophylaxis: In the initial assessment, the assessors 
would complete this box. The investigator would record any subsequent 
thromboprophylaxis and this helped to differentiate between primary and 
secondary prophylaxis. 
To calculate the assessed patient overall score, the raters would simply add 
the ring- out scores. Aggregate score recorded placed the patients into one 
of the risk categories. 
Finally, the independently risk assessed charts kept in a box file would be 
collated by the researcher for measure of equivalence. Any discrepancy or 
disagreement between the raters would be discussed with them. 
This standard procedure was implemented in all the three clinical 
directorates of the NHS trusts. Strategically, one trust was targeted at a time 
and this freed the investigator to concentrate in one area of practice and 
manage the research process effectively. The investigators decision to 
target one NHS trust at a time was influenced by several pragmatic factors. 
The rationale for singling out one NHS trust was as follows: 
• It enabled the researcher to make more frequent visits to the clinical 
resea~ch area, which would not have been possible if the study was 
being undertaken simultaneously on multi-sites of the trusts. As a result, 
the limited human resource was channelled effectively. 
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• It enabled the research process to be managed strictly within the 
approved protocol. 
• It facilitated prompt feedback to staff on Queries relating to the data 
collection process and thus prevented departure from the agreed 
protocol. 
• Focusing on one clinical area enabled the researcher to submit up to 
date and reliable reports to the research and development office of the 
trust as required within the terms of indemnity of the project. 
• It facilitated close monitoring of the patients for the predicted outcomes. 
• It enabled for a group of 50 patients to be followed up after discharge. 
noting that liaison with general practice, anticoagulant clinics, outpatient 
clinics, case notes library and community nursing services was 
paramount for monitoring predicted outcomes. 
The data derived.from a snapshot of 150 patients would be subjected to the 
following statistical analyses to evaluate the effectiveness of the OVf scale: 
• kappa statistic to measure the inter rater reliability of the OVf scale. 
• 8ayesian method to calculate the sensitivity, specificity, predictive 
validity and likelihood ratios of the tool. Saves' theorem links the 
probabilities of events before an experiment (a prion) to the probabilities 
of events after an experiment (a posteriori) Campbell. 2001). 
• A Receiver Operating Characteristic (ROC) curve to determine the best 
cutoff score for optimal predictive accuracy. 
• Logistic regression to evaluate the discriminatory power of the 
independent variable in the causation of OVT. 
• A postal survey to evaluate the practical application of the OVT scale. 
Finally, data from all sources would also be pooled and analysed to 
determine the current venous thromboprophylaxis protocol in relation to the 
recommendations of the consensus groups. 
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Summary 
A longitudinal study was undertaken to evaluate the DVT risk assessment 
for its consistency, predictive validity, sensitivity, specificity and practical 
application. Available data was also analysed to determine how current . 
venous thromboprophylaxis strategies compare with the recommendations 
of national and international consensus groups. A convenience sample of 
150 patients were recruited from the orthopaedic, medical and surgical 
directorates of two trusts. 
Five reliability studies were undertaken to estimate the consistency of the 
DVT scale. Registered nurses were paired in terms of parity clinical 
knowledge and experience and were required to risk assess patients 
independently with the risk assessment tool, within 24 hours of admission. 
The independent recordings were subjected to kappa statistics to measure 
the inter rater reliability of the DVT scale. 
To evaluate the predictive validity of the instrument, the predicted patients 
were monitored for any DVT occurrence during their hospital stay. They 
were also followed up for a period of three months post discharge as DVT is 
a continuing problem and 25 per cent of patients develop DVT after 
discharge home. 
At the end of data collection on each ward, users (registered nurse 
assessors) of the DVT risk assessment scale were sent a postal 
questionnaire (figure 5) to evaluate the overall effectiveness and practical 
application of the DVT scale. 
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Chapter Five 
Results 
The purpose of this chapter is to analyse data gathered, in terms of the aims 
of the study outlined in chapter one. Data collected and pooled from the 150 
patients were analysed to evaluate the consistency, predictive accuracy, 
sensitivity and specificity of the OVT risk assessment scale. An instrument 
may have considerable ability to discriminate yet being of little value for 
patient management if it does not have practical application (Zweig & 
Campbell, 1993). A practical tool that is an optimal risk predictor must also 
be widely available, standardised, reproducible, cheap, user friendly and 
well defined (Lowe, 1993). Postal questionnaires were scrutinised to 
determine the practical application of the OVT scale. Available data on 
venous thromboprophylaxis were also analysed to establish a current local 
DVT prophylaxis protocol, in relation to the national and international 
consensus groups recommendation on venous thromboprophylaxis. 
Reliability of the Autar DVT scale 
Reliability is the first characteristic that any tool must possess and this is an 
absolute precondition to validity (Gibbon, 1995). Reliability can be 
conceptualised in terms of stability, equivalence and consistency 
(Oppenheim 1992). It is a measure of the stability of an instrument in 
relation to the repeatability of the data captured (Anthony, 1999). 
The question of whether a tool is reliable or repeatable is therefore a 
significant consideration in assessing a screening tool such as the OVT 
predictive index. After all, clinical judgements lack the gold standard 
(Brennan & Hayes, 1992). Agreement is the proportion of all patients about 
whom the observers agree on the presence or absence of an observation or 
event. Agreement of two or more observers is defined as inter-observer 
agreement and agreement of an observer with themselves regarding 
repeated observations is termed intra-observer agreement (Koran, 1975). 
Inter rater reliability is the consistency of performance between two or more 
assessors, in relation to the degree of agreement in rating when carried out 
independently but simultaneously on the same person (Tomalin et ai, 1992). 
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Estimates of reliability computed by different procedures for the same 
instrument are not identical (Polit, 1996). 
Hartmann (1977) demonstrated that percentage agreement and correlation 
like procedures such as kappa (Cohen, 1960) often yield very different 
values when used for the same data. The reason for this difference is that a 
correlation like estimate of 0.00 indicates randomly occurring agreement 
while a percentage agreement of 00 implies absolutely no agreement (Lewin 
& Wakefield, 1979). 
In order to communicate variability in the data captured for the 
establishment of the consistency of the DVT scale, both total percentage 
agreement (T%) and kappa statistic were reported. Percentage agreement 
is relatively simple to calculate more accurately. However, one of the major 
criticisms of percentage agreement is that it does not take into account the 
varying contribution of chance agreements to observed agreement rate. 
Some agreement between raters can generally be accounted for by chance 
alone, particularly if the variability among subjects is low and the number of 
categories limited. 
It is for this reason that data pooled were also analysed to determine a 
kappa estimate and adjust for chance agreement. It is arguably an 
improvement on altemative methods of estimation for dichotomous nominal 
and categorical data (Fleiss, 1981). kappa estimation is now the most 
frequently used reliability measure for instruments providing categorical data 
(Seeken & Prescott, 1986). Also a clear understanding of reliability obtained 
in one study necessitates the reporting of more than one indication of 
reliability (Brennan & Hayes, 1992). 
In order to calculate total percentage agreement (T%) the following equation 
was applied: 
Number of agreement 
-----------x 100= (T%) Number of agreement & disagreement 
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kappa statistics (Cohen. 1960) were devised as an omnibus index of 
agreement for nominal scales that is. categories that lack a natural ordering. 
The advantage of the k coefficient over percentage agreement is its 
correction or adjustment for the amount of agreement expected to occur by 
chance. This apparent virtue of the kappa statistic has made it increasingly 
popular in stUdies of observer variability but has a problem of its own. 
Unweighted kappa treats all disagreements. large or small as equally 
serious and identical. Although weighted kappa (Cohen. 1968) addresses 
this weakness. it allows weight to be arbitrary in relative magnitude. This 
means that the magnitude of weighted kappa may be arbitrary and that 
standard weight should be used (Maclure and Willett. 1987). 
kappa is symbolically expressed as: 
Where: 
Po-Pe 
K --I-Pe 
Po is the observed proportion of agreement 
Pe is the chance expected proportion of agreement 
The numerator Po-Pe is the proportion of observer agreement. 
explicitly corrected for the proportion of chance or expected 
agreements 
The denominator 1· Pe is similarly correction for chance 
agreement. 
One of the striking paradoxes of this equation is that despite a relatively high 
result for interobserver agreement. the corresponding value of k can be 
relatively low. The value of k is the correction factor for chance agreement 
and is subtracted from the observed agreement and from perfect 
agreement. Consequently. k gets its highest value when Pe is as small as 
possible. On the other hand if Pe is large. the correction process converts a 
relatively high k to a low value of k (Feinstein and Cicchetti. 1990). 
Another factor that affects k is the true prevalence of a diagnosis. If the 
prevalence of a diagnosis is high. the proportion of agreement expected by 
chance (Pe) is increased. This lowers the value of k (Byrt et ai, 1993). 
Devising a prevalence index (PI). Byrt et al (1993) estimate the true 
prevalence of a diagnosis as (a-dlN) where a is the number with the 
condition minus d those without it. divided by the total. The prevalence index 
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can take values from -1 to +1. In the application of this index (28-120/148) a 
PI of -0.6 for DVT was recorded. 
DVT is a universal problem that crosses all traditional departments, 
specialities and subspecialities of clinical practice (Bell and Simon, 1982). 
The Autar DVT scale was designed to have universal application to clinical 
. practice. It was therefore fitting that a reliability study was undertaken in 
each of the five wards to evaluate the consistency of the instrument across 
diverse specialities. 
kappa is appropriate for either dichotomous or polychotomous ratings and 
has been extended to 6 raters and 5 categories with a sample of 30 (Fleiss, 
1971). But for the purpose of this study, pairwise kappa was applied. 
There are three assumptions to be met when undertaking the kappa 
statistics. First of all, the subjects to be rated are independent of one 
another. Secondly, the raters operate independently of one another. The 
third assumption is that the categories are mutually exclusive and 
exhaustive (Cohen, 1960). In the typically reliability study, the raters were 
paired on the basis of equality of nursing experience and education, 
additional to having attended the same staff preparation brief. They were 8 
priori deemed equal in their ability to make judgement and recording. The 
data collected simultaneously and independently by the paired assessors 
(Tables 5.1 to 5.5) were computed to calculate both the total percentage 
agreement and the kappa values. 
Each table is then converted into a schema for examining variation between 
the two assessors on each of the five clinical areas. Recordings of assessor 
A are cross tabulated against the recordings of assessor B. 
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Table 5.1: Reliability study on trauma I orthopaedic ward C 
Assessor Patients Age Build Mobility Special Trauma Surgery High Risk Assesor Assesor A-B risk Disease A B 
Total Scores 
1 0-0 1-1 0-0 0-0 0-0 
2 4-4 1-1, 4-4 0-0 4-4 
3 4-4 1-1 4-4 0-0 4-4 
4 4-4 0-0 4-4 0-0 4-4 
5 1-1 1-1 4-4 0-0 0-0 
6 3-3 2-2 0-0 0-0 0-0 
7 4-4 0-1 2-2 0-0 4-4 
8 1-1 1-1 4-4 0-0 4-4 
9 4-4 1-1 4-4 0-0 4-4 
10 2-2 1-1 0-0 0-0 0-0 
11 1-1 1-1 0-0 0-0 0-0 
12 4-4 0-0 4-4 0-0 4-4 
13 1-1 1-1 0-0 0-0 0-0 
14 1-1 1-1 0-0 0-0 0-0 
15 0-0 1-1 4-4 0-0 4-4 
DVT 16 4-4 1-1 4-4 0-0 4-4 
17 2-2 1-1 0-0 0-0 0-0 
18 1-1 1-1 0-0 0-0 0-4 
19 0-0 1-1 0-1 0-0 0-0 
20 3-3 1-1 3-3 0-0 0-0 
DVT 21 4-4 4-4 4-4 0-0 4-4 
DVT 22 4-4 1-0 4-4 0-0 9-9 
23 0-0 1-1 0-0 0-0 4-4 
24 4-4 1-1 0-1 0-0 0-0 
25 0-0 1-1 0-0 0-0 0-0 
26 2-2 1-1 0-0 0-0 4-4 
Total Percentage Agreement: 22 x 100 = 84.6% 
26 
1-1 0-0 
0-0 0-0 
0-0 0-0 
0-0 0-0 
4-4 0-0 
4-4 2-2 
0-0 0-0 
0-0 0-0 
0-0 0-0 
4-4 0-0 
4-4 0-0 
0-0 0-0 
4-4 0-0 
4-4 0-0 
0-0 . 0-0 
0-0 7-7 
1-0 0-0 
4-0 0-0 
4-4 0-0 
4-4 0-0 
0-0 0-0 
0-0 8-8 
0-0 0-0 
1-1 11-11 
1-1 0-0 
0-0 0-0 
Table 5.2: Agreement matrix on trauma I orthopaedic ward C 
No risk Low risk Moderate High risk 
Risk 
No risk 9 
- - -
Low risk 
-
5 
- -
Moderate risk 
-
1 7 
-
High risk 
- - -
4 
Total 9 6 7 4 
2 
13 
13 
12 
10 
11 
10 
10 
13 
7 
6 
12 
6 
6 
9 
20 
4 
6 
5 
11 
16 
26 
5 
17 
2 
7 
Total 
9 
5 
8 
4 
26 
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2 
13 
13 
12 
10 
11 
11 
10 
13 
7 
6 
12 
6 
6 
9 
20 
3 
6 
5 
11 
16 
25 
5 
18 
2 
7 
Although only 22 items of agreement were recorded out of the 26 ratings, 
converting them into four nominal categories of risk yielded 25 observed 
agreements for kappa correlation. 
25 
Observed Agreement (po) =-
26 
9x9 6x5 8x7 4x4 
Expected Agreement: (pe) =-+ - + - +-
26 26 26 26 
3.1 + 1.2 + 2.2 + 0.6 = 7.1 
26 26 =0.27 
K = 0.96-0.27 = 0.69 = 0.95 
1- 0.27 0.73 
kappa value on ward C= 0.95 
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Table 5.3: Reliability study on the trauma I orthopaedic ward 0 
Assessor Patients Age Build Mobility Special Trauma Surgery High Risk Assesor Assesor A-B risk Disease A B 
Total Scores 
1 4-4 0-0 0-0 0-0 
2 4-4 3-3 4-4 0-0 
3 4-4 0-0 2-2 0-0 
4 4-4 1-1 1-1 0-0 
DVT 5 4-4 1-1 0-0 0-0 
6 4-4 2-2 4-4 0-0 
7 4-4 1-1 4-4 0-0 
8 0-0 1-1 4-4 1-1 
9 4-4 3-3 4-4 0-0 
10 3-3 1-1 0-0 0-0 
11 1-1 1-1 0-0 0-0 
12 4-4 0-0 1-1 0-0 
13 4-0 1-0 2-0 0-0 
14 4-4 1-2 4-4 0-0 
15 4-4 1-1 0-1 0-0 
16 4-4 1-1 4-4 0-0 
17 4-4 1-1 4-4 0-0 
18 4-4 1-2 4-4 0-0 
19 4-4 1-1 4-4 0-0 
DVT 20 4-4 2-2 4-4 0-0 
DVT 21 4-4 3-3 4-4 0-0 
22 4-4 0-0 4-4 0-0 
DVT 23 4-4 1-1 4-4- 0-0 
DVT 24 4-4 1-1 4-4 0-0 
Total Percentage Agreement: 21 x 100 = 91% 
23 
4-4 0-0 
4-4 0-0 
0-0 0-0 
3-3 0-0 
4-4 0-0 
4-4 0-0 
0-0 2-2 
0-0 0-0 
4-4 0-0 
4-4 0-0 
4-4 0-0 
4-4 0-0 
0-0 4-0 
4-4 0-0 
0-0 4-0 
4-4 0-0 
4-4 0-0 
4-4 0-0 
4-4 0-0 
4-4 0-0 
4-4 0-0 
4-4 0-0 
4-4 0-0 
4-4 0-0 
Table 5.4: Agreement matrix on orthopaedic ward 0 
B No risk Low risk Moderate risk 
A 
No risk 2 
- -
Low risk 
- 4 -
Moderate 
- 1 9 
risk 
High risk 
- - -
Total 2 5 9 
Number in total= 23 
0-0 12 
12-12 27 
5-5 11 
--
9 
0-0 9 
5-5 19 
0-0 11 
0-0 6 
0-0 15 
0-0 8 
0-0 6 
0-0 9 
0-0 11 
7-10 20 
0-0 9 
3-3 16 
7-7 20 
0-0 13 
0-0 13 
0-0 14 
0-0 15 
0-0 12 
0-0 13 
0-0 13 
High risk Total 
-
2 
-
4 
-
10 
7 7 
7 23 
One recording excluded from data analysis due to incompleteness of data. 
Data Analysis: n = 23 
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12 
27 
11 
9 
9 
19 
11 
6 
15 
8 
6 
9 
0 
24 
6 
16 
20 
14 
13 
14 
15 
12 
13 
13 
22 
Observed Agreement: 23 =0.96 
2 x 2 5 x 4 9 x 9 7 x 7 4 20 81 49 
Expected Agreement : (Pe) =- +-+-+-= - +- +-+-
23 23 23 23 23 23 23 23 
0.26 + 0.86 + 3.5 + 2.1 6.63 
23 23 
K = 0.96-0.29 = 0.67 = 09 .4 
1 - 0.29 0.71 
kappa value on ward 0 is: 0.94 
=0.29 
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Table 5.5: Reliability study on medical ward 29. 
Assesor Patients Age Build A-B 
1 3-2 1-1 
DVT 2 2-2 3-3 
3 4-4 1-1 
4 4-4 0-0 
5 4-4 1-1 
6 4-4 0-0 
7 4-4 1-1 
DVT 8 4-4 1-1 
9 0-0 1-1 
10 4-4 1-1 
11 4-4 1-1 
12 2-2 0-0 
13 4-4 1-1 
14 4-4 0-0 
15 4-4 0-0 
16 4-4 1-1 
DVT 17 4-4 2-2 
18 4-4 0-1 
19 4-4 1-1 
20 3-3 1-1 
21 4-4 2-2 
22 4-4 1-1 
DVT 23 4-4 2-2 
DVT 24 4-4 1-1 
DVT 25 4-4 1-1 
Percentage agreement: 
23 xlOO=92% 
25 
Mobility Special Risk 
0-0 0-0 
1-1 0-0 
0-0 0-0 
0-0 0-0 
1-1 0-0 
0-0 0-0 
0-0 0-0 
0-0 0-0 
0-0 0-0 
1-1 0-0 
4-4 0-0 
4-4 0-0 
1-1 0-0 
1-1 0-0 
2-2 0-0 
0-0 0-0 
2-2 0-0 
0-0 0-0 
0-0 0-0 
0-0 0-0 
2-2 0-0 
0-0 0-0 
2-2 0-0 
1-1 0-0 
4-4 0-0 
Table 5.6: Agreement matrix on ward 29 
Trauma 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
Surgery 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
1-1 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
3-3 
B No risk Low risk Moderate risk A 
No risk 13 1 -
Low risk 
- 6 -
Moderate risk 
- -
3 
High risk 
- - -
Total 13 7 3 
High Risk Assessor Assessor 
Diseases A B 
Total score 
3-3 7 6 
0-0 6 6 
5-5 10 10 
5-5 9 9 
4-4 10 10 
0-0 4 4 
0-0 5 5 
0-0 5 5 
0-0 1 1 
0-0 6 6 
7-7 16 16 
5-5 11 11 
0-0 6 6 
0-0 5 5 
4-4 10 10 
0-0 5 5 
7-7 16 16 
0-0 4 5 
0-0 5 5 
0-0 4 4 
7-7 15 15 
0-0 5 5 
0-0 8 8 
7-7 13 13 
0-0 12 12 
High risk Total 
-
14 
-
6 
-
3 
2 2 
2 25 
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Observed agreement: 24 
Expected 
agreement: 
13x14 + 7x6 + 3x3 + 2x2 = 7.28 + 1.68 + 0.36 + 0.16 = 9.48 =0.38 
25 25 25 25 25 25 25 25 25 
K = 0.96 -0.38 = 0.58 = 0.94 
1-0.38 0.62 
kappa value on ward 29 is 0.94. 
Table 5.7: Reliability study: medical ward 30: 
Assessor Patients Age A-B 
DVT 1 3-3 
2 3-3 
3 4-4 
DVT 4 4-4 
5 4-4 
6 4-4 
7 4-4 
8 2-2 
9 3-3 
10 1-1 
11 4-4 
12 4-4 
13 4-4 
DVT 14 3-3 
15 4-4 
DVT 16 4-4 
17 4-4 
18 4-4 
19 4-4 
20 4-4 
21 4-4 
22 4-4 
DVT 23 4-4 
DVT 24 4-4 
25 4-4 
Percentage agreement: 
23 
-xlOO=92% 
25 
Build Mobility Special Trauma Risk 
1-1 0-0 0-0 0-0 
1-1 0-0 0-0 0-0 
1-1 1-1 0-0 0-0 
1-1 0-0 0-0 0-0 
2-2 2-2 0-0 0-0 
1-1 0-0 0-0 0-0 
1-1 1-1 0-0 0-0 
1-1 1-1 0-0 0-0 
1-1 0-0 0-0 0-0 
1-1 0-0 3-3 0-0 
1-1 4-4 0-0 0-0 
1-1 2-2 0-0 0-0 
1-1 2-1 0-0 0-0 
3-3 2-1 0-0 0-0 
1-1 1-1 0-0 0-0 
1-1 0-0 0-0 0-0 
0-0 0-0 0-0 0-0 
2-2 1-1 0-0 0-0 
3-3 2-2 0-0 0-0 
1-1 0-0 0-0 0-0 
1-1 1-1 0-0 0-0 
2-2 4-4 0-0 0-0 
2-2 0-0 0-0 0-0 
2-2 2-2 0-0 0-0 
1-1 0-0 0-0 0-0 
SUrgery 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
0-0 
High Risk 
Disease 
4-4 
0-0 
7-7 
0-0 
0-0 
3-3 
3-3 
4-4 
0-0 
0-0 
5-5 
3-3 
0-0 
3-3 
7-7 
7-7 
7-7 
0-0 
7-7 
0-0 
3-3 
3-3 
0-0 
3-3 
0-0 
Assessor Assessor 
A B 
Total Score 
8 8 
4 4 
13 13 
5 5 
8 8 
8 8 
9 9 
8 8 
4 4 
5 5 
14 14 
10 10 
7 6 
11 10 
13 13 
12 12 
11 11 
7 7 
16 16 
5 5 
9 9 
13 13 
6 6 
11 11 
5 5 
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Table 5.8: Agreement matrix on medical ward 30 
B No risk Low risk Moderate risk A 
No risk 8 
Low risk 
-
Moderate risk -
High risk 
-
Total 8 
23 Observed agreement - = 0.92 
25 
1 
7 
1 
-
9 
8x9 9x7 7x8 lxl Expected agreement -+--+-+-
25 25 25 25 
K = 0.92 - 0.31 = 0.61 = 0.88 
1-0.31 0.69 
kappa value on ward 30 = 0.88. 
-
-
7 
-
7 
High risk Total 
-
9 
- 7 
-
8 
1 1 
1 25 
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Table 5.9: Reliability study on ward 27 (Surgical directorate) 
Assessor Patients Age Build Mobility I s=al Trauma I Surgery High Risk Assesor Assesor A-8 Diseases A B 
Total Scores 
DVT 1 4-4 2-2 0-0 0-0 0-0 1-1 7-7 14 14 
DVT 2 2-2 2-2 2-2 0-0 0-0 2-2 0-0 8 8 
3 0-0 1-1 0-0 0-0 0-0 3-3 0-0 4 4 
4 1-1 1-1 0-0 0-0 0-0 3-3 0-0 5 5 
DVT 5 3-3 2-2 0-0 0-0 0-0 3-3 0-0 8 8 
6 3-3 2-2 0-0 0-0 0-0 1-1 0-0 6 6 
7 2-2 2-2 0-0 0-0 0-0 1-1 3-3 8 8 
8 1-1 2-2 0-0 0-0 0-0 1-1 0-0 4 4 
9 4-4 2-2 1-1 0-0 0-0 2-2 0-0 9 9 
10 3-3 2-1 2-2 0-0 0-0 3-3 1-1 11 10 
11 0-0 0-0 0-0 0-0 0-0 1-1 0-0 1 1 
12 4-4 1-1 1-1 0-0 0-0 3-3 0-0 9 9 
13 4-4 1-1 2-2 0-0 0-0 3-3 0-0 10 10 
14 2-2 1-1 1-1 0-0 0-0 3-3 0-0 7 7 
15 4-4 1-1 2-2 0-0 0-0 3-3 0-0 10 10 
DVT 16 4-4 1-1 2-2 0-0 0-0 3-3 5-5 15 15 
17 4-4 1-1 1-1 0-0 0-0 3-3 0-0 9 9 
18 4-4 2-2 0-0 0-0 0-0 3-3 4-4 13 13 
19 4-4 1-1 2-2 0-0 0-0 0-0 3-3 10 10 
20 0-0 3-3 1-1 0-0 0-0 2-2 0-0 6 6 
21 4-4 1-1 2-2 0-0 0-0 3-3 0-0 10 10 
22 4-4 1-1 0-0 0-0 0-0 0-0 6-6 11 11 
23 1-1 3-3 0-0 0-0 0-0 2-2 0-0 6 6 
24 4-4 1-1 0-0 0-0 0-0 0-0 3-3 8 8 
DVT 25 4-4 1-1 2-2 0-0 0-0 0-0 10-10 17 17 
26 4-4 0-0 2-2 0-0 0-0 0-0 0-0 6 6 
27 4-4 0-0 0-0 0-0 0-0 0-0 7-7 11 11 
28 1-1 1-1 0-0 0-0 0-0 3-3 0-0 5 5 
29 4-4 1-1 2-2 0-0 0-0 3-3 0-0 10 10 
30 4-4 2-2 3-3 0-0 0-0 3-3 0-0 12 12 
31 1-1 0-0 4-4 0-0 0-0 0-0 0-0 5 5 
32 4-4 3-3 1-1 0-0 0-0 1-1 0-0 9 9 
DVT 33 4-4 1-1 0-0 0-0 0-0 3-3 3-3 11 11 
34 4-4 2-2 4-4 0-0 0-0 0-0 7-7 17 17 
35 3-3 1-1 0-0 0-0 0-0 3-3 0-0 7 7 
36 4-4 1-1 0-0 0-0 0-0 3-3 0-0 8 8 
37 4-4 0-0 1-1 0-0 0-0 0-0 5-5 10 10 
38 4-4 0-0 0-0 0-0 0-0 0-0 5-5 9 9 
DVT 39 4-4 3-3 0-0 0-0 0-0 0-0 5-5 12 12 
40 1-1 1-1 0-0 0-0 0-0 0-0 7-7 9 9 
41 4-4 4-4 0-0 0-0 0-0 0-0 0-0 8 8 
42 2-2 1-1 2-2 0-0 0-0 3-3 0-0 8 8 
43 4-4 1-1 2-2 0-0 0-0 3-3 0-0 10 10 
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Assessor Patients Age Build Mobility A-8 
44 4-4 0-0 2-2 
45 3-3 1-1 0-0 
DVT 46 4-4 1-1 0-0 
47 3-3 2-2 0-0 
48 4-4 2-2 0-0 
49 3-3 2-2 0-0 
50 4-4 1-1 0-0 
Percentage agreement: 
49 ' 
-xl00=98% 
50 
Special Trauma Surgery risk 
0-0 0-0 3-3 
0-0 0-0 0-0 
0-0 0-0 2-2 
0-0 0-0 1-1 
0-0 0-0 1-1 
0-0 0-0 3-3 
0-0 0-0 0-0 
Table 5.10: Agreement matrix on the surgical ward. 
B No risk Low risk 
A 
No risk 12 
-
Low risk - 26 
Moderate risk 
- -
High risk 
- -
Total 12 26 
49 Observed agreement (Po) = - = 98 
50 
Expected agreement: 
Moderate risk 
-
1 
8 
-
9 
High Risk 
Diseases 
0-0 
0-0 
6-6 
3-3 
0-0 
0-0 
0-0 
High risk 
-
-
-
3 
3 
(Pe) = 12x12 + 26x27 + 9x8 + 3x3 = 2.9+14.04+1.4+0.18 =0.37 
50 50 50 50 50 
K= 0.96-0.37 = 0.59 =0.94 
1-0.37 0.63 
kappa value on ward 27 = 0.94 
Assesor Assesor 
A 8 
Total Scores 
10 10 
4 4 
13 13 
9 9 
7 7 
8 8 
5 5 
Total 
12 
27 
8 
3 
50 
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Summary & interpretation of results 
There is a consensus that a minimum of 70 per cent agreement is 
necessary, 80 per cent is adequate and 90 per cent is good (Hartmann et ai, 
House et ai, 1981). Total percentage agreements within the five reliability 
studies were high and ranged from 85- 98 per cent. 
Like a correlation coefficient, kappa values vary from -1.0 for complete 
disagreement, 0 for chance agreement to +1 for perfect agreement. 
The kappa values for the same five reliability studies ranged from 0.88 -
0.95, confirming an almost perfect agreement as tabulated below by the 
heuristic for the various values of k (Landis and Koch, 1977). Expected 
values for chance correction or adjustment ranged from 0.27-0.38, thus 
further substantiating the high kappa values reported. 
Table 5.11: Interpretation of various values of kappa 
Kappa statistic Strength of agreement 
<0.00 Poor agreement 
0.00-0.20 Slight agreement 
0.21-40 Fair agreement 
0.41-0.60 Moderate agreement 
0.61-0.80 Substantial agreement 
0.81-1.00 Almost perfect agreement 
Landis and Koch (1977) admit that the boundaries between the adjacent 
categories are arbitrary, albeit useful benchmarks. What constitutes a good 
kappa value is controversial. Landis and Koch (1977) claim a SUbstantial 
agreement for a kappa value 0.61 but other researchers have insisted on a 
kappa value of no lower than 0.75 (Mehrens & Lehmans, 1978; Blenner, 
1993). 
Intra-class correlation coefficient (ICC) 
Further to substantiate the high inter rater reliability of the DVT scale, Ice 
was computed for all the five clinical areas. Ice estimates the average 
correlation among all possible pairs of observation (Bland & Altman, 1996; 
Anthony, 1999). It takes into account the error between two raters in both 
their absolute scores and the ranking of scores (Tomalin et ai, 1993). 
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As the number of observation was the same for each subject recorded by 
paired assessors, Ice was considered appropriate. Bland & Altman (1996) 
suggest that the following equation be applied to calculate ICC, when a 
computer software package is unavailable: 
Where: r1 is the intra-class correlation coefficient 
m is the number of observation 
SSb is the between subjects sum of squares 
SSt is the total sum of squares 
The available data from Tables 5.1, 5.3,5.5.5.7 and 5.9 used to estimate 
the total percentage agreement and kappa values, were computed to 
estimate ICC, using SPSS (version 11) via statistic pull down and selection 
of intra-class correlation coefficient (Table 5.12). 
Table 5.12: Intra-class correlation coefficients analysis 
Intra-class correlation coefficients:Ward C 
Method 1 (space saver) will be used for this analysis. 
R ELl A B I LIT Y A N A L Y S I S - S C ALE (A L P H A) 
lntraclass Correlation Coefficient 
One-way random effect model: People Effect Random 
Single Measure Intraclass Correlation - .9975 
95.00% C.!.: Lower - .9945 Upper -
.9989 
F - 803.8800 DF - ( 25, 26.0) Sig. - .0000 (Test Value -
.0000 ) 
Average Measure Intraclass Correlation - .9988 
95.00% C.l.: Lower - .9973 Upper -
.9994 
F - 803.8800 DF - ( 25, 26.0) Sig. - .0000 (Test Value -
.0000 ) 
Reliability Coefficients 
N of Cases .. 26.0 N of Items - 2 
Alpha - .9987 
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Intra-class correlation coefficients: Ward 0 
* Method 1 (space saver) will be used for this analysis. 
R ELl A B I LIT Y A N A L Y S I S - S C ALE (A L P H A) 
Intraclass Correlation Coefficient 
One-way random effect model: People Effect Random 
Single Measure Intraclass Correlation - .8967 
95.00% C.I.: Lower - .7789 Upper -
.9537 
F... 18.3564 DF ... 23, 24.0) Sig. = .0000 (Test Value -
• 0000 ) 
Average Measure lntraclass Correlation - .9455 
95.00% C.I.: Lower... .8757 Upper "" 
.9763 
F" 18.3564 
.0000 ) 
DF - 23, 24.0) Sig. = .0000 (Test Value -
Reliability Coefficients 
N of Cases ... 24.0 N of Items'" 2 
Alpha = • 9445 
Intra-class correlation coefficients: Ward 29 
* Method 1 (space saver) will be used for this analysis. 
R ELl A B I LIT Y A N A L Y S I S - S C ALE CA L P H A) 
Intraclass Correlation Coefficient 
One-way random effect model: People Effect Random 
Single Measure Intraclass Correlation - .9976 
95.00% C.l.: Lower - .9947 Upper -
.9989 
F - 836.1250 DF ... ( 24, 25.0) Sig. - .0000 (Test Value -
.0000 ) 
Average Measure Intraclass Correlation - .9988 
95.00% C.l.: Lower - .9973 Upper -
.9995 
F - 836.1250 DF - 24, 25.0) Sig. - .0000 (Test Value -
.0000 ) 
Reliability Coefficients 
N of Cases = 25.0 N of Items - 2 
Alpha ... .9988 
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Intra-class correlation coefficients: Ward 30 
* Method 1 (space saver) will be used for this analysis. 
R ELl A B I LIT Y A N A L Y S I S - S C ALE (A L P H A) 
Intraclass Correlation Coefficient 
One-way random effect model: People Effect Random 
Single Measure Intraclass Correlation - .9966 
95.00% C.I.: Lower ~ .9923 Upper = 
.9985 
F = 580.9583 OF x ( 24, 25.0) Sig. = .0000 (Test Value -
.0000 ) 
Average Measure Intraclass Correlation - .9983 
95.00% C.I.: Lower - .9961 Upper = 
.9992 
F ~ 580.9583 OF = 24, 25.0) Sig. = .0000 (Test Value -
.0000 ) 
Reliability Coefficients 
N of Cases 25.0 N of Items'" 2 
Alpha - .9984 
Intra-class correlation coefficients: ward 27 
* Method 1 (space saver) will be used for this analysis. 
R ELl A B I LIT Y A N A L Y S I S - S C ALE (A L P H A) 
Intraclass Correlation Coefficient 
One-way random effect model: People Effect Random 
Single Measure Intraclass Correlation - .9991 
95.00% C.l.: Lower = .9983 Upper -
.9995 
F - 2117.571 OF - ( 49, 50.0) Sig. - .0000 (Test Value -
.0000 ) 
Average Measure Intraclass Correlation - .9995 
95.00% C.I.: Lower - .9992 Upper -
.9997 
F - 2117.571 OF - 49, 50.0) Sig. - .0000 (Test Value -
.0000 ) 
Reliability Coefficients 
N of Cases = 50.0 N of Items - 2 
Alpha - .9995 
The ICCs and their significance level for each ward are summarised below: 
Table 5.13: Summary of Intra-class correlation coefficients on all wards. 
Clinical areas ICC value Significance level 
(Alpha) 
Ward c (orthopaedics) .9987 < 0.0001 
Ward d (orthopaedics) .9445 < 0.0001 
Ward 29 (medicine) .9988 < 0.0001 
Ward 30 (medicine) .9984 < 0.0001 
Ward 27 (surgery) .9995 < 0.0001 
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Interpretation of the reliability coefficient 
There is no standard for what an acceptable reliability coefficient should be 
(Polit & Hungler, 1999). A coefficient in the vicinity of .75 specified by 
Ventura et al (1980) might be sufficient, although coefficient of .80 or greater 
is highly desirable. 
On the other hand, if measures are to be used as a basis for making 
decision about an individual, then the reliability coefficient ideally should be 
.90 or better. The high ICCs recorded in all five clinical areas mirror the high 
percentage agreement and kappa values and are well above the criterion of 
.75 specified by Ventura et ai, 1980. 
Sensitivity and specificity of the Autar DVT scale 
Epidemiological methods are available to predict that a tool is truly able to 
discriminate between individuals with and without a particular characteristic. 
The prime factor to consider in the selection of a predictive index or a 
diagnostic tool is its accuracy. Wheeler et al (1994) identify four components 
of test accuracy which are: 
• Sensitivity 
• Specificity 
• Positive Predictive Value (PPV) 
• Negative Predictive Value (NPV) 
All of the four measurements were applied to evaluate the clinimetric 
properties and predictive accuracy of the DVT scale. 
Sensitivity relates to the proportion of patients with the disease (OVf) and 
who were correctly predicted to be at risk. 
Sensitivity Formula: 
= True Positive x 100 
True Positive + False Negative 
(All individuals with the disease) 
Specificity is the proportion of patients without the condition (OVf) and who 
were predicted not to be at risk. 
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Table 5.14: Diagnostic clinical model for pretest probability of DVT 
(Wells et al 1995) 
Clinical manifestation Score 
Active cancer( treatment ongoing or within 6 months or 
palliative) 
Paralysis, paresis or recent immobilisation of the legs 
Recent immobilisation >3 days or major surgery within 12 
weeks requiring general or regional anaesthesia 
Localised tenderness along the distribution of the deep 
venous system 
Entire leg swollen 
Calf swelling> 3 cm than asymptomatic side ( measured 10 
cm below tibial tuberosity) 
Pitting_ oedema confined to the symptomatic leg 
Collateral su~erficial veins ( non-varicose) 
Alternative diagnosis equally or more likely than DVT 
Assessment Protocol: 
High risk= 3 points Moderate risk=2 points Low = 0 point 
In approximately 70 per cent of patients with clinically suspected DVT, 
alternative diagnoses are ultimately found as follows: 
• Achilles tendonitis 
• Arterial insufficiency 
• Rheumatoid arthritis 
1 
1 
1 
1 
1 
1 
1 
1 
-2 
• Peripheral oedema due to chronic heart disease, liver or renal failure 
• Cellulitis 
• Lymphangitis 
• Haematoma 
• Lymphodema 
• Muscle or soft tissue injury 
• Post phlebitis syndrome 
• Limb paralysis 
• Ruptured Baker cyst 
• Superficial phlebitis 
• Varicose veins 
Data: emedicine. com.inc, 2001. 
This pretest probability model enables clinicians to reliably stratify their 
patients into high, moderate and low risk categories. Combining this with the 
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Specificity Formula: 
True Negative xl00 
True Negative + False Positive 
(All patients without the disease) 
Sensitivity and specificity are useful and practical statistics in as much as 
they yield consistency of result. Sensitivity is conditional on the disease 
being present and specificity on being absent. Both sensitivity and specificity 
are useful tests because they are unaffected by disease prevalence. If the 
number of subjects is doubled, then twice as many patients will give a 
particular outcome. Sensitivity and specificity would be unchanged from 
previous values and therefore yield a consistent result for the diagnostic test 
in a variety of patient group with different disease prevalence (Campbell & 
Machin,1993). In brief, sensitivity and specificity are characteristics of the 
test and not the population to which it is applied. 
To estimate the sensitivity and specificity of the Autar OVT scale, data 
gathered prospectively from the 150 patients from the orthopaedic, medical 
and surgical directorates were pooled for analysis .Two patients were 
excluded from the sensitivity and specificity data analysis, as it was not 
possible to follow them up from hospital on discharge to no fixed abodes. 
Irrespective of primary prophylaxis, all subjects were closely monitored for 
occurrence of OVT. Patients who were suspected of OVT were duly 
investigated by following the established trust screening protocol, before 
secondary venous thromboprophylaxis was administered for DVT treatment. 
The diagnostic clinical predictive guide developed by Wells et al (1994) was 
adopted by the trust as a protocol and applied to all patients suspected of 
OVT. This diagnostic tool quantifies the pretest probability of OVT (Table 
5.14) The Wells et al clinical prediction guide incorporates risk factors, 
clinical signs and the presence and absence of alternative diagnoses. 
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results of objective testing provides an algorithm that greatly simplifies the 
clinical work-up of patients suspected of DVT (Table 5.15). 
Table 5.15: An algorithm for the investigation of suspected DVT 
Diagnostic Clinical Probability of suspected DVT 
Compression Ultrasonography 
Low Moderate Probability High 
Probability (5%) (25%) Probability (80%) 
Non Invasive Test Non Invasive Test Non InvaSive Test 
I I I I 
Negative Positive Negative Positive Negative 
I I I 
Wrthhold Further Test Wrthhold Further Test Further Test 
Wells et al (1993 & 1994) evaluated the clinical model in patients suspected 
of DVT in order to determine their pretest probability of the disease. The 
pretest clinical probability was classified as low, moderate and high based 
on a simple scoring system (Table 5.12). After determining the pretest 
probability, the 243 patients had a venogram and the findings were 
interpreted without the knowledge of the clinical groupings. An overall 
prevalence of 20 per cent (49) DVT was recorded. Patients classified as 
having low probability of DVT constituted 60 per cent (145) of the total 
population and the prevalence of DVT in this large group was only 5 per 
cent. In patients classified as having moderate pretest probability of DVT, a 
prevalence of nearly 25 per cent was recorded. In the high pretest clinical 
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I 
Positive 
I 
Treat 
probability group which constituted only 15% of the total population, the 
prevalence was nearly 80 per cent (28/36) 
A clinical prediction rule must clearly define the event to be predicted and 
such definition must be free from bias and ambiguity (Wasson et ai, 1985). 
In this prospective study, the predictive rule was that the patients predicted 
to develop DVT ultimately contracted this silent and asymptomatic condition. 
For the purpose of statistical analysis of the DVT scale for its sensitivity and 
specificity, the gold standard was defined as patients with a confirmed 
diagnosis of DVT treated with secondary anticoagulant therapy. Twenty-
eight such subjects met the gold standard. All the patients were closely 
monitored for occurrence of DVT on the ward as well as followed up for 
three months after discharge home. DVT is a continuing problem as risk 
factors persist well after discharge from hospital (Scurr et al,1988; Scurr, 
1990; Anderson et ai, 1995). Some patients become rather complacent and 
less mobile and 25 percent of patients (13/51) develop DVT within six weeks 
of discharge from hospital (Scurr et ai, 1988). This report is further 
substantiated by the clinical findings that 11 out of the 28 patients (39 %) 
developed DVT at home (Tables 5.31,5.32 & 5.34). 
The DVT risk assessment scores of all patients from the orthopaedics, 
medical and surgical directorates were computed to establish the sensitivity 
and specificity of the DVT scale. 
Overall, the convenience sample yielded a DVT prevalence of 19% (28/148) 
and is tabulated below: 
Table 5.16: Incidence of DVT on the three clinical specialities 
Speciality No of patients No ofDVT % 
Orthopaedic Trauma 50 8 16 
Medical 50 12 24 
Surgical 48 8 17 
Total 148 28 19 
The score values of all patients with and without DVT is exhibited in table 
5.17. 
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Table 5.17: Score values of patients with and without DVT. 
Raw data converted to percentages. 
% DVT present Scores DVT absent 
0 0 1 2 
0 0 2 2 
0 0 4 8 
7 2 5 14 
7 2 6 12 
3.5 1 7 6 
11 3 8 11 
3.5 1 9 13 
0 0 10 15 
11 3 11 11 
11 3 12 5 
14 4 13 8 
7 2 14 1 
7 2 15 3 
7 2 16 3 
3.5 1 17 2 
0 0 19 1 
3.5 1 20 2 
3.5 1 26 0 
0 0 27 1 
100% 28 120 
% 
2 
2 
7 
12 
10 
5 
9 
11 
13 
9 
4 
7 
1 
2.5 
2.5 
2 
1 
2 
0 
1 
100% 
N = 148 
Most clinical data have a fair degree of overlap (Sackett et ai, 1991). A tied 
score is of interest when a diseased subject has the same test result as a 
non diseased individual (Zweig & Campbell, 1993). Interestingly, within the 
medical directorate, two patients with a tied score of 5 had DVT and 
fourteen did not. Close scrutiny of the sensitivity and specificity data reveals 
that although several patients in the orthopaedic and surgical directorates 
also had tied scores of 5, none of them as correctly predicted developed 
DVT. Patients who developed DVT in the latter directorates had scores 
. ranging within the bound of moderate to high-risk categories. 
On the medical directorate within the tied score of 5 between subjects with 
and without DVT, the event was seemingly coincidental, albeit advancing 
age appeared to be a powerful discriminating risk factor. It is possible that 
the nature and extent of nursing intervention given to those patients with a 
tied score of 5 was influential of the outcome. Some subjects might have 
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attracted more attention than others, resulting in receiving little or more 
nursing intervention, directed at preventing DVT. 
Equally, some patients with recorded tied scores of 15~ developed DVT and 
others did not. The tied scores of 15~ with and without DVT across the 
clinical specialities are exhibited in table 5.18. 
Table 5.18: Tied scores of 15~ 
Speciality DVT present DVT absent 
Orthopaedics 4 7 
Medical 1 3 
General Surgery 2 2 
A likely explanation is that the patients with the tied score of 15 ~ did not 
develop DVT, irrespective of pharmacological prophylaxis, on account of 
aggressive DVT nursing interventions. 
Nurses are at the forefront of assessment, planning, care delivery and the 
evaluation processes. By virtue of having identified patients at high risk of 
DVT, it followed that they would "act always in such a manner as to promote 
and safeguard the interest and well being of patients or clients" and 
therefore: 
"ensure that no action or omission on your part, or within your sphere of 
responsibility, is detrimental to·the interests, condition or safety of patients 
and clients" (UKCC, 1992). 
DVT nursing interventions in the form of mechanical prophylaxis such as 
active physiotherapy, ambulation, leg elevation and application of graduated 
elasticated compression stockings are effective measures at preventing 
DVT even in high risk group, with no adverse effect. 
On the medical directorate coexisting high risk diseases such as myocardial 
infarction and chronic heart diseases were associated with the occurrence 
ofDVT. 
In the trauma I orthopaediC directorate, advanced age, immobility due to 
fracture neck of femur and the nature of surgical procedures to repair the 
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damage were significant risk variables in the causation of OVT in some 
patients. 
On the surgical directorate, elderly patients who underwent abdominal 
surgery for malignancies, were the highest risk group. One patient with 
inoperable malignancy of the bowel and receiving palliative care developed 
OVT. 
All patients across the clinical specialities with previous DVT had recurrence 
of the condition, thus confirming outcome of previous studies that 
recurrence rate is as high as 68 per cent (Nicolaides & Irving, 1975; 
Wheeler, 1988). 
High-risk patients carry an absolute risk of OVT ranging between 40-80% 
(Weinmann and Saltzmann, 1994). The absolute score of ~ 15 of the 
assessment protocol was chosen to represent the high risk group and 
calculate the sensitivity and specificity of the DVT scale. The sensitivity and 
specificity of the absolute cutoff value is illustrated in the contingency table 
below: 
Table 5.19: The Sensitivity and specificity of absolute scores In DVT. 
DVT present DVT absent Total 
Score 15 ~ A 7 B 12 19 
Score s 14 C 21 o 108 129 
Total 28 120 148 
Sensitivity: _a_x 100 = 7 xl 00 = 25% 
a+c 7+21 
S 'fi'ty d 108 peel Cl :--xlOO= xl00=9001o 
h+d 12+108 
A highly sensitive tool will rarely miss people with disease and conversely a 
specific instrument will rarely misclassify people without the disease as 
diseased (Fletcher, Fletcher & Wagner, 1988). 
True positives are those who are predicted as positive and have the 
disease. Seven patients were correctly classified as true positive. 
153 
-----------------------------------------------
False positives are those who are incorrectly predicted to have the disease 
when they do not. Twelve patients belonged to the score range of ~ 15 but 
did not develop DVT as predicted. 
Those who are predicted negative and who do not have the disease are the 
true negatives and 108 patients were correctly classified. 
False negatives are those subjects who are predicted negative for the 
disease but contracted it. 21 false negatives were recorded. 
The DVT scale achieved a sensitivity of only 25 % in contrast to the 
remarkably high specificity of 90% of patients who did not develop DVT and 
were correctly predicted. 
Sensitivity and specificity are inversely related (Mausner & Kramer 1985). A 
high specificity of 90% was achieved at the expense of a low sensitivity of 
only 25%. 
Test accuracy is defined as the number of true positive and true negative 
divided by the number of patients studied (Wheeler et ai, 1994).Overall, 
using the absolute score range, the DVT scale correctly classified 115 
patients 
(7 TP+ 108TN/148=78%) and misclassified 33 patients (22%).14% of the 
misclassified patients developed DVT. 
Apparently. there are two problems arising from the application of the 
absolute score. First of all, concomitantly, the decreed score of ~ 15 ruled in 
only 25% of patients with DVT and ruled out 75% with the predicted target 
disorder (Table 5.17). 
Secondly, there is no guarantee that the absolute score would generate 
similar distribution of scores in the cohort of the next 150 patients. 
Invariably, as more and more patients are sampled, the range of scores can 
only get bigger and probably more patients without DVT will exhibit higher 
and higher scores. Consequently. one would be forced to move the absolute 
score to an even greater extreme level to predict patient with DVT. 
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On the other hand, if the score were lowered, say ~ 11, more patients would 
reside within this DVT risk category and would encompass 68% compared 
to the previously recorded 25% (Table 5.17). 
On account of the limitations presented by the absolute score value, in 
predicting patients for DVT risk, the four cutoff values for the four risk 
categories in the Autar DVT scale assessment protocol were also 
calculated. Table 5.20 highlights the distribution of patients with and without 
DVT by cutoff score values and table 5.21 exhibits the sensitivity and 
specificity for the four cutoff values, as illustrated in table 5.17. 
Table 5.20: Distribution of non DVT and DVT patients by cutoff score 
values 
Cutoff values DVT absent DVT present 
>15 High Risk 12 7 
11-14 Moderate risk 25 12 
7-10 Low risk 45 5 
:s6 No risk 38 4 
Total 120 28 
Table 5.21: Sensitivity and specificity for the four cutoff values 
Cutoff High risk ~16 Moderate risk Low risk 7·10 
scores 11·14 
No rlsk~6 
Sensitivity 7/28= 25% (12+ 7)128=68% (5+ 12+ 7)/28=86% (4+5+12+7)/28=1000/0 
Specificity 12/120=10% (12+25)/120=31% (45+25+12)/120= (120/120)=100% 
68% 
1-Specificity .90 .69 .32 .0 
The choice of 11-14 score range optimises the predictive potential of the 
DVT scale and allocate subjects to a specifiC risk category and deals with 
the problem of outliers and subjects belonging to" no man's land" (Sackett et 
aI1991). A sensitivity of 68 per cent was recorded. 
Overall, fewer patients in the high risk score range were recruited. The 
distribution of patients in each of the four score ranges is illustrated in table 
5.22. 
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Table 5.22: Distribution of patients by risk categories 
Score range No of patients % 
>15 19 13 
11-14 37 25 
7-10 50 34 
s6 42 28 
Although sensitivity and specificity provide consistency and information 
about the accuracy of the test, they do not add to the meaning of positive 
and· negative test results, While sensitivity and specificity are conditioned by 
the knowledge of the disease state, predictive values are conditioned by the 
nature of the test result (Essex-Sorlie, 1995). 
Predictive values were therefore used to measure the frequency with which 
the DVT scale correctly identified those at risk. 
Positive Predictive Values (PPV) are the proportion of testing positive or 
predicted at risk of DVT, who actually develop DVT. This is summarised by: 
True Positive 
---------xlOO 
True Positive + False Positive 
Negative Predictive Values NPV) is the proportion of those predicted 
negative who do not have DVT. This is expressed as: 
True Negative x 100 
True Negative + False Negative 
PPV and NPV for the absolute score is shown in table 5.23 
Table 5.23: The Predictive values of the DVT scale for the absolute 
score range 
DVT present DVT absent Total Predictive values 
Score values True positive False Positive 19 Positive Predictive ~15 7 12 Value: 37% 
s14 False negative True negative 129 Negative predictive 21 108 Value: 84% 
Total 28 120 148 
Difference between prior probability (prevalence) and posterior probability 
(predictive value) is one way of assessing the usefulness of a test 
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(Camp bell & Machin, 1994). A ovr prevalence of 19% was recorded and 
predictive +ve value almost doubled (37%). 
However, considerable caution must be exercised in the interpretation of 
predictive values, as there are two factors that influence the predictive 
values of an instrument: prevalence of the target disorder and sensitivity and 
specificity of the tool (Essex-Sorlie, 1994). 
"As prevalence falls, positive predictive value must fall alongside it, and 
negative predictive value must rise" 
(Sackett et ai, 1991:p 88. 
If the prevalence of the disease is low, the positive predictive value will not 
be close to 1 even if the sensitivity and specificity are high. It is therefore 
inevitable that many people predicted positive will be false positive (Altman 
& Bland, 1994). 
A fall in PPV (37%) due to low prevalence of ovr (19%) was associated 
with a concomitant rise in NPV (84%). 
Also, predictive values observed in one study do not apply universally 
(Altman & Bland, 1994). An instrument with a high predictive value in one 
clinical setting may be of little predictive utility in another area, because of 
the difference in prevalence in the two populations. For instance, the 
prevalence of ovr in the medical patients ranges between 13-16 % 
(Kierkegaard, 1987) and approximately 25% in the surgical population 
(Clagett & Reisch, 1988) compared to 40-80 in the orthopaedic population 
(Weinmann & Salzman, 1994). 
When prevalence is low, the greater are the false positives. 12 subjects 
were classified as false positive. 
Conversely, when a highly sensitive test is applied to a population where the 
prevalence is high, negative test results will be largely false negatives. 
Twenty-one false negatives were identified. 
There is also a relationship between the sensitivity and specificity and the 
predictive value of an index. When the sensitivity of an instrument 
increases, it is less likely that an individual with a negative prediction will 
have OVT. Thus, the greater the sensitivity of a test, the higher is the 
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negative predictive value. On the other hand, if the specificity of the test 
increases, its positive predictive value is increased. Diagnostic tools require 
the highest levels of sensitivity and specificity (Larsen 1986). But the same 
level is not expected of a screening tool and is even less likely to occur 
when the condition is preventable (Morris 1985). Even if the DVf scale 
accurately predicts those at risk, patients who receive care that successfully 
prevents DVf become classified as false positives. Screening tests are 
therefore not designed to be diagnostic but to identify patients with a high 
probability of having the disease (Larsen, 1986). 
Norton (1989) is satisfied that measures of predictive validity should not be 
rigidly applied to risk assessment scales. She argues that it is a more 
reasonable approach to hold a risk assessment scale to a level of predictive 
efficiency for any screening test rather than that of a diagnostic tool. Some 
instruments may fail to address some issues but this does not necessarily 
invalidate the tool because of unrealistic expectation of what can be 
achieved with a single instrument (Gibbon, 1998). Perhaps a risk 
assessment tool should carry a health warning that it should be used in 
conjunction with clinical judgement. 
Cutoff scores 
A sensitive tool is one that correctly identifies or predicts those with the 
condition as well as those without. However, 100 per cent test accuracy or 
prediction is unachievable and invariably there will be some overlap and 
misclassification of the predictive outcomes (Larsen, 1986). Some high risk 
patients who are predicted to develop DVf may not and others who are not 
may do so. A sensitive measure at the expense of specificity is not 
necessarily a better one (Anthony, 1999). 
A perfect prediction would be no false positive or false negative outcomes. 
Since sensitivity and specificity are inversely correlated (Lilienfield & 
Lilienfield 1980; Mausner & Kramer, 1985) increasing sensitivity by lowering 
the score at which a prediction is considered possible, decreases the 
specificity of the instrument and vice versa. 
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The complex tradeoffs between sensitivity require consideration of the 
following values: 
• True positive 
• True negative 
• False positive 
• False negative 
Cost of true positive: The whole point of a diagnostic tool is to correctly 
make prediction about the target disorder (A1tman, 1994). Predicting a true 
positive means that the patients who are potential subject for DVT will be 
prescribed primary prophylaxis in the anticipation that this will prevent DVT 
or be seen to minimise the risk. 
Cost of true negative: The benefit of true negative implies that patients 
who are not at risk of DVT will not unnecessarily commence primary 
pharmacological prophylaxis and be at risk of iatrogeniC bleeding. Limited 
resources can then be allocated to those who need them most. 
Cost of false positive: A false positive prediction can place the patients at 
risk by unnecessarily being administered pharmacological prophylaxis. They 
may be at risk of iatrogenic bleeding. However, choosing the more benign 
mechanical venous thromboprophylaxis over a pharmacological one 
eliminates this problem. 
Cost of false negative: The subjects are initially predicted not to be at risk 
and therefore do not require prophylaxis against DVT. The consequential 
penalty of this misclassification is the potential development of DVT, which 
is preventable by the appropriate venous thromboprophylaxis. Additionally I 
a false negative could carry the risk of litigation due to clinical omission and 
negligence (Parker-Williams & Vickers, 1989). Such cases are on the 
increase (NAHAT, 1991). 
The sensitivity and specificity of the DVT scale is dependent on the 
threshold used. However, tests do not have only one sensitivity and 
specificity. Calculating just one pair of sensitivity and specificity provides 
only a very brief glimpse of a test performance.The sensitivity and specificity 
of the absolute score for the DVT scale only achieved 25% sensitivity but 90 
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% specificity (Table 5.19), using a ~ 15 cutoff value. This might be far from 
revealing of the real diagnostic abilities of the DVT risk calculator. 
The application of an absolute cutoff score range of ~ 15 ruled in only 25 per 
cent of patients with DVT and ruled out 75 per cent of the cases (Table 
5.17). On the other hand, lowering the score range to ~ 11 captures 68 per 
cent of patients with DVT. Data from tables 5.1,5.3,5.5,5.7 and 5.9 
representing the five wards of the trust were analysed to compare the 
outcome of a cutoff score of ~ 11 with the cutoff score range of ~ 15. On all 
five wards, the cutoff score of ~ 11 performs better in terms of negative 
predictive validity of the DVT scale (Tables 5.24 -5.28). 
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Table 5.24:Cutoff scores on orthopaedic ward C. No of patients: 26. 
Total DVT recorded: 3 
DVT cutoff TP FP TN FN PPV NPV 
11 > 3 9 14 0 25% 100% 
15 > 3 1 22 0 75% 100% 
Table 5.25:Cutoff scores on orthopaedic ward D. No of Patients 24. 
Total DVT recorded: 5 
DVT cutoff TP FP TN FN PPV 
11> 4 13 6 1 24% 
15 > 1 6 14 4 14% 
Table 5.26:Cutoff scores on medical directorate ward 29. No of 
patients: 25. Total DVT recorded: 6 
DVT cutoff TP FP TN FN PPV 
11 > 3 3 16 3 50% 
15 > 1 2 17 5 33% 
Table 5.27:Cutoff scores on medical directorate ward 30. No of 
Patients: 25. Total DVT recorded: 6 
DVT cutoff TP FP TN FN PPV 
11 r! 3 6 13 3 33% 
15 > 0 1 18 6 
--
NPV 
86% 
50% 
NPV 
84% 
77% 
NPV 
81% 
75% 
Table 5. 28 :Cutoff scores on surgical ward 27: No of patients: 48 out of 
50. Total DVT recorded: 8 
DVT cutoff TP FP TN FN PPV NPV 
11r! 6 5 36 1 55% 97% 
15 r! 2 1 40 5 66% 89% 
Although a decision threshold must be chosen for risk assessment and 
management, it is undesirable to choose any particular decision threshold 
for assessing accuracy. Assessing a single pOint may result in misleading 
impression about the test performance (Zweig & Campbell, 1993). 
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Receiver Operating Characteristics (ROC) 
In order to address the limitation of selecting a single pair of sensitivity and 
specificity values, several thresholds were applied in the construction of a 
Receiver Operating Characteristics (ROC) curve for optimal predictive 
accuracy of the DVT scale. A ROC (figure 6) is simply a plot of the true 
positive rate against the false positive rate for the given thresholds and "is a 
fundamental evaluation tool in clinical medicine" (Zweig & Campbell, 1993). 
It is based on the statistical decision theory, developed in the 1950's for 
radar signal detection. It is a method of assessing the sensitivity and 
specificity of a classification at a variety of thresholds, allowing for a 
qualitative comparison of several classifiers (Anthony, 1999). 
Figure 6: Receiver Operating Characteristics (ROC) 
ROC Curve 
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Area Under the Curve 
Test Result Variable(s): SCORE 
Asymptotic 95% Confidence 
Asymptotic Interval 
Area Std. Errof Sig.b Lower Bound Upper Bound 
.696 .056 .001 .587 .806 
The test result variable(s): SCORE has at least one tie between the 
positive actual state group and the negative actual state group. Statistics 
may be biased. 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5 
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Coordinates of the Curve 
Test Result Variable( s): SCORE 
Positive if 
Greater Than 
a 
or Equal To Sensitivity 1 - Specificity 
.00 1.000 1.000 
1.50 1.000 .983 
3.00 1.000 .967 
4.50 1.000 .893 
5.50 .929 .777 
6.50 .857 .678 
7.50 .821 .628 
8.50 .714 .537 
9.50 .679 .430 
10.50 .679 .30S 
11.50 .571 .215 
12.50 .464 .174 
13.50 .321 .107 
14.50 .250 .099 
15.50 .179 .074 
1S.50 .107 .050 
18.00 .071 .033 
19.50 .071 .025 
23.00 .036 .008 
2S.50 .000 .008 
28.00 .000 .000 
The test result variable(s): SCORE has at least one tie 
between the positive actual state group and the negative 
actual state group. 
a. The smallest cutoff value is the minimum 
observed test value minus 1, and the largest cutoff 
value is the maximum observed test value plus 1. 
All the other cutoff values are the averages of two 
consecutive ordered observed test values. 
Using the version 11 of the SS PS (2001) data on 148 patients were 
analysed to construct the ROC, DVT being the state variable. ROC analysis 
provides a graphic view of the whole spectrum of sensitivity and specificity 
decision at the various selected thresholds. 
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The ROe curve that is closest to the upper left hand corner is the best cutoff 
score in terms of making fewer mistakes when the prevalence of DVT was 
only 19%. 
A score of 11 in the moderate risk category achieved a sensitivity of 
approximately 70% and a 100-Specificity of 30%. Two thirds of the 
population were deemed to have been correctly identified as true positives 
and developed DVT. Because sensitivity considered only those with OVT 
and specificity was those without DVT, the ROe plot was independent of the 
19% OVT prevalence. 
The area under the ROe curve for the above plot was calculated to be 
approximately 70%. This means that a randomly selected patient from the 
DVT group has a higher DVT risk assessment score than one from the 
group without DVT. However, it does not mean that a DVT occurs with a 
probability of 0.70 or that DVT is associated with a positive result 70% of the 
time. 
Additionally, the result for the co-ordinates is statistically significant at < 
.001. 
For the chosen threshold, the ROe also provided an unbiased estimate of 
the sensitivity and 1-specificity. This meant that the point neither 
overestimated nor underestimated the true value of sensitivity and 
specificity. The 95% Confidence Interval resided between 0.6-0.8. 
Data extrapolation from Table 5.17 and the ROe curve (Figure 6) affirm that 
the score of 11 is the optimum cutoff point and reduces the amount of false 
negatives. However, lowering the cutoff value from 0 15 to 11 means that 
some patients identified as true positives will not develop DVT and thus 
increases the false positives. This situation is not problematic when non 
pharmacological and side effects free prophylaxes are applied. On the other 
hand, if heparin is given for the prevention of OVT, it may have some 
serious consequential effects. Heparin is associated with an increased risk 
of bleeding (approximately 5%) and Heparin Induced Thrombocytopenia 
Thrombosis (HITT) which occurs in approximately 1 % of cases (Warkentin 
et ai, 1995). HITT characterised by low platelet count, haemorrhage and 
thrombi formation, causes serious adverse reactions and can be fatal 
(Anand et ai, 1998). In such circumstances, clinicians must allow flexibility of 
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clinical judgement above the cutoff point of 11 in order to minimise the 
significant effect on false positives. In brief, the choice of the cutoff level 
relates to the relative importance of false positivity and false negativity for 
the condition (Gordis, 1996). 
Likelihood ratios 
Likelihood ratio is an alternative way of describing the performance of a 
diagnostic tool or a predictive index (Fletcher, Fletcher & Wagner, 1988). 
It is the ratio between the probability of a defined test result indicating the 
presence of a disease and the probability of a defined test result indicating 
the absence of a disease. Likelihood ratio summarises the same information 
as sensitivity and specificity but is more stable than sensitivity and 
specificity. This is because ifthe mix (Iow, moderate and high risk) of 
patients with DVT varies when their prevalence varies, sensitivity and 
specificity will change as well as predictive values. Because likelihood ratios 
can be generated for quite narrow slices of a test result, they will be less 
susceptible to such changes in the mix of patients with OVT (Sackett et ai, 
1991). 
Likelihood ratio for the score values of the OVT scale was calculated for the 
following three reasons: 
• First of all, it is independent of prevalence of OVT. 
• Secondly, it offers the option of calculating all the four levels of cutoff 
score of the OVT assessment protocol and not just the absolute scores 
of~15 and s14. 
• Thirdly, it subdivides and assigns patients to particular levels of 
measurement, thus resolving the problem of dealing with patients who 
are "outliers" to the levels of measurement. 
To calculate the likelihood ratio of the OVT scale, the following formula was 
applied: 
LR= TP/(TP+FN} 
FP/(FP+TN) 
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Table 5.29 calculates the likelihood ratio for the four levels of measurement 
of the cutoff scores used for the performance of the DVT scale. 
Table 5.29: Likelihood ratios for several levels of cutoff scores 
DVT DVT 
Present Absent 
Cutoff Number Proportion Number Proportion Likelihood 
range Ratio 
>15 7 7/28=0.25 12 12/120=0.1 0.25/0.1 =2.5 
11-14 12 12/28=0.428 25 25/120=0.208 0.428/0.208=2.0 
7-10 5 5/28=0.178 45 45/120=0.375 0.178/0.375=0.47 
<6 4 4/28=0.142 38 38/120=0.316 0.142/0.316=0.44 
Total 28 120 
Given the likelihood ratios are 2.0 and 2.5 for the cutoff scores of 11-14 and 
;;::15 respectively, probability of OVT increases when the patients have such 
score values. 
The likelihood ratios for cutoff scores of s6 and 7-10 are 0.44 and 0.47 
respectively and less than 1.0 and the probability of DVT declines. 
The likelihood ratios for the four levels of cutoff scores lend support to the 
four score ranges of the risk assessment protocol. 
The Positive Predictive Value (37%) of the OVT scale was largely influenced 
by the rather low prevalence of OVT reported. Importantly, the findings of 
the sensitivity and specificity of the DVT scale were also partially influenced 
by some uncontrollable factors in the study: efficacy of primary venous 
thromboprophylaxis and DVT preventative measures to combat venous 
stasis. Such preventative nursing interventions are leg elevation, application 
of graduated compression stockings, physiotherapy and early programme of 
ambulation. Graduated compression stockings reduce the incidence of OVT 
by approximately 68% (Wells et al. 1994). Data pooled for the sensitivity and 
specificity estimates were from patients across three directorates. In 
contrast to the low uptake of primary pharmacological venous 
thromboprophylaxis on the orthopaedic directorate. 52% of patients on the 
medical unit and almost 100% of the surgical patients were recipient of 
pharmacological intervention for DVT. Consequently, a large number of 
patients initially risk assessed and predicted true positive for DVT 
appropriately received venous thromboprophylaxis and became false 
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positive. As a result. the current moderate findings of the sensitivity and 
specificity of the DVT scale is likely to underestimate its predictive accuracy. 
It is no longer acceptable and ethical to plan case and control groups and 
withhold venous thromboprophylaxis in order to test the true sensitivity and 
specificity of a predictive index. when the efficacy of venous 
thromboprophylaxis has been proven beyond doubt (Kakkar & Lawrence. 
1997). DVT and PE prophylaxis reduces the incidence by 50% or more 
(Vanek et al. 1991) and THRiFT (1998) recommends that prophylaxis 
should be mandatory in moderate and high risk groups. 
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Logistic regression 
Logistic regression is a generalisation of the chi-squared test to examine the 
association of a binary-dependent variable with one or more independent 
variables (Campbell, 2001). 
In order to predict the occurrence or non-occurrence of an episode of DVT, 
logistic regression analysis was applied. DVT as the state or dependent 
variable was dichotomous and took two values. If the patient developed 
DVT, it was coded 1 and 0 for no DVT. 
Logistic regression was used to: 
• investigate the relationship between the causal variables and a binary 
output variable, allowing for the confounding variables. 
• find the independent factors that discriminated those who developed 
DVT from those who did not. 
• provide a fast and effective way to obtain the estimate of probabilities of 
belonging to a specific population and the estimate of odds ratio of 
having a specific problem or condition (Yarandi & Simpson, 1991). 
• develop prognostic indicators so those patients at risk could be duly 
identified so that the most appropriate venous thomboprophylaxis is 
administered. 
To perform the logistic regression analysis, SPSS version 11 (2001) 
software programme was used for data collated on the three clinical 
directorates. The seven parameters of the DVT seale were entered for each 
patient. The trauma and surgical intervention parameters were constant for 
the patients on the medical ward, as was trauma to the surgical patients. 
Variables that were not applicable were removed from the analysis by 
default. The special risk category variables were not applicable to any of the 
150 patients and were therefore useless as predictive indicators. The salient 
features of the SPSS output for logistic regression on the orthopaediC, 
medical and surgical directorates are illustrated in appendices 8,9 &10 
respectively. 
Logistic regression like multiple regression allows variables to be included or 
excluded according to various algorithms and options. A folWSrd variable 
selection procedure using the Wald Statistic was used, starting off with no 
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variables and adding variables if they were significant, stopping when no 
more significant ones were found. An equation was constructed using those 
variables found to be significant which computed the likelihood of 
developing DVT for given values of the significant variables. 
The model for the data was also analysed for its goodness of fit statistic. It 
compared the observed probabilities to those predicted by the model. The 
probability of the observed results is known as the likelihood. Since the 
likelihood is a small number, less than 1, it is customary to use -2 times the 
log of the likelihood (-2LL) as a measure of how well the estimated model 
fits the data. A good model is one that results in a high likelihood (LL) 
function. This means a small value of -2LL. If the model fits perfectly, -2LL 
would be equal to O. 
To test the goodness of fit statistic, the Hosmer-Lemeshow statistic was 
applied to the data on the three clinical directorates. On the surgical unit, the 
chi-square statistic was 4.328 with 6 df with a p- value of .632 (Appendix 10) 
indicating that the null hypothesis was accepted and the model fits the data. 
The two R (residual) values ranged between 24% to 41%, quantifying the 
proportion of the variance explained by the model. Cox & Snell and 
Nagelkerke are estimates of the variance accounted for in the analysis. 
Using the same test for the goodness of fit for the data, the chi-square was 
.001 with 1df and a p- value of .977 (Appendix 8) confirming that the data fit 
the model on the orthopaedic directorate. The variance was 24% to 34%. 
On the medical unit, the Hosmer-Lemeshow test recorded a chi-square of 
3.698 with 7 df and a p- value of 0.814 suggesting that the data fit the 
model. Proportion of variance ranged from 17% to 25%. A nonSignificant 
goodness of fit test (.722) indicates that the data fit the model (Munro, 
2001). 
The classification of the table in logistic regression helps to assess the 
performance of the model by cross tabulating the observed response 
categories with the predicted response categories. Cells on the diagonal are 
correct prediction and cells off the diagonal represent incorrect prediction. 
The patients were considered to be in the predicted DVT group if the value 
of the predicted probability was greater than 0.5 or were considered 
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predicted non-DVT group otherwise. These predictions were compared to 
whether the patients had a DVT and the correct percentage given. 
On the orthopaedic directorate 42 TN were correctly predicted and 1 TP was 
identified. 
On the medical directorate, an overall 80 per cent of the patients were 
correctly predicted and classified. Only four of the twelve patients with DVT 
were correctly predicted (33.3 %). 
On the surgical ward, an overall 90 per cent of the patients were correctly 
predicted. Of the TN, 41were correctly classified and 4TP were also 
correctly identified. 5 patients were misclassified (4 FP and 1 FN). 
The variables found to be Significant were also given. The variables in the 
equation summarise the roles of the parameters in the model. B is the 
estimated coefficient with Standard Error (SE). The ratio of B to SE in 
column 2 and 3 respectively squared equals the Wald Statistic. Model 
parameters were deemed significant at the 5% level using the Wald 
Statistic. In logistic regression the B- weights are used to determine the 
probability of a subject having DVT or not. Instead of a score, as with the 
continuous response linear regression, the logistic model reports on 
probability ranging from 0 to 1. If the probability is greater than 0.5, the 
patient would be predicted to have DVT. If it is less than 0.5, the individuals 
would be predicted not to have DVT. 
The covariate trauma was found to be significant to the orthopaedic patients 
as build was to the medical patients and high risk diseases to the patients 
undergoing surgery. Interestingly, although DVT increases exponentially 
with advancing age, it was not found to be significant in all three clinical 
areas. On the other hand, high risk diseases were computed as a significant 
variable and presumably patients with advancing age developed the high 
risk diseases. Due to the number in the population being sampled, it must 
be pointed out that the analysis was not definitive. It was not possible to 
consider all the covariates of the scale as their applicability were restricted 
within the three directorates and with a limited number of patients 
considered. The required regression sample size depends on the desired 
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power, alpha and beta levels, number of predictors and the expected effect 
size. The simplest rule of thumb is N~ 50+8m, when N~ 50 is the minimum 
cases to each independent variable and m is the number of independent 
variables (Tabachnick & Fidells, 1996). Therefore, to achieve the desired 
power, a-level=0.05 and 8= 0.80 for evaluation of the 7 independent DVT 
variables, 106 cases (50+ (8)(7)= 106) would be required and a total of 318 
patients accrued for the three clinical directorates. 
The analysis described has certain disadvantages. It has been performed in 
a series of patients and the results apply to this particular series only. Even 
if validity were tested and confirmed in another prospective similar series, it 
would not necessarily be applicable to a different group of patients in other 
clinical areas that were not tested because of the probable presence and 
absence of other known risk factors. 
Although the logistic regression analysis discussed had some limitations, it 
was undertaken in the spirit of a preliminary investigative study and is a 
worthwhile exercise planning a prospective and a much larger study for 
testing the discrimination of the independent variables. 
LogistiC regression in SPSS also allowed for the data to be stored to 
construct a ROC curve for the independent variables (appendices 11, 12 & 
13). 
Practical application of the DVT scale 
In order to evaluate the practical application of the DVT scale, a postal 
questionnaire survey was undertaken. Comments were invited from the 
users of the DVT scale and 22 out of 25 (88 %) DVT scale users responded. 
All the respondents were registered nurses with varying level of experience. 
Clinical experience ranged from less than six months for newly qualified staff 
to fifteen years of post registration experience for the senior practitioners. A 
skill mix of trained staff was represented: 0 grade staff nurse whose prime 
responsibility was to assess, implement and evaluate care delivery and F 
grade staff who led a team of E grade staff and below. 
All respondents had no prior experience of using the DVT scale and this 
was considered to be important to the integrity of their responses. Any prior 
usage of the DVT scale could influence their clinical judgement and bias 
their eventual responses, in relation to its utility and practical application. 
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Detailed analyses of the questionnaires from the orthopaedic, medical and 
surgical directorates are located in appendices 14, 15 & 16 respectively. 
The feedback from the respondents are summarised below: 
The DVf scale was very favourably evaluated across the three dinical 
directorates. Its design permitted its application and evaluation in all the 
three clinical specialities without necessitating any modification to the 
proforma. Items that were not applicable to a particular speciality were 
simply not rated. For example, the trauma risk category subscale was not 
applicable to the medical and general surgical directorates. Equally, 
covariates in the special risk category were not tested, as no patients were 
recruited with such dinical risk factors. 
The DVf scale was described as promising. user friendly and easy to apply. 
There was good consensus that the cumulative effects of the risk factors 
enabled the respondents to configure a clinical risk profile based on 
multifactoral aetiology. Such dinimetry individualises DVf risk assessment 
in less than 3 minutes. It purported to complement clinical judgement and 
"reminds us of patients who otherwise might have been overtooked·, thus 
making DVT assessment visible to demonstrate clinical effectiveness. 
There was broad agreement that the DVf scale was a valuable teaching 
tool and could be readily used for education of staff and patient health 
promotion. It was generally acknowledged that the DVT scale had good 
practical potential as an audit tool, in terms of monitoring the incidence of 
DVf in patients and evaluation of their current venous thromboprophylaxis 
protocol. It has also been recognised that a formal assessment tool 
facilitates the audit cycle and improves the uptake of venous 
thromboprophyfaxis (Byme et ai, 1996). 
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The following free text qualitative comments were recorded in relation to its 
strengths, limitations and recommendations for improvement: 
Strengths 
• "It gives a clear indication of who may be at risk-. 
• "It reminds you of patients who are vulnerable". 
• Easy to apply in any area. 
• Quick and self explanatory. 
• Virtually self-explanatory. 
• Covers all the categories. 
• "It identifies patients at risk, who may not have been realised until doing 
the risk assessment". 
• "Useful for patients who don't appear to be at risk at first glance-. 
• "It makes you take a second look for patients at risk". 
• "It enhances clinical assessment, highlighting areas that may otherwise 
be missed". 
• It makes the whole assessment process visible. 
Limitations 
• It does not differentiate between male and female. 
• It does not recommend which prophylaxis to be used for moderate and 
high risk group. 
• Needs a bit of background information with the scale and its application. 
• Needs to get doctors on board so those high risk patients receive 
appropriate prophylaxis. 
• Is myocardial infarction in the high risk disease category a previous MI or 
a current event? 
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Comments on improving the practical application of the scale 
• Needs to be an integral part of patient assessment and not a stand-alone 
document. 
• MI needs to imply previous medical history or current event. 
• "Hope this tool become part of risk assessment in the same way the 
Waterlow has and we will quickly see an impact on patient care and 
standards" . 
• Can be integrated in a careplan already in use on the unit. 
• It could be laid out in a more linear fashion as the Waterlow scale. 
• Not really, all aspects of risks have been covered. 
Discussion 
Most of the limitations and comments in relation to the improvement of the 
DVT scale have been addressed in the concluding chapter of the study. 
However, the following three areas of concern also reported deserve some 
explanation as to their initial omission: sex difference 
for each risk category. 
A daily risk assessment recording 
Types of venous thromboprophylaxis 
Sex difference 
Reportedly, the DVT scale did not differentiate between male and female 
patients, assuming that the females were the riskier of the sexes. Such 
assumption in terms of DVT occurrence is unfounded and presumably 
based on the understanding of the clinical tenet that female patients are at 
greater risk of developing pressure ulcer than males (Waterlow, 1985). 
Although Anderson et al (1985) reported a higher incidence of DVT in 
females in the Worcester study. they lived longer than their male 
counterparts and had additional DVT risk factors such as pregnancy and 
puerperium, HRT and oral contraceptives, which put them at greater risk. 
Coon (1978) and Nordstrom 91992) found no difference in the sex 
distribution of DVT. 
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A daily risk assessment protocol 
It was also inferred that the layout of the DVT risk calculator did not allow 
for daily risk assessment to alert changes in general condition of patients. 
Pressure sore risk assessment is undertaken daily for prompt detection of 
pressure ulcer. Although the Autar DVT scale looks deceptively like the 
Waterlow scale for pressure sore risk assessment, it is founded on the 
universally recognised Virchow's triad in the genesis of DVT and backed by 
best external evidence from researches and biosciences. Perhaps, the DVT 
scale should carry a warning that it is remotely a pressure sore risk 
calculator. Apart from changes in the level of mobility subscale, it is most 
unlikely that the other relatively permanent DVT risk factors of the subscale 
will change significantly on a day to day basis as to influence outcome. 
Significant thrombi development occurs as early as 24 hours of admission. It 
is for this reason that the International Consensus Statement (2001) 
recommends that DVT risk assessment be undertaken within this defined 
time frame, to enable prompt application of the most appropriate 
thromboprophylaxis. 
Types of venous thromboprophylaxes for each risk category 
Although the DVT scale identifies patients into a particular risk category 
based on the cumulative effect of the risk factors, reportedly it did not 
signpost the nature and type of prophylaxis required for each risk group. 
The Autar DVT scale (1997) was essentially as a data collection tool and for 
the purpose of evaluating the sensitivity of the tool was not designed to draw 
attention to any prophylaxis. However, the ultimate goal of any risk 
assessment tool is to guide clinical decision into the management of risk. 
The comment of the respondents was duly noted and the recommended 
DVT prophylaxis for each particular risk category now features prominently 
in the revalidated DVT scale (Figure 7: p187). 
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Venous thromboprophylaxls strategies 
Available data were also analysed to audit the uptake of venous 
thromboprophylaxis strategies. The data collection tool (Autar, 1997) 
allowed for the recording of the types of prophylaxis prescribed for each 
patient. Data collated and analysed were used to compare and contrast 
current local thromboprophylaxis strategy with the recommendations of the 
international and national venous thromboprophylaxis consensus groups as 
previously outlined in table 1.5. 
Data on venous thromboprophylaxis across the three clinical directorates 
are exhibited in table 5.30 
Table 5.30: Venous thromboprophylaxls strategies on the three clinical 
directorates. 
Types of venous Orthopaedics Surgery Medical 
thromboprophylaxis Frequency Frequency Frequen~ 
Leg elevation 4 0 0 
Graduated Compression 0 0 0 
Stockings (GCS) 
Intermittent Pneumatic 0 0 0 
Compression (IPC) 
Unfractionated Heparin( UFH) 0 39 1 
Low Molecular Weight Heparin 1 6 18 
(LMWH) 
Unfractionated Heparin + 0 2 4 
Warfarin 
Low Molecular Weight Heparin 0 1 1 
+ Warfarin 
Antiplatelets 1 0 2 
No prophylaxis 44 1 24 
Warfarin only 0 1 0 
Total number of patients 50 50 50 
The uptake of venous thromboembolism was strikingly low on the trauma! 
orthopaedics, considering that the incidence of DVT ranges from 50-70 per 
cent in patients with hip fractures (Paiement & Mendelsohn, 1997). The 
International Consensus Statement (1997) recommends LMWH pre surgery 
and every 12 hours post-operatively or Warfarin within a therapeutiC INR of 
2.0-3.0 pre and post surgery. 
Table 5.31 outlines the clinical characteristics ofthe coded patients with 
DVT on the orthopaedic directorate. 
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Table 5.31: Clinical data of the orthopaedic patients with DVT. 
Patients'code Age Diagnosis Prophylaxis DVT destination 
W100/22/c 92 Fracture neck of Nil Ward 
femur 
W100/21/c 67 Fracture neck of Nil Home 
femur 
W100/16/c 79 Ruptured patella Tinzaparin 4,500 Ward 
tendon units daily (post 
OVT) 
W100/05/d 69 Infected right hip Nil Home 
prosthesis 
W100/20/d 88 Fracture neck of Nil Home 
right femur 
W100/21/d 74 Fractured right tibia Nil Ward 
and fibula 
W100/24/d 89 Fracture neck of Nil Ward 
right femur 
W100/23/d 90 Fracture neck of Nil Ward 
right femur 
Five patients who were admitted for repair of hip fracture and who did not 
receive any known and proven venous thromboprophylaxis developed DVT. 
Leg elevation as a DVT prophylaxis was applied to four patients. Although 
leg elevation is simple, safe, increases blood velocity and mechanically 
prevents venous stasis (Ashby et ai, 1995). there is insufficient data to 
substantiate its role in DVT prophylaxis when other altematives already exist 
(Levine et ai, 1996). 
One patient was recipient of low dose aspirin. Opinion is divided into the 
efficacy of aspirin in DVT prevention. Anti pi ate let Trialists Collaboration 
(1994) claims that antiplatelets such as aspirin reduces incidence of OVT by 
37 per cent but others have reported that they are generally ineffective and 
convey no benefit in orthopaedic patients (Levine et ai, 1996). 
One patient was administered subcutaneous LMWH Tinzaparin 4,500 units 
daily to prevent recurrence of the problem and PE. Already established as 
effective therapy for DVT. Tinzaparin is also the first low molecular weight 
heparin to be licensed for the prevention and treatment of PE (Fegan, 
1998). 
In sharp contrast to the trauma! orthopaedic directorate, a venous 
thromboprophylaxis strategy was in place on the surgical unit. Forty-nine 
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patients received some known prophylaxis and the one patient who was 
admitted for assessment and observation of abdominal pain did not and was 
discharged within 24 hours. It was not possible to follow up the patient for 
monitoring post discharge OVf, due to destination being unknown. As 
shown in table 5.23, a diversity of pharmacological prophylaxis was given 
but low dose heparin was the most popular choice. Thirty-nine patients 
received 5000 units of calcium heparin 12 hourly until they were ambulant. 
Although laboratory monitoring of heparin requires the estimation of 
Activated Partial Thromboplastin Time (APTT), no monitoring is necessary 
for low dose calcium heparin administered (BNF, 2000). 
LMWH is as effective as low dose heparin in reducing the incidence of DVT 
(Kakkar et ai, 1997). Six of the patients on the same directorate, but under 
the medical management of a different clinical consultant, were prescribed 
LMWH. Tinzaparin was given two hours before surgery subcutaneously 
followed by 3,500units every 24 hours for 7-10 days or until the patient was 
ambulant. LMWH has a number of advantages over conventional UFH. It 
reduces the risk of bleeding and the incidence of haematoma caused by 
LDH (Collins et ai, 1988). 
Interestingly, despite the risk of bleeding associated with heparin, no 
patients were prescribed any mechanical method of prophylaxiS. Intermittent 
Pneumatic Compression and Graduated Compression Stockings have 
proved to be effective in reducing incidence of DVT (Wells et ai, 1994) but 
. seemingly, the consultants on the directorate were not convinced.IPC is not 
proven to prevent PE (Hull et al,1990) in general surgery, which heparin 
does. 
Regrettably, eight patients (8/50=16%) who all received pharmacological 
venous thromboprophytaxis, developed DVT. The clinical characteristics of 
patients with DVT on the surgical directorate are outlined in table 5.32. 
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Table 5.32: Clinical characteristics of surgical patients with DVT. 
Patients 'code Age Diagnosis Proj)_~ylaxis DVT destination 
W100101s 71 Bowel malignancy Sodium Home 
heparin 
W/100/02s 52 Epigastric pain Tinzaparin Ward 
W 1001 05s 70 EUA rectal biopsy Sodium Home 
heparin 
W 100/16s 78 Bowel malignancy Sodium Ward 
heparin 
W100/25 s 77 Bowel malignancy Sodium Ward 
heparin 
W100/33 s 77 Bowel adhesions Sodium Home 
he~arin 
W100/39 s 77 Abdominal pain Sodium Home 
heparin 
W 100145 s 90 Bowel malignancy Sodium Ward 
heparin 
This reported incidence of 16 per cent DVT is consistent with the 16.2 per 
cent frequency reported for a population of surgical patients in North 
America (Clagett et ai, 1995). Two of the DVT patients developed the 
condition on the ward and were duly treated by standard secondary 
prophylaxis of sodium heparin infusion and titrated warfarin therapy. The 
other four patients developed DVT while convalescing at home and were 
duly referred to the anticoagulant clinic for treatment. While it is almost 
impossible for the whole population being studied to be DVT free, the 16 per 
cent DVT recorded on the surgical directorate could have been further 
reduced or halved by a combined regimen of venous thromboprophylaxis. It 
appears that general surgeons are yet to be convinced of the benefits of a 
combined regimen of venous thromboprophylaxis despite three studies on 
surgical patients confirming the efficacy of the combined pharmacological 
method with mechanical prevention (Tongren, 1980; Borrow & Goldson 
1981; Wille Jorgenson et ai, 1985) (Table 5.33). 
Table 6.33: Combination regimens of prophylaxis In surgical patients 
Study LDH LDH +GCS 
Tongren (1980) 12198= 12% DVT 4/98=4 % DVT 
Borrow & Goldson (1981) 23/80= 26.7 % DVT 2163= 3% DVT 
Wille Jorgensen et al J 1985) 12/102=12% DVT 2194= 2% DVT 
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DVT does not exclusively affect orthopaedic and surgical patients and there 
are few prospective studies on incidence of DVT In medical patients. 
Kierkegaard et al (1987) reported an incidence range of 13-28 per cent in 
bedridden non-surgical patients. However, there are certain medical 
conditions that are associated with occurrence of DVT and PE. Additionally, 
medical patients who develop DVT usually present a combination of high 
risk factors such as advanced age and immobilisation, which increase their 
global risk. 
Table 5.34 outlines the clinical characteristics of patients with DVT on the 
medical directorate. 
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Table 5.34: Clinical characteristics of the medical patients with DVT 
Primaryl DVT Patient'code Age Diagnosis secondary destination prophylaxis 
W100/02l29 48 Myocardial infarction LMWH(Primary) Home 
W100/08/29 77 PE UFH (Primary) Ward 
Warfarin 
(Secondary) 
W100/17/29 73 Myocardial infarction UFH (Primary) Ward 
Warfarin 
(Secondary) 
W100/23/29 77 Left ventricular UFH (Primary) Ward 
Failure Warfarin 
(Second aryl 
W100/24/29 78 Congestive cardiac UFH (Primary) Ward 
failure Warfarin 
(Secondary) 
W100/25/29 78 PE UFH (Primary) Ward. 
Warfarin 
(Secondary) 
W100/01/30 58 Left ventricular failure None Ward 
UFH& 
Warfarin 
(secondary) 
W100/04/30 62 Myocardial infarction None Ward 
UFH& 
Warfarin 
( secondary) 
W100/14/30 60 Chronic heart disease LMWH (Primary) Ward 
Previous PE UFH& 
Warfarin 
(Secondary) 
W100/16/30 75 Post myocardial None Home 
infarction 
W100/23/30 79 Congestive cardiac None Home 
failure 
W100/24/30 82 Congestive cardiac None Home 
failure 
In the sample of 50 medical patients. a DVT frequency of 24 percent (12150) 
was reported and an overall. 48 per cent (24/50) did not receive any venous 
prophylaxis. Eight of the 12 patients developed DVT during their hospital 
stay and the other 4 had DVT at home as DVT remains a continuing 
problem after discharge (Scurr et al. 1988). It is obvious from table 5.34 that 
five patients, who did not receive prophylaxis. developed DVT. While DVT is 
preventable and prophylaxis reduces the incidence of DVT, it is never 
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reduced to an unachievable zero rate (Mol & Egberts, 1994). Although UFH 
was the preferred primary prophylaxis, 10 per cent of the patients developed 
DVT. This is quite high but broadly in agreement with the findings of 
Simmons et ai, 1973 and McCarthyet ai, 1977, noting that a fourfold 
increase is reported in control groups. 
Thirty six per cent of the patients (18/50) received LMWH as primary 
prophylaxis but 11 per cent (2/18) developed DVT. All patients who 
developed DVT on the ward were treated with secondary prophylaxis to 
prevent recurrence of the condition and PE, its ultimate and fatal 
complication. 
Antiplatelet therapy has shown to prevent DVT and PE in high risk medical 
patients and the Antiplatelet Trialists Collaboration (1994) recommend that 
low dose heparin is routinely used in patients with myocardial infarction and 
stroke. No patients in the study were recipients of antiplatelet therapy. 
Overall, there is sufficient evidence to suggest that some venous 
thromboprophylaxis strategies are in place across the three clinical 
directorates, but were inconsistently applied. They do not measure up with 
the recommendations of the national and international consensus groups 
(International Consensus Statement 1997; THRiFT, 1998) who vigorously 
advocated the administration of DVT prophylaxis based on risk levels. 
Although all patients on the surgical directorate received pharmacological 
prophylaxis, it was indiscriminately administered, irrespective of risk levels. 
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Summary 
Data from 148 patients were analysed to establish the consistency, 
sensitivity, specificity and predictive validity of the DVT scale. Venous 
thromboprophylaxis strategies were also scrutinised to evaluate the 
effectiveness of current protocol. 
Five reliability studies were undertaken. A high total percentage agreement 
and kappa values ranging between 0.88 to 0.97 confirmed the consistency 
of the DVT scale. A DVT prevalence of 19 per cent (28 patients) was 
recorded. Using a cutoff score of ~ 15, 115 patients (78%) were correctly 
predicted for outcomes and 33 patients (22%) were misclassified. 14 
percent of patients who were incorrectly predicted developed DVT. For the 
optimal predictive accuracy of the DVT scale, a ROe curve was constructed. 
The co-ordinates of the curve indicated that a score of 11 captured nearly 
70 per cent of patients predicted for DVT. However, the predictive ability of 
the prognostic index was deemed to be underestimated as the outcomes 
could have been influenced by uncontrollable factors such as the efficacy of 
venous thromboprophylaxis. A large number of patients, who were predicted 
to be at high risk, were recipient of venous thromboprophylaxis and as a 
result became false positives. Although there was evidence of venous 
thromboprophylaxis strategies, they were inconsistently and indiscriminately 
applied. DVT is a continuing problem and 39 per cent of patients (11/28) 
developed DVT after discharge from hospital. 
Logistic regression analysiS was also applied to data, but findings were not 
definitive due to insufficiency of data and lack of testability of some 
independent variables. 
Finally, analysis of the postal questionnaire survey lent support to the value 
and practicable application of the DVT scale. 
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Chapter Six 
Discussion, recommendations and conclusion 
This final chapter reviews the analysed quantitative and qualitative data of 
the study and, based on the findings, evaluates the consistency, predictive 
validity and practical application of the Autar DVT risk assessment scale. 
The DVT risk calculator will be examined also in terms of its effectiveness in 
guiding clinical decision making for the primary prevention of deep vein 
thrombosis. In the light of the discussion of the findings, some changes to 
the clinimetric properties of the DVT scale will be recommended to enhance 
its overall performance as a risk calculator and prognostic index. 
Reliability of the DVT scale 
An assessment tool is of little value if it is inconSistently applied, even if it 
has a high sensitivity and specificity (Gordis, 1996). Reliability and validity 
are both necessary conditions (Gibbon, 1995) and it is within such a context 
that the DVT scale will be judged. 
High total percentage agreement and excellent kappa values recorded in 
the five reliability studies and discussed in chapter five confirm the 
consistency of the DVT scale. The findings indicate some modification to 
enhance reliability of the scale further. Nursing assessment instruments 
often get misconstrued in their application due to unavailability of the original 
information to understand the theory underpinning them. Such a 
misunderstanding results in inter rater disagreement. It is extremely 
important to ensure that potential users of an instrument have a good 
understanding of the underpinning theory as well as access to the Original 
references for familiarisation with the tool (Cormack & Reynolds, 1992). The 
relevant publications on the DVT scale were made available to the ward 
staff where the DVT scale in this study was tested and this enabled them to 
access the literature as and when needed. Additionally, regular visits to the 
clinical areas by the researcher to monitor the research activity allow for 
dialogues and clarification of issues with the nurse participants. Despite the 
high consistency of the DVT scale as substantiated by the recorded 
measure of agreement, there is no room for complacency and higher 
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reliability was achieved by responding appropriately to the feedback from 
the postal questionnaires. Some problematic issues in terms of the clarity of 
some variables were reported. It was noted that some assessors on the 
medical directorate were uncertain as to when the variable "myocardial 
infarction" as a risk factor applied to their patients. Acute myocardial 
infarction is one of the leading causes of admission to the Medical 
Assessment Unit (MAU) and incidence of DVT ranges from 20-40 per cent 
in the acutely ill patients with this serious dinical condition (Carter et ai, 
1987). Although a previous history of DVT increases the likelihood of its 
recurrence sevenfold (Samama et ai, 1993), currently available data do not 
support the assumption that a previous history of myocardial infarction 
makes patients vulnerable to DVT. Recent advances in coronary care have 
revolutionised the management of myocardial infarction and a high recovery 
rate has been recorded (Jowett & Thompson, 1989). Most patients with 
myocardial infarction go on to have a normal life after a period of 
rehabilitation (Lindsay & Gaw, 1997). 
As the variable "myocardial infarction" is ambiguous and is inclined to lead 
to a bias in its interpretation as either an acute episode or a past medical 
history of the patient, it is recommended that the clinical variable be 
redefined. The term "acute myocardial infarction" (Figure 7) is preferred and 
serves to emphasise an acute attack of event necessitating hospital 
admission and its immediate potential for causing DVT. 
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I AUTAR DVT RISK ASSESSMENT SCALE REVALIDATED (2002) I 
- -- --.- -
I'" Name: Age: 
Unit No: Type of admission: 
Ward: Diagnosis 
AGE SPECIFIC GROUP (years) score BUILD I BODY MASS INDEX (BMI) 
10-30 0 Wt(kg! Ht (m)2 
31-40 1 Build BMI score 
41-50 2 Underweight 16-18 0 
51-60 3 Average! Desirable 20-25 1 
61-70 4 Overweight 26-30 2 
71+ 5 Obese 31-40 3 
Very obese (morbid) 41+ 4 
~ 
MOBILITY score SPECIAL RISK CATEGORY score 
Ambulant 0 Oral Contraceptives: 
Limited (uses aids, self) 1 20-35 years 1 
Very limited (needs helps) 2 35+ years 2 
Chair bound 3 Hormone replacement therapy 2 
Complete bed rest 4 Pregnancy! puerperium 3 Thrombophilia 4 
TRAUMA RISK CATEGORY SURGICAL INTERVENTION: Score only one 
Score item(s) only preoperatively. score appropriate surgical intervention. score 
Head injury 1 Minor surgery < 30 mins 1 
Chest injury 1 Planned major surgery 2 
Spinal injury 2 Emergency major surgery 3 
Pelvic injury 3 Thoracic 3 
11 Lower limb injury 4 Gynaecological 3 Abdominal 3 
Urological 3 
Neurosurgical 3 
Orthopaedic (below waist) 4 
; CURRENT HIGH RISK DISEASES: Score the ASSESSMENT INSTRUCTION 
: appropriate item(s) score Complete within 24 hours of admission 
! Ulcerative colitis 1 Scoring: Ring out the appropriate item(s) from I Polycythaemia 2 
: Varicose veins 3 each box, add score and record total below; 
i Chronic heart disease 3 Total score: I Acute myocardial infarction 4 
Malignancy (active cancer) 5 Assessor: Cerebrovascular accident 6 
Previous DVT 7 Date: 
ASSESSMENT PROTOCOL VENOUS THROMBOPROPHYLAXIS 
Score range Risk categories Low risk: Ambulation+ Graduated Compression Stockings. 
~10 Low risk Moderate risk: Graduated Compression 
stockings+ Heparin + Intermittent Pneumatic 
11·14 Moderate risk Compression Stockings. . High risk: Graduated Compression Stockings+ 
15 ~ High risk Heparin+ Intermittent Pneumatic Compression. 
Please record any other clinical observations that International Consensus Group recommendation, 
may supplement this DVT risk assessment. 2001 © R Autar,2002. 
------~--- -
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The consistency of any risk assessment tool can be maximised by careful 
design, simple and clear instruction (Gibbon, 1998). A problem was 
identified in this area despite a clear and simple instruction. In the DVT risk 
assessment of patients, the assessors were clearly briefed and instructed to 
record the trauma risk category of the DVT scale only preoperatively. This 
variable is no longer applicable if the subjects undergo surgery for 
therapeutic management of the trauma within 24 hours of admission. 
However, despite the explanation and the italicised instruction (figure 3), a 
few assessors continued to record the trauma risk factor and the surgical 
intervention simultaneously for some subjects. It can only be assumed that 
their action was automatic and the response, accidental. As a result, some 
patients received double risk weighting, which inflated their aggregate score 
and overstated the degree of risk. This human oversight can be resolved by 
writing the OVT scale into a user friendly computer software programme. 
This means that the assessors will be asked to choose only one most 
appropriate option between the trauma risk factor and the surgical 
intervention category. Any attempt to score both categories will not be 
permitted and the assessor not allowed to progress to the next stage to 
complete the assessment process until the computer prompt has been 
executed. 
In the interim, it is anticipated that the new layout of the DVT risk 
assessment chart (Figure 7) designed as a risk calculator and not a data 
collection tool will address this misunderstanding. 
The surgical intervention subscale is also an area where additional specific 
information can enhance the consistency of the scale. OrthopaediC surgery 
as an independent risk factor carries a high weighted score of 4 relative to 
the other types of surgery in this subscale. Incidence of DVT in orthopaedic 
patients ranges from 50 to 75 per cent (Das, 1994). Manipulation ofthe leg 
causes distortion and occlusion of the femoral and popliteal veins and is 
claimed to cause DVT (Stamatakis et ai, 1977). However, this high 
incidence of OVT in orthopaedics relates only to patients undergoing below 
waist surgery such as total hip and total knee arthroplasties and surgical 
repair of fractured femur and tibia and fibula (Geerts et ai, 1994). Incidence 
of DVT for other orthopaedic procedures such as upper limb surgery is not 
188 
---------------------------------------------------
proportional to lower limb surgery. For this reason, it is recommended that 
the variable "orthopaedic" be more explicitly redefined to denote below waist 
orthopaedic surgery (figure 7) and this will serve to differentiate this from 
other orthopaedic surgical procedures carrying little or no risk of DVT. 
In the same subscale, to make the distinction between major surgery and 
emergency major surgery further, the former is redefined as "planned major 
surgery", to highlight the difference in risk. Elective major surgery carries an 
incidence range of 0.2 to 2.2 per cent rising to 2.7 per cent for major 
emergency surgery (Kakkar et ai, 1970, Coon, 1976). 
Predictive validity 
The DVT risk assessment scale correctly predicted and classified 78 per 
cent of patients. Sensitivity and specificity are inversely related (Mausner & 
Kramer, 1985). 
108 patients were correctly predicted not to be at risk and did not develop 
DVT. A high negative predictive specificity of 90 per cent was achieved 
against a low positive predictive value of 25 per cent (Table 5.12). A high 
predictive value of 84 per cent of negative outcomes was also achieved at 
the cost of a predictive value of 37 per cent of positive outcomes (table 5.16) 
and was consistent with the caveat that: 
1& As prevalence falls, positive predictive value must fall alongside and 
negative predictive value must rise" 
Sackett et ai, 1991: p8S. 
Testing and refining an instrument to augment its predictive validity is an 
iterative process and needs ongoing evaluation (Priest et ai, 1995). 
DVT prophylaxis or intervention masks the efficiency of any risk assessment 
scale and the higher the quality of intervention, the least well risk 
assessment scales perform (Deek, 1999). In view of interventions, risk 
assessment scales must not be seen in terms of absolute risk measurement 
but as conditional risk (Lyne, 2000).Future validation of the DVT scale must 
continue to focus on those risk factors, old and new alike associated with 
DVT and their inclusion or exemption based on compelling evidence. 
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Some of the subscales of the DVT risk calculator will need to be revisited 
and recommendations made accordingly, in order to enhance its predictive 
ability. 
Age specific group 
Great Britain is an ageing society. Since the early 1930's, the number of 
people aged over 65 has more than doubled and today a fifth of the 
population is over 60. Between 1995 and 2025, it is estimated that the 
number of people over the age of 80 is set to increase by almost a half and 
the number of people over 90 will double (DoH, 2001). 
DVT increases exponentially with advancing age (Rosendall, 1997). People 
are living longer. Older people now comprise two thirds of all patients in 
acute hospital settings, partly due to the demographic shift but also due to 
lack of alternative settings for health and social care (DoH, 2001). 
A DVT rise of 20 per cent is reported in the 40-60 year old patients. This 
doubles between the age of 60 and 70 years and in patients over 70 the 
figure trebles (Borrow & Goldson.1981; Caprini & Natonson, 1989). This 
exponential rise is further substantiated by the Office Population of 
Censuses and Surveys (OPCS, 1990) which reported 205 recorded cases 
per 1000 of DVT in the 75-79 age group compared to 123 cases in the 70-
74 group and 100 in the 65-69 years old. Data analysis on the medical 
directorate also noted an increase in the number of elderly patients admitted 
in their 70's and 80's who are the most vulnerable group. Despite an overall 
low aggregate risk score placing them in the no risk category, two medical 
patients in this category developed DVT and advancing age was the only 
independent risk factor. In the age specific subscale, the 51-60 and 61 + age 
groups were assigned respective scores of 3 and 4. Relative to the 
incidence of DVT that rises sharply in the different age specific groups, it is 
judged that elderly patients in the 70-80 age group should be recognised as 
a higher risk group and therefore be assigned a risk score of 5. 
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Hormone Replacement Therapy (HRT) 
Opinion has been divided on the association between Hormone 
Replacement Therapy (HRn and the occurrence of venous thromboembolic 
diseases (THRiFT, 1998). At the time of the pilot study (Autar, 1994) and the 
launch of this investigation (Autar, 1997), the causal association between 
HRT and DVT was inconclusive and questionable. Evidence from earlier 
studies did not lend support to an increased risk of DVT or PE among HRT 
users (Boston Collaborative Drug Surveillance 1974; Moore, 1976). 
Notelowitz & Ware (1982) and'Carter (1992) also found no association 
between HRT and DVT. Based on insufficiency of evidence available at that 
particular time, HRT as a risk factor was not considered in the development 
of the DVT scale. 
However, two recent stUdies (Daly et aI, 1996 and Jick et ai, 1996) have 
demonstrated a positive causal relationship between HRT and DVT and the 
estimated relative risk was 3.5 and 3.6 respectively. Perez Gutthann et al 
(1997) conducted a case control study and concluded an overall twofold 
relative risk of venous thromboembolic diseases associated with the current 
use of HRT. Most recently, a randomised controlled trial (Lowe et ai, 2000) 
confirmed a two to fourfold increase of DVT rate in women taking HRT. 
The benefits of HRT outweigh its potential side effects (Cook et ai, 2001). 
However, there is now overwhelming evidence from the most recent studies 
to conclude that a causal relationship between HRT and DVT exists. As a 
result, HRT is now considered as a risk factor in the revalidation of the DVT 
scale (Autar, 2002). As illustrated in the re-validated scale (figure 7), HRT is 
a new addition to the special risk subscaJe and is assigned a risk score of 2. 
Thrombophilia 
Thrombophilia or Hereditary Thrombotic Disease (HTD) represents a group 
of abnormalities in which patients have recurrent thrombotic events because 
of genetic defect(s). At least nine abnormalities have been confirmed but in 
60-70 per cent of cases the cause of thrombophilia are still unknown 
(Marlar: in Wood & Burn, 1994). As a new condition is confirmed, risk 
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assessment followed by venous thromboprophylaxis must be seriously 
considered. To reflect this change, thrombophilia as a hypercoagulable state 
and independent risk factor is included in the special risk category subscale. 
90-95 per cent of patients with thrombophilia present with DVT (Marlar & 
Mastovich, 1990) and proportional to the degree of risk relative to other risk 
factors in this subscale, it is assigned at a risk score of 4 
Air travel as a risk factor 
Long-haul flights and air travel in general as causative of DVT have been a 
subject of much controversy. As a result of recent press publicity, audiences 
at workshops, conferences and study days have often challenged the 
researcher in relation to the omission of air travel as a risk factor for DVT. 
First of all, to justify this omiSSion, it is important to put air travel into some 
perspective regarding the risk. Most reports published are narratives and the 
estimated risk in terms of percentage of person trips affected is 
unquantifiable and marginal. Most of the reports are derived from small 
numbers of air passengers and they can be criticised on account of their 
inaccuracy due to the retrospective analysis of the insufficient data. There 
appears to be an individual susceptibility to DVT. The passengers who 
developed DVT had other "patient-related" risk factors such as advanced 
age, previous DVT, chronic illnesses, malignancy. hormone therapy and 
recent lower limb injury (Eklof et a, 1996). These well-recognised risk factors 
have a cumulative effect (Autar, 1996a) and are already well represented in 
the DVT scale. Such an argument is also in agreement with the "multiple hit 
theory" of venous thromboembolism postulated by Rosendaal (1997) that 
several factors combine to provoke an acute episode of DVT or PE in an 
individual. Co-morbid features such as obesity and varicose veins are often 
present in those passengers who developed DVT (Tardy et ai, 1993). 
Seven "cabin -related" risk factors have also been implicated, linking air 
travel with DVT (Eckloff, 1996). Traditional narrative review articles are 
frequently misleading and therefore unreliable for evidence based decision 
making (Antmann et ai, 1992). While current evidence on air travel as a risk 
factor is anecdotal and weak, there is strong consensus that immobility 
rather than the environment is the significant factor (Cook, 2001). A 
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comparison of "First Class" with "Economy Class" passengers should make 
a revealing study. 
High risk diseases 
The high risk disease subscale is an area of risk assessment that needs to 
be critically reviewed. In the light of recently available evidence or lack of it, 
some of the high risk diseases need to be re-examined and any change 
warranted duly justified. 
Specifically, clinical conditions such as sickle cell anaemia, haemolytic 
anaemia, varicose veins and cerebrovascular accident as risk fadors for 
DVT need to be re-evaluated. 
Haematologiea. conditions 
Pearson & Wetherby-Mein (1978) reported a positive correlation between 
DVT and polycythaemia. The Polycythaemia Study Group (PSG) has 
confirmed a high incidence of DVT in patients over the age of 70 
(Wasserman et ai, 1981) and hypercoagulability in Virchow's triad is the 
most prominent clinical pathophysiology. It is therefore sensible to retain 
polycythaemia as a risk fador with its original risk score of 2. 
On the other hand, current data and evidence on sickle cell anaemia and 
haemolytic anaemia do not lend any conviction to the view that they are risk 
factors in the genesis of DVT. Both sickle cell anaemia and haemolytic 
anaemia have been implicated in earlier literature for the reason of restrided 
blood flow and the release of cell breakdown produds. In sickle cell 
anaemia thrombi occur frequently in the microcirculation, resulting in 
infardion in the lung tissue, spleen, kidneys and bone. There is no recorded 
evidence that it affeds the macrocirculation and causes PE, secondary to 
proximal and distal DVT (Bell & Simon, 1982). 
Haemolytic anaemia is a premature accelerated destruction of erythrocytes 
and has been previously implicated as a risk fador. While haemolytic 
anaemia causes jaundice due to haemolysis, incidence of DVT is relatively 
rare and there is no classified data to support any direct causal association 
with DVT (Belcher, 1993). It appears that early publications linking sickle cell 
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anaemia and haemolytic anaemia to DVT, due to increased blood viscosity 
may have been speculative and exaggerated. A paucity of literature and 
unavailability of any classified hard and recorded data do not substantiate 
any causal association with DVT (Serjeant, 1992). In the absence of 
classified data and no new evidence, it is highly unlikely that they will 
contribute to the predictive accuracy of the DVT scale. It is therefore 
reasonable to recommend that the two items be deleted from the subscale 
(Figure 7). 
Varicose veins 
The positive association between varicose veins and frequency of DVf is 
not a matter of controversy per se. Consistent with its high ranking by the 
European Consensus Group (1991) and THRiFT (1992), varicose veins as a 
DVT risk factor features prominently in the high risk disease subscale. It is 
associated with a high risk score of 6, second only to previous DVT and 
CVA (Autar, 1994; Autar, 1997). 
Recent debate on varicose vein as a covariate in the genesis of DVT is not 
disputed but is challenged in relation to the nature of its association. An 
association does not necessarily imply a direct causation (Norrell, 1995). 
Associated risk factors combine to exert an additive effect, culminating into 
an episode. On the other hand, independent risk factors are discriminative 
markers, acting singly to provoke an acute event (Nicolaides & lrving, 1975). 
Clinical opinion is divided about the direct relationship between varicose 
veins and DVT occurrence. Several investigators have utilised varicose 
veins as an independent covariate in their predictive indices to identify 
patients at risk of DVT (Nicolaides & Irving, 1975; Clayton et a11976; 
Crandon et ai, 1980; Lowe et aI1982). Many vascular surgeons (Campbell 
& Riddler, 1995; Campbell,1996) are now challenging this clinical view. 
They claim the assumption that DVT is an independent risk factor is derived 
from a lack of understanding of the differences between the deep and 
superficial veins of the lower limbs. This scepticism is evident in a survey of 
venous thromboprophylaxis for varicose veins surgery. Only 29 per cent of 
vascular surgeons consider varicose veins as a high risk covariate, 
necessitating primary prevention (Campbell & Ridler, 1995). 
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Current literature on varicose veins is controversial and does not provide 
specific data on the frequency of DVT, primarily to the presence of varicose 
veins. The studies showing a relationship between DVT and varicose veins 
were undertaken in patients who had major abdominal surgery and invited 
criticism for the population sample also contained older and obese patients. 
Varicose veins may have coexisted incidentally with major abdominal 
surgery, advancing age and obesity as additive factors to cause DVT. Hirsh 
& Hoake (1996) and Gorman et al (2000) accept that varicose veins 
increase the risk of DVT but concede that some more definitive work need 
to be done in this area. In a study of 1231 patients. Anderson and Wheeler 
(1995) reported a DVf incidence of only 5.8 per cent due to varicose veins. 
Most patients with varicose veins belong to a group of population with 
advancing age and limited mobility who may also be affected by leg ulcers, 
secondary to the complication of varicose vein (Callum, 1992). 
Future studies must take into account other covariates in patients are 
discriminated from varicose vein in the pathogenesis of DVT. 
In the interim, retaining the high risk score of 6 for varicose veins is 
unjustified because it overpredicts the risk and increases the false positive 
rate. In conclusion as there is little evidence currently to support varicose 
veins as an independent risk factor (Campbell, 1996; Agu, 1999), the 
associated role of varicose vein in predisposing to DVT should be 
acknowledged, but its original risk score is halved (Figure 7). 
CV A and previous DVT 
CV A and a previous DVT are very well recognised high risk diseases in the 
causation of DVT, each associated with a risk score of 7 (Autar, 1994; 
Autar, 1997). The incidence of DVT ranges between 42-60 per cent for CVA 
(KamaI1987; Brunner & Suddarth. 1992). In patients with a previous history 
of DVT, the recurrence of an episode is reported to be between 48-68 per 
cent (Kakkar et al 1970; Dalen et al. 1986). An even higher risk than CVA 
was reported by Samama et al (1993) who recorded an odds ratio of7.9 for 
patients with previous DVT. There is now a general consensus that previous 
DVT predisposes to the recurrence of the condition and is the highest risk 
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factor in the causation of DVT (Nordstrom et ai, 1992; Samama et ai, 1993; 
Anderson et ai, 1995). 
As the risk of DVT is higher for patients with previous DVT than with CVA, 
previous DVT is capped at the risk score of 7 and revised risk score of 6 
assigned to CVA. In this way, a small difference in the risk associated with 
these conditions is maintained. 
The DVT risk assessment protocol 
Evaluation of the sensitivity and specificity of the DVT scale indicates that 
some minor modification to its assessment proforma would enhance the 
predictive accuracy of the instrument. The current DVT risk assessment 
strategy (Autar, 1997) requires the known clinical risk factors for the patients 
to be identified. This places them into one of the following risk categories: no 
risk, low, moderate and high risk. It is important to identify those at risk and 
differentiate them from those who are not so that the limited resources could 
be targeted most effectively. That is why a no risk category was 
incorporated into the assessment protocol. 
DVT is a disease of the hospitalised patients (Douglas, 1978) and in reality 
all patients, by virtue of admission for investigation or treatment should be 
regarded as at risk. This was evident in the data analysis for the medical 
directorate. Two patients on the medical ward developed DVT despite 
having a low score of less than 6, which placed them into the no risk 
category. With an increasing number of claims being made for clinical 
mismanagement (NAHAT, 1991) it is prudent to err on the side of caution 
and assume all patients. are at risk. A DVT incidence of 11 % for patients 
with no risk factors present and deemed not to be at risk, was reported by 
Anderson & Wheeler (1995; Table 3.16). It is therefore recommended that 
the four risk categories of the DVT scale be reviewed to merge into three 
distinct risk categories (figure 7). The removal of the no risk category from 
the assessment protocol places the low risk category into a wider risk score 
range of less than 10 and resolves any problem of spurious preCision 
between the two risk categories. The other risk score ranges of 11-14 and 
15 and over remain unchanged and identify the moderate and high risk 
categories respectively. Modification of the assessment protocol into three 
__________________________________________ ~196 
risk categories is also consistent with the recommended assessment 
strategy by the national and international consensus groups (European 
Consensus Group, 1991; International Consensus Group, 1997; THRiFT, 
1998). 
Collapsing the no risk category into the low risk category rules in a total of 
92 patients and yields a DVT incidence of 10% (9/92) for the low risk 
category. This is consistent with previous DVT occurrences reported by 
Salzman & Hirsh (1982) and THRIFT(1998). An absolute DVT incidence of 
32% (12/37) reported in this study, is compatible with the generally recorded 
incidence range of 11-40 % for the moderate risk category (International 
Consensus Statement,1997). Although the incidence of DVT ranges 
between 40-80 % for high risk category, in this study a 37% (7/19) 
occurrence is noted and this is primarily due to fewer patients in the high 
risk group being recruited. Table 6.1 exhibits the DVT incidence for the three 
risk categories of the modified risk assessment protocol. 
Table 6.1: DVT incidence for the three risk categories. 
Risk No of patients NoofDVT DVT (%) 
categories in risk category recorded recorded 
Low 92 9 10 
Moderate 37 12 32 
High 19 7 37 
Total 148 28 19 
Practical application of the scale 
The DVT risk assessment scale has achieved some promiSing results in 
terms of consistency and overall correct percentage prediction. It is 
reproducible, easy to use, comprehensive and takes less than 3 minutes to 
complete. It can be universally applied to clinical areas, as all proven and 
known clinical risk factors in the pathogenesis of DVT have been included. 
The special risk category subscale is represented by specific variables such 
as oral contraceptive and oestrogen therapy, pregnancy and puerperium 
and thrombophilia. Due to the special nature of the risk factors present in a 
particular patient population, the testability of the items in this subscale was 
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not possible. None of these variables were applicable to the patients in the 
study and were recorded as constant in the logistic regression analysis. 
Patients who were taking oral contraceptive therapy were advised to stop 
the contraception three weeks prior to the planned surgery to minimise risk 
of venous thromboembolism, as recommended by the British Medical 
Association (BMA) and the Royal Pharmaceutical Society of Great Britain 
(BNF, 1994). No patients receiving HRT or sufferers of thrombophilia were 
admitted. Further to test the validity of the items in the special risk category, 
it is suggested that such populations will be targeted in future studies. In 
particular, validating the DVT scale on the obstetric speciality will enable the 
testability of pregnancy and puerperium as a high risk factor. 
DVT scale as a teaching tool 
It is generally recognised that the DVT scale is also a valuable teaching tool 
as evident in the evaluative responses of the clinicians to the postal 
questionnaires (appendices 14,15 & 16). Other risk assessment instruments 
(Arcelus et al 1991; Caprini et al 1991; Bahal & Silverman et ai, 1993) have 
all utilised the known risk factors to assess patients for risk of DVT. While 
this approach classifies patients into risk categories according to the 
number of risk factors present, it provides no basis for comparison of the risk 
for individual patients and explaining why some individuals are more at risk 
than others. On the other hand, the very design of each subscale puts the 
assessment process in a risk perspective and explains why an individual is 
or is not at risk. The covariates making up each subscale illustrate the low or 
absent risk relative to the highest risk factor, as quantified by the risk score 
assigned for each item. The assessment protocol is self explanatory, as a 
low risk score denotes a low level of risk and the assignment of a high score 
identifies a high level of risk. 
The DVT risk assessment tool has already been incorporated into the spiral 
nurse education curriculum for students undertaking programmes, leading to 
BSc in Nursing and Diploma in Nursing awards, at the local university. As 
DVT is a problem common to all the clinical specialities, the DVT risk 
calculator is used as a tool for teaching the primary prophylactic and 
secondary crisis intervention management of the condition. In the current 
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curriculum, the DVT scale is first introduced to explain the thrombogenic 
mechanisms (Table 3.16) underpinning Virchow's triad in the 
pathophysiology of DVT. This introduction is then followed by a problem 
solving approach learning strategy to evaluate the learning outcomes. The 
students are presented with case studies and using the DVT scale, they are 
required to work out the assessment process and place each patient into an 
appropriate risk category. 
Staff preparation is critical to the successful development an 
Implementation of any protocol. Current literature review suggests that there 
is no publication with regard to the evaluation of nurses' knowledge of 
venous thromboembolism and the DVT scale can potentially fulfil two 
functions. First of all, risk assessment lies at the very core of a venous 
thromboprophylaxis protocol and the DVT risk scale is developed for this 
purpose. Secondly, it can be applied to evaluate nurse's knowledge of DVT 
and ultimately prepare them for implementation of the protocol. 
The DVT scale can also be used to train anticoagulant nurse specialists, 
practice nurses and those undertaking the formal community nurse 
education programme. They are becoming increasingly involved in the 
primary and secondary venous thromboprophylaxis management of DVT in 
their integrated caseload. Historically, patients with DVT have been treated 
initially by Unfractionated Heparin (UFH), necessitating inpatient care. But 
with the advent of Low Molecular Weight Heparin (LMWH), all these patients 
are now managed effectively by domiciliary nursing services and outpatient 
anticoagulant clinics. The introduction of LMWH has revolutionised the 
management of DVT and their benefits are listed below: 
• It needs only be administered subcutaneously and eliminates the need 
for infusion equipments and monitOring and saves staff time (Fegan, 
1998). 
• A single dose daily provides anticoagulation for 24 hours (Friedal & 
Balfour, 1994). 
• It removes the need for extensive laboratory monitOring. Clotting tests as 
Prothrombin Time (PT) and Activated Partial Thromboplastin Time 
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(APTT), which are regularly required for UFH, are not required (Clagett 
et ai, 1992). 
• It reduces the adverse high rate of wound haematoma caused by UFH 
(Collin et ai, 1988). 
• Incidence of DVT is 5.3 per cent for LMWH compared to 6.7 per cent for 
UFH (Perkins & Galland, 1999). 
• Managing adverse outcome of LMWH costs £144.75 compared to 
£ 195.50 for UFH (Valette et aI1991). 
• Patients who receive LMWH spend a mean of 1.1 days in hospital as 
compared with 6.5 days for standard heparin (Levine et ai, 1996). 
It is recognised that with the appropriate training, nurse speCialists, practice 
nurses and community nurses can run anticoagulant clinics as well as 
haematologists do (Van de Pette & Mackie, 1996). Nurse-led anticoagulant 
clinics (Brown et ai, 1999) and Community Nurse-led outpatient cliniCS 
(Oeagle, 1998) for OVT management are evolving rapidly to meet the needs 
of the health care. More patients are being treated at home, and the 
Southampton University Trust Hospitals (SUTH) initiative described in 
chapter one, is an example of effective care delivery at the point of demand 
to benefit patients and reduce hospital cost. 
OVT is a continuing problem and patients often develop thromboembolic 
complications up to six weeks following discharge from hospitals (Scurr et al 
1988). The old cliche that DVT Is a disease of the hospitals (Douglas 1978, 
Grace, 1993, Anderson et ai, 1995) does not ring entirely true. Nilsson et al 
(1997) reported a DVT incidence of 38 per cent occurring at home in 
patients whose prophylaxis was restricted only to their hospital stay. The 
report is further supported by the findings this study. Eleven out of the 28 
patients with OVT (39%) developed the condition at home: none of them 
were recipient of any prophylaxis post hospital discharge. There is now an 
inverse relationship between the duration of hospitalisation and 
thromboembolic complications, due to early discharge (Haas, 1997). With 
increasing demand for hospital beds for acute admission, patients are being 
discharged home earlier. Risk factors persist beyond hospitalisation and 
community nurses are well placed to assess the patients with the DVT scale 
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and monitor them for any venous thromboembolic events. One fourth of PE 
occurs after discharge home (Huber et ai, 1992) and registered nurses 
must: 
"Safeguard and protect the interests of individual patients and clients· 
(UKCC, 1992) and 
"act to identify and minimise the risk to patients and clients" Nursing and 
Midwifery Council (NMC, April 2002). 
Having applied the DVT scale to assess risk, the community nurses can also 
take appropriate actions to minimise them and prevent DVT. Although the 
prescription of pharmacological prophylaxis is the province of physicians, 
nurses can actively initiate side-effects free and safe mechanical 
prophylaxis. They can recommend and encourage patients to wear 
graduated compression stockings to promote venous return. In a meta-
analysis, Wells et al (1994) reported a 68 per cent overall risk reduction for 
prophylaxis with graduated compression stocking. Other methods of 
mechanical prophylaxis can be achieved by a health promotion programme 
aimed at encouraging active and passive exercises and leg elevation. Active 
and passive exercises prevent stasis by promoting venous valve function 
and muscle action pump (Cotton & Roberts, 1977). A 1 O-degree elevation of 
lower limbs effects a 30 per cent increase in blood velocity (Wolfe & 
Sarbiston, 1980). A more recent study by Ashby et al (199S) confirms that 
leg elevation of around 6 degrees in the supine position aids blood flow and 
is a simple yet very effective prophylaxis against DVT. 
Decision making process 
Evidence from audit of venous thromboprophylaxis across the three clinical 
directorates for this study, suggests that it is inconSistently applied due to 
lack of organised strategies to guide the decision making process. In the 
absence of any venous thromboprophylaxis protocol in place, uptake is 
alarmingly weak on the trauma/orthopaedic unit (12%) and only moderate 
(48%) on the medical directorate in one NHS trust. A DVT incidence of 20% 
was recorded. On the other hand, although there were no documented 
venous thromboprophylaxis strategies, 98%{48/S0) of the patients on the 
surgical directorate of another NHS trust received some proven form of 
prophylaxis. 
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SIGN (1995) and THRiFT (1998) have strongly recommended protocol 
development to facilitate the uptake of the most effective prophylaxis, based 
on risk assessment. Just as assessment is the initial stage of the nursing 
process (Crow, 19n), DVT risk assessment is at the very foundation of 
protocol development. DVT risk assessment predicts risk and enables the 
clinicians to make professional judgement as to what is the most effective 
prophylaxis. Although prediction is not always accurate, it serves to guide 
action to benefit patients. 
Simms & Fought (1989) state that decision making is a blend of theory and 
expertise. The more experience the practitioner has, the better is the nature 
of clinical judgement to guide decision-making. Benner (1984) describes 
expertise as being generated from concrete past experience. Experience 
"does not refer to the mere passage of time or longevity. Rather it is the 
refinement of preconceived notions and theory through encounters with 
many actual situations". 
Benner,1984. 
The novice, on the other hand, does not have the ability to reflect on past 
experience and Benner (1984) suggests that expertise and knowledge can 
only be gained by direct encounter with an event. Experience appears 
fundamental to explaining the concepts of "art" and "science" of dinical 
decision making. This may have implications for future training, which can 
be developed to indude an apprenticeship component, with the necessary 
supervision within a dinical setting. As it happened, all the data collectors in 
the study were registered nurses with good clinical background and 
experience in the management of thromboembolic diseases. 
In order to remind clinicians about the internationally and nationally 
recommended venous thromboprophylaxis for each of the three risk groups, 
they are now printed on the DVT scale chart (Autar, 2002: p192). A formal 
DVT risk assessment chart promotes the uptake of venous 
thromboprophylaxis (Bahal & Silverrnan 1993; Byrne et ai, 1996). Thus far, 
the DVT scale has focused primarily on the risk calculation and future 
studies should audit the impact of this instrument in making decision about 
the choice of prophylaxis. 
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Conclusion 
The DVT scale has yielded some promising results and attracted 
considerable interest both nationally and internationally. It has good 
practical application and the theory underpinning it is knowledge embedded 
and developed in clinical practice. The DVT scale is not set in tablets of 
stone and nurses must not be complacent in its application but should 
exercise their professional and clinical judgement to complement it. For 
example to put this into a clinical perspective, some high risk patients with a 
score of 0 15 develop DVT while others with the tied score do not. Those 
who do not are often patients whose mental status enables them to co-
operate in care to minimise DVT risk. Although they are immobile, they 
understand simple nursing instruction to engage in antistasis exercise such 
as flexion and dorsiflexion of the foot to activate the muscle pump. In such 
clinical situations, while recognising the risk to patients and acknowledging 
that mental status is not a known DVT risk factor, using their professional 
judgement adjunctively with the DVT scale, can make a difference. 
Capitalising on the co-operation of the patients has enabled them to reduce 
the risk associated with immobility. The new design of the revalidated scale 
should encourage clinicians to record such relevant observations based on 
professional judgement to supplement the DVT risk calculator. 
The goal of this study has been to obtain a large enough sample for 
statistical significance yet expedient and economical at the same time. 
A priori sample size was estimated using the G* Power computer software 
and for a low to medium effect sizes of 0.23, 149 patients were required. 
Cohen (1977) concedes that for a new area of research enquiry such as the 
evaluation of the DVT scale, effect sizes are likely to be small. 150 patients 
were recruited to the study and they were all followed up for a period of 
three months from the time of admission, as risk factors persist after 
discharge home. 
It must be remembered that focusing on a specific problem such as the 
occurrence of DVT, to evaluate the predictive accuracy of the DVT scale, 
can lead to a source of error. In this study, the applications of preventative 
measures were not excluded because of legal and ethical considerations. 
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The efficacy of mechanical and pharmacological prophylaxis has been so 
firmly confirmed (Kakkar 1990, Kakkar et ai, 1997) that it would be 
considered a serious omission of Kduty of care" and clinical negligence not 
to administer prophylaxis to the needy. 81 out ofthe 150 patients (54%) 
received some form of known and proven prophylaxis, and this could have 
influenced the DVT outcome and explain the poorer sensitivity of the DVT 
scale. 
If the results of nursing studies are to be applied to nursing practice, then 
the nursing community needs assurance that the effects are substantial 
enough and supported by statistical evidence. Future studies on the ongoing 
evaluation of the DVT scale must involve more patients, so as to obtain 
greater effect size and power. The most obvious and straightforward method 
is to increase the sample size. 
The versatility of the DVT scale was demonstrated in its application across 
the three clinical directorates without having to modify its actual design. 
Some items were easier to test in one area than the other. The trauma risk 
category predominantly applies to the orthopaedic patients and the high risk 
disease category to the medical patients as is the surgical intervention 
category to the patients on the general surgical ward. Its application and 
evaluation in diverse clinical specialities will allow for the testability of all the 
items and provide further evidence to its portability and universal 
application. A single cutoff score range of 15 ~ applied across the medical, 
orthopaedic and surgical patients yielded different levels of sensitivity, 
specificity, positive predictive and negative predictive values due to the 
nature of the specialities (Table 6.2). A ROe plot must be applied by users 
of the DVT scale to optimise its predictive accuracy as one cutoff score 
value may not be appropriate for all. 
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Table 6.2: Sensitivity, specificity, positive and negative predictive 
values of DVT scale across the three specialities 
Specialities Cutoff Sensitivity Specificity PPV scores (%) (%) (%) 
Orthopaedics 15~ 25 83 36 N=50 
Medical 
. 15~ 8 95 33 N=50 
Surgical 15~ 25 98 67 N=48 
NPV 
(%) 
90 
77 
87 
Noting that sensitivity and specificity are inversely related, a low sensitivity 
of the DVT scale is punctuated by a very high specificity and a low 
predictive value for cases is significantly outweighed by a high predictive 
value for negatives. 
A comparative analysis of the Autar DVT scale 
The DVT scale has demonstrated several advantages over other forms of 
risk assessment strategies. A broad-brush guesstimate of "potential problem 
of DVT" as used on pre-printed care plan (Autar, 1994) provides only a very 
crude index of risk assessment. Unless risk is quantified and patients 
classified into risk categories, clinical decision making in terms of what 
constitutes the best prophylaxis, is likely to be ineffective (THRiFT, 1998; 
International Consensus Statement, 1997; 2001). 
On the other hand, the revalidated Autar DVT risk assessment protocol 
(figure 7:p187) uses quantifiable clinical data to rank patients into one of the 
three levels of DVT risk. This strategy makes the whole DVT assessment 
process visible and guides practitioners into implementing the most 
appropriate venous thromboprophylaxis as recommended by the national 
and international consensus groups. 
It is in the area of primary prevention of DVT that the Autar DVT scale has 
exhibited considerable promises. Essentially, there are two types of venous 
thromboprophylaxes: primary and secondary. Primary prophylaxis is about 
preventing DVT. DVT is most preventable and appropriate venous 
prophylaxis reduces its occurrence by 50% (Vanek, 1991). On the other 
contrary, secondary prevention is directed at treating DVT once it occurs, in 
order to prevent extension of the condition or fatal complications such as PE 
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or PPS. Risk factors are additive and the crux of primary prophylaxis is to 
quantify risk in patients, so that the recommended intervention can be 
promptly initiated. Calculating DVT risk objectively in an individual within a 
multifactoral aetiology, the DVT scale allows for this problem to be 
addressed proactively. This proactive approach to DVT management is in 
very sharp contrast to the reactive nature of the problem, whereby OVT is 
treated, as it occurs to prevent extension its immediate serious 
complications. Wells et al (1994) develop a clinical prediction guide to 
confirm any provisional suspected DVT, so that it can be promptly and 
safely treated. This reactive approach to DVT is very costly to the health of 
the individual and socio-economically. 
Consistency and practical application are other two areas where the Autar 
DVT scale outperforms alternative strategy such as haematological data for 
detecting hypercoaguability. 
Although several researchers (Clayton et ai, 1976: Crandon et ai, 1980 and 
Lowe et ai, 1982) have used the same predictive index and on similar 
population, the outcomes have very dissimilar and inconsistent. This is 
because the laboratory procedure lacks standardisation, yielding different 
cutoff scores and values (Palareti et ai, 1991) and are forbiddingly complex 
to interpret (Gallus,1987). On the other hand, the high percentage 
agreement, kappa values and intra-class correlation coefficients of the DVT 
scale are proof to the conSistency of its application. 
Another problem with laboratory testing is that it can only be initiated by 
medical staff at the exclusion of nurses and other health care professionals 
who play a key role in the prevention of OVT. Additionally, this heavy 
dependency on laboratory data to predict risk, means that venous 
thromboprophylaxis cannot be implemented, until rheologiesl test results are 
available. On the other hand, the Autar OVT scale relies on routine data 
gathered on admission, allowing for a prompt DVT risk assessment and 
timely interventions. Like the universally recognised Glasgow coma scale, 
the Autar OVT scale can be applied by nurses and doctors alike and other 
health care professionals 
The use of computer programmed with logistic regression formulas, as 
devised by Janssen (1987) is technology for the future. Until artificial 
__________________________________________ ~206 
intelligence is available for carrying bedside assessment, paper and pencil 
assessment tools as the DVT scale, remain the most cost-effective method 
of predicting risk and guiding decision making. The DVT risk factors are 
readily assessable items and day to day observations undertaken by 
nurses. This confers the advantage of generating a pragmatic DVT risk 
assessment instrument. It takes only a few minutes to complete, requiring 
only minimal education and training and no other formal measurements or 
additional equipments. 
Summary 
The Autar OVT scale has demonstrated good consistency in five reliability 
studies. However, it is also recognised that the existing reliability of the 
instrument can be increased by the simple clarification of several variables. 
The term "acute myocardial infarction" is preferred to explain an acute 
episode and to rule out "myocardial infarction" as a past medical event. Staff 
must be reminded constantly to choose either from the trauma risk category 
of the subscale or the surgical intervention category, as not to overstate risk. 
The layout of the revalidated scale is designed to minimise this kind of 
human error. Clarifying orthopaedic surgery as below waist procedures 
(figure 7) in the surgical intervention category, differentiates such high risk 
procedures from other types of orthopaedic surgery carrying less risk of 
OVT. 
In terms of its predictive validity, the DVT scale correctly classified 78 per 
cent of the patients. The inverse relationship between specificity and 
sensitivity meant a high specificity of 90 per cent was achieved against a 
low sensitivity of 25 per cent. A high predictive value of 84 per cent of 
negative outcome was accomplished at a cost of a predictive value of 37 per 
cent of positive outcome. Refining some of the covariates of the tool could 
improve its predictive validity. As DVT increases exponentially with 
advancing age, and the patients over the age of 70 is set to rise by almost a 
half, a fifth element is included in the age specific category subscale. 
Patients in the 70+ group are assigned a high risk score of 5. 
Evidence is now overwhelmingly supportive of the association between HRT 
and OVT. HRT is an addition to the special risk category and is assigned a 
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risk score of 2. Hereditary Thrombotic Disease is increasingly recognised as 
a high risk factor and Thrombophilia is another addition to the special risk 
category with a risk score of 4. 
On the other hand, despite recent publicity, air travel as risk factor is 
inconclusive and not considered in the DVT scale. Haematological 
conditions such as haemolytic anaemia and sickle cell anaemia, previously 
linked with DVT, have been removed from the high risk disease subscale, 
due to lack of supporting evidence. Opinion is divided on varicose veins as 
an independent variable. Current evidence acknowledges varicose veins as 
an associated factor but concedes the high risk is not what it is made out to 
be. Varicose veins risk is assigned a revised risk score of 3. The covariate 
CVA has a revised score of 6 to differentiate it from the slightly higher risk 
posed by a previous DVT. 
In order to reduce the rate of false positives, the risk assessment protocol 
has been reduced to three risk categories, namely low, moderate and high 
risk. This classification is consistent with the recommended risk assessment 
protocol of the international consensus group. Overall, the DVT scale has 
exhibited good practical application and can be applied to guide clinical 
decision making, in relation to the most appropriate prophylaxis. Finally, 
future studies on the ongoing evaluation of the DVT scale must involve more 
patients, so as to obtain greater effect sizes and power 
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Appendix 1 
Thrombosis Risk Factor Assessment 
Medical and Surgical Patients 
Due within 24 hours of admission. 
Nameo ____________________ Age ____ Sex - __ _ 
Diagnosis ________________ Admission: Elective or Emergency 
~eofsurgeryp~nned~------------------------
Please check all pertinent factors (Each risk factor has value oj one unless otherwise noted). 
o Age 41 to 60 years 0 Pelvic surgery or total joint replacement 
o Age 61 to 70 years (2 factors) 0 Confining travel, air/rail/road 
o Age over 70 years (3 factors) (>4 hours within week of admission) 
o Anticipated bed confinement over 72 hours 0 History of pelvic or long bone fracture 
o History of DVT/PE (3 factors) q Leg oedema, ulcers, stasis 
o Varicose veins 0 Malignancy 
o Obesity (>20% of ideal body weight) 0 Pregnancy or post-partum «1 month) 
o History of previous major surgery 0 Inflammatory bowel disease 
o Previous immobilisation (>72 hours) 0 Severe infection 
o MI 0 Hormone therapy 
o CHF . Name -----------
o Stroke Dosage 
o Crystalloid infusion (>5 litres/24 hours) 0 Hypercoagulable states 
o Severe COPD Congenital 
o Trauma Acquired 
o Planned operation over 2 hours 0 Other ------------
o LOW RISK o MODERATE RISK DIllGH RISK 
(l/actor) (2 - 4 factors) (>4 factors) 
IN-PATIENT IN-PATIENT IN-PATIENT 
T.E.D. Thigh Length T.E.D. Thigh Length T.E.D. Thigh Length 
Stockings Stockings Stockings 
+ + + 
early ambulation SCD /Heparin* SeD /Heparin/Vhrfarin * 
Regimen: Regimen: 
DISCHARGE DISCHARGE DISCHARGE 
ResT.E.D. Below Knee ResT.E~D. Thigh Length ResT.E.D. Thigh Length 
Stockings Stockings Stockings 
+ + + 
early ambulation early ambulation early ambulation 
*Delete as appropriate 
Otherinstructions--------------------------------
C/l to anticoagulants 0 Yes 0 No 
If yes, explain -----------------------------
Prescriber's signature ___________________ Date ----
Arcelus J I et al, Venous Thromboembolism Prophylaxis and Risk Assessment in Medical Patients 
Seminars in Thrombosis and Hemostasis, Vol17, S, 1991 
Capnni J A et al. Clinical Assessment o/Venous Thromboembolic Risk in Surgical Patients 
Seminars in ll1rombosis and Hemostasis. Vo117. 3,1991 VCl2 
LEICESTERSHIRE HEALTH AUTHORITY (Appendix 2) 
Project Id: 
Date Received: 
Decision Code: 
Committee on the Ethics of Clinical Research Investigation 
Application for Research Ethics Approval 
The following application form is for submission to the Ethics Committee for 
approval of proposed medical research involving human subjects*. Please complete 
the form in typescript and return to the address given at the bottom of this page for 
approval. 
The following must also be submitted with the protocol: 
Detailed Protocol 
Questionnaires Used 
Proposed Consent Form 
Patient Information Leaflet 
CTX (if appropriate) 
Confirmation of compensation arrangements 
N.B. The Ethics Committee in considering an application for ethical approval bears 
in mind the Royal College of Physicians guideline that "badly planned, poorly 
designed research that causes inconvenience to subjects and may carry 
risk without producing useful or valid results, is unethical. " 
Notes for completing application 
Please complete every section of the form as fully as possible. The shaded areas are 
only for office use, so please do not fill these in. Respond to all YesINo questions by 
circling the appropriate answer. . 
Address: Director of Public Health 
Ethics Committee 
Leicestershire Health 
Gwendolen Road 
Leicester, LE5 4QF 
If your work will be done in the LRI, LGH or GGH, please send this form to the 
Research and Development Office of your Trust, who will forward it to the address 
above .. 
11. Title Of Project 
Advancing clinical practice in the management of Deep Vein Thrombosis(DVT). 
Development, application and evaluation of the Autar DVT Scale. 
12. Miscellaneous Details 
2.1 Where will the research be done? 
(tick one as appropriate) 
If other please state where: Community Hospitals-
LRI 
LGH 
GGH 
Other hospital 
GP 
Other location 
2.2 
2.3 
Starting Date (DD-MON-YY): ~~4-8~-+--""""-"" 
Duration (in months): . 
3. Responsible Investigator (Supervisor of Project) 
I 
I 
I 
N.B. This is the individual with overall responsibility of the proposed study, 
not necessarily the individual who will be carrying out the study. 
3.1 Name: STUART BRAND 
Address:School ofHealth&Policy Studies 
University of Central England 
Perry Barr 
Birmingham 
B422SU. 
Title( Dr): 
Position/post held (Consultant, Senior Nurse etc.): Principal Lecturer 
Qualification:BSc(Hons)PHYSIOLOGY(Manchester University) 
PhD( PHYSIOLOGy)Leicester University) 
3.2 List the individual(s) who will be carrying out the study. 
Name PositionIPost Held 
ARAUTAR SENIOR LECTURER 
Nurses from negotiated Registered Nurses 
wards 
Person to whom correspondence should be addressed: 
ARAUTAR 
Senior Lecturer 
Department of Nursing&Midwifery 
De Montfort University 
Charles Frears Campus 
266,London Road 
Leicester 
LE12RQ. 
Named Clinician:Mr WM Harper, 
Consultant Orthopaedic Surgeon. 
Department of Orthopaedics 
LRI NHS Trust. 
LevelS 
Balmoral Building 
LRI. 
Qualification 
BA(Hons)MSc,RN,RMN, 
DN(Lond)ENB lOO,CERT 
ED,RNT 
Pre-registration & 
Registered Nurses 
14. Purpose of Research 
4.1 Please state the objectives of the research and briefly and simply describe the 
scientific background. 
Background. 
Nursing assessment is a domain of clinical practice that is undergoing considerable 
change and development.Some measuring instruments such as Pain scales, Pressure 
sore risk assessment calculators, Glasgow coma scale and the Barthel Index,to name a 
few, enable nurses to carry out and objective,systematic and comprehensive nursing 
assessment. 
Nurses who are in the forefront of care delivery have a clear role in the primary 
prevention and management of Deep Vein Thrombosis(DVT).A blanket nursing 
assessment of "Potential problem of DVT" provides a very crude index of 
measurement. The Autar DVT Scale (1994) was developed to: 
• enable a systematic and objective risk assessment of clients at risk of DVT. 
• identify patients at risk of DVT. 
• calculate DVT risk in an individual in the context of multifactorial aetiology. 
• provide quantifiable data for evaluation of practice. 
• facilitate understanding of preventative and therapeutic practices ofDVT. 
Following formal approval by the Leicestershire Ethic Committee 
(1994) a small study was undertaken to evaluate the DVT scale. It yielded some 
interesting and promising results in terms of the consistency and sensitivity of the 
instrument. However,the small scale study limits the generalisation of the results. 
Objectives of proposed plan of Study 
• to evaluate the consistency,sensitivity,specificity and predictive validity of the 
DVT scale in a large clinical population,to enable generalisation of findings. 
• to evaluate the practical application of the DVT Scale. 
• to explore current preventative practices in relation to the management of DVT. 
15. Design of Study 
5.1 Please describe what will be done, what results you expect and how you will 
analyse the results. Remember to attach a full copy of the protocol. Please 
identify potential dangers, discomfort or inconvenience to subjects of any of 
the techniques involved. 
The DVT risk assessment scale is designed to enable its practical application in 
diverse clinical areas,where DVT is a problem.For this particular reason,this proposed 
research project is planned in the following clinical areas: 
2 Orthopaedic Wards 
1 General Surgical Ward 
2 Integrated Medical Wards. 
It is anticipated that a minimum of 150 patients will be recruited to the study from the 
above diverse clinical areas.Identification of those who are at risk as well as those 
who are not are equally important for targeting limited resources.Therefore, in the 
selected specialities, all patients carry some varying degree of risk and for this 
reason,sample randomisation is unnesssary and any patient admitted will be a 
prospective subject. 
This will be essentially a data generating and quantitative study to test the consistency, 
sensitivity, specificity and practicality of the Autar DVT scale.Patients admitted to the 
negotiated diverse clinical areas will be risk assessed for DVT within 24 hours of 
admission, using the DVT scale.In order to ascertain that patients confidentiality is 
-- iOi 
maintained in its totality, only the ward nurses working in the negotiated areas,will be 
approached to access data on their patients. Data generated by staff mix of nurses will 
be analysed to determine the consistency of the DVT scale.As in the previous study 
(1994) nurses will be recruited to the study. The nursing record of each of the patients 
admitted to the study will be used to record the items in the DVT scale.Two registered 
nurses will independently complete a record on each patient,in order to provide 
comparative data,which will then be used to determine the consistency of this nursing 
assessment tool. For the consistency study, total percentage agreement (TOIo) and 
Kappa statistic will be applied. 
Available data will also be translated into sensitivity and specificity of the instrument. 
Patients'scores will be analysed in terms of the optimal cutoff score for predictive 
accuracy. 
Cross referencing the analysed data in relation to the 3 risk categories(low,moderate 
and high) with the patient's prescription chart,will provide an overview of the current 
therapeutic and prophylactic management strategy ofDVT. 
To evaluate the practicality of the DVT scale,a questionnaire will be applied to the 
DVT scale users. 
As this is essentially a data generating study,it will not in anyway interfere with or 
alter the management of patients . The study will be undertaken after access has been 
duly negotiated and authorisation of the responsible nurse managers and consultants 
obtained. Colleagues (registered nurses) will be recruited on a voluntary basis and a 
programme of induction given to familiarise them with the DVT risk assessment 
scale. 
6. Specific Details on Purpose and Design of Study 
6.1 Has this work been carried out before? Yes 
If yes, why is there a need to repeat? 
The very small study limits the application and generalisation of findings. 
6.2 Is this a multi-centre study? Yes 
6.3 What type of a study is this (tick one as a 
,.........--, 
Pilot 
Definitive 
Follow on of a previous study ES 
Modification of a previous study 
If a follow on or modification of a previous study, please give reference 
number of previous application and approval date: 
Previous study reference number: AEC\MS 
Approval date:6th June 1994. 
N.B. For the next two sections circle one as appropriate. 
6.4 Is this research of direct benefit to the subj ect: Yes 
6.5 Is this research related to: Diagnosis. No 
If yes to therapy then what type (tick any as appropriate): 
Drugs § 
Surgery 
Other 
7. New Chemical Entityrrherapeutic Agent or Established Agent 
NOT APPLICABLE 
7.1 Is this an investigation of an established agent? No 
If yes, is the established agent being used for a new/unlicensed indication? 
YeslNo 
7.2 Is this a study of a new chemical entity/therapeutic agent? No 
If yes, What stage is this in its evaluation? ( tick one as appropriate) 
Phase 11 
Phase III 
Phase IV 
7.3 If this drug is being supplied by a pharmaceutical company as part of 
sponsored research, has a clinical trial certificate/exemption certificate been 
provided? . 
YeslNo 
(---- .. . --- - ------
8. Substances to be Administered 
NOT APPLICABLE 
Route Amount! Risks Precautions 
Frequency 
Drugs* 
Isotopes 
Fluids & Diets 
Others 
-
* On completion of a clinical trial the investigator should notify the pharmacist who will destroy any chemical trial material still being 
held. 
19. Financial Arrangements 
NOT APPLICABLE 
9.1 Will you be receiving any financial contributions towards your research? 
No 
9.2 
If yes, from whom and how much? 
N.B. Tick main source only. NOT APPLICABLE 
Whom: Pharmaceutical Company 
Research Grant 
(MRC, BHF, RHA e.t.c) 
Other 
How much? (Please state approx total amount): £ 
How will these funds be spent? 
(tick any as appropriate) 
If 'other' briefly describe: 
Staff costs 
Running Costs 
Other 
110. Recruitment of Subjects 
B 
Please say how you will recruit subjects, with rules of inclusion and exclusion and any 
proposals to deny and delay treatment and any other relevant details e.g. age, sex, type 
of patient. 
N.B. Investigators are reminded of the need to notify General Practitioners when 
patients under their immediate care are to be included in a study. Investigators should 
ensure that any patients or healthy volunteers involved in a particular project are not 
included in another study which also involves drugs or isotopes. 
10.1 Data access will be from a convenient sample of 150 patients across the diverse 
clinical specialities. 
10.2 Controls? Not applicable. 
10.3 Number of subjects to be recruited: 150 subjects across the specialities for data 
collection by at least two registered nurses(volunteers) from each of the negotiated 
wards. 
lOA Type of subjects to be recruited? 
(tick any as appropriate) 
Patients 
Volunteers 
If volunteers, then please tick any of the options from the list 
below to sper the r: 
Staff / 
Student 
Other 
10.5 Any financial inducements offered to subjects or relatives?No 
If yes, what? 
10.6 Informed Consent 
N.B. Written informed consent is preferred, a copy of the consent form and 
information leaflet to be used must be supplied. 
Please note that special consideration must be given to children, mentally ill 
and handicapped. 
Will informed consent be obtained? Yes 
If yes, then tick any of the options from the list below to specify the method 
used: 
Written: 
Oral 
10.7 Compensation NOT APPLICABLE 
What kind of arrangements for compensation/indemnity for subj ects are in 
place for the study, please tick any of the options from the list below: 
ABPI Guidelines on compensation for medicine induced injury § 
Trust Indemnity 
Other 
If yes to 'Other', please give details: 
10.8 Investigations of Subjects/Controls: NOT APPLICABLE 
Venous samples 
If yes, then 
YeslNo 
Where From: 
Frequency: 
Amount: 
Arterial samples 
If yes, then 
YeslNo 
Where From: 
Frequency: 
Amount: 
N.B. If yes to any of the following questions, please give details below. 
X-rays 
Radiation 
Ultrasonics 
Biopsies 
If yes, then 
Yes/No 
Yes/No 
YeslNo 
YeslNo 
Site: 
Method: 
Size: 
Number: 
Anaesthesia Yes/No 
If yes, then Local or General 
Other invasions Cannulae/ Probes/ Catheters/ Endoscopes/ Lumbar 
Punctures 
Any non-invasive tests? EEGIEMGIECG 
Psychological tests? Yes/No 
Questionnaires? YeslNo 
If yes, pi ease include copy. 
Other Activities YeslNo 
Additional Details: 
111. Likely Benefits or Stu~y . I 
The DVT scale could provIde consIstency in the assessment of patients. It has the 
potential for development into a predictive index for DVT risk. Formalising the 
assessment of DVT could improve uptake of accurate ven~us thromboembolism 
prophylaxis(Byme et al 1996). 
112. Documents Enclosed 
Please remember to enclose the following documents where appropriate: 
• Detailed Protocol (DVT Scale) Yes 
• Questionnaire Yes 
• Proposed Consent F onn No 
• Patient Information Leaflet No 
• CTX No 
• Confirmation of compensation arrangements No 
13. Applicant(s) Signature 
Signature(s) of Applicant( ) 
~~ 
114. Countersignature of Consultant 
Countersignature of Consultant (in the case of junior medical and dental staff), Head 
of Department, Nurse Tutor, Director of Nursing Services etc. 
I have discussed the research proposal with the investigator, who is in my 
department, and I supp0r.! hislher application to the Ethical Committee. 
Signature(s) ..... ,! ... "~ ........................................... D~: ?:~\:.t~l ...... . 
Please print name: Dr Stuart Brand . 
.................................................................... " ..................... . 
R&D Department Stamp 
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Melanie Sursham 
Direct Dial 0116 2588610 
27 May 1997 
MrRAutar . 
Senior Lecturer in Biological Sciences & Nursing 
De Montfort University 
Charles Frears Campus 
266 London Road 
Leicester LE2 IRQ 
Dear Mr Autar 
~8rn~tw!sili~ 
LEICESTERSHIRE HEALTH 
Gwendolen Road, Leicester LE5 401 
Tel: (0116) 213 1173 . Fax: (0116) 258 8577 
OX 709470 Leicester 12 
Advancing Nursing Practice in the management of Deep Vein Thrombosis-
Development - Application and Evaluation of the Autar DVT Scale - our ref. no. 
4593 
Further to your letters. dated 29 April and 12 May, you will be pleased to know that 
the Leicestershire Ethics Committee at its meeting held on the 2 May, 1997 approved 
your request to undertake the above-mentioned research. . 
Your attention is drawn to the attached. paper which reminds the researcher of 
infonnation that needs to observed when ethics committee approval is given. 
Yours sincerely 
RFBing fP 
Chairman I 
Leicestershire Ethics Committee 
(NB All communications relating to Leicestershire Ethics Committee must be sent to the 
Committee Secretariat at Leicestershire Health) 
LEICESTERSHIRE HEALTH" Ih" """r;III11V I,,!m" ,,' UI("f:ST~RSHIRE IiE.\L TH .\rTHORITY 
.... OORESS 
) Leicester 
'-.E15WW 
\ )-el~phone 
l6254141~ 
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LEICESTER ROYAL INFIRMARY 
Department of Nursing & Midwifery, 
De Montfort University 
Charles Frears Campus 
266 London Road 
Dear Autar, 
NHS TRUST 
June 10. 1997 
Protect Rer: RFD 863 
P1_ uacthia nsf~ in all 
cm tiIiif)(liJdGJc:e 'NiIh tIN 
teIeCdI offic:e, reprdin& this 
pro;cd. 
Re: AdvaDcing NursiDg Practice in tbe MJinagement orDeep Vein Thrombosis (DVT). 
De'VeiopmeDt, application aDd evaluadon of tbe Autar DVf risk assessment scale 
Your research notification form has been approved and your project is indemnified by the 
Trust. 
Could you please notify this department if there are any changes to the commencement or 
end dates for the project. 
Yours sincerely, 
Or Trevor A. Howlett, MD, FRCP. 
Director of Research & Development 
~ARTMENTOF 
;' . ~OPAEDIC 
,SURGERY 
l~ HEAD OF 
~EPARTMENT 
. fessor P J GREGG 
"tELEPHONE 
01162563012 
~IOR L~cruRERS· 
~ 11 WM HARPER 
,." R PO TRIFFITT 
It 
"tELEPHONE 
01162563050 
I H THOMAS (Hon) 
~ON.CLINICAL 
LECTURER 
l::)RPROONEY 
TELEPHONE 
; 01162563049 
~EARC~ OFFICE 
TELEPHONE 
01162563019 
FACSIMILE 
0116 232 1702 
THE QUEEN'S ~ IVERSARV PRIZES 
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Appendix 5.1 
UNIVERSITY OF LEICESTER 
SCHOOL OF MEDICINE· THE GLENFIELD HOSPITAL NHS TRUST 
GROBY ROAD· LEICESTER LE3 9QP . ENGLAND 
WMH/j as/AUT AR 
28 January 1997 
Ricky Autar 
Senior Lecturer in Nursing 
School of Health and Community Studies 
Department of Nursing and Midwifery 
De Montfort University 
Charles Frear Campus 
266 London Road 
LEICESTER LE2 IRQ 
Dear Ricky 
Thanks very much for your note and paper which I will read in due course. I am more 
than happy for you to have access to my patients on the orthopaedic level at the Leicester 
Royal Infirmary, and also my elective patients at the Glenfield Hospital. It may interest 
you to note that all my elective joint replacements have a venogram performed 
postoperatively. 
May I wish you every success with your work. 
Yours sincerely 
~v ~Harper \ 
Senior LecturerlHon. Consultant Orthopaedic Surgeon 
HTHURSTON 
BSc MD FRCP 
TELEPHONE 
01162523183 
(Direct line) 
FACSIMILE 
01162523273 
EMAIL 
hth@le.ac.uk 
I 
: Appendix 5.2 
UNIVERSITY OF LEICESTER 
FACULTY OF MEDICINE AND BIOLOGICAL SCIENCES 
ROBERT KILPATRICK CLINICAL SCIENCES BUILDING· LEICESTER ROYAL INFIRMARY 
PO BOX 65 . LEICESTER LE2 7LX . ENGLAND 
HT/SW 
5th October 1999 
Ricky Autar 
Senior Lecturer in Biological Sciences & Nursing 
De Montfort University 
Charles Frears Campus 
266 London Road 
Leicester LE2 IRQ 
Dear Ricky 
Re: DVT Risk Assessment Study 
Thank you for your letter deflning a few details of your study. and sending me a copy 
of your paper on the Autar DVT scales .. 
I am quite happy for any of my patients to take part in the study and I await thl! 
results with interest 
Yours sincerely 
H Thurston 
Professor of Medicine 
Appendix 5.3 
ADNS/CJ 
18th March 1999 
MrRAutar, 
Senior Lecturer in Biological Science & Nursing, 
De Montfort University, 
Charles Frears Campus, 
266 London road, 
Leicester, 
LE21RQ. 
Dear Mr Autar, 
. ,\., 
>"'RF.fE'G ENFIELD 
>·.":.'\. .. 1::l;'tJ,,··'.,;~·,'>i:·~~fj, ,:t' .. ., .. I ...... ~ •• ~·."., _ • 
'ffOSP.1TAt~NHS 
. T~f~Siltt:~ 
: Y '1\"~ .)W"""),,,,,-, '., Lelcester!!'t:E3ri~9QP':r ' 
~. I ,·1", " .,,)~"", ... ,~";, " .j .... ~, .,' , •. " :,;' • 
Tal;, (0 L 1.6.1'(2:8!7i J 471 
I,Fa'~'(Oiil~6?~';:iS8 3950 
.~ .• L:';.; > ..... :' .. t'~~':!i: ,,:~':"~""'.'" .. :-1 
DEPARTMENT OF 
GENERAL SURGERY 
Many thanks for your letter of March 12th concerning the proposed study on DVT 
risk assessment. I remain happy for data from the Surgical Unit to be used for this 
study. 
However, I remain uneasy as to the amount of input required from nursing staff on the 
ward. This seems to involve not only completing the risk assessment itself but also 
maintaining a coded register of patients and, most worryingly of all, obtaining the 
consent of patients to be included in the study. Conventionally it is the researcher 
who takes responsibility for obtaining consent and carrying out the data collection and 
I do not have the authority to sanction the use of ward staff in this way. I have asked 
Ruth Chapman, the Business Manager in Surgery, to discuss this with the Department 
of Nursing and the ward nurses in order to ascertain the feasibility and practicality of 
this study. 
With best wishes, 
Yours sincerely, 
f~~ 
AD N SCOTT BSc MS FRCS 
Clinical Chainnan 
c.c. Mrs R Chapman, 
Assistant Specialty Manager - Surgical Services, 
Glenfield Hospital. 
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Appendix 6 
Sample size: apriori calculation 
~. ~ GPOWER I!!I~ 
Ana s s 
Calc Effect:;iz e GI'<\ph 
'~JfJ • Luahda 
lpha '~JI~k Critical 
oweI' I~JI:I~ lotal saRple size 
E • Actual power 
Effect size con vention:;: small = U.1U medium ~ U. JU large = U . ~~ 
Alt ~ Exit Chi 2 -Test 
) 
Appendix 7 
Standard Deviation of the risk assessment score & Standard Error of Mean 
Mean= 10 
N= 141 
Df= 1 
Observations (x) Deviations (x - X ) Squared deviations (x - X )2 
1 1-10=9 81 
1 1-10=9 81 
2 2-10=8 64 
2 2-10=8 64 
4 4-10=6 . 36 
4 4-10=6 36 
4 4-10=6 36 
4 4-10=6 36 
4 4-10=6 36 
4 4-10=6 36 
4 4-10=6 36 
4 4-10=6 36 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
5 5-10=5 25 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
6 6-10=4 16 
7 7-10=3 9 
7 7-10=3 9 
7 7-10=3 9 
7 7-10=3 9 
7 7-10=3 9 
7 7-10=3 9 
7 7-10=3 . 9 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
8 8-10=2 4 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
9 9-10=1 1 
10 10-10=0 0 
10 10-10=0 0 
10 10-10=0 0 
10 10-10=0 0 
10 10-10=0 0 
10 10-10=0 0 
10 10-10=0 0 
10 10-10=0 0 
10 10-10=0 0 
10 10-10=0 0 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
11 11-10=1 1 
12 12-10=2 4 
12 12-10=2 4 
12 12-10=2 4 
12 12-10=2 4 
12 12-10=2 4 
12 12-10=2 4 
12 12-10=2 4 
12 12-10=2 4 
13 13-10=3 9 
13 13-10=3 9 
13 13-10=3 9 
13 13-10=3 9 
13 13-10=3 9 
13 13-10=3 9 
13 13-10=3 9 
13 13-10=3 9 
13 13-10=3 9 
13 13-10=3 9 
13 13-10=3 9 
13 13-10=3 9 
14 14-10=4 16 
14 14-10=4 16 
14 14-10=4 16 
15 15-10=5 25 
15 15-10=5 25 
15 15-10=5 25 
15 15-10=5 25 
15 15-10=5 25 
16 16-10=6 36 
16 16-10=6 36 
16 16-10=6 36 
16 16-10=6 36 
16 16-10=6 36 
17 17-10=7 49 
17 17-10=7 49 
17 17-10=7 49 
19 19-10=9 81 
20 
20 
20 
26 
27 
Total= 141 
2865 
S2=_- =20.4642 
141-1 
SD = .J20.4642 = 4.5237 = :!:= 5 
SEM= SD 2-= :!:= 0.04 ~141 
20-10=10 100 
20-10=10 100 
20-10=10 100 
26-10=16 256 
27-10=17 289 
L= 2865 
The SO of 5 measured the variability among the individual risk assessment 
scores, SEM calculated the variability among the samples. 
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~gistic Regression( orthopaedics) appendix 8 
J ! Case Processing Summary 
Unweighted Casesa N Percent 
Selected Cases Included in Analysis 50 100.0 
Missing Cases 0 .0 
Total 50 100.0 
Unselected Cases 0 .0 
Total 50 100.0 
a. If weight is in effect, see classification table for the total number of cases. 
i:)ependent Variable Encoding 
Original Value Internal Value 
0 0 
1 1 
~IOCk 0: Beginning Block 
Classification Table·,b 
Predicted 
DVT Percentage 
Observed 0 1 Correct 
Step 0 DVT 0 42 0 100.0 
1 8 0 .0 
Overall Percentage 84.0 
a. Constant is included in the model. 
b. The cut value is .500 
Variables In the Equation 
B S.E. Wald df Sill. Exp(B) 
Step 0 Constant ·1.658 .386 18.478 1 .000 .190 
Variables not In the Equation 
Score df Sig. 
Step Variables AGE 4.801 1 .028 
0 MOBILITY 3.930 1 .047 
BUILD 6.042 1 .014 
TRAUMA 8.470 1 .004 
SURGERY 3.554 1 .059 
DISEASES .303 1 .582 
TOTAL 6.275 1 .012 
Overall Statistics 14.907 7 .037 
Block 1: Method = Forward Stepwise (Wald) 
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Omnibus Tests of Model Coefficients 
Chi-square df Sig. 
Step 1 Step 11.369 1 .001 
t Block 11.369 1 .001 , 
Model 11.369 1 .001 
Model Summary 
-2 Log Cox& Snell Nagelkerke R 
Step likelihood R Square Square 
1 32.598 .203 .348 
Hosmer and Lemeshow Test 
( ~tep df Sig. I 
.977 
Contingency Table for Hosmer and Lemeshow Test 
DVf=O DVf= 1 
Observed Expected Observed Expected Total 
Step 1 18 18.000 0 .000 18 
1 2 1 .999 0 .001 1 
3 23 23.000 8 8.000 31 
Classlflcatlon Table-
Predicted 
DVT Percentage 
Observed 0 1 Correct 
Step 1 DVT 0 42 0 100.0 
1 7 1 12.5 
Overall Percentage 86.0 
a. The cut value is .500 
Variables In the Equatlonb 
B S.E. Wald df Sig. Exp(B) 
Slep TRAUMA 5.942 35.392 .028 1 .867 380.553 
1 Constant -24.956 141.562 .031 1 .860 .000 
Page 2 
, 
Variables In the Equatlonb 
"'" 95.0% C.l.for EXP(B) 
Lower Upper 
SJep TRAUMA .000 5.0BE+32 
1 Constant 
a. Variable(s) entered on step 1: TRAUMA. 
b. Stepwise procedure stopped because removing the least significant variable result in a previously fitted model. 
Correlation Matrix 
Constant TRAUMA 
Step Constant 1.000 -1.000 
1 TRAUMA -1.000 1.000 
Variables not In the Equation· 
Score df 
Step Variables AGE 1.936 1 
1 MOBILITY .528 1 
BUILD 4.635 1 
SURGERY .000 1 
DISEASES .137 1 
TOTAL .559 1 
a. Residual Chi-Squares are not computed because of redundancies. 
32 
24 
o 
o 
16 0 
o 
o 
o 
8 0 
o 
Step number: 1 
Observed Groups and Predicted Probabilities 
1 
1 
1 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 0 
Sig. 
.164 
.467 
.031 
1.000 
.711 
.455 
o 0 1 
Predicted I 
Prob: 0 .25 .5 .75 1 
Group: 000000000000000000000000000000111111111111111111111111111111 
Predicted Probability is of Membership for 1 
The Cut Value is .50 
Symbols: 0 - 0 
1 - 1 
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Each Symbol Represents 2 Cases. 
Casewlse LIst" 
Selected Observed Predicted Temporarv Variable 
Case Status8 DVT Predicted Group Resid ZResid 
4 S 0 .001 0 -.001 -.028 
a. S = Selected, U = Unselected cases, and ** = Misclassified cases. 
b. Cases with studentized residuals greater than 2.000 are listed. 
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Case Processing Summary 
Unweighted Casesg N Percent 
Selected Casesa Included in Analysis 50 100.0 
Missing Cases 0 .0 
Total 50 100.0 
Unselected Cases 0 .0 
Total 50 100.0 
a. The variable TRAUMA is constant for all selected cases. Since a constant 
was requested in the model, it will be removed from the analysis. 
b. If weight is in effect, see classification table for the total number of cases. 
Dependent Variable Encoding 
Original Value Internal Value 
0 0 
1 1 
~Iock 0: Beginning Block 
Classification Table-,b 
Predicted 
DVT Percentage 
Observed 0 1 Correct 
.. Step 0 DVT 0 38 0 100.0 
1 12 0 .0 
Overall Percentage 76.0 
a. Constant is included In the model. 
b. The cut value is .500 
Variables In the Equation 
B S.E. Wald df Sig~ ExP(B) 
Step 0 Constant -1.153 .331 12.117 1 .000 .316 
Variables not In the Equation 
Score df Sic. 
Step Variables AGE .048 1 .827 
0 BUILD 8.416 1 .004 
MOBILITY .163 1 .687 
SPECIAL .322 1 .570 
TOTAL 1.176 1 .278 
Overall Statistics 9.145 5 .103 
~~~IOCk 1: Method = Enter 
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Omnibus Tests of Model Coefficients 
Chi-square df Sig. 
Step 1 Step 9.492 5 .091 
Block 9.492 5 .091 
Model 9.492 5 .091 
Model Summary 
-2 Log Cox & Snell Nagelkerke R 
Step likelihood R Square Square 
1 45.616 .173 .259 
Hosmer and Lemeshow Test 
I ~tep Chi-sguare I 3.698 df 7 I Sig. I .814 
Contingency Table for Hosmer and Lemeshow Test 
DVT=O DVT= 1 
Observed Expected Observed Expected Total 
Step 1 6 5.814 0 .186 6 
1 2 4 4.545 1 .455 5 
3 5 4.316 0 .684 5 
4 6 4.968 0 1.032 6 
5 6 ·6.470 2 1.530 8 
6 3 3.142 1 .858 4 
7 3 3.719 2 1.281 5 
8 3 3.000 2 2.000 5 
9 2 2.025 4 3.975 6 
Classification Table-
Predicted 
DVT Percentage 
Observed 0 1 Correct 
Step 1 DVT 0 36 2 94.7 
1 8 4 33.3 
Overall Percentage 80.0 
a. The cut value is .500 
Variables In the Equation 
B S.E. Wald df Sig. Exp(B) 
SAep AGE .069 .599 .013 1 .908 1.072 
1 BUILD 1.479 .618 5.721 1 .017 4.388 
MOBILITY -.369 .450 .670 1 .413 .692 
SPECIAL -1.851 12.231 .023 1 .880 .157 
TOTAL .083 .140 .350 1 .554 1.086 
Constant -3.611 2.340 2.380 1 .123 .027 
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Variables In the Equation 
95.0% C.l.for EXP(B) 
Lower Upper 
S~ep AGE .331 3.466 
1 BUILD 1.306 14.741 
MOBILITY .286 1.672 
SPECIAL .000 4.05E+09 
TOTAL .826 1.428 
Constant 
a. Variable(s) entered on step 1: AGE, BUILD, MOBILITY, SPECIAL, TOTAL. 
Step 
1 
16 
12 
8 
4 
Correlation Matrix 
Constant AGE BUILD MOBILITY 
Constant 1.000 -.861 -.454 .200 
AGE -.861 1.000 .215 .016 
BUILD -.454 .215 1.000 -.299 
MOBILITY .200 .016 -.299 1.000 
SPECIAL -.041 .041 .010 .003 
TOTAL -.058 -.330 -.096 -.584 
Step number: 1 
Observed Groups and Predicted Probabilities 
o 
o 
1 
1 
o 
o 
o 
o 
o 
o 
000 1 
o 0 00 000 10 1 1 
SPECIAL 
-.041 
.041 
.010 
.003 
1.000 
-.008 
000 010000000000 10 0 10 0 1 1 1 0 
~redicted I I 
TOTAL 
-.058 
-.330 
-.096 
-.584 
-.008 
1.000 
Prob: 0 .25 .5 .75 1 
Group: 000000000000000000000000000000111111111111111111111111111111 
Predicted Probability is of Membership for 1 
The Cut Value is .50 
Symbols: 0 - 0 
1 - 1 
Each Symbol Represents 1 Case. 
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Casewlse Llstb 
Selected Observed Predicted TemporaN Variable 
Case Status· DVT Predicted Group Resid ZResid 
25 S 1** .088 0 .912 3.220 
44 S 0" .844 1 -.844 -2.324 
a. S = Selected, U = Unselected cases, and ** = Misclassified cases. 
b. Cases with studentized residuals greater than 2.000 are listed. 
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Case Processing Summary 
Unweighted CasesC N Percent 
Selected Cases8,b Included in Analysis 50 100.0 
Missing Cases 0 .0 
Total 50 100.0 
Unselected Cases 0 .0 
Total 50 100.0 
a. The variable Special risk is constant for all selected cases. Since a 
constant was requested in the model, it will be removed from the analysis. 
b. The variable TRAUMA is constant for a" selected cases. Since a constant 
was requested in the model, it will be removed from the analysis. 
c. If weight is in effect, see classification table for the total number of cases. 
Dependent Variable Encoding 
Original Value Internal Value 
NoDVT 0 
DVT 1 
Block 0: Beginning Block 
Classification TableA,b 
Predicted 
DVT 
Observed NoDVT DVT 
Step 0 DVT NoDVT 42 0 
DVT 8 0 
Overall Percentage 
a. Constant is included in the model. 
b. The cut value Is .500 
Variables In the Equation 
Percentage 
Correct 
100.0 
.0 
84.0 
B S.E. Wald df Slg. Exp(B) 
Step 0 Constant -1.658 .386 18.478 1 .000 .190 
Variables not In the Equation. 
Score df Sig. 
Step Variables AGE 1.553 1 .213 
0 BUILD .846 1 .358 
MOBILITY .131 1 .717 
SURGERY .027 1 .868 
HIGH_RIS 9.433 1 .002 
Overall Statistics 15.236 5 .009 
Block 1: Method = Forward Stepwise (Wald) 
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Omnibus Tests of Model Coefficients 
I 
~ 
Chi-square df Sig. 
Step 1 Step 8.184 1 .004 
Block 8.184 1 .004 
Model 8.184 1 .004 
Step 2 Step 5.695 1 .017 
Block 13.879 2 .001 
Model 13.879 2 .001 
Model Summary 
-2 Log Cox & Snell Nagelkerke R 
Step likelihood R Square Square 
1 35.783 .151 .258 
2 30.088 .242 .414 
Hosmer and Lemeshow Test 
Step Chi-square df Sig. 
1 .411 2 .814 
2 4.328 6 .632 
Contingency Table for Hosmer and Lemeshow Test 
DVT = No DVT OVT= ovr 
Observed Expected Observed Expected Total 
Step 1 30 29.969 2 2.031 32 
1 2 5 5.035 1 .965 6 
3 3 3.515 2 1.485 5 
4 4 3.480 3 3.520 7 
Step 1 5 4.983 0 .017 5 
2 2 5 4.946 0 .054 5 
3 5 5.811 1 .189 6 
4 2 1.829 0 .171 2 
5 17 16.283 1 1.717 18 
6 4 4.279 1 .721 5 
7 3 2.854 2 2.146 5 
8 1 1.015 3 2.985 4 
Classification Table· 
Predicted 
OVT Percentage 
Observed NoDVT OVT Correct 
Step 1 DVT No Dvr 42 0 100.0 
DVT 7 1 12.5 
Overall Percentage 86.0 
Step 2 DVT NoDvr 41 1 97.6 
OVT 4 4 50.0 
Overall Percentage 90.0 
a. The cut value is .500 
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Variables In the Equation 
B S.E. Wald df Sig_. Exp(Bl 
SJep HIGH_RIS .380 .143 7.097 1 .008 1.463 
1 Constant -2.692 .660 16.614 1 .000 .068 
~ep SURGERY 1.139 .558 4.164 1 .041 3.122 
2 HIGH_RIS .720 .242 8.865 1 .003 2.053 
Constant 
-5.665 1.774 10.201 1 .001 .003 
Variables In the Equation 
95.0% C.l.for EXP(B) 
Lower Upper 
SJep HIGH_RIS 1.106 1.93~ 
1 Constant 
~ep SURGERY 1.046 9.319 
2 HIGH_RIS 1.279 3.298 
Constant 
a. Variable(s) entered on step 1: HIGH_RIS. 
b. Variable(s) entered on step 2: SURGERY. 
Correlation Matrix 
Constant HIGH RIS SURGERY 
Step Constant 1,000 -.759 
1 HIGH_RIS -.759 1.000 
Step Constant 1.000 -.894 -.921 
2 SURGERY -.921 .776 1.000 
HIGH_RIS 
-.894 1.000 .776 
Variables not In the Equation 
Score df Sig. 
Step Variables AGE .341 1 .559 
1 BUILD 2.257 1 .133 
MOBILITY 
.113 1 .736 
SURGERY 4.958 1 .026 
Overall Statistics 7.453 4 .114 
Step Variables AGE .047 1 .828 
2 BUILD 3.794 1 .051 
MOBILITY .246 1 .620 
Overall Statistics 4.554 3 .208 
Step number: 1 
Observed Groups and Predicted Probabilities 
32 t D t 
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N 
N 
~ N 
~ 24 N 
t N 
Q N 
o N 
(; 16 N 
~ N 
C N 
Y N 
8 N 
N D 
N N D N 
NN N N N N N D 
Predicted I I I 
Prob: 0 .25 .~ .75 1 
Group: NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD 
20 
F 
R 15 
E 
Q 
o 
E 10 
N 
C 
Y 
5 
Predicted Probability is of Membership for DVT 
The Cut Value is .50 
Symbols: N - No DVT 
D - DVT 
Each Symbol Represents 2 Cases. 
Step number: 2 
Observed Groups and Predicted Probabilities 
D 
N 
N 
N 
N 
N 
N 
N 
N N 
N N 
N N 
ND N 
NN N 
NN N 
NN NN N 
NN NN N N N D D N D 0 D 
Predicted I I 
prob: 0 .25 • 5 .75 1 
Group: NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD 
Predicted Probability is of Membership for DVT 
The Cut Value is .50 
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Case 
2 
5 
39 
Symbols: N - No DVT 
D - DVT 
Each Symbol Represents 1.25 Cases. 
Casewlse Llstb 
Selected Observed Predicted 
Status8 OVT Predicted Group 
S 0** .033 N 
S 0- .095 N 
S 0- .112 N 
Temporar J Variable 
Resid ZResid 
.967 5.441 
.905 3.079 
.888 2.811 
a. S = Selected, U = Unselected cases, and - = Misclassified cases. 
b. Cases with studentized residuals greater than 2.000 are listed. 
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Case Processing Summary 
Valid N 
ovf> (Iistwise) 
Positivea 8 
Negative 42 
Larger values of the test result variable(s) indicate 
stronger evidence for a positive actual state. 
a. The positive actual state is 1. 
b. The test result variable(s): TRAUMA has at 
least one tie between the positive actual state 
group and the negative actual state group. 
ROC Curve 
100....---------,.----
75 
.50 
~ .25 
·s 
~ 
fI) 
c: 
Source of th Curv 
R..I---
o BP C 
Q) 
Cl) 0.00 ~--_.__----.---___r--__l 0 AG 
0.00 .25 50 75 1 00 
1 - Spedfidty 
• produced by 
Area Under the Curve 
Asymptotic 95% Confidence 
Asymptotic Interval 
Test Result Variable(s) Area Std, Error Sig,b Lower Bound Upper Bound 
AGE .726 .077 .044 .576 .877 
MOBILITY .702 .094 .072 .518 .887 
SPECIAL .500 .112 1.000 .280 .720 
TRAUMA .760 .077 .021 .610 .911 
DISEASES .539 .117 .731 .308 .769 
TOTAL ,801 ,076 .008 ,652 ,949 
The test result variable(s): AGE, MOBILITY, SPECIAL, TRAUMA, DISEASES, TOTAL has at least ( 
tie between the positive actual state group and the negative actual state group. Statistics may be 
biased. 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0,5 
2 
Coordinates of the Curve 
Positive if 
Greater Than 
Test Result Variable(s) or Equal Toa Sensitivity 1 - Specificity 
AGE 
-1.00 1.000 1.000 
.50 1.000 .857 
1.50 1.000 .690 
2.50 1.000 .619 
3.50 1.000 .548 
5.00 .000 .000 
MOBILITY 
-1.00 1.000 1.000 
.50 .875 .595 
1.50 .875 .548 
2.50 .875 .476 
3.50 .875 .452 
5.00 .000 .000 
SPECIAL 
-1.00 1.000 1.000 
1.00 .000 .000 
TRAUMA 
-1.00 1.000 1.000 
1.50 1.000 .571 
3.50 1.000 .548 
6.50 .125 .000 
10.00 .000 .000 
DISEASES 
-1.00 1.000 1.000 
1.00 .250 .190 
2.50 .250 .167 
4.00 .250 .143 
6.00 .250 
.095 
7.50 .125 
.048 
9.50 .000 
.048 
11.50 .000 
.024 
13.00 .000 
.000 
TOTAL 1.00 1.000 1.000 
3.00 1.000 
.952 
4.50 1.000 
.929 
5.50 1.000 
.881 
6.50 1.000 
.738 
7.50 1.000 .690 
8.50 1.000 .667 
9.50 .875 .571 3 
10.50 .875 .500 
11.50 .875 .381 
ROC Curve (medical directorate) Appendix 12. 
Case Processing Summary 
Valid N 
DVT (Iistwise) 
Positive a 12 
Negative 38 
Larger values of the test result variable(s) indicate 
stronger evidence for a positive actual state. 
a. The positive actual state is 1. 
ROC Curve 
1.00 ,------------"""7""-~ 
.75 
.50 
>- .25 
-.:;; 
:0::: 
'c;; 
C 
Cl> 0.00 Cl) 
Source of the Curve 
Reference Line 
TOTAL 
o DISEASES 
o SURGERY 
o SPECIAL 
o BUILD 
o AGE 
0.00 .25 .50 .75 1.00 
1 - Specificity 
Diagonal segments are produced by ties. 
Area Under the Curve 
Asymptotic 95% Confidence 
Asymptotic Interval 
Test Result Variable(s) Area Std. Error Sig.b Lower Bound Upper Bound 
AGE .487 .096 .892 .299 .675 
BUILD .735 .083 .015 .571 .898 
SPECIAL .487 .095 .892 .300 .674 
SURGERY .542 .100 .666 .346 .737 
DISEASES .537 .097 .699 .348 .726 
TOTAL .620 .087 .216 .448 .791 
The test result variable(s): AGE, BUILD, SPECIAL, SURGERY, DISEASES, TOTAL has at least one 
tie between the positive actual state group and the negative actual state group. Statistics may be 
biased. 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5 
2 
Coordinates of the Curve 
Positive if 
Greater Than 
Test Result Variablef~ or Equal T08 Sensitivity 1 - Specificity 
AGE 
-1.00 1.000 1.000 
.50 1.000 .974 
1.50 1.000 .947 
2.50 .917 .895 
3.50 .750 .789 
5.00 .000 .000 
BUILD -1.00 1.000 1.000 
.50 1.000 .816 
1.50 .500 .132 
2.50 .167 .026 
4.00 .000 .000 
SPECIAL 
-1.00 1.000 1.000 
1.50 .000 .026 
4.00 .000 .000 
SURGERY -1.00 1.000 1.000 
.50 .083 .000 
2.00 .000 .000 
DISEASES 
-1.00 1.000 1.000 
1.50 .583 .500 
3.50 .333 .342 
4.50 .250 .263 
6.00 .250 .158 
8.00 .000 .000 
TOTAL .00 1.000 1.000 
2.50 1.000 .974 
4.50 1.000 .842 
5.50 .833 .632 
6.50 .667 .579 
7.50 .667 .500 
8.50 .500 .421 
9.50 .500 .342 
10.50 .500 .237 
11.50 .333 .184 
12.50 .167 .184 
13.50 .083 .105 
14.50 .083 .079 
15.50 .083 .053 
17.00 .000 .000 
The test result variable(s): AGE, BUILD, SPECIAL, SURGERY, 
DISEASES, TOTAL has at least one tie between the positive actual 
state group and the negative actual state group. 
a. The smallest cutoff value is the minimum observed test value 
minus 1, and the largest cutoff value is the maximum 
observed test value plus 1. All the other cutoff values are the 
averages of two consecutive ordered observed test values. 
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ROC Curve: (surgical directorate) Appendix 13 
Case Processing Summary 
Valid N 
DVT (Iistwise) 
Positivea 8 
Negative 42 
Larger values of the test result variable(s) indicate 
stronger evidence for a positive actual state. 
a. The positive actual state is DVT. 
ROC Curve 
1.00 ..--------------r-:r-- ~ 
Source of the Curve 
.75 
Reference Line 
High Risk 
.50 
o SURGERY 
o TRAUMA 
.?: .25 o Special risk 
.> 
:;J 
·in o BUILD 
c 
Q) 
0.00 (j) D AGE 
0.00 .25 .50 .75 1.00 
1 - Specificity 
Diagonal segments are produced by ties. 
Area Under the Curve 
Asymptotic 95% Confidence 
Asymptotic Interval 
Test Result Variable(s) Area Std. Errof Sig.b Lower Bound Upper Bound 
AGE .612 .097 .321 .422 .801 
BUILD .610 .098 .328 .417 .803 
Special risk .500 .112 1.000 .280 .720 
TRAUMA .500 .112 1.000 .280 .720 
SURGERY .506 .106 .958 .299 .713 
High Risk .768 .100 .017 .571 .965 
The test result variable(s): AGE, BUILD, Special risk, TRAUMA, SURGERY, High Risk has at leas1 
one tie between the positive actual state group and the negative actual state group. Statistics may 
be biased. 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5 
2 
Coordinates of the Curve 
Positive if 
Greater Than 
Test Result Variable(s) or Equal Toa Sensitivity 1 - Specificity 
AGE 
-1.00 1.000 1.000 
.50 1.000 .929 
1.50 1.000 .786 
2.50 .875 .714 
3.50 .750 .571 
5.00 .000 .000 
BUILD -1.00 1.000 1.000 
.50 1.000 .833 
1.50 .500 .357 
2.50 .125 .095 
3.50 .000 .024 
5.00 .000 .000 
Special risk 
-1.00 1.000 1.000 
1.00 .000 .000 
TRAUMA 
-1.00 1.000 1.000 
1.00 .000 .000 
SURGERY 
-1.00 1.000 1.000 
.50 .750 .690 
1.50 .625 .524 
2.50 .375 .452 
4.00 .000 .000 
High Risk 
-1.00 1.000 1.000 
.50 .750 .286 
2.00 .750 .262 
3.50 .625 .167 
4.50 .625 .143 
5.50 .375 .095 
6.50 .250 .071 
8.50 .125 .000 
11.00 .000 .000 
The test result variable(s): AGE, BUILD, Special risk, TRAUMA, 
SURGERY, High Risk has at least one tie between the positive actual 
state group and the negative actual state group. 
a. The smallest cutoff value is the minimum observed test value 
minus 1, and the largest cutoff value is the maximum 3 
observed test value plus 1. All the other cutoff values are the 
averages of two consecutive ordered observed test values. 
Appendix 14 
Data Analysis: DVT scale questionnaires (Trauma Directorate). 
Total No of postal questionnaire:13 (100%). Total No of respondents: 12 (92%). 
R d t es)on en s 
Item 1 2 3 4 5 
No 
1 21yrs <6 6 .. 5 14yrs 2yrs 
mts mts 
2 EN RGN RGN RGN RGNI 
DlP ENB DlP 
3 D D F F E 
4 21yrs <6mts 7yrs 14 18mts 
mts 
5 No No No No No 
6 <5 11-15 <5 <5 <5 
7.1 2 5 4 4 4 
7.2 4 5 4 4 4 
7.3 4 4 4 4 4 
7.4 4 4 4 4 4 
8 4 5 4 4 4 
9 5 5 5 3 4 
10 4 4 5 2 4 
11 4 4 4 4 4 
12 4 4 5 5 4 
13 4 4 5 4 4 
14 3-6 3-6 <3 <3 3-6 
15 
- - · · · 
16 . . 
· · · 
17 . . 
· · · 
18 4 4 4 4 4 
19 4 3 4 4 4 
20 5 5 4 4 4 
20.1 5 5 5 4 4 
21 5 5 5 5 4 
22 5 5 5 5 4 
22.1 5 5 5 5 4 
23 3 5 5 4 4 
24 5 5 5 4 4 
Mts mdlcates months and NI A IS not apphcable. 
Likert Scoring: Strongly Agree=S 
Agree=4 
Neutra1=3 
Disagree=2 
Strongly Disagree=1 
6 7 8 9 10 
30yrs 18yrs 33yrs 2.5yrs 6yrs 
RGN RGN RGN RGN RGN 
ONC ONC DlP DIP ENB 
D D D E E 
2yrs 18mts <6mts 18mts 18mts 
No No No No No 
5-10 <5 11- 11- 11-
15 15 15 
4 5 3 4 4 
4 4 3 4 4 
4 5 4 4 5 
4 3 4 3 4 
4 4 4 5 4 
4 5 4 4 5 
4 4 5 4 4 
3 4 4 4 4 
4 5 4 5 4 
4 4 4 4 4 
<3 <3 3-6 <3 3-6 
· · · · · 
· · · · · 
· · · · · 
4 4 4 5 5 
4 4 1 5 5 
3 4 1 5 5 
4 4 4 5 5 
4 4 2 5 5 
4 4 2 5 5 
4 4 2 5 5 
4 4 2 5 5 
4 4 2 5 5 
Except for items 9 & 10 when reversed scoring applies (eg: Strongly 
Agree=1,Agree=2,Neutral=3,Dlsagree=4,Strongly Disagree=5). 
11 
8yrs 
RGN 
ENB 
E 
8yrs 
No 
5-10 
4 
4 
4 
3 
4 
3 
5 
4 
4 
4 
<3 
· 
· 
· 
4 
4 
3 
3 
4 
4 
4 
4 
4 
Please refer to separate sheets for qualitative data analysis of Items 15,16 and 11. 
12 
llyrs 
RGN 
ENB 
F 
llyrs. 
No 
<5 
4 
4 
4 
4 
4 
2 
4 
4 
4 
4 
<3 
· 
· 
· 
4 
4 
4 
4 
5 
5 
5 
5 
5 
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QUALITATIVE DATA ANALYSIS OF DVT SCALE QUESTIONNAIRE. 
( Trauma Directorate) 
SECTION ONE: BIOGRAPHICAL DATA 
1. How long have you been qualified? 
One registered nurse was qualified for less than 6 months. The remaining eleven 
trained staff who participated in the data collection had varying levels of clinical 
experience, ranging from 2 to 33 years. 
2. What are your professional qualifications. 
Staff in the study represented a good skill mix. One of the trained staff was a second 
level nurse with 21 years of experience and another was a first level nurse with 4 
years experience in trauma I orthopaedics. The remaining 10 qualified staff were 
Nursing Diplomates with post-registration experience and qualifications awarded by 
the English National Board (ENS). 
3. What Is your job title I clinical grade? 
Six staff were employed in the clinical capacity of 0 grade, three as E grade and the 
other three staff held the F grade. 
Within the clinical grading structure, post-holders in 0 grade are responsible for 
assessing care needs and the development of programme of care and or the 
implementation and evaluation of their programmes. 
E grade applies to those who are responsible for the assessment of care and the 
development, implementation and the evaluation of programme of care and is 
designated to take regular charge of a ward. They are expected to supervise Junior 
staff. 
Additional to undertaking the role of 0 and E grade, F grade post-holders are 
required to lead a team of staff at grade E and below. 
4. How long have you been working in this area of practice? 
Staff had worked on the trauma I orthopaedics directorate for varying period, 
ranging from less than 6 months for newly qualified staff to very experienced nurses 
with 18 years in this area of practice. 
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5. Have you worked in other clinical area(s) where the Autar DVT scale Is 
being used? 
None of the respondents had prior experience of using the DVT scale as none of 
them had worked in other clinical areas where this risk assessment tool was being 
used. 
SECTION TWO 
6. How many patients have you assessed with the DVT risk assessment 
scale? 
During the data collection duration process of two months, staff had limited and 
varying experience of assessing patients with the DVT risk calculator. Six staff 
assessed less than five patients and the remaining staff recorded between five and 
fifteen patients. 
7. The DVT scale enables me to: 
7.1. make a thorough DVT risk assessment based on the patient clinical 
profile. 
The DVT scale was positively evaluated by the majority of staff, enabling them to 
make a through DVT risk assessment. One respondent was neutral and another 
noted that the scale should be used in conjunction with patient assessment. 
7.2. Individualise the nursing assessment of patients. 
There is consensus that the DVT scale individualised nursing assessment, identified 
patients into a particular risk category and allows for prophylactic anticoagulant and 
mechanical interventions to be initiated. 
7.3. translate the risk factors as applicable to patients Into DVT risk categories. 
The respondents unanimously agreed that the risk factors could be construed to 
identify patients into DVT risk categories. 
7.4. state why patients are at risk. 
Nine respondents concurred that the DVT scale enabled them to understand why 
patients were at risk. One of the three neutral responses noted that the reason for 
patients at risk should be apparent to nurses 
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8. The DVT scale can be applied to facilitate care planning. 
All respondents acknowledged that the DVT scale could be applied to facilitate care 
planning. 
9. The DVT scale does not enable me to take preventative nursing action to 
minimise risk. 
There were some mixed responses to this statement. The DVT scale highlighted the 
risk factors to consider and while anticoagulation prescription was the province of 
physicians, nurses were well placed to identify those are risk and make appropriate 
referral. 
10. The DVT scale has no value as a teaching tool. 
There was broad consensus that the scale was a valuable teaching tool. It enabled 
the staff to teach patients and their relatives of the risk factors of DVT and how to 
minimise risk. 
11. The DVT scale has potential application as an audit tool for quality 
assurance. 
The potential application of the DVT scale as an audit tool for quality assurance was 
fully endorsed by all the respondents. It could be used to monitor venous 
thromboprophylaxis protocol. 
12. The DVT scale has practical application to my area of practice. 
The incidence of DVT is notoriously high among trauma I orthopaedic patients and 
the respondents concurred that the DVT risk calculator had practical application to 
their speciality. 
13. The layout of the DVT scale facilitates the data collection process for risk 
assessment. 
It was commonly accepted that the easy to follow layout facilitated a quick DVT risk 
assessment. 
14. The DVT scale enables me to complete a risk assessment In within < than 
3 mlns to> than 10 mlns. 
Its user-friendliness enabled staff to complete risk assessment within less than 3 
minutes to 6 minutes. It appeared that the time taken by the staff was experienced 
related. Those who took less than 3 minutes to complete the risk assessment were 
senior clinical nurses and team leaders who occupied high position in the clinical 
grading structure. 
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15 Please comment on the strengths of the DVT scale. 
The following qualitative comments about the DVT scale were reported: 
• Sets out well, easy to read and score. 
• Very good and reminds you of patients who are vulnerable. 
• Well laid out. 
• Simple to understand and complete. 
• Virtually self-explanatory. 
• Covers all categories. 
• Identifies patients at risk. 
• A good assessment tool. 
• Easy to apply in any area of practice. 
• Helps to take preventative measures to minimise risk. 
16. Please comment on the weaknesses I limitations of the DVT scale. 
The following qualitative records were noted in relation to the weaknesses and 
limitations of the DVT scale: 
• Does not differentiate between male and female. 
• Does not recommend what prophylaxis could be used In moderate and high risk 
patients. 
• Needs a space to record daily changes in progress. 
• Time consuming on an admission ward. 
• Can't think of any. 
• Needs a bit of background information with the scale and its application. 
17 Any comments on how the practical application of the DVT scale can be 
improved. 
The following suggestions were put forward to improve the practical applications of 
the scale: 
• Can be Integrated in a careplan already in use on the unit. 
• Merged into Waterlow scale so that it can also be used to assess patients at risk 
of pressure sore. 
• It could be laid out in a more linear fashion as the Waterlow scale. 
• Not really, all aspects of risks have been covered. 
• Included into an admission package or folder. 
18. Age Specific Group: 
This category is sufficiently clear to score. 
The respondents unanimously agreed that the age specific group category was 
clear to score. 
s 
19. Mobility: 
Scoring item from this category is reasonably clear. 
Majority of the respondents found this category reasonably clear. One respondents 
was uncertain as to whether mobility related to pre-admission mobility or mobility 
status on admission. 
20. Build: 
I am able to differentiate between underweight and average build. 
Most respondents were able to differentiate between underweight and average 
build. BMI ready reckoner facilitates the process when in doubt. One respondent 
strongly disagreed with this statement but provided no explanation. 
20.1. I am able to differentiate the overweight patients from the obese and very 
obese. 
Eleven participants were positively able to differentiate the overweight from the 
obese and very obese patients. One respondent was neutral but offered no reasons 
for the cause of the uncertainty. 
21. Special risk category: 
Although this category was not applicable to the area of practice, there was general 
agreement that it was clear to score. 
22. Trauma risk category: 
Please answer this question if this category is applicable to your area of practice. 
I am reasonably clear as to what constitutes scoring for lower limb injuries. 
This category was very relevant to the area of practice. Eleven respondents were 
clear as to what constituted scoring for the lower limbs. One respondent disagreed 
with the statement but offered no reason to justify disagreement. 
23. Surgical Intervention category: 
Eleven respondents could differentiate between minor and major surgical 
intervention. The very same respondent to item 21 disagreed and offered no 
explanation 
23.1. I am able to differentiate between major surgery and the other types of 
surgery. 
The same response as item 22. 
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24. High risk diseases: 
I have no difficulty scoring any item from this category: 
The same response as items 22 and 22.1. 
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Appendix 15 
Data Analysis: DVT scale questionnaires (Medical Directorate). 
Total No of respondents: 8 
RESPONDENTS 
Items 1 2 3 
no 
1 5Yrs 12yrs lyr 
2 RN RN DipN 
3 E E D 
4 3yrs 10mts Ilmts 
5 No No No 
6 5-10 5-10 <5 
7.1 5 4 5 
7.2 4 4 4 
7.3 5 5 4 
7.4 4 5 4 
8 4 4 4 
9 4 5 4 
10 2 3 4 
11 4 4 3 
12 4 4 4 
13 5 4 4 
14 <3mins 3- 6 <3mins 
mins 
15 
- - -
16 
- - -
17 - - -
18 5 4 4 
19 5 4 5 
20 4 4 4 
20.1 4 4 4 
21 5 4 3 
22 5 4 4 
23 4 4 4 
23.1 4 4 4 
24 5 4 4 
Likert Sconng:Strongly Agree= 5 
Agree=4 
Neutral=3 
Disagree=2 
Strongly Disagree=1 
4 5 6 
17.5y!s 3yrs 3mts 
RN DipN DipN 
FETe 
G F D 
13yrs 3yrs 3mts 
No No No 
5-10 >15 <5 
5 5 4 
5 4 4 
5 4 4 
5 5 4 
5 4 4 
5 5 4 
5 4 4 
5 5 4 
5 5 
-
5 5 3 
<3mins <3mins <3mins 
- - -
- - -
- - -
5 5 4 
5 5 4 
5 5 4 
5 4 4 
5 N\A N\A 
5 N\A N\A 
5 N\A N\A 
5 N\A N\A 
5 4 4 
7 8 
4.5:yrs ~s 
DipN DipN 
F E 
4.5yrs 3.5yrs 
No No 
<5 <5 
5 5 
5 4 
5 4 
4 4 
4 4 
4 4 
4 3 
5 3 
5 4 
5 4 
<3mins <3mins 
- -
-
- -
5 4 
5 4 
5 4 
5 4 
5 4 
5 N\A 
5 N\A 
5 N\A 
5 4 
Except for items 9 & 10 when reversed recording applies( eg: Strongly Agree=l. 
Agree=2. Neutral=3, Disagree=4. Strongly Disagree=5). 
Please refer to freetexts comments for qualitative data analysis of items 15,16 and 17. 
QUALITATIVE DATA ANALYSIS OF DVT SCALE QUESTIONNAIRE. 
(Medical Directorate) 
SECTION ONE: BIOGRAPHICAL DATA 
1. How long have you been qualified? 
Participants had a broad and varying range of experiences little as three months for 
a newly registered nurse to 17.5 years for the very experienced team leader. 
2. What are your professional qualifications? 
All participants were professionally registered nurses. Three of the participants were 
registered through the traditional3-year nurse training at certificate level. The other 
five nurses had 
undertaken the 3-year Diploma HE Nursing programme. Although the diploma 
nurses had less experience in terms of longevity, they were competent and • 
knowledgeable doer". Experience does not necessarily relate to the mere passage 
of time or longevity, but" rather the refinement of preconceived notions and theory 
through encounter with many actual practical situations that add nuances or shades 
to theory"(8enner 1984). 
3. What Is your Job title I clinical grade? 
Respondents belonged to different grades in the light of their clinical accountability 
and responsibility as defined by the national clinical grading structure. Two recently 
qualified staff were employed as D grade staff nurse. Other appointees included 
three E grade, two F Grade and the Ward manager I Team Leader at G grade level. 
4. How long have you been working In this area of practice? 
Newly qualified staff worked on the medical directorate for as little as 3 months and 
the most experienced staff for 13 years. 
5. Have you worked In other clinical area(s) where the Autar DVT scale Is 
being used? 
None of the participants had prior experience of the practical application of the Autar 
DVT scale. 
SECTION TWO 
6. How many patients have you assessed with the DVT risk assessment 
scale? 
Participants had varying amount of practical experience in terms of the application of 
the DVT scale to risk assessment.Five participants recorded less than five patients 
each and the remaining three staff risk assessed between five to ten patients. 
7. The DVT scale enables me to: 
7.1. make a thorough DVT risk assessment based on the patient clinical 
profile. 
Responses were held from strongly agree to agree, unanimously concurring that the 
DVT scale configured a patient profile, which facilitated a through and 
comprehensive DVT risk assessment. 
7.2. Individualise the nursing assessment of patients. 
There was a strong consensus among the respondents that the DVT scale 
individualised risk assessment. It identified the nature of risk, derived from 
multifactoral aetiology and placed the patient into one of the risk categories. 
Individualisation of risk subsequently facilitated the application of the most 
appropriate intervention (Caprini et ai, 1991; Clagett et al,1992). 
7.3. translate the risk factors as applicable to patients Into DVT risk 
categories. 
There was general agreement that the risk factors were readily construed Into risk 
categories: the risk factors are additive and the aggregate score of the risk factors 
places patient into one of the risk categories within the assessment protocol. 
7.4. state why patients are at risk. 
It was generally accepted that the reasons for the patients being at risk of DVT were 
seamlessly made transparent by the DVT scale. 
8. The DVT scale can be applied to facilitate care planning. 
The respondents unanimously acknowledged the positive association between the 
DVT scale and care planning. It helped ton highlight certain issues and provides 
better clinical judgement to care planning". 
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9. The DVT scale does not enable me to take preventative nursing action to 
minimise risk. 
All respondents disagreed with this statement and positively identified the value of 
the scale in terms of enabling them to take appropriate actions. It "serves as a 
reminder as to whether prophylaxis is in use or required". 
10. The DVT scale has no value as a teaching tool. 
Mixed responses were evident to this item. One respondent agreed with the 
statement but offered no supportive explanation. Five respondents valued the risk 
calculator as a teaching tool. Two staff gave neutral responses but no comments 
were offered to support their responses. 
11. The DVT scale has potential application as an audit tool for quality 
assurance. 
Six respondents concurred on the potential application of the DVT scale as an audit 
tool for quality assurance. Two neutral responses were also received. 
12. The DVT scale has practical application to my area of practice. 
There was consensus on the relevancy and practical application of the DVT scale to 
their area of practice. 
13. The layout of the DVT scale facilitates the data collection process for risk 
assessment. 
All respondents but one strongly agreed that the layout of the calculator eased the 
data collection process. It was described as" clear, preCise, easy to understand and 
complete". The neutral participant offered no explanation as to her uncertainty. 
14. The DVT scale enables me to complete a risk assessment in within < than 
3 mlns to > than 10 mlns. 
The" quick and easy to use features of the DVT scale enabled the participants to 
complete DVT risk assessment in less than 3 minutes. 
15 Please comment on the strengths of the DVT scale. 
The following freetext comments were noted: 
• It enhances clinical assessment, highlighting areas that may otherwise be 
missed. 
• Good. 
• It identifies patients at risk, which may not have been realised until doing the risk 
assessment. 
• Useful for those patients who don't appear to be at risk at first glance". 
• Easy to use, not time consuming and steers towards the need for prophylaxis. 
• Quick and self-explanatory. 
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16. Please comment on the weaknesses I limitations of the DVT scale. 
The following freetext comments were recorded: 
• It must not be used on its own but applied to support clinical knowledge and 
judgement. 
• Need to get the doctor on board to ensure that high score patients have 
prescribed prophylaxis. 
• It does not state previous MI in the high risk category. 
• Very generalised. 
17 Any comments on how the practical application of the DVT scale can be 
Improved. 
• Needs to be an integral part of patient assessment and not a stand-alone 
document. 
• It is unclear that the risk factors in the high risk category imply previous medical 
history or current health status. 
• "Hope this useful tool will become part of risk assessment in the same way the 
Waterlow has and that we will quickly see an impact on patient care and 
standards". 
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18. Age Specific Group: 
This category is sufficiently clear to score. 
All respondents affirmed that this subscale was clear to score. 
19. Mobility: 
Scoring item from this category is reasonably clear. 
It was unanimously agreed that this category was clear to record. 
20. Build: 
I am able to differentiate between the underweight and average bUild. 
Patients were not generally weighed or measured on the unit, although most 
respondents agreed that there was no difficulty in differentiating between the 
underweight and average build. One respondent was neutral. 
20.1. I am able to differentiate the overweight patients from the obese and very 
obese. 
All respondents were able to differentiate the overweight from the obese and very 
obese. 
21: Special Risk Category. 
Please answer this question if it is applicable to your patients. 
This category is reasonably clear for me to score. 
Two staff claimed that this category was not applicable, One was neutral and the 
other five agreed that this category was clear to score and should be included, as 
this risk factor was occasionally applicable to their patients. 
22. Trauma risk category: 
Please answer this question if this category is applicable to your area of practice. 
I am reasonably clear as to what constitutes scoring for lower limb Injuries. 
Three respondents noted that this was not applicable to their area of practice 
although one staff observed that this category was equally appropriate as patients 
were often admitted from the Trauma Unit. 
s 
23. Surgical Intervention category: 
I am able to differentiate between minor and major surgery. 
Responses were relatively similar to item 22. 
23.1. I am able to differentiate between major surgery and the other types of 
surgery. 
As item 23. 
24. High risk diseases: 
I have no difficulty scoring any item from this category: 
There was broad consensus that there was no difficulty In scoring item(s) from this 
category. 
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Appendix 16 
Data Analysis: surgical directorate 
Practical application of the DVT scale 
Questionnaire Item No Respondent 1 
1 15 Years 
2 EN/RGN/ENB 
qualifications 
3 F grade/ Team Leader 
4 6 Years 
5 No 
6 50 patients 
7.1 4 
7.2 4 
7.3 4 
7.4 4 
8 4 
9 2 
10 3 
11 4 
12 4 
13 3 
14 < 3 minutes 
15 See separate sheet 
16 See separate sheet 
17 See separate sheet 
18 4 
19 2 
20 4 
20.1 4 
21 4 
22 4 
23 5 
23.1 5 
24 5 
Likert scoring: Strongly Agree: 5 
Agree: 4 
Neutral: 3 
Disagree: 2 
Strongly Disagree: 1 
Respondent 2 
15 Years 
ENIRGNIENB 
qualifications 
E Grade/ Senior Clinical 
Nurse 
13 Years 
No 
50 patients 
4 
4 
4 
4 
3 
2 
3 
4 
4 
4 
3-6 minutes 
See separate sheet 
See separate sheet 
See separate sheet 
4 
4 
4 
4 
4 
o (not applicablel 
4 
4 
5 
Reversed scoring order for items 9 & 10 (e.g.: Disagree: 4 and Strongly Disagree: 
5. 
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QUALITATIVE DATA ANALYSIS OF DVT SCALE QUESTIONNAIRE. 
Surgical Directorate) 
In the current cost cutting climate, staff shortage and plea for minimal 
imposition on nursing time, only the support of two registered nurses could be 
negotiated. They voluntarily and willingly offered to undertake the data 
generating activity on the targeted fifty patients on the surgical directorate. 
Two postal questionnaires mailed to them were duly received, evaluated and 
the following responses summarised: 
SECTION ONE: BIOGRAPHICAL DATA. 
1. How long have you been qualified? 
The two nurses were senior clinical staff with fifteen years of post registration 
experience. 
2. What are your professional qualifications? 
Initially, both nurses commenced their professional career as level two 
Enrolled Nurses (EN) and successfully completed a conversion programme to 
register as level one nurse (RN). As part of their professional portfOlio 
development, both registered nurses undertook validated English National 
Board (ENB) courses and gained appropriate post registration qualification. 
3. What Is your Job title/clinical grade? 
One nurse was grade F Team Leader Ward Sister) and her paired colleague, 
an E grade Senior Clinical Nurse (SCN). 
4. How long have you been working In this area of practice? 
Both nurses were experienced and competent clinical practitioners: the Team 
Leader worked in the surgical directorate for six years and the Senior Clinical 
Nurse had worked in the same area of practice for thirteen years. 
5. Have you worked In other clinical area(s) where the Autar DVT scale 
Is being used? 
None of the two practitioners had any working experience of using the DVT 
scale. 
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SECTION TWO: THE AUTAR DVT RISK ASSESSMENT SCALE. 
6. How many patients have you assessed with the DVT scale? 
Both paired nurses independently assessed all fifty patients who were 
recruited to the study for DVT risk. As a result, both respondents developed 
good working experience of the scale and were in a position to make 
constructive feedback on the clinimetry of the DVT calculator as well as its 
practical application. 
7: (7.1, 7.2, 7.3 & 7.4) 
Evidently, there was good consensus that the clinical profile of the patient 
enabled the assessors to make a thorough and comprehensive assessment 
for risk of DVT as well as individualising the assessment process. 
Additionally, there was strong agreement that assessment protocol of the DVT 
scale allowed the risk factors to be translated into main risk categories. 
Identification of patients in the main risk categories facilitates the choice of the 
most appropriate venous thromboprophylaxis (NIH, 1986, International 
Consensus Statement, 1997, THRiFT,1998). It was also acknowledged that 
reflecting on the risk factors for DVT enabled them to be watchful and "take a 
second look at patients for risk". 
8.The DVT scale can be applied to facilitate care planning. 
Mixed responses were received. One respondent acknowledged the potential 
of the DVT scale to facilitate care planning, while the other response was 
neutral. No comments were made on the choice of the neutrality of response. 
9. The DVT scale does not enable me to take preventative nursing action 
to minimise risk. 
Both respondents disagreed with this statement. In fact, this statement was 
deliberately structured in a negative overtone, to ensure that respondents to 
the Likert type scale questions do not respond passively in an automatic and 
central tendency mode (Oppenheim 1992). They actively affirmed that an 
awareness of the risk of DVT to a particular patient prompted them to initiate 
measures to minimise the risk. 
10. The DVT scale has no value as a teaching tool. 
Responses to the value of the DVT scale as a teaching tool were neutral. No 
comments were made as to the choice of the neutrality. 
11. The DVT scale has potential application as an audit tool for quality 
assurance. 
Respondents concurred that the DVT scale had potential for auditing 
performance. A formal assessment that helps to complete an audit cycle 
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improves the uptake of venous thromboprophylaxis (8ahal & Silverman,1993; 
8yrne et al,1996). 
12. The DVT scale has practical application In my area of practice. 
It was commonly acknowledged that the DVT scale has practical application 
to the surgical directorate. Surgical patients are a high risk group and with the 
exception of one, all forty-nine patients were recipients of pharmacological 
prophylaxis against DVT. 
13. The layout of the DVT scale facilitates the data collection process for 
risk assessment. 
Responses varied from being uncertain to complete endorsement of the 
layout of the DVT scale in relation to facilitating the data collection process 
and "is good as it is". 
14. The DVT scale enables me to complete a risk assessment within less 
than 3 minutes to more than ten minutes. 
Duration of DVT risk assessment with the risk calculator varied from less than 
3 minutes to 3-6 minutes. 
15. Please comment on the strengths of the DVT scale. 
The following freetext comments were made: 
" It gives clear indication of who may be at risk". 
" It is a good way to double check if a patient Is at risk". 
• It makes you aware of who may be at risk". 
16. Please comment on the weaknesses I limitations of the DVT scale. 
It was viewed by one respondent as "yet another form to fill", noting that this 
was essentially a data generating study. 
Another respondent suggested that the mobility subscale of the chart be more 
explicit. Complete bed rest as a risk factor weighted at a score of 4 could be 
further reviewed to indicate its duration in terms of days and weeks as some 
surgical patients were unavoidably confined to bed for long period following 
some major surgical intervention 
18. This category Is sufficiently clear to score. 
The two respondents concurred that this risk subscale was easy to score. 
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19. Scoring item from this category Is reasonably clear. 
There was some disagreement between the two respondents on ringing out 
this risk category, albeit scoring and a calculated kappa statistics of 0.97 
clearly indicated excellent consistency. While one respondent agreed that this 
category was transparent, this view was not shared by her colleague, 
suggesting that mobility as a category was not explicit enough, in terms of Its 
temporality. This issue recurred in item 16 of the questionnaire. 
20.Bulld. I am able to differentiate between underweight and average 
build. 
Both nurses agreed that they were able to differentiate between the 
underweight and average build patient as confirmed in the recording of this 
subsca\e. 
20.1. I am able to differentiate the overweight patients from the obese 
and very obese. 
Both respondents ably differentiated between the overweight, obese and very 
obese as demonstrated in the recording of this category. Additionally, If In 
doubt as to what is the most appropriate type of build the BMI chart on the 
reverse of the DVT scale offered practical guide to recording this risk 
category. 
21. Special risk category. This category Is reasonably clear for me to 
score. 
Both respondents agreed that this risk category is clear, although this Item 
was not applicable to their area of practice. 
22. Please answer this question if this category Is applicable to your 
area of practice. 
One nurse who previously worked on the orthopaedic unit confidently 
commented that this was clear, although no such patient was recruited to the 
study. Her paired colleague had no such previous background and thus was 
unable to comment on this item. 
23.1 am able to differentiate between minor and major surgery. 
Responses varied from strongly agree to agree. Major surgery Is defined as a 
procedure on a patient requiring more than thirty minutes of general 
anaesthesia (Goucke, 1989; Moser, 1989). 
23.1. I am able to differentiate between major surgery and the other 
types of surgery. 
Responses varied from strongly agree to agree. Inter-observer consistency 
was evident. 
s 
24. High risk diseases. 
I have no difficulty scoring any Item from this category. 
No inter-observer variation was demonstrated and extent of agreement was 
expressed in perfect qualitative term in the risk assessment process. 
6 
